ID	1.1.1.1
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Gallus gallus   <44>
PR	#2# Cricetulus griseus   <1>
PR	#3# Vicia faba   <4>
PR	#4# Drosophila melanogaster   <8,43,58,62,63,64,65>
PR	#5# Mus musculus   <9,48,109,116,118,139,140,198,210>
PR	#6# Thermus thermophilus   <167>
PR	#7# Escherichia coli   <134>
PR	#8# Homo sapiens  
	<10,11,12,13,14,15,16,17,18,19,20,21,22,23,53,96,106,108,114,115,118
	123,148,178,184,189,192,204>
PR	#9# Rattus norvegicus   <10,49,50,51,140,165>
PR	#10# Saccharomyces cerevisiae  
	<3,86,87,88,89,90,91,94,103,119,120,121,137,142,146,168,177,180,182,185
	187,188,190,191,194,197,200,201,203,207>
PR	#11# Triticum aestivum   <80>
PR	#12# Oryctolagus cuniculus   <45,46>
PR	#13# Euglena gracilis   (#13# At5g56760, SERAT1.1 <209>) <209>
PR	#14# Geobacillus stearothermophilus   <111,125,174>
PR	#15# Emericella nidulans   <81>
PR	#16# Neurospora crassa   <133,170>
PR	#17# Hordeum vulgare   (#17# isoenzyme mMDH <79>) <79>
PR	#18# Pisum sativum   <80>
PR	#19# Zea mays   <75,76,80,97>
PR	#20# Glycine max   <71,80>
PR	#21# Petroselinum crispum   <72>
PR	#22# Avena sativa   <80>
PR	#23# Entamoeba histolytica   <100,122,127>
PR	#24# Pseudomonas fluorescens   <105>
PR	#25# Devosia riboflavina   <186>
PR	#26# Pseudomonas aeruginosa   <128,134>
PR	#27# Brassica napus   <74>
PR	#28# Acinetobacter calcoaceticus   <132>
PR	#29# Natronomonas pharaonis   <179>
PR	#30# Camellia sinensis   <73>
PR	#31# Schizosaccharomyces pombe   <91>
PR	#32# Klebsiella pneumoniae   <134>
PR	#33# Mesocricetus auratus   <47,95>
PR	#34# Meyerozyma guilliermondii   <85>
PR	#35# Kluyveromyces marxianus   <3>
PR	#36# Rhodococcus erythropolis   <130>
PR	#37# Equus caballus  
	<26,27,28,29,30,31,32,33,34,35,36,37,39,40,41,42,54,55,86,92,93,98,102
	110,115,116,141,173,176,196,199,202,203>
PR	#38# Zymomonas mobilis   <67,68,138>
PR	#39# Macaca mulatta   <25>
PR	#40# Rhodococcus ruber   <113>
PR	#41# Oryza sativa   <6,80>
PR	#42# Sulfolobus solfataricus  
	<56,66,70,107,150,151,152,153,155,156,157,158,159,161,162,163>
PR	#43# Brevibacterium sp.   <147>
PR	#44# Thermus sp.   <164>
PR	#45# Hafnia alvei   <134>
PR	#46# Candida sp.   <82>
PR	#47# Oncorhynchus mykiss   <59>
PR	#48# Cucumis melo   <149>
PR	#49# Desulfovibrio gigas   <99>
PR	#50# Methylobacterium extorquens   <145>
PR	#51# Fragaria x ananassa   <145>
PR	#52# Suncus murinus   <5>
PR	#53# Acetobacter pasteurianus   <112>
PR	#54# Malus x domestica   <144>
PR	#55# Kluyveromyces lactis   <143>
PR	#56# Naja naja   <57>
PR	#57# Citrullus lanatus   <80>
PR	#58# Vitis vinifera   <181>
PR	#59# Klebsiella oxytoca   <134>
PR	#60# Triticum monococcum   <78>
PR	#61# Chlamydomonas moewusii   <69>
PR	#62# Coturnix coturnix   <60>
PR	#63# Sporotrichum pulverulentum   <84>
PR	#64# Thermoanaerobacter brockii   <120,203>
PR	#65# Drosophila virilis   <8,64>
PR	#66# Ctenopharyngodon idella   <2>
PR	#67# Najas marina   <7>
PR	#68# Drosophila simulans   <8,63,64>
PR	#69# Drosophila funebris   <8>
PR	#70# Drosophila immigrans   <8>
PR	#71# Scaptodrosophila lebanonensis   <8,38,61,129>
PR	#72# Saimiri sciureus   <24>
PR	#73# Saara hardwickii   <52>
PR	#74# Triticum turgidum   (#74# isoenzyme mMDH <77>) <77>
PR	#75# Euglena longa   <83>
PR	#76# Alligator mississippiensis   <101>
PR	#77# Rana perezi   <124>
PR	#78# Mucor circinelloides   <135>
PR	#79# Aeropyrum pernix   <126>
PR	#80# Thermomicrobium roseum   <117>
PR	#81# Zygosaccharomyces rouxii   <131>
PR	#82# Crocus sativus   <104>
PR	#83# Anastrepha fraterculus   <206>
PR	#84# Flavobacterium frigidimaris Q8L3C9 SwissProt <142>
PR	#85# Leifsonia sp.   <136>
PR	#86# Sulfolobus solfataricus Q9UXF1 UniProt (#86# ODC1 <160>) <160>
PR	#87# Sulfolobus sp. P50381 UniProt <157>
PR	#88# Pseudomonas putida Q76HN6 UniProt <154>
PR	#89# Candida parapsilosis B2KJ46 UniProt <166>
PR	#90# Neurospora crassa Q9P6C8 SwissProt <170>
PR	#91# Picrophilus torridus Q6L0S1 SwissProt <171>
PR	#92# Corynebacterium glutamicum R   <169>
PR	#93# Dipodascus capitatus   <183>
PR	#94# Schizosaccharomyces pombe Q09669 SwissProt <172>
PR	#95# Kluyveromyces marxianus A1IIA3 SwissProt <175>
PR	#96# Kluyveromyces marxianus A1IIA4 SwissProt <175>
PR	#97# Sulfolobus solfataricus P39462 UniProt <205>
PR	#98# Homo sapiens P00326 UniProt <212>
PR	#99# Thermoanaerobacter ethanolicus Q0PH30 UniProt <193>
PR	#100# Anastrepha obliqua   <206>
PR	#101# Homo sapiens P08319 UniProt <212>
PR	#102# Geobacillus thermoglucosidasius Q6RS93 UniProt <208>
PR	#103# Thermoplasma acidophilum Q9HIM3 UniProt <211>
PR	#104# Thermus sp. B2ZRE3 UniProt <195>
PR	#105# Saccharomyces carlsbergensis B6UQD0 UniProt <200>
PR	#106# Geobacillus thermodenitrificans A4IP64 UniProt <213>
PR	#107# Geobacillus thermodenitrificans A4ISB9 UniProt <213>

RECOMMENDED_NAME
RN	alcohol dehydrogenase


SYSTEMATIC_NAME
SN	alcohol:NAD+ oxidoreductase


SYNONYMS
SY	 Aldehyde reductase
SY	 dehydrogenase, alcohol
SY	 alcohol dehydrogenase (NAD)
SY	 aliphatic alcohol dehydrogenase
SY	 ethanol dehydrogenase
SY	 NAD-dependent alcohol dehydrogenase
SY	 NAD-specific aromatic alcohol dehydrogenase
SY	 NADH-alcohol dehydrogenase
SY	 NADH-aldehyde dehydrogenase
SY	 primary alcohol dehydrogenase
SY	 yeast alcohol dehydrogenase
SY	 FDH
SY	 FALDH
SY	 40 kDa allergen
SY	 ADH-A2
SY	 ADH-B2
SY	 ADH-C2
SY	 ADH-HT
SY	 Alcohol dehydrogenase-B2
SY	 Gastric alcohol dehydrogenase
SY	 Glutathione-dependent formaldehyde dehydrogenase
SY	 GSH-FDH
SY	 Octanol dehydrogenase
SY	 Retinol dehydrogenase
SY	#10# SCAD <180>
SY	#10# YADH <119,120,177>
SY	#10# Y-ADH <121>
SY	#10# alcohol dehydrogenase I <103,197>
SY	#10# YADH-1 <187>
SY	#10# Adh1p <188>
SY	#10# alcohol:NAD+ oxidoreductase <197>
SY	#10,38# alcohol dehydrogenase II <138,168>
SY	#10,88,90,105,106# ADH1 (#10# isozyme <200>) <154,170,200,213>
SY	#102# ADH-I <208>
SY	#103# Ta1316 ADH <211>
SY	#106,107# long-chain alkyl alcohol dehydrogenase <213>
SY	#13# medium-chain NAD+-dependent ADH <209>
SY	#13# NAD+-ADH <209>
SY	#14# HtADH <174>
SY	#37# HLAD <202>
SY	#38# ADH II <138>
SY	#40# sec-ADH A <113>
SY	#40# medium-chain secondary alcohol dehydrogenase <113>
SY	#42# SSADH <163>
SY	#42# alcohol-aldehyde/ketone oxidoreductase, NAD+-dependent (#42# the
	enzyme transfers the pro-R hydrogen from coenzyme to substrate and is
	therefore an A-specific dehydrogenase <153>) <153>
SY	#44# TaDH <164>
SY	#48# Cm-ADH2 <149>
SY	#5# class III alcohol dehydrogenase <139>
SY	#5# alcohol dependent dehydrogenase <198>
SY	#5# alcohol dehydrogenase 3 <198>
SY	#5# ADH 1 <210>
SY	#5,10# alcohol dehydrogenase 1 (#10# mutant enzyme S109P/L116S/Y294C
	<191>) <188,191,210>
SY	#5,10,23,86,98,107# ADH2 (#10,98# isozyme <200,212>)
	<109,122,127,160,168,200,212,213>
SY	#5,16,98# ADH3 (#98# isozyme <212>) <139,170,198,212>
SY	#5,8,10,13,14,26,37,42,53,64,79,80,83,87,97,100,103,104# ADH
	<107,110,112,114,116,117,118,125,126,128,150,151,152,153,155,156,157
	158,159,161,162,192,194,195,197,198,199,201,203,204,205,206,207,209,211>
SY	#55# KlDH3 <143>
SY	#55# KlADH4 <143>
SY	#6# NAD(H)-dependent alcohol dehydrogenase <167>
SY	#64# TBADH <120>
SY	#71# DADH <129>
SY	#77# ADH8 <124>
SY	#79# medium chain alcohol dehydrogenase <126>
SY	#8# ADH1C*1 <115>
SY	#8# ADH1C*2 <115>
SY	#8# class I ADH (#8# isoenzyme <204>; #8# isozyme <178>) <178,204>
SY	#8# class II ADH (#8# isoenzyme <204>; #8# isozyme <178>) <178,204>
SY	#8# class IV ADH (#8# isozyme <178>) <178>
SY	#8,94,101# ADH4 (#101# isozyme <212>) <123,172,212>
SY	#85# LSADH <136>
SY	#91# AdhA <171>
SY	#95# KmADH3 <175>
SY	#96# KmADH4 <175>
SY	#97# NAD+-dependent (S)-stereospecific alcohol dehydrogenase <205>
SY	#98# ADH1C (#98# isozyme <212>) <212>
SY	#99# AdhE (#99# the purified AdhE exhibits high enzymatic activity
	attributed to aldehyde dehydrogenase and low alcohol dehydrogenase
	activity <193>) <193>
SY	#99# aldehyde/alcohol dehydrogenase <193>

CAS_REGISTRY_NUMBER
CR	9031-72-5

REACTION
RE	a primary alcohol + NAD+ = an aldehyde + NADH + H+ (#4,37# ordered
	bi-bi mechanism <31,43>; #4,68# rapid equilibrium random mechanism
	<63>; #8# ordered bi bi mechanism with cofactor adding first to form a
	binary enzyme complex <23>; #37# isoenzyme EE and SS: ordered bi bi
	mechanism <35>; #10,31# mechanism is predominantly ordered with
	ethanol, but partially random with butanol <91>; #37# kinetic mechanism
	is random for ethanol oxidation and compulsory ordered for acetaldehyde
	reduction <41>; #34# oxidizes ethanol in an ordered bi-bi mechanism
	with NAD+ as the first substrate fixed <85>; #10# compulsory-order
	mechanism with the rate-limiting step being the dissociation of the
	product enzyme-NAD+ complex <90>; #27,61,71# Theorell-Chance mechanism
	<38,69,74>; #40# sequential reaction mechanism <113>; #79# active site
	structure <126>; #71# catalytic mechanism involves a proton relay
	modulated by the coupled ionization of the active site Lys155/Tyr151
	pair, and a NAD+ ribose 2-OH switch, other active site residues are
	Ser138 and Trp144, ionization properties, substrate binding, overview
	<129>; #8# class IV alcohol dehydrogenase also functions as retinol
	dehydrogenase, reaction and kinetic mechanism: asymmetric rapid
	equilibrium random mechanism with 2 dead-end ternary complexes fro
	retinol oxidation and a rapid equilibrium ordered mechanism with one
	dead-end ternary complex for retinal reduction, a unique mechanistic
	form fro zinc-containing ADH in the medium chain
	dehydrogenase/reductase superfamily of enzymes <123>; #10# detailed
	determination of the reaction and kinetic mechanisms, active site
	structure and determination of amino acid residues involved in
	catalysis, 3 isozymes <119>; #5# ordered bibi mechanism, structural and
	functional implications of amino acid residue 47 <109>; #37# ordered
	sequential bibi reaction mechanism, modeling of oxidation kinetic
	mechanism <116>; #37# reaction mechanism, His51 is involved, but not
	essential, in catalysis facilitating the deprotonation of the hydroxyl
	group of water or alcohol ligated to the catalytic zinc <110>; #8#
	Ser48 is involved in catalysis, isozyme gamma(2)gamma(2) <108>; #26#
	the catalytic triad consists of Cys44, His67, and Cys154, active site
	structure <128>)
RE	a secondary alcohol + NAD+ = a ketone + NADH + H+

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1,2,5,8,9,12,33,37,39,47,52,62,66,72,73,76,98# liver (#5# isoenzyme A2
	and B2 <48>; #33# isoenzyme AA-ADH and BB-ADH most abundant in <95>;
	#8# isozyme ADH1C*2 <115>; #9# females show 70% higher hepatic alcohol
	dehydrogenase activity and display 60% lower voluntary ethanol intake
	than males. Following ethanol administration (1 g/kg ip), females
	generate a transient blood acetaldehyde increase with levels that are
	2.5fold greater than in males. Castration of males leads to an increase
	alcohol dehydrogenase activity the appearance of an acetaldehyde burst
	a reduction of voluntary ethanol intake comparable with that of females
	<165>; #8# the activities of total alcohol dehydrogenase, aldehyde
	dehydrogenase and class I alcohol dehydrogenase isoenzyme between
	cancer liver tissues and healthy hepatocytes might be a factor in
	ethanol metabolism disorders which can intensify carcinogenesis <184>;
	#98# isozymes ADH1C and ADH3 <212>; #8# most abundant in the liver
	<178>; #8# the total alcohol dehydrogenase activity is significantly
	higher in cancer tissues than in healthy liver <192>)
	<1,2,5,10,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31
	32,33,34,35,36,37,39,40,41,42,44,45,46,48,49,51,52,54,55,59,60,86,92,93
	95,98,101,110,115,116,141,165,173,176,178,184,192,196,198,199,202,203
	210,212>
ST	#10,37,64# commercial preparation (#10# lyophilized <121>) <116,120,121>
ST	#10,86,95,96# culture condition:ethanol-grown cell (#86# highest
	ethanol consumption rate in cultures grown on 0.79% w/v ethanol <160>;
	#10# during the biological aging of sherry wines, where Saccharomyces
	bayanus has to grow on ethanol owing to the absence of glucose, this
	isoenzyme plays a prominent role by converting the ethanol into
	acetaldehyde and producing NADH in the process. Overexpression of the
	gene ADH2 (from Saccharomyces cerevisiae) during alcoholic fermentation
	has no effect on the proteomic profile or the net production of some
	metabolites associated with glycolysis and alcoholic fermentation such
	as ethanol, acetaldehyde, and glycerol. However, it affects indirectly
	glucose and ammonium uptakes, cell growth, and intracellular redox
	potential, which lead to an altered metabolome <168>; #95,96#
	significantly expressed in ethanol medium <175>) <160,168,175>
ST	#17# root <79>
ST	#17# shoot <79>
ST	#17,21,58# leaf (#58# the changes in the carbon metabolism-associated
	proteins reflect altered patterns of carbon flux in response to changes
	in ADH activity in transformed plant leaves <181>) <72,79,181>
ST	#19# seedling <76>
ST	#19# scutellum <75>
ST	#19# kernel <97>
ST	#20,74# embryo <71,77>
ST	#23# trophozoite <100,122,127>
ST	#3,17,27,30,41,67# seed <4,6,7,73,74,79>
ST	#41# coleoptile <80>
ST	#47# cecum <59>
ST	#48,54# fruit (#54# peel and flesh, alcohol dehydrogenase is
	independent of ethylene modulation <144>; #48# upregulated during
	ripening, the enzyme plays a specific role in the regulation of aroma
	biosynthesis in melon fruit <149>) <144,149>
ST	#5# blood (#5# ADH3 plays an important role in systemic ethanol
	metabolism at higher levels of blood ethanol through activation by
	cytoplasmic solution hydrophobicity <139>) <139>
ST	#5,8# hepatocyte (#8# the activities of total alcohol dehydrogenase,
	aldehyde dehydrogenase and class I alcohol dehydrogenase isoenzyme
	between cancer liver tissues and healthy hepatocytes might be a factor
	in ethanol metabolism disorders which can intensify carcinogenesis
	<184>) <116,184>
ST	#5,8# retina (#5,8# isozyme ADH4 <118>) <118>
ST	#5,8,9,77# stomach (#5# isoenzyme C2 <48>; #8# stomach mucosa,
	mue-alcohol dehydrogenase <96>; #8# isozymes ADH5 and ADH4, the total
	alcohol dehydrogenase activity is significantly higher in cancer
	tissues than in healthy stomach <192>) <48,49,50,53,96,124,192>
ST	#5,9# more (#5,9# tissue-specific expression patterns of class I, III,
	and IV Adh <140>; #5# ADH3 is expressed ubiquitously and with
	relatively little inter-tissue variation in mammals, in contrast to
	other ADHs <198>) <140,198>
ST	#78# mycelium (#78# aerobically grown <135>) <135>
ST	#8# skin <192>
ST	#8# hepatoma cell <178>
ST	#8# serum <192>
ST	#8# aorta (#8# the activity of the class I ADH isoenzyme is
	significantly lower in the wall of aortic aneurysm than in healthy
	aorta <204>) <204>
ST	#8# esophagus (#8# isozyme ADH4, the total alcohol dehydrogenase
	activity is significantly higher in cancer tissues than in healthy
	esophagus <192>) <192>
ST	#8# blood serum (#8# among all tested classes of ADH isoenzymes, only
	class I has higher activity in serum of patients with breast cancer in
	stage IV. The total ADH activity is not significantly higher in
	patients with breast cancer than in healthy controls. The changes in
	activity, especially in class I ADH, appear to be caused by isoenzymes
	being released from the organ damaged by metastatic disease <148>; #8#
	the total ADH activity is significantly higher (44%) among patients
	with cancer than healthy ones. The activity of class I ADH isoenzymes
	is elevated only in the serum of patients with metastatic liver cancer.
	This increase of activity seems to be caused by the enzyme released
	from liver cancer cells and primary tumors originating in other organs
	<184>) <148,184>
ST	#8# colorectum (#8# the total alcohol dehydrogenase activity is
	significantly higher in cancer tissues than in healthy colorectum
	<192>) <192>
ST	#8,9# pancreas (#8# total activity of alcohol dehydrogenase is not
	significantly different in cancer and normal cells. The differences
	between enzymes of drinkers and nondrinkers in both cancer and healthy
	tissue are not significant <189>) <49,189>
ST	#8,9# kidney (#8# isozyme ADH1 <192>) <49,192>
ST	#8,9# lung (#8# isozyme ADH1 <192>) <49,192>
ST	#8,9# cornea (#8# isozyme ADH4 <192>) <49,192>
ST	#8,9,33# testis (#8# the class III enzyme contributes by far the bulk
	of the total alcohol dehydrogenase activity <11>; #33# isoenzyme TT-ADH
	is only found in testis <95>; #33# activity increases during the
	prepubertal development <47>) <11,47,49,95>
ST	#82# corn (#82# dormant <104>) <104>
ST	#83,100# larva <206>
ST	#9# ovary <49>
ST	#9# uterus <49>
ST	#9# heart <49>
ST	#9# spleen <49>
ST	#9# brain <49>
ST	#9# muscle <49>
ST	#9# adrenal gland <49>
ST	#9# intestine <49>
ST	#9# thymus <49>
ST	#9# epididymis <49>
ST	#92# culture condition (#92# adhA transcription is induced by ethanol
	or n-propanol, adhA transcription is subject to glucose catabolite
	repression. Accordingly, both induction of AdhA activity and ethanol
	utilization are detected only after depletion of glucose <169>) <169>
ST	#95# culture condition:glycerol-grown cell (#95# strongly expressed in
	glycerol medium <175>) <175>
ST	#98,101# buccal mucosa (#98,101# isozyme ADH4 <212>) <212>

LOCALIZATION
LO	#23,88# more (#23# detection in the membrane pellet is probably due to
	cosedimentation of the multimeric enzyme during membrane purification
	<127>; #88# no activity can be localized in the periplasm <154>)
	<127,154>
LO	#5# nucleus <198>
LO	#5# extracellular <116>
LO	#5,10,88,105# cytoplasm (#88# 68% of total activity measured <154>)
	<154,198,200,207>
LO	#55,95,96# mitochondrion (#55# KlDH3 and KlADH4 are genes encoding
	mitochondrial alcohol dehydrogenase activities located within the
	mitochondria. Ethanol induces the transcription of KlADH4 and,
	conversely, represses that of KlADH3 <143>; #95# KmAdh3 possesses an
	amino-terminal extension as a mitochondrial targeting sequence <175>;
	#96# KmAdh4 possesses an amino-terminal extension as a mitochondrial
	targeting sequence <175>) <143,175>
LO	#7,8,23,26,32,45,53,59,98,101# cytosol (#53# 2 isozymes <112>; #23#
	enzyme polymer forms rod-like helical particles <127>)
	<112,127,134,192,212>
LO	#88# membrane (#88# 32% of total activity measured <154>) <154>
LO	#94# mitochondrial matrix <172>

NATURAL_SUBSTRATE_PRODUCT
NSP	#10# acetaldehyde + NADH + H+ = ethanol + NAD+ (#10# cells with an
	extra copy of ADH1 display chronological life-span extension.
	Antioxidant enzymes are induced in 2xADH1 cells. Strains carrying an
	extra ADH1 copy show extended replicative life span and increased Sir2p
	activity <188>) {r} <188>
NSP	#10# acetaldehyde + NADH + H+ = ethanol + NAD+ (#10# cells with an
	extra copy of ADH1 display chronological life-span extension.
	Antioxidant enzymes are induced in 2xADH1 cells. Strains carrying an
	extra ADH1 copy show extended replicative life span and increased Sir2p
	activity <188>) {} <188>
NSP	#10# acetaldehyde + NADH + H+ = ethanol + NAD+ (#10# cells with an
	extra copy of ADH1 display chronological life-span extension.
	Antioxidant enzymes are induced in 2xADH1 cells. Strains carrying an
	extra ADH1 copy show extended replicative life span and increased Sir2p
	activity <188>) <188>
NSP	#5# allyl alcohol + NAD+ = acrolein + NADH |#5# product is toxic in
	mouse hepatocytes due to cell protein carbonylation following exposure
	to crotyl alcohol <116>| <116>
NSP	#5# allyl alcohol + NAD+ = acrolein + NADH |#5# product is toxic in
	mouse hepatocytes due to cell protein carbonylation following exposure
	to crotyl alcohol <116>| {r} <116>
NSP	#5# octanol + NAD+ = octanal + NADH {?} <198>
NSP	#5# octanol + NAD+ = octanal + NADH <198>
NSP	#5# a primary alcohol + NAD+ = an aldehyde + NADH + H+ (#5# ADH3 is
	involved in multiple cellular pathways, as diverse as formaldehyde
	detoxification, retinoid metabolism and NO homeostasis, ADH3 is
	considered to play only a minor role in hepatic alcohol metabolism
	because ethanol concentrations rarely exceed 50 mM <198>) {?} <198>
NSP	#5,37# crotyl alcohol + NAD+ = crotonaldehyde + NADH (#37# product is
	toxic in mouse hepatocytes due to cell protein carbonylation following
	exposure to crotyl alcohol <116>) |#5# product is toxic in mouse
	hepatocytes due to cell protein carbonylation following exposure to
	crotyl alcohol <116>| <116>
NSP	#5,8# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#8# ADH4
	might be involved in biosynthesis of retinoic acid <123>) {?} <123,198>
NSP	#5,8# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#8# ADH4
	might be involved in biosynthesis of retinoic acid <123>) <123,198>
NSP	#5,8# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#8# ADH4
	might be involved in biosynthesis of retinoic acid <123>) {r} <123,198>
NSP	#5,8,10,29,37# ethanol + NAD+ = acetaldehyde + NADH (#5# role of the
	major liver isoenzyme A2 in ethanol metabolism <48>; #37# plays an
	important role in the metabolism of ethanol <102>; #8# chi-ADH plays an
	important role in the metabolism of long chain alcohols and aldehydes
	<21>; #8# the anodic enzyme form may contribute significantly to
	alcohol elimination in man, particularly at high concentrations when
	the other enzyme species are saturated <18>; #8# the enzyme plays a
	significant role in first-pass metabolism of ethanol in human <96>; #8#
	enzyme is responsible for the major ethanol oxidation capacity in the
	body. The products acetaldehyde and NADH are responsible for the most
	of the toxic effects and metabolic disturbances produced by ethanol
	ingestion <10>; #10# rate-limiting step of the alcoholic fermentation
	<121>; #5# DH3 plays an important role in systemic ethanol metabolism
	at higher levels of blood ethanol through activation by cytoplasmic
	solution hydrophobicity <139>) {} <10,18,21,48,96,102,115,121,139,179>
NSP	#5,8,10,29,37# ethanol + NAD+ = acetaldehyde + NADH (#5# role of the
	major liver isoenzyme A2 in ethanol metabolism <48>; #37# plays an
	important role in the metabolism of ethanol <102>; #8# chi-ADH plays an
	important role in the metabolism of long chain alcohols and aldehydes
	<21>; #8# the anodic enzyme form may contribute significantly to
	alcohol elimination in man, particularly at high concentrations when
	the other enzyme species are saturated <18>; #8# the enzyme plays a
	significant role in first-pass metabolism of ethanol in human <96>; #8#
	enzyme is responsible for the major ethanol oxidation capacity in the
	body. The products acetaldehyde and NADH are responsible for the most
	of the toxic effects and metabolic disturbances produced by ethanol
	ingestion <10>; #10# rate-limiting step of the alcoholic fermentation
	<121>; #5# DH3 plays an important role in systemic ethanol metabolism
	at higher levels of blood ethanol through activation by cytoplasmic
	solution hydrophobicity <139>) {r} <10,18,21,48,96,102,115,121,139,179>
NSP	#5,8,10,29,37# ethanol + NAD+ = acetaldehyde + NADH (#5# role of the
	major liver isoenzyme A2 in ethanol metabolism <48>; #37# plays an
	important role in the metabolism of ethanol <102>; #8# chi-ADH plays an
	important role in the metabolism of long chain alcohols and aldehydes
	<21>; #8# the anodic enzyme form may contribute significantly to
	alcohol elimination in man, particularly at high concentrations when
	the other enzyme species are saturated <18>; #8# the enzyme plays a
	significant role in first-pass metabolism of ethanol in human <96>; #8#
	enzyme is responsible for the major ethanol oxidation capacity in the
	body. The products acetaldehyde and NADH are responsible for the most
	of the toxic effects and metabolic disturbances produced by ethanol
	ingestion <10>; #10# rate-limiting step of the alcoholic fermentation
	<121>; #5# DH3 plays an important role in systemic ethanol metabolism
	at higher levels of blood ethanol through activation by cytoplasmic
	solution hydrophobicity <139>) <10,18,21,48,96,102,115,121,139,179>
NSP	#8# isobutyramide + NAD+ = ? {r} <123>
NSP	#8,10,33,37,38,46,47,54,71,104# More = ? (#10# constitutive enzyme
	<94>; #38# key enzyme in ethanol production <68>; #46# one constitutive
	enzyme, ADH-MI and one inducible enzyme, ADH-MII <82>; #47# enzyme may
	be involved in the metabolism of dietary wax esters in salmonid fish
	<59>; #71# the enzyme oxidizes alcohols to aldehydes or ketones both
	for detoxification and metabolic purposes <38>; #33# involvement in the
	development of male hamster reproductive system <47>; #54# alcohol
	dehydrogenase activity may not limit alcohol supply for ester
	production during ripening <144>; #37# activity is severely reduced
	towards aliphatic alcohols of more than 8 carbon atoms for the free
	enzyme, but not so with immobilized HLAD, exhibiting an activity
	towards C22 and C24 aliphatic alcohols higher than 50% of the highest
	value, obtained with C8 <202>; #8# differences in the activities of
	total ADH and class I ADH isoenzyme between cancer liver tissues and
	healthy hepatocytes may be a factor in ethanol metabolism disorders,
	which can intensify carcinogenesis <178>; #104# TADH is a
	NAD(H)-dependent enzyme and shows a very broad substrate spectrum
	producing exclusively the (S)-enantiomer in high enantiomeric excess
	(more than 99%) during asymmetric reduction of ketones <195>) {}
	<38,47,59,68,82,94,144,178,195,202>
NSP	#8,10,33,37,38,46,47,54,71,104# More = ? (#10# constitutive enzyme
	<94>; #38# key enzyme in ethanol production <68>; #46# one constitutive
	enzyme, ADH-MI and one inducible enzyme, ADH-MII <82>; #47# enzyme may
	be involved in the metabolism of dietary wax esters in salmonid fish
	<59>; #71# the enzyme oxidizes alcohols to aldehydes or ketones both
	for detoxification and metabolic purposes <38>; #33# involvement in the
	development of male hamster reproductive system <47>; #54# alcohol
	dehydrogenase activity may not limit alcohol supply for ester
	production during ripening <144>; #37# activity is severely reduced
	towards aliphatic alcohols of more than 8 carbon atoms for the free
	enzyme, but not so with immobilized HLAD, exhibiting an activity
	towards C22 and C24 aliphatic alcohols higher than 50% of the highest
	value, obtained with C8 <202>; #8# differences in the activities of
	total ADH and class I ADH isoenzyme between cancer liver tissues and
	healthy hepatocytes may be a factor in ethanol metabolism disorders,
	which can intensify carcinogenesis <178>; #104# TADH is a
	NAD(H)-dependent enzyme and shows a very broad substrate spectrum
	producing exclusively the (S)-enantiomer in high enantiomeric excess
	(more than 99%) during asymmetric reduction of ketones <195>) {}
	<38,47,59,68,82,94,144,178,195,202>
NSP	#8,10,33,37,38,46,47,54,71,104# More = ? (#10# constitutive enzyme
	<94>; #38# key enzyme in ethanol production <68>; #46# one constitutive
	enzyme, ADH-MI and one inducible enzyme, ADH-MII <82>; #47# enzyme may
	be involved in the metabolism of dietary wax esters in salmonid fish
	<59>; #71# the enzyme oxidizes alcohols to aldehydes or ketones both
	for detoxification and metabolic purposes <38>; #33# involvement in the
	development of male hamster reproductive system <47>; #54# alcohol
	dehydrogenase activity may not limit alcohol supply for ester
	production during ripening <144>; #37# activity is severely reduced
	towards aliphatic alcohols of more than 8 carbon atoms for the free
	enzyme, but not so with immobilized HLAD, exhibiting an activity
	towards C22 and C24 aliphatic alcohols higher than 50% of the highest
	value, obtained with C8 <202>; #8# differences in the activities of
	total ADH and class I ADH isoenzyme between cancer liver tissues and
	healthy hepatocytes may be a factor in ethanol metabolism disorders,
	which can intensify carcinogenesis <178>; #104# TADH is a
	NAD(H)-dependent enzyme and shows a very broad substrate spectrum
	producing exclusively the (S)-enantiomer in high enantiomeric excess
	(more than 99%) during asymmetric reduction of ketones <195>) {}
	<38,47,59,68,82,94,144,178,195,202>

SUBSTRATE_PRODUCT
SP	#10# n-propanol + NAD+ = n-propanal + NADH {r} <119>
SP	#10# 2-propanol + NAD+ = acetone + NADH <121>
SP	#10# n-hexanol + NAD+ = n-hexanal + NADH {r} <119>
SP	#10# (S)-2-butanol + NAD+ = 2-butanone + NADH {r} <119>
SP	#10# ethylenglycol + NAD+ = ? + NADH {r} <119>
SP	#10# n-butanol + NAD+ = butyraldehyde + NADH <121>
SP	#10# n-decanol + NAD+ = n-decanal + NADH {r} <119>
SP	#10# Tris + NAD+ = ? + NADH {r} <119>
SP	#10# 5-hydroxymethylfurfural + NADH + H+ = ? (#10# mutant enzyme
	S109P/L116S/Y294C <191>) <191>
SP	#10# ethanol + beta-NAD+ = acetaldehyde + NADH + H+ <190>
SP	#10# formaldehyde + NADH + H+ = methanol + NAD+ <185>
SP	#10# furfural + NADH + H+ = furfuryl alcohol + NADH (#10# mutant enzyme
	S109P/L116S/Y294C <191>) <191>
SP	#10# phenylglyoxylic acid + NADH + H+ = hydroxy(phenyl)acetic acid +
	NAD+ (#10# enzyme covalently immobilized to magnetic Fe3O4
	nanoparticles via glutaraldehyde retains 48.77% activity of its
	original activity <180>) <180>
SP	#10# ethyl 3-oxobutyrate + NADH + H+ = ethyl (S)-3-hydroxybutyrate +
	NAD+ {} <194>
SP	#10,105# (R)-2-butanol + NAD+ = (R)-2-butanone + NADH + H+ {?} <200>
SP	#10,105# (R,S)-2-methylbutan-1-ol + NAD+ = (R,S)-2-methyl-butan-1-one +
	NADH + H+ {?} <200>
SP	#10,105# (S)-2-butanol + NAD+ = (S)-2-butanone + NADH + H+ {?} <200>
SP	#10,105# (S)-2-methylbutan-1-ol + NAD+ = (S)-2-methyl-butan-1-one +
	NADH + H+ {?} <200>
SP	#10,105# 2-methylpropan-1-ol + NAD+ = 2-methyl-propan-1-one + NADH + H+
	{?} <200>
SP	#10,105# 3-methylbutan-1-ol + NAD+ = 3-methyl-butan-1-one + NADH + H+
	{?} <200>
SP	#10,105# p-methoxybenzyl alcohol + NAD+ = p-methoxybenzaldehyde + NADH
	+ H+ {r} <200>
SP	#10,105# pentanol + NAD+ = pentanal + NADH + H+ {?} <200>
SP	#10,13# isopropanol + NAD+ = acetone + NADH + H+ (#13# low affinity
	<209>) <137,209>
SP	#10,13# isopropanol + NAD+ = acetone + NADH + H+ (#13# low affinity
	<209>) {?} <137,209>
SP	#10,37# n-propanol + NAD+ = propanal + NADH <110,121>
SP	#10,37,105# octanol + NAD+ = octanal + NADH + H+ (#37# immobilized and
	free HLAD show 100% reaction rate with octanol compared to ethanol at
	pH 8.8 and 30°C <202>) {?} <200,202>
SP	#10,64# 2-propanol + NAD(P)+ = acetone + NAD(P)H <120>
SP	#104# (-)-carvone + NADH + H+ = ? + NAD+ (#104# 1% activity compared to
	cyclohexanone <195>) {?} <195>
SP	#104# (1S,3S)-3-methylcyclohexanol + NAD+ = (rac)-3-methylcyclohexanone
	+ NADH + H+ (#104# 125% activity compared to cyclohexanol <195>) |#104#
	163% activity compared to cyclohexanone <195>| {r} <195>
SP	#104# (R)-3-methylcyclohexanone + NADH + H+ = ? + NAD+ (#104# 2%
	activity compared to cyclohexanone <195>) {?} <195>
SP	#104# (S)-1-phenyl-2-propanol + NAD+ = phenylacetone + NADH + H+ |#104#
	9% activity compared to cyclohexanone <195>| {r} <195>
SP	#104# (S)-4-phenylbutan-2-ol + NAD+ = benzylacetone + NADH + H+ |#104#
	3% activity compared to cyclohexanone <195>| {r} <195>
SP	#104# (S)-heptan-2-ol + NAD+ = 2-heptanone + NADH + H+ {r} <195>
SP	#104# (S)-pentan-2-ol + NAD+ = 2-pentanone + NADH + H+ {r} <195>
SP	#104# (S)-perillylalcohol + NAD+ = (S)-perillaldehyde + NADH + H+
	(#104# 52% activity compared to cyclohexanol <195>) {?} <195>
SP	#104# 1-(p-tolyl)-ethanol + NAD+ = 1-(4-methyl phenyl)ethanone + NADH +
	H+ (#104# 19% activity compared to cyclohexanol <195>) |#104# 26%
	activity compared to cyclohexanone <195>| {?} <195>
SP	#104# 1-phenyl-1,2-ethanediol + NAD+ = 1-phenyl-2-propanone + NADH + H+
	(#104# 1% activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 1-phenylethanol + NAD+ = 1-phenylethanone + NADH + H+ (#104# 3%
	activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 1-phenylethanol + NAD+ = acetophenone + NADH + H+ |#104# 1%
	activity compared to cyclohexanone <195>| {?} <195>
SP	#104# 2-chlorocyclohexanone + NADH + H+ = ? + NAD+ (#104# 3% activity
	compared to cyclohexanone <195>) {?} <195>
SP	#104# 2-decalone + NADH + H+ = ? + NAD+ (#104# 28% activity compared to
	cyclohexanone <195>) {?} <195>
SP	#104# 2-mercaptoethanol + NAD+ = ? (#104# 11% activity compared to
	cyclohexanol <195>) {?} <195>
SP	#104# 2-methyl-2,4-pentanediol + NAD+ = ? (#104# 1% activity compared
	to cyclohexanol <195>) {?} <195>
SP	#104# 2-methylcyclohexanone + NADH + H+ = ? + NAD+ (#104# 46% activity
	compared to cyclohexanone <195>) {?} <195>
SP	#104# 2-pentanone + NAD+ = 2-pentanal + NADH + H+ (#104# 6% activity
	compared to cyclohexanol <195>) {r} <195>
SP	#104# 2-phenylcyclohexanone + NADH + H+ = ? + NAD+ (#104# 2% activity
	compared to cyclohexanone <195>) {?} <195>
SP	#104# 2-phenylethanol + NAD+ = 2-phenylethanone + NADH + H+ (#104# 57%
	activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 3,3,5-trimethylcyclohexanone + NADH + H+ = ? + NAD+ (#104# 2%
	activity compared to cyclohexanone <195>) {?} <195>
SP	#104# 3,4-dimethylbenzyl alcohol + NAD+ = 3,4-dimethylbenzaldehyde +
	NADH + H+ (#104# 45% activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 3,5-dimethylcyclohexanol + NAD+ = 3,5-dimethylcyclohexanone +
	NADH + H+ (#104# 1% activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 3-aminobenzyl alcohol + NAD+ = 3-aminobenzaldehyde + NADH + H+
	(#104# 8% activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 3-methyl-2-cyclohexenone + NADH + H+ = ? + NAD+ (#104# 1%
	activity compared to cyclohexanone <195>) {?} <195>
SP	#104# 3-methylbutanol + NAD+ = 3-methylbutanone + NADH + H+ (#104# 133%
	activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 3-methylphenylethyl alcohol + NAD+ = ? (#104# 64% activity
	compared to cyclohexanol <195>) {?} <195>
SP	#104# 3-penten-2-one + NADH + H+ = ? + NAD+ (#104# 2% activity compared
	to cyclohexanone <195>) {?} <195>
SP	#104# 4-ethylcyclohexanol + NAD+ = 4-ethylcyclohexanone + NADH + H+
	(#104# 60% activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 4-ethylcyclohexanone + NADH + H+ = ? + NAD+ (#104# 22% activity
	compared to cyclohexanone <195>) {?} <195>
SP	#104# 4-methylcyclohexanol + NAD+ = 4-methylcyclohexanone + NADH + H+
	(#104# 56% activity compared to cyclohexanol <195>) {r} <195>
SP	#104# 4-methylcyclohexanone + NADH + H+ = ? + NAD+ (#104# 25% activity
	compared to cyclohexanone <195>) {?} <195>
SP	#104# acetylacetone + NADH + H+ = acetophenone + NADH + H+ (#104# 1%
	activity compared to cyclohexanone <195>) |#104# 1% activity compared
	to cyclohexanone <195>| {r} <195>
SP	#104# cyclopentanone + NADH + H+ = ? + NAD+ (#104# 1% activity compared
	to cyclohexanone <195>) {?} <195>
SP	#104# decahydro-2-naphthol + NAD+ = ? (#104# 37% activity compared to
	cyclohexanol <195>) {?} <195>
SP	#104# isopropanol + NAD+ = 2-propanone + NADH + H+ {r} <195>
SP	#104# octanol + NAD+ = heptaldehyde + NADH + H+ |#104# 178% activity
	compared to cyclohexanone <195>| {r} <195>
SP	#104# pentanol + NAD+ = valeraldehyde + NADH + H+ |#104# 240% activity
	compared to cyclohexanone <195>| {r} <195>
SP	#104# propan-2-ol + NAD+ = acetone + NADH + H+ |#104# 6% activity
	compared to cyclohexanone <195>| {r} <195>
SP	#104# tetrahydro-4H-pyran-4-one + NADH + H+ = ? + NAD+ (#104# 10%
	activity compared to cyclohexanone <195>) {?} <195>
SP	#106# ethanol + 2 NADP+ + H2O = acetic acid + 2 NADPH + 2 H+ {r} <213>
SP	#106# glycerol + 2 NAD+ + H2O = ? + 2 NADH + 2 H+ (#106# about 45% of
	the activity with ethanol <213>) {r} <213>
SP	#106,107# 1,3-propanediol + 2 NAD+ + H2O = ? + 2 NADH + 2 H+ (#106#
	about 45% of the activity with ethanol <213>; #107# about 5% of the
	activity with 1-octanol <213>) {r} <213>
SP	#106,107# 1-butanol + 2 NAD+ + H2O = butanoic acid + 2 NADH + 2 H+
	(#106# about 45% of the activity with ethanol <213>; #107# about 50% of
	the activity with 1-octanol <213>) {r} <213>
SP	#106,107# 1-hexanol + 2 NAD+ + H2O = hexanoic acid acid + 2 NADH + 2 H+
	(#107# about 55% of the activity with 1-octanol <213>; #106# about 70%
	of the activity with ethanol <213>) {r} <213>
SP	#106,107# 1-octanol + 2 NAD+ + H2O = octanoic acid + 2 NADH + 2 H+
	(#107# best substrate <213>; #106# about 30% of the activity with
	ethanol <213>) {r} <213>
SP	#106,107# ethanol + 2 NAD+ + H2O = acetic acid + 2 NADH + 2 H+ (#106#
	best substrate <213>; #107# about 45% of the activity with 1-octanol
	<213>) {r} <213>
SP	#107# octanal + NAD+ + H2O = octanoic acid + NADH + H+ (#107# about 25%
	of the activity with 1-octanol <213>) {r} <213>
SP	#107# 1-octanol + 2 NADP+ + H2O = octanoic acid + 2 NADPH + 2 H+ {r}
	<213>
SP	#107# acetaldehyde + NADH + H+ = ethanol + NAD+ + H+ {r} <213>
SP	#107# acetone + NAD+ + H2O = ? + NADH + H+ (#107# about 5% of the
	activity with 1-octanol <213>) {r} <213>
SP	#107# isoamylalcohol + 2 NAD+ + H2O = ? + 2 NADH + 2 H+ (#107# about 5%
	of the activity with 1-octanol <213>) {r} <213>
SP	#107# isopropanol + 2 NAD+ + H2O = ? + 2 NADH + 2 H+ (#107# about 10%
	of the activity with 1-octanol <213>; #107# about 15% of the activity
	with 1-octanol <213>) {r} <213>
SP	#107# methanol + 2 NAD+ + H2o = formic acid + 2 NADH + 2 H+ (#107#
	about 25% of the activity with 1-octanol <213>) {r} <213>
SP	#107# octanoic acid + 2 NADH + 2 H+ = 1-octanol + 2 NAD+ + H2o {r} <213>
SP	#13# isopentanol + NAD+ = ? + NADH + H+ (#13# low affinity <209>) {?}
	<209>
SP	#14# secondary alcohol + NAD+ = aldehyde + NADH <125>
SP	#16#
	(6S)-5,6-dihydro-6-methyl-4H-thieno[2,3b]thiopyran-4-one-7,7-dioxide +
	NADH + H+ =
	(4S,6S)-5,6-dihydro-4-hydroxy-6-methyl-4H-thieno[2,3b]thiopyran-7
	7-dioxide + NAD+ {} <133>
SP	#19# 3-butene-1-ol + NAD+ = ? + NADH <75>
SP	#19# 3-phenyl-2-propen-1-ol + NAD+ = ? + NADH <75>
SP	#19,33,34,60,71,74# hexan-1-ol + NAD+ = n-hexanal + NADH
	<47,61,75,77,78,85,97>
SP	#19,60,63,71,74# 2-methylpropan-1-ol + NAD+ = 2-methyl-propan-1-one +
	NADH (#19# weak activity <75>) <61,75,77,78,84,97>
SP	#19,60,63,71,74# 2-methylpropan-1-ol + NAD+ = 2-methyl-propan-1-one +
	NADH (#19# weak activity <75>) {} <61,75,77,78,84,97>
SP	#21# methylglyoxal + NADH = ? + NADH (#21# 11.9% of the activity with
	acetaldehyde <72>) <72>
SP	#21# 2,3-pentanedione + NADH = ? + NADH (#21# 5.5% of the activity with
	acetaldehyde <72>) <72>
SP	#21,37,38,49# propionaldehyde + NADH = propanol + NAD+ (#21# 94% of the
	activity with acetaldehyde <72>) <42,68,72,99>
SP	#24# acetophenone + NADH = (R)-alpha-phenyl ethanol + NAD+ (#24# the
	enzyme exhibits high stereoselectivity in the desymmetrization of the
	prochiral ketone acetophenone, producing optically pure
	(R)-alpha-phenyl ethanol at high conversion <105>) <105>
SP	#24,37# cyclohexanone + NADH = cyclohexanol + NAD+ (#24# best cyclic
	ketone substrate <105>) <28,42,105>
SP	#25# diacetyl + NADH + H+ = ? (#25# 16.1fold higher activity compared
	to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# acetophenone + NADH + H+ = 1-phenylethanol + NAD+ (#25# 1.8fold
	higher activity compared to activity with N-benzyl-3-pyrrolidinone
	<186>) <186>
SP	#25# 1-octanol + NAD+ = 1-octanal + NADH + H+ (#25# 6% of activity with
	N-benzyl-3-pyrrolidinol <186>) <186>
SP	#25# 2-acetylpyrrole + NADH + H+ = 1-(1H-pyrrol-2-yl)ethanol + NAD+
	(#25# 70% of activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 2-butanone + NADH + H+ = butan-2-ol + NAD+ (#25# 2.8fold higher
	activity compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 2-hexanone + NADH + H+ = hexan-2-ol + NAD+ (#25# 50.4fold higher
	activity compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 2-nitrobenzaldehyde + NADH + H+ = 2-nitrophenylbenzyl alcohol +
	NAD+ (#25# 33% of activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 2-oxo-butyric acid + NADH + H+ = 2-hydroxybutyric acid + NAD+
	(#25# 15% of activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 3-acetylpyridine + NADH + H+ = 1-pyridin-3-ylethanol + NAD+ (#25#
	7.9fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 3-phenylpropionaldehyde + NADH + H+ = 3-phenylpropanol + NAD+
	(#25# 6.9fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# 4-acetylpyridine + NADH + H+ = 1-pyridin-4-ylethanol + NAD+ (#25#
	64.5fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# acetone + NADH + H+ = propan-2-ol + NAD+ (#25# 1.9fold higher
	activity compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# benzoin + NADH + H+ = 1,2-diphenylethane-1,2-diol (#25# 13% of
	activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# benzyloxycarbonyl-3-pyrrolidinone + NADH + H+ =
	(S)-benzyloxycarbonyl-3-pyrrolidinol + NAD+ (#25# production with 99.6%
	enantiomeric excess <186>) <186>
SP	#25# dihydro-4,4-dimethyl-2,3-furandione + NADH + H+ = ? (#25# 13.1fold
	higher activity compared to activity with N-benzyl-3-pyrrolidinone
	<186>) <186>
SP	#25# ethyl 4-chloroacetoacetate + NADH + H+ = ? (#25# 6.8fold higher
	activity compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# ethyl acetoacetate + NADH + H+ = ? (#25# 42.4fold higher activity
	compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# glutaraldehyde + NADH + H+ = ? (#25# 70.8fold higher activity
	compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# hexanal + NADH + H+ = n-hexanol + NAD+ (#25# 22.3fold higher
	activity compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# levulinic acid + NADH + H+ = ? (#25# 11% of activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# m-chlorophenacyl chloride + NADH + H+ =
	2-chloro-1-(3-chlorophenyl)ethanol + NAD+ (#25# 4.6fold higher activity
	compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# methyl glyoxal + NADH + H+ = ? (#25# 3.5fold higher activity
	compared to activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# methyl pyruvate + NADH + H+ = methyl 2-hydroxypropanoate + NAD+
	(#25# 18.9fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# N-benzyl-3-piperidone + NADH + H+ = N-benzylpiperidin-3-ol + NAD+
	(#25# 2.3fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# N-benzyl-3-pyrrolidinone + NADH + H+ = (R)-N-benzyl-3-pyrrolidinol
	+ NAD+ (#25# (R)-stereoselectivity of the reduction carried out with
	the heat-treated cells <186>) {r} <186>
SP	#25# N-benzyl-4-piperidone + NADH + H+ = N-benzylpiperidin-4-ol + NAD+
	(#25# 10.7fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# n-butyraldehyde + NADH + H+ = n-butanol + NAD+ (#25# 7.3fold
	higher activity compared to activity with N-benzyl-3-pyrrolidinone
	<186>) <186>
SP	#25# N-tert-butoxycarbonyl-3-pyrrolidinone + NADH + H+ =
	(S)-N-tert-butoxycarbonyl-3-pyrrolidinol + NAD+ (#25# production of
	(S)-N-tert-butoxycarbonyl-3-pyrrolidinol with 99.6% enantiomeric excess
	<186>) <186>
SP	#25# oxalacetic acid + NADH + H+ = ? (#25# 14% of activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# p-chlorobenzaldehyde + NADH + H+ = p-chlorobenzyl alcohol + NAD+
	(#25# 1.2fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# p-nitrobenzyloxycarbonyl-3-pyrrolidinone + NADH + H+ =
	(S)-N-p-nitrobenzyloxycarbonyl-3-pyrrolidinol + NAD+ (#25# production
	with 90.7% enantiomeric excess <186>) <186>
SP	#25# phenylethanol + NAD+ = phenylacetaldehyde + NADH + H+ (#25# 15% of
	activity with N-benzyl-3-pyrrolidinol <186>) <186>
SP	#25# propiophenone + NADH + H+ = 1-phenylpropan-1-ol + NAD+ (#25# 27%
	of activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# pyridine-3-aldehyde + NADH + H+ = pyridin-3-yl ethanol + NAD+
	(#25# 82% of activity with N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25# pyridine-4-aldehyde + NADH + H+ = pyridin-4-yl methanol + NAD+
	(#25# 4.4fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <186>
SP	#25,84,93,103# 2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#84# weak
	activity <142>; #25# 45% of activity with N-benzyl-3-pyrrolidinol
	<186>; #93# activity is 9fold higher than with
	(S)-N-benzyl-3-pyrrolidinol <183>; #103# 5.7% activity compared to
	ethanol <211>) {r} <142,183,186,211>
SP	#25,84,93,103# 2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#84# weak
	activity <142>; #25# 45% of activity with N-benzyl-3-pyrrolidinol
	<186>; #93# activity is 9fold higher than with
	(S)-N-benzyl-3-pyrrolidinol <183>; #103# 5.7% activity compared to
	ethanol <211>) <142,183,186,211>
SP	#25,84,93,103# 2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#84# weak
	activity <142>; #25# 45% of activity with N-benzyl-3-pyrrolidinol
	<186>; #93# activity is 9fold higher than with
	(S)-N-benzyl-3-pyrrolidinol <183>; #103# 5.7% activity compared to
	ethanol <211>) {?} <142,183,186,211>
SP	#25,85# 1-phenyl-2-butanone + NADH + H+ = 1-phenylbutan-2-ol + NAD+
	(#85# 12% of the activity with phenyl trifluoromethyl ketone <136>;
	#25# 1.5fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <136,186>
SP	#25,85# chloroacetone + NADH + H+ = 1-chloropropan-2-ol + NAD+ (#85#
	238% of the activity with phenyl trifluoromethyl ketone <136>; #25#
	41.7fold higher activity compared to activity with
	N-benzyl-3-pyrrolidinone <186>) <136,186>
SP	#25,85,97# (R)-2-butanol + NAD+ = 2-butanone + NADH + H+ (#85# 50% of
	the activity with 2-propanol <136>; #25# 55% of activity with
	N-benzyl-3-pyrrolidinol <186>) {r} <136,186,205>
SP	#25,85,97# (R)-2-butanol + NAD+ = 2-butanone + NADH + H+ (#85# 50% of
	the activity with 2-propanol <136>; #25# 55% of activity with
	N-benzyl-3-pyrrolidinol <186>) {ir} <136,186,205>
SP	#25,85,97# (R)-2-butanol + NAD+ = 2-butanone + NADH + H+ (#85# 50% of
	the activity with 2-propanol <136>; #25# 55% of activity with
	N-benzyl-3-pyrrolidinol <186>) <136,186,205>
SP	#25,93# N-benzyl-3-pyrrolidinone + NADH + H+ =
	(S)-N-benzyl-3-pyrrolidinol + NAD+ (#93# (S)-N-benzyl-3-pyrrolidinol is
	produced at an enantiomeric excess of more than 99.9% <183>) {r}
	<183,186>
SP	#26# ethylene glycol + NAD+ = ? (#26# poor substrate <128>) {r} <128>
SP	#26# primary or secondary alcohol + NAD+ = aldehyde or ketone + NADH
	{r} <128>
SP	#28# 6-benzyloxy-3,5-dioxo-hexanoic acid ethyl ester + NADH + H+ =
	(3R,5S)-6-benzyloxy-3,5-dihydroxy-hexanoic acid ethyl ester + NAD+ {}
	<132>
SP	#29,50,84,88,90,97,102,103,104# 1-butanol + NAD+ = butanal + NADH + H+
	(#88# 30% activity compared to benzyl alcohol <154>; #29# 15.7% of the
	activity with ethanol <179>; #90# about 80% of activity with ethanol,
	ADH1 <170>; #104# 142% activity compared to cyclohexanol <195>; #103#
	67.7% activity compared to ethanol <211>)
	<142,145,154,170,179,195,205,208,211>
SP	#29,50,84,88,90,97,102,103,104# 1-butanol + NAD+ = butanal + NADH + H+
	(#88# 30% activity compared to benzyl alcohol <154>; #29# 15.7% of the
	activity with ethanol <179>; #90# about 80% of activity with ethanol,
	ADH1 <170>; #104# 142% activity compared to cyclohexanol <195>; #103#
	67.7% activity compared to ethanol <211>) {r}
	<142,145,154,170,179,195,205,208,211>
SP	#29,50,84,88,90,97,102,103,104# 1-butanol + NAD+ = butanal + NADH + H+
	(#88# 30% activity compared to benzyl alcohol <154>; #29# 15.7% of the
	activity with ethanol <179>; #90# about 80% of activity with ethanol,
	ADH1 <170>; #104# 142% activity compared to cyclohexanol <195>; #103#
	67.7% activity compared to ethanol <211>) {r}
	<142,145,154,170,179,195,205,208,211>
SP	#29,50,84,88,90,97,102,103,104# 1-butanol + NAD+ = butanal + NADH + H+
	(#88# 30% activity compared to benzyl alcohol <154>; #29# 15.7% of the
	activity with ethanol <179>; #90# about 80% of activity with ethanol,
	ADH1 <170>; #104# 142% activity compared to cyclohexanol <195>; #103#
	67.7% activity compared to ethanol <211>) {?}
	<142,145,154,170,179,195,205,208,211>
SP	#3,10,19,34,38,75# allyl alcohol + NAD+ = prop-2-en-1-al + NADH (#10#
	no activity <87>) <4,67,68,75,83,85,87,97>
SP	#3,10,19,34,38,75# allyl alcohol + NAD+ = prop-2-en-1-al + NADH (#10#
	no activity <87>) {} <4,67,68,75,83,85,87,97>
SP	#3,4,5,9,10,15,23,37,38,39,41,46,48,49,54,63,106# acetaldehyde + NADH +
	H+ = ethanol + NAD+ (#49# the reduction of acetaldehyde is 4.9fold
	faster than the oxidation of ethanol <99>; #5# reduced by isoenzyme A2
	and C2, no activity with isoenzyme B2 <48>; #3# reduced at the highest
	rate of all aldehydes tested <4>; #10# cells with an extra copy of ADH1
	display chronological life-span extension. Antioxidant enzymes are
	induced in 2xADH1 cells. Strains carrying an extra ADH1 copy show
	extended replicative life span and increased Sir2p activity <188>; #10#
	mutant enzyme S109P/L116S/Y294C <191>) {r}
	<4,6,25,28,41,42,43,48,49,51,68,81,82,84,90,99,122,144,149,188,191,213>
SP	#3,4,5,9,10,15,23,37,38,39,41,46,48,49,54,63,106# acetaldehyde + NADH +
	H+ = ethanol + NAD+ (#49# the reduction of acetaldehyde is 4.9fold
	faster than the oxidation of ethanol <99>; #5# reduced by isoenzyme A2
	and C2, no activity with isoenzyme B2 <48>; #3# reduced at the highest
	rate of all aldehydes tested <4>; #10# cells with an extra copy of ADH1
	display chronological life-span extension. Antioxidant enzymes are
	induced in 2xADH1 cells. Strains carrying an extra ADH1 copy show
	extended replicative life span and increased Sir2p activity <188>; #10#
	mutant enzyme S109P/L116S/Y294C <191>) {}
	<4,6,25,28,41,42,43,48,49,51,68,81,82,84,90,99,122,144,149,188,191,213>
SP	#3,4,5,9,10,15,23,37,38,39,41,46,48,49,54,63,106# acetaldehyde + NADH +
	H+ = ethanol + NAD+ (#49# the reduction of acetaldehyde is 4.9fold
	faster than the oxidation of ethanol <99>; #5# reduced by isoenzyme A2
	and C2, no activity with isoenzyme B2 <48>; #3# reduced at the highest
	rate of all aldehydes tested <4>; #10# cells with an extra copy of ADH1
	display chronological life-span extension. Antioxidant enzymes are
	induced in 2xADH1 cells. Strains carrying an extra ADH1 copy show
	extended replicative life span and increased Sir2p activity <188>; #10#
	mutant enzyme S109P/L116S/Y294C <191>)
	<4,6,25,28,41,42,43,48,49,51,68,81,82,84,90,99,122,144,149,188,191,213>
SP	#30# prop-2-en-1-ol + NAD+ = ? + NADH (#30# 140.6% of the activity with
	ethanol <73>) <73>
SP	#30# (Z)-hex-2-en-1-ol + NAD+ = (Z)-hex-2-en-1-one + NADH (#30# 9.7% of
	the activity with ethanol <73>) <73>
SP	#33# methylcrotonyl alcohol + NAD+ = methylcrotonaldehyde + NADH <95>
SP	#33,37# 3beta-hydroxy-5beta-androstan-17-one + NAD+ =
	5beta-androstan-3,17-dione + NADH (#33# catalyzed by isoenzyme BB-ADH,
	no activity with isoenzyme AA-ADH and TT-ADH <95>) <28,95>
SP	#34,37,42,63,71# pentan-2-ol + NAD+ = 2-pentanone + NADH (#37#
	(R)-2-pentanol and (S)-2-pentanol <31>) <31,61,66,84,85>
SP	#34,37,42,63,71# pentan-2-ol + NAD+ = 2-pentanone + NADH (#37#
	(R)-2-pentanol and (S)-2-pentanol <31>) {r} <31,61,66,84,85>
SP	#34,37,75# cinnamyl alcohol + NAD+ = cinnamaldehyde + NADH <83,85,92>
SP	#36# 1-phenyl-2-propanone + NADH + H+ = (S)-1-phenyl-2-propanol + NAD+
	{} <130>
SP	#37# ethanol + 3-benzoylpyridine-adenine dinucleotide = acetaldehyde +
	? (#37# rapid equilibrium bi bi mechanism <33>) {} <33>
SP	#37# 3-methyl-1-butanol + NAD+ = ? + NADH <92>
SP	#37# 3-pentanone + NADH = pentan-3-ol + NAD+ {r} <31>
SP	#37# 2-pentanone + NADH = pentan-2-ol + NAD+ {r} <31>
SP	#37# 3beta,17beta-dihydroxy-5beta-androstane + NAD+ =
	5beta-androstan-3,17dione + NADH <28>
SP	#37# 3beta-hydroxy-5beta-cholanoate + NAD+ = 3-oxo-5beta-cholanoate +
	NADH <28>
SP	#37# 3beta-hxdroxy-5alpha-cholanoate + NAD+ = 3-oxo-5alpha-cholanoate +
	NADH <28>
SP	#37# 5beta-pregnan-21-ol-3,20-dione hemisuccinate + NADH =
	5beta-pregnan-3,20,21-trione hemisuccinate + NADH <42>
SP	#37# all-trans-retinal + NADH + H+ = all-trans-retinol + NAD+ <93>
SP	#37# 11-cis-retinal + NADH + H+ = 11-cis-retinol + NAD+ <29>
SP	#37# 13-cis-retinal + NAD+ = 13-cis-retinol + NADH <29>
SP	#37# p-nitrophenyl octanoate + H2O = p-nitrophenol + octanoate (#37#
	acid-assisted nucleophilic catalysis involving the ammonium ion of Lys
	and the thiolate of Cys in the acyl-oxygen cleavage <39>) <39>
SP	#37# 5beta-cholanic acid-3-one + NAD+ = 5beta-cholanic acid-3-ol + NAD+
	<115>
SP	#37# butanol + NAD+ = n-butanal + NADH <110>
SP	#37# hexadecanol + NAD+ = hexadecanal + NADH + H+ (#37# immobilized
	HLAD shows about 60% reaction rate and free HLAD shows about 15%
	reaction rate with hexadecanol compared to ethanol at pH 8.8 and 30°C
	<202>) {?} <202>
SP	#37# docosanol + NAD+ = ? + NADH + H+ (#37# immobilized HLAD shows
	about 60% reaction rate and free HLAD shows about 20% reaction rate
	with docosanol compared to ethanol at pH 8.8 and 30°C <202>) {?} <202>
SP	#37# dodecanol + NAD+ = dodecanal + NADH + H+ (#37# immobilized HLAD
	shows about 60% reaction rate and free HLAD shows about 35% reaction
	rate with dodecanol compared to ethanol at pH 8.8 and 30°C <202>) {?}
	<202>
SP	#37# ethanol + NAD+ = aldehyde + NADH + H+ (#37# immobilized HLAD shows
	100% reaction rate and free HLAD shows about 55% reaction rate with
	ethanol at pH 8.8 and 30°C <202>) {?} <202>
SP	#37# tetracosanol + NAD+ = ? + NADH + H+ (#37# immobilized HLAD shows
	about 55% reaction rate and free HLAD shows about 15% reaction rate
	with tetracosanol compared to ethanol at pH 8.8 and 30°C <202>) {?}
	<202>
SP	#37,104# butanol + NAD+ = butyraldehyde + NADH + H+ (#37# immobilized
	HLAD shows about 95% reaction rate and free HLAD shows about 90%
	reaction rate with butanol compared to ethanol at pH 8.8 and 30°C
	<202>) |#104# 359% activity compared to cyclohexanone <195>| {r}
	<195,202>
SP	#37,104# butanol + NAD+ = butyraldehyde + NADH + H+ (#37# immobilized
	HLAD shows about 95% reaction rate and free HLAD shows about 90%
	reaction rate with butanol compared to ethanol at pH 8.8 and 30°C
	<202>) |#104# 359% activity compared to cyclohexanone <195>| {?}
	<195,202>
SP	#37,38,49# butyraldehyde + NADH = n-butanol + NAD+ (#38# activity with
	enzyme form ADH I, no activity with enzyme form ADH II <68>) {r}
	<42,68,99>
SP	#37,42# acetone + NADH = isopropanol + NAD+ {r} <31,66>
SP	#37,42# butan-2-one + NADH = butan-2-ol + NAD+ {r} <31,66>
SP	#37,42# pentan-3-ol + NAD+ = 3-pentanone + NADH {r} <31,66>
SP	#37,42# pentan-3-ol + NAD+ = 3-pentanone + NADH <31,66>
SP	#38# n-pentylaldehyde + NAD+ = n-pentanol + NADH {r} <68>
SP	#38# furfural + NADH = furfuryl alcohol + NADH (#38# activity with
	enzyme form ADH I, no activity with enzyme form ADH II <68>) {r} <68>
SP	#4,5,7,8,9,10,12,14,15,19,20,21,23,26,27,29,30,32,33,37,38,39,41,43,45
	46,47,49,51,53,59,60,61,62,63,64,65,66,68,72,73,74,75,76,80,82,90#
	ethanol + NAD+ = acetaldehyde + NADH (#80# best substrate <117>; #8#
	class III isoenzyme chi-ADH oxidizes ethanol very poorly <16>; #8# no
	oxidation with class III enzyme <11>; #9# isoenzyme ADH-1 and ADH-3, no
	activity with isoenzyme ADH-2 <49>; #49# the reduction of acetaldehyde
	is 4.9fold faster than the oxidation of ethanol <99>; #46# the
	reduction of acetaldehyde of ADH-MII is about 7times higher than that
	of the oxidation of ethanol <82>; #5# no activity with isoenzyme B2,
	oxidized by isoenzyme A2 and C2 <48>; #5# role of the major liver
	isoenzyme A2 in ethanol metabolism <48>; #37# plays an important role
	in the metabolism of ethanol <102>; #8# chi-ADH plays an important role
	in the metabolism of long chain alcohols and aldehydes <21>; #8# the
	anodic enzyme form may contribute significantly to alcohol elimination
	in man, particularly at high concentrations when the other enzyme
	species are saturated <18>; #8# the enzyme plays a significant role in
	first-pass metabolism of ethanol in human <96>; #8# enzyme is
	responsible for the major ethanol oxidation capacity in the body. The
	products acetaldehyde and NADH are responsible for the most of the
	toxic effects and metabolic disturbances produced by ethanol ingestion
	<10>; #10# rate-limiting step of the alcoholic fermentation <121>; #37#
	isomerization of the enzyme-NAD+ complex is the rate-limiting step for
	acetaldehyde reduction by the wild-type enzyme <110>; #82# no
	cooperativity between the 2 active sites of the enzyme <104>; #5# DH3
	plays an important role in systemic ethanol metabolism at higher levels
	of blood ethanol through activation by cytoplasmic solution
	hydrophobicity <139>; #43# 76% of the activity with 2-phenylethanol
	<147>; #14# proton and hydride equivalent transfer in the alcohol
	dehydrogenase enzymatic reaction are modulated by the correlated
	motions between NAD+ and the cofactor domain <174>) |#53# acetaldehyde
	is the best substrate for isozyme ADH I <112>| {}
	<2,6,10,11,12,13,14,16,17,18,20,21,24,25,28,35,41,42,43,45,47,48,49,51
	52,53,59,60,64,65,67,68,69,71,72,73,74,75,76,77,78,81,82,83,84,87,90,92
	95,96,97,99,101,102,104,110,112,114,115,116,117,118,119,120,121,125,127
	134,139,145,147,168,170,174,179>
SP	#4,5,7,8,9,10,12,14,15,19,20,21,23,26,27,29,30,32,33,37,38,39,41,43,45
	46,47,49,51,53,59,60,61,62,63,64,65,66,68,72,73,74,75,76,80,82,90#
	ethanol + NAD+ = acetaldehyde + NADH (#80# best substrate <117>; #8#
	class III isoenzyme chi-ADH oxidizes ethanol very poorly <16>; #8# no
	oxidation with class III enzyme <11>; #9# isoenzyme ADH-1 and ADH-3, no
	activity with isoenzyme ADH-2 <49>; #49# the reduction of acetaldehyde
	is 4.9fold faster than the oxidation of ethanol <99>; #46# the
	reduction of acetaldehyde of ADH-MII is about 7times higher than that
	of the oxidation of ethanol <82>; #5# no activity with isoenzyme B2,
	oxidized by isoenzyme A2 and C2 <48>; #5# role of the major liver
	isoenzyme A2 in ethanol metabolism <48>; #37# plays an important role
	in the metabolism of ethanol <102>; #8# chi-ADH plays an important role
	in the metabolism of long chain alcohols and aldehydes <21>; #8# the
	anodic enzyme form may contribute significantly to alcohol elimination
	in man, particularly at high concentrations when the other enzyme
	species are saturated <18>; #8# the enzyme plays a significant role in
	first-pass metabolism of ethanol in human <96>; #8# enzyme is
	responsible for the major ethanol oxidation capacity in the body. The
	products acetaldehyde and NADH are responsible for the most of the
	toxic effects and metabolic disturbances produced by ethanol ingestion
	<10>; #10# rate-limiting step of the alcoholic fermentation <121>; #37#
	isomerization of the enzyme-NAD+ complex is the rate-limiting step for
	acetaldehyde reduction by the wild-type enzyme <110>; #82# no
	cooperativity between the 2 active sites of the enzyme <104>; #5# DH3
	plays an important role in systemic ethanol metabolism at higher levels
	of blood ethanol through activation by cytoplasmic solution
	hydrophobicity <139>; #43# 76% of the activity with 2-phenylethanol
	<147>; #14# proton and hydride equivalent transfer in the alcohol
	dehydrogenase enzymatic reaction are modulated by the correlated
	motions between NAD+ and the cofactor domain <174>) |#53# acetaldehyde
	is the best substrate for isozyme ADH I <112>| {r}
	<2,6,10,11,12,13,14,16,17,18,20,21,24,25,28,35,41,42,43,45,47,48,49,51
	52,53,59,60,64,65,67,68,69,71,72,73,74,75,76,77,78,81,82,83,84,87,90,92
	95,96,97,99,101,102,104,110,112,114,115,116,117,118,119,120,121,125,127
	134,139,145,147,168,170,174,179>
SP	#4,5,7,8,9,10,12,14,15,19,20,21,23,26,27,29,30,32,33,37,38,39,41,43,45
	46,47,49,51,53,59,60,61,62,63,64,65,66,68,72,73,74,75,76,80,82,90#
	ethanol + NAD+ = acetaldehyde + NADH (#80# best substrate <117>; #8#
	class III isoenzyme chi-ADH oxidizes ethanol very poorly <16>; #8# no
	oxidation with class III enzyme <11>; #9# isoenzyme ADH-1 and ADH-3, no
	activity with isoenzyme ADH-2 <49>; #49# the reduction of acetaldehyde
	is 4.9fold faster than the oxidation of ethanol <99>; #46# the
	reduction of acetaldehyde of ADH-MII is about 7times higher than that
	of the oxidation of ethanol <82>; #5# no activity with isoenzyme B2,
	oxidized by isoenzyme A2 and C2 <48>; #5# role of the major liver
	isoenzyme A2 in ethanol metabolism <48>; #37# plays an important role
	in the metabolism of ethanol <102>; #8# chi-ADH plays an important role
	in the metabolism of long chain alcohols and aldehydes <21>; #8# the
	anodic enzyme form may contribute significantly to alcohol elimination
	in man, particularly at high concentrations when the other enzyme
	species are saturated <18>; #8# the enzyme plays a significant role in
	first-pass metabolism of ethanol in human <96>; #8# enzyme is
	responsible for the major ethanol oxidation capacity in the body. The
	products acetaldehyde and NADH are responsible for the most of the
	toxic effects and metabolic disturbances produced by ethanol ingestion
	<10>; #10# rate-limiting step of the alcoholic fermentation <121>; #37#
	isomerization of the enzyme-NAD+ complex is the rate-limiting step for
	acetaldehyde reduction by the wild-type enzyme <110>; #82# no
	cooperativity between the 2 active sites of the enzyme <104>; #5# DH3
	plays an important role in systemic ethanol metabolism at higher levels
	of blood ethanol through activation by cytoplasmic solution
	hydrophobicity <139>; #43# 76% of the activity with 2-phenylethanol
	<147>; #14# proton and hydride equivalent transfer in the alcohol
	dehydrogenase enzymatic reaction are modulated by the correlated
	motions between NAD+ and the cofactor domain <174>) |#53# acetaldehyde
	is the best substrate for isozyme ADH I <112>|
	<2,6,10,11,12,13,14,16,17,18,20,21,24,25,28,35,41,42,43,45,47,48,49,51
	52,53,59,60,64,65,67,68,69,71,72,73,74,75,76,77,78,81,82,83,84,87,90,92
	95,96,97,99,101,102,104,110,112,114,115,116,117,118,119,120,121,125,127
	134,139,145,147,168,170,174,179>
SP	#4,8,10,12,15,19,34,37,38,42,49,63,65,68,71# propan-2-ol + NAD+ =
	acetone + NADH (#10# no activity <87>; #38# very low activity <67>;
	#49# 3% of the activity with ethanol <99>)
	<14,43,45,61,64,65,66,67,68,81,84,85,87,90,92,97,99>
SP	#4,8,10,12,15,19,34,37,38,42,49,63,65,68,71# propan-2-ol + NAD+ =
	acetone + NADH (#10# no activity <87>; #38# very low activity <67>;
	#49# 3% of the activity with ethanol <99>) {}
	<14,43,45,61,64,65,66,67,68,81,84,85,87,90,92,97,99>
SP	#4,8,10,12,19,20,34,38,42,47,49,60,63,71,74,75# propanol + NADH =
	propionaldehyde + NADH
	<20,45,53,59,61,65,66,67,68,71,75,77,78,83,84,85,87,90,96,97,99>
SP	#4,8,10,12,19,20,34,38,42,47,49,60,63,71,74,75# propanol + NADH =
	propionaldehyde + NADH {}
	<20,45,53,59,61,65,66,67,68,71,75,77,78,83,84,85,87,90,96,97,99>
SP	#4,8,19,33,34,37,42,47,63,65,68,71,75# butan-2-ol + NAD+ = butan-2-one
	+ NADH (#19# no activity <97>; #19# weak activity <75>; #37#
	(R)-2-butanol and (S)-2-butanol <31>)
	<20,31,47,53,59,61,64,66,75,83,84,85,92,95,97>
SP	#4,8,19,33,34,37,42,47,63,65,68,71,75# butan-2-ol + NAD+ = butan-2-one
	+ NADH (#19# no activity <97>; #19# weak activity <75>; #37#
	(R)-2-butanol and (S)-2-butanol <31>) {}
	<20,31,47,53,59,61,64,66,75,83,84,85,92,95,97>
SP	#4,8,9,10,12,19,33,34,37,38,42,47,60,62,65,68,71,74,75,76# butanol +
	NAD+ = butyraldehyde + NADH (#10# weak <87>; #38# activity with ADH I,
	no activity with ADH II <68>; #38# oxidized by enzyme form ADH-I, no
	activity with enzyme form ADH-II <67>; #9# pH 10.0: oxidized by ADH-1
	and ADH-3, no activity with isoenzyme ADH-2 <49>)
	<16,18,20,42,45,47,49,53,59,60,61,64,66,67,68,75,77,78,83,85,87,90,95
	96,97,101>
SP	#4,8,9,10,12,19,33,34,37,38,42,47,60,62,65,68,71,74,75,76# butanol +
	NAD+ = butyraldehyde + NADH (#10# weak <87>; #38# activity with ADH I,
	no activity with ADH II <68>; #38# oxidized by enzyme form ADH-I, no
	activity with enzyme form ADH-II <67>; #9# pH 10.0: oxidized by ADH-1
	and ADH-3, no activity with isoenzyme ADH-2 <49>) {}
	<16,18,20,42,45,47,49,53,59,60,61,64,66,67,68,75,77,78,83,85,87,90,95
	96,97,101>
SP	#40# alcohol + NAD+ = aldehyde or ketone + NADH (#40# medium chain
	sec-alcohols or (omega-1)-ketones, no activity with primary alcohols or
	aldehydes <113>) {r} <113>
SP	#42# 3-methylbutan-2-one + NADH = 3-methylbutan-2-ol + NAD+ <66>
SP	#42# cyclopetanone + NADH = cyclopentanol + NADH <66>
SP	#42# 3-methylcyclohexanol + NAD+ = 3-methylcyclohexanone + NADH {r} <66>
SP	#42# 3-methylcyclohexanone + NADH = 3-methylcyclohexanol + NAD+ {r} <66>
SP	#42# anisaldehyde + NADH = anisic alcohol + NADH <66,70>
SP	#42# 3-bromobenzyl alcohol + NAD+ = 3-bromobenzaldehyde + NADH + H+
	<151>
SP	#42# 3-bromobenzylalcohol + NAD+ = 3-bromobenzaldehyde + NADH + H+ <161>
SP	#42# 3-methoxybenzylalcohol + NAD+ = 3-methoxybenzaldehyde + NADH + H+
	<161>
SP	#42# 3-methylbutan-2-one + NADH + H+ = 3-methylbutan-2-ol + NAD+ <153>
SP	#42# 4-bromobenzyl alcohol + NAD+ = 4-bromobenzaldehyde + NADH + H+
	<151>
SP	#42# 4-bromobenzylalcohol + NAD+ = 4-bromobenzaldehyde + NADH + H+ <161>
SP	#42# 4-carboxybenzaldehyde + NADH + H+ = 4-carboxybenzyl alcohol + NAD+
	<151>
SP	#42# 4-carboxybenzaldehyde + NADH + H+ = 4-carboxybenzylalcohol + NAD+
	<161>
SP	#42# 4-methoxybenzylalcohol + NAD+ = 4-methoxybenzaldehyde + NADH + H+
	{r} <161>
SP	#42# 4-nitrobenzaldehyde + NADH + H+ = 4-nitrobenzyl alcohol + NAD+
	<151>
SP	#42# 4-nitrobenzaldehyde + NADH + H+ = 4-nitrobenzylalcohol + NAD+ <161>
SP	#42# anisaldehyde + NADH + H+ = anisic alcohol + NAD+ <153>
SP	#42# benzyl aclohol + NAD+ = benzaldehyde + NADH + H+ <163>
SP	#42# butyraldehyde + NADH + H+ = n-butanol + NAD+ <156>
SP	#42,50,84,90,97,104# 1-propanol + NAD+ = propanal + NADH + H+ (#90#
	about 75% of activity with ethanol, ADH1 <170>; #104# 153% activity
	compared to cyclohexanol <195>) <142,145,151,152,161,170,195,205>
SP	#42,50,84,90,97,104# 1-propanol + NAD+ = propanal + NADH + H+ (#90#
	about 75% of activity with ethanol, ADH1 <170>; #104# 153% activity
	compared to cyclohexanol <195>) {r} <142,145,151,152,161,170,195,205>
SP	#42,50,84,90,97,104# 1-propanol + NAD+ = propanal + NADH + H+ (#90#
	about 75% of activity with ethanol, ADH1 <170>; #104# 153% activity
	compared to cyclohexanol <195>) {r} <142,145,151,152,161,170,195,205>
SP	#42,50,93,102,103,104# 2-propanol + NAD+ = 2-propanone + NADH + H+
	(#93# activity is 3.1fold higher than with (S)-N-benzyl-3-pyrrolidinol
	<183>; #104# 6% activity compared to cyclohexanol <195>; #103# 73.5%
	activity compared to ethanol <211>) <145,151,161,183,195,208,211>
SP	#42,50,93,102,103,104# 2-propanol + NAD+ = 2-propanone + NADH + H+
	(#93# activity is 3.1fold higher than with (S)-N-benzyl-3-pyrrolidinol
	<183>; #104# 6% activity compared to cyclohexanol <195>; #103# 73.5%
	activity compared to ethanol <211>) {?} <145,151,161,183,195,208,211>
SP	#42,50,93,102,103,104# 2-propanol + NAD+ = 2-propanone + NADH + H+
	(#93# activity is 3.1fold higher than with (S)-N-benzyl-3-pyrrolidinol
	<183>; #104# 6% activity compared to cyclohexanol <195>; #103# 73.5%
	activity compared to ethanol <211>) {r} <145,151,161,183,195,208,211>
SP	#42,84,86# benzylalcohol + NAD+ = benzaldehyde + NADH + H+ (#84# weak
	activity <142>) {r} <142,160,161>
SP	#42,84,86# benzylalcohol + NAD+ = benzaldehyde + NADH + H+ (#84# weak
	activity <142>) <142,160,161>
SP	#43# 1-octanol + NAD+ = octanal + NADH (#43# 101% of the activity with
	2-phenylethanol <147>) <147>
SP	#43# 1-dodecanol + NAD+ = dodecanal + NADH (#43# 68% of the activity
	with 2-phenylethanol <147>) <147>
SP	#43# (R)-2-phenylpropanol + NAD+ = (R)-2-phenylpropanal + NADH + H+
	(#43# 63% of the activity with 2-phenylethanol <147>) <147>
SP	#43# (S)-2-phenylpropanol + NAD+ = (S)-2-phenylpropanal + NADH + H+
	(#43# 156% of the activity with 2-phenylethanol <147>) <147>
SP	#43# 2-phenylethanol + NAD+ = phenylacetaldehyde + NADH + H+ {r} <147>
SP	#43# 3-phenylpropanol + NAD+ = 3-phenylpropanal + NADH + H+ (#43# 135%
	of the activity with 2-phenylethanol <147>) <147>
SP	#43,51# 1-butanol + NAD+ = butanal + NADH (#43# 111% of the activity
	with 2-phenylethanol <147>) <145,147>
SP	#43,51,91# 2-propanol + NAD+ = 2-propanone + NADH (#43# 54% of the
	activity with 2-phenylethanol <147>) <145,147,171>
SP	#43,91# 1-phenylethanol + NAD+ = 1-phenylethanone + NADH (#43# 46% of
	the activity with 2-phenylethanol <147>) <147,171>
SP	#44# rac-3-methylcyclohexanone + NADH + H+ =
	(1S,3S)-3-methylcyclohexanol + NAD+ <164>
SP	#47# hexadecanol + NAD+ = hexadecanal + NADH (#47# very low activity
	<59>) <59>
SP	#48# acetaldehyde + NADPH + H+ = ethanol + NADP+ (#48# 16% of the
	activity with NADH <149>) {r} <149>
SP	#48# 2-methylbutyraldehyde + NADH + H+ = 2-methylbutanol + NAD+ (#48#
	1.4% of the activity with acetaldehyde <149>) <149>
SP	#48# 2-methylpropionaldehyde + NADH + H+ = 2-methylpropanal + NAD+
	(#48# 3.3% of the activity with acetaldehyde <149>) <149>
SP	#48# 3-methylbutyraldehyde + NADH + H+ = 3-methylbutanol + NAD+ (#48#
	2.9% of the activity with acetaldehyde <149>) <149>
SP	#48# butyraldehyde + NADH + H+ = butanol + NAD+ (#48# 56% of the
	activity with acetaldehyde <149>) <149>
SP	#48# butyraldehyde + NADPH + H+ = butanol + NADP+ (#48# 22% of the
	activity with NADH <149>) <149>
SP	#48# hexanal + NADH + H+ = 1-hexanone + NAD+ (#48# 49% of the activity
	with acetaldehyde <149>) <149>
SP	#48# hexanal + NADPH + H+ = 1-hexanone + NADP+ (#48# 24% of the
	activity with NADH <149>) <149>
SP	#49# 1,3-propanediol + NAD+ = ? + NADH (#49# 7% of the activity with
	ethanol <99>) <99>
SP	#49,61# propan-1,2-diol + NAD+ = ? + NADH <69,99>
SP	#5# benzaldehyde + NADH = benzyl alcohol + NAD+ (#5# reduced by
	isoenzyme A2 and C2, no activity with isoenzyme B2 <48>) {r} <48>
SP	#5# p-nitrobenzaldehyde + NADH = p-nitrobenzyl alcohol + NAD+ <48>
SP	#5# hexanol + NAD+ = hexaldehyde + NADH <118>
SP	#5# a primary alcohol + NAD+ = an aldehyde + NADH + H+ (#5# ADH3 is
	involved in multiple cellular pathways, as diverse as formaldehyde
	detoxification, retinoid metabolism and NO homeostasis, ADH3 is
	considered to play only a minor role in hepatic alcohol metabolism
	because ethanol concentrations rarely exceed 50 mM <198>) {?} <198>
SP	#5,10,37# allyl alcohol + NAD+ = acrolein + NADH |#5# product is toxic
	in mouse hepatocytes due to cell protein carbonylation following
	exposure to crotyl alcohol <116>| <116,119>
SP	#5,10,37# allyl alcohol + NAD+ = acrolein + NADH |#5# product is toxic
	in mouse hepatocytes due to cell protein carbonylation following
	exposure to crotyl alcohol <116>| {r} <116,119>
SP	#5,30# (E)-hex-2-en-1-ol + NAD+ = (E)-hex-2-en-1-one + NADH (#30# 43.2%
	of the activity with ethanol <73>) <48,73>
SP	#5,37,80# crotyl alcohol + NAD+ = crotonaldehyde + NADH (#37# product
	is toxic in mouse hepatocytes due to cell protein carbonylation
	following exposure to crotyl alcohol <116>) |#5# product is toxic in
	mouse hepatocytes due to cell protein carbonylation following exposure
	to crotyl alcohol <116>| <116,117>
SP	#5,38,49# formaldehyde + NAD+ = methanol + NADH (#38# activity with ADH
	I, no activity with ADH II <68>; #5# reduced by isoenzyme A2, no
	activity with isoenzyme B2 and C2 <48>) <48,68,99>
SP	#5,38,49# formaldehyde + NAD+ = methanol + NADH (#38# activity with ADH
	I, no activity with ADH II <68>; #5# reduced by isoenzyme A2, no
	activity with isoenzyme B2 and C2 <48>) {r} <48,68,99>
SP	#5,8# 7-cis-retinol + NAD+ = 7-cis-retinal + NADH <118>
SP	#5,8# octanol + NAD+ = octanal + NADH {?} <109,114,198>
SP	#5,8# octanol + NAD+ = octanal + NADH <109,114,198>
SP	#5,8,10,13,29,37,38,42,50,64,78,83,84,86,87,91,92,94,97,98,99,100,101
	102,103,104# ethanol + NAD+ = acetaldehyde + NADH + H+ (#103# 100%
	activity <211>; #92# no activity with NADP+, in reverse reaction no
	activity with NADPH <169>; #29# the enzyme is highly specific for
	ethanol with NAD+ as the coenzyme <179>; #104# 88% activity compared to
	cyclohexanol <195>; #98# substrate for isozyme ADH1C, extremely poor
	substrate for isozyme ADH3 <212>; #98# substrate for isozyme ADH2
	<212>; #101# substrate for isozyme ADH4 <212>) {?}
	<135,137,138,141,142,145,146,151,157,159,160,161,169,171,172,179,192
	193,194,195,201,203,205,206,207,208,209,210,211,212>
SP	#5,8,10,13,29,37,38,42,50,64,78,83,84,86,87,91,92,94,97,98,99,100,101
	102,103,104# ethanol + NAD+ = acetaldehyde + NADH + H+ (#103# 100%
	activity <211>; #92# no activity with NADP+, in reverse reaction no
	activity with NADPH <169>; #29# the enzyme is highly specific for
	ethanol with NAD+ as the coenzyme <179>; #104# 88% activity compared to
	cyclohexanol <195>; #98# substrate for isozyme ADH1C, extremely poor
	substrate for isozyme ADH3 <212>; #98# substrate for isozyme ADH2
	<212>; #101# substrate for isozyme ADH4 <212>) {r}
	<135,137,138,141,142,145,146,151,157,159,160,161,169,171,172,179,192
	193,194,195,201,203,205,206,207,208,209,210,211,212>
SP	#5,8,10,13,29,37,38,42,50,64,78,83,84,86,87,91,92,94,97,98,99,100,101
	102,103,104# ethanol + NAD+ = acetaldehyde + NADH + H+ (#103# 100%
	activity <211>; #92# no activity with NADP+, in reverse reaction no
	activity with NADPH <169>; #29# the enzyme is highly specific for
	ethanol with NAD+ as the coenzyme <179>; #104# 88% activity compared to
	cyclohexanol <195>; #98# substrate for isozyme ADH1C, extremely poor
	substrate for isozyme ADH3 <212>; #98# substrate for isozyme ADH2
	<212>; #101# substrate for isozyme ADH4 <212>)
	<135,137,138,141,142,145,146,151,157,159,160,161,169,171,172,179,192
	193,194,195,201,203,205,206,207,208,209,210,211,212>
SP	#5,8,10,13,29,37,38,42,50,64,78,83,84,86,87,91,92,94,97,98,99,100,101
	102,103,104# ethanol + NAD+ = acetaldehyde + NADH + H+ (#103# 100%
	activity <211>; #92# no activity with NADP+, in reverse reaction no
	activity with NADPH <169>; #29# the enzyme is highly specific for
	ethanol with NAD+ as the coenzyme <179>; #104# 88% activity compared to
	cyclohexanol <195>; #98# substrate for isozyme ADH1C, extremely poor
	substrate for isozyme ADH3 <212>; #98# substrate for isozyme ADH2
	<212>; #101# substrate for isozyme ADH4 <212>) {r}
	<135,137,138,141,142,145,146,151,157,159,160,161,169,171,172,179,192
	193,194,195,201,203,205,206,207,208,209,210,211,212>
SP	#5,8,33,37# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#8#
	ADH4 might be involved in biosynthesis of retinoic acid <123>) {?}
	<47,53,93,95,106,118,123,198>
SP	#5,8,33,37# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#8#
	ADH4 might be involved in biosynthesis of retinoic acid <123>)
	<47,53,93,95,106,118,123,198>
SP	#5,8,33,37# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#8#
	ADH4 might be involved in biosynthesis of retinoic acid <123>) {r}
	<47,53,93,95,106,118,123,198>
SP	#5,8,33,37,38,63,76# hexanol + NAD+ = n-hexanal + NADH (#38# activity
	with ADH I, no activity with ADH II <68>)
	<20,21,42,48,53,68,84,92,95,101>
SP	#5,8,33,37,38,63,76# hexanol + NAD+ = n-hexanal + NADH (#38# activity
	with ADH I, no activity with ADH II <68>) {}
	<20,21,42,48,53,68,84,92,95,101>
SP	#5,8,34,62# ethylene glycol + NAD+ = ? + NADH (#62# no activity <60>;
	#8# class III isoenzyme chi-ADH shows no activity <16>; #5# oxidized by
	isoenzyme A2, no activity with isoenzyme B2 and C2 <48>)
	<13,14,16,48,60,85>
SP	#5,8,34,62# ethylene glycol + NAD+ = ? + NADH (#62# no activity <60>;
	#8# class III isoenzyme chi-ADH shows no activity <16>; #5# oxidized by
	isoenzyme A2, no activity with isoenzyme B2 and C2 <48>) {}
	<13,14,16,48,60,85>
SP	#5,8,37# 9-cis-retinol + NAD+ = 9-cis-retinal + NADH <93,118>
SP	#5,8,37# 11-cis-retinol + NAD+ = 11-cis-retinal + NADH <93,118>
SP	#5,8,37# 13-cis-retinol + NAD+ = 13-cis-retinal + NADH (#5,8# no
	activity with isozyme ADH1 <118>) <93,118>
SP	#5,8,37,39,63,72# pentanol + NAD+ = pentanone + NADH (#5# oxidized by
	isoenzyme A2 and B2, no activity with isoenzyme C2 <48>)
	<14,16,18,20,24,25,48,53,84,92,96>
SP	#5,8,9,12,19,34,38,39,46,47,50,51,62,63,72,76,80,91,92,103# methanol +
	NAD+ = formaldehyde + NADH + H+ (#8,19,34,38,62,63# no activity
	<21,60,67,68,75,84,85>; #80# low activity <117>; #46# reaction is
	extremly weak <82>; #8# anodic enzyme form shows no activity <18>; #12#
	no activity at pH 7.5, slight activity at pH 10.8 <45>; #5# weak
	activity with isoenzyme A2, no activity with isoenzyme B2 and C2 <48>;
	#9# oxidized with ADH-3, no activity with ADH-1 and ADH-2 <49>; #8#
	class I isoenzymes <13>; #8# no activity with isoenzyme beta3,beta3
	<20>; #72# reaction is catalyzed by the pyrazole-sensitive enzyme, no
	activity with the pyrazole-insensitive enzyme <24>; #39# reaction is
	catalyzed by the cathodic pyrazole-sensitive enzyme, no activity by the
	cathodic pyrazole-insensitive enzyme and by the anodic
	pyrazole-insensitive enzyme <25>; #8# activity detected with class II
	isoenzyme pi-ADH <14>; #8# oxidized by isoenzyme beta1,beta1 <20>; #8#
	class III isoenzyme chi-ADH shows no activity <16>; #8# no activity
	with class III enzyme <11>; #103# 49.9% activity compared to ethanol
	<211>)
	<11,12,13,14,16,18,20,21,24,25,45,48,49,59,60,67,68,75,82,84,85,101,117
	145,169,171,211>
SP	#5,8,9,12,19,34,38,39,46,47,50,51,62,63,72,76,80,91,92,103# methanol +
	NAD+ = formaldehyde + NADH + H+ (#8,19,34,38,62,63# no activity
	<21,60,67,68,75,84,85>; #80# low activity <117>; #46# reaction is
	extremly weak <82>; #8# anodic enzyme form shows no activity <18>; #12#
	no activity at pH 7.5, slight activity at pH 10.8 <45>; #5# weak
	activity with isoenzyme A2, no activity with isoenzyme B2 and C2 <48>;
	#9# oxidized with ADH-3, no activity with ADH-1 and ADH-2 <49>; #8#
	class I isoenzymes <13>; #8# no activity with isoenzyme beta3,beta3
	<20>; #72# reaction is catalyzed by the pyrazole-sensitive enzyme, no
	activity with the pyrazole-insensitive enzyme <24>; #39# reaction is
	catalyzed by the cathodic pyrazole-sensitive enzyme, no activity by the
	cathodic pyrazole-insensitive enzyme and by the anodic
	pyrazole-insensitive enzyme <25>; #8# activity detected with class II
	isoenzyme pi-ADH <14>; #8# oxidized by isoenzyme beta1,beta1 <20>; #8#
	class III isoenzyme chi-ADH shows no activity <16>; #8# no activity
	with class III enzyme <11>; #103# 49.9% activity compared to ethanol
	<211>) {r}
	<11,12,13,14,16,18,20,21,24,25,45,48,49,59,60,67,68,75,82,84,85,101,117
	145,169,171,211>
SP	#5,8,9,12,19,34,38,39,46,47,50,51,62,63,72,76,80,91,92,103# methanol +
	NAD+ = formaldehyde + NADH + H+ (#8,19,34,38,62,63# no activity
	<21,60,67,68,75,84,85>; #80# low activity <117>; #46# reaction is
	extremly weak <82>; #8# anodic enzyme form shows no activity <18>; #12#
	no activity at pH 7.5, slight activity at pH 10.8 <45>; #5# weak
	activity with isoenzyme A2, no activity with isoenzyme B2 and C2 <48>;
	#9# oxidized with ADH-3, no activity with ADH-1 and ADH-2 <49>; #8#
	class I isoenzymes <13>; #8# no activity with isoenzyme beta3,beta3
	<20>; #72# reaction is catalyzed by the pyrazole-sensitive enzyme, no
	activity with the pyrazole-insensitive enzyme <24>; #39# reaction is
	catalyzed by the cathodic pyrazole-sensitive enzyme, no activity by the
	cathodic pyrazole-insensitive enzyme and by the anodic
	pyrazole-insensitive enzyme <25>; #8# activity detected with class II
	isoenzyme pi-ADH <14>; #8# oxidized by isoenzyme beta1,beta1 <20>; #8#
	class III isoenzyme chi-ADH shows no activity <16>; #8# no activity
	with class III enzyme <11>; #103# 49.9% activity compared to ethanol
	<211>) {ir}
	<11,12,13,14,16,18,20,21,24,25,45,48,49,59,60,67,68,75,82,84,85,101,117
	145,169,171,211>
SP	#5,8,9,12,19,34,38,39,46,47,50,51,62,63,72,76,80,91,92,103# methanol +
	NAD+ = formaldehyde + NADH + H+ (#8,19,34,38,62,63# no activity
	<21,60,67,68,75,84,85>; #80# low activity <117>; #46# reaction is
	extremly weak <82>; #8# anodic enzyme form shows no activity <18>; #12#
	no activity at pH 7.5, slight activity at pH 10.8 <45>; #5# weak
	activity with isoenzyme A2, no activity with isoenzyme B2 and C2 <48>;
	#9# oxidized with ADH-3, no activity with ADH-1 and ADH-2 <49>; #8#
	class I isoenzymes <13>; #8# no activity with isoenzyme beta3,beta3
	<20>; #72# reaction is catalyzed by the pyrazole-sensitive enzyme, no
	activity with the pyrazole-insensitive enzyme <24>; #39# reaction is
	catalyzed by the cathodic pyrazole-sensitive enzyme, no activity by the
	cathodic pyrazole-insensitive enzyme and by the anodic
	pyrazole-insensitive enzyme <25>; #8# activity detected with class II
	isoenzyme pi-ADH <14>; #8# oxidized by isoenzyme beta1,beta1 <20>; #8#
	class III isoenzyme chi-ADH shows no activity <16>; #8# no activity
	with class III enzyme <11>; #103# 49.9% activity compared to ethanol
	<211>) {}
	<11,12,13,14,16,18,20,21,24,25,45,48,49,59,60,67,68,75,82,84,85,101,117
	145,169,171,211>
SP	#5,8,9,12,19,34,38,39,46,47,50,51,62,63,72,76,80,91,92,103# methanol +
	NAD+ = formaldehyde + NADH + H+ (#8,19,34,38,62,63# no activity
	<21,60,67,68,75,84,85>; #80# low activity <117>; #46# reaction is
	extremly weak <82>; #8# anodic enzyme form shows no activity <18>; #12#
	no activity at pH 7.5, slight activity at pH 10.8 <45>; #5# weak
	activity with isoenzyme A2, no activity with isoenzyme B2 and C2 <48>;
	#9# oxidized with ADH-3, no activity with ADH-1 and ADH-2 <49>; #8#
	class I isoenzymes <13>; #8# no activity with isoenzyme beta3,beta3
	<20>; #72# reaction is catalyzed by the pyrazole-sensitive enzyme, no
	activity with the pyrazole-insensitive enzyme <24>; #39# reaction is
	catalyzed by the cathodic pyrazole-sensitive enzyme, no activity by the
	cathodic pyrazole-insensitive enzyme and by the anodic
	pyrazole-insensitive enzyme <25>; #8# activity detected with class II
	isoenzyme pi-ADH <14>; #8# oxidized by isoenzyme beta1,beta1 <20>; #8#
	class III isoenzyme chi-ADH shows no activity <16>; #8# no activity
	with class III enzyme <11>; #103# 49.9% activity compared to ethanol
	<211>) {?}
	<11,12,13,14,16,18,20,21,24,25,45,48,49,59,60,67,68,75,82,84,85,101,117
	145,169,171,211>
SP	#5,8,9,19,33,37,42,51,62# benzyl alcohol + NAD+ = benzaldehyde + NADH
	(#19# no activity <75>; #5# oxidized by isoenzyme A2 and C2 no activity
	with isoenzyme B2 <48>; #9# oxidation with isoenzyme ADH-1 and ADH-3,
	no activity with isoenzyme ADH-2 <49>) {r}
	<13,14,16,42,47,48,49,60,66,70,75,96,109,145>
SP	#5,8,9,19,33,37,42,51,62# benzyl alcohol + NAD+ = benzaldehyde + NADH
	(#19# no activity <75>; #5# oxidized by isoenzyme A2 and C2 no activity
	with isoenzyme B2 <48>; #9# oxidation with isoenzyme ADH-1 and ADH-3,
	no activity with isoenzyme ADH-2 <49>)
	<13,14,16,42,47,48,49,60,66,70,75,96,109,145>
SP	#5,8,9,19,33,37,42,51,62# benzyl alcohol + NAD+ = benzaldehyde + NADH
	(#19# no activity <75>; #5# oxidized by isoenzyme A2 and C2 no activity
	with isoenzyme B2 <48>; #9# oxidation with isoenzyme ADH-1 and ADH-3,
	no activity with isoenzyme ADH-2 <49>) {}
	<13,14,16,42,47,48,49,60,66,70,75,96,109,145>
SP	#5,8,9,19,33,39,60,62,71,74,76# cyclohexanol + NAD+ = cyclohexanone +
	NADH (#19# no activity <75>; #5# oxidized by isoenzyme A2, no activity
	with isoenzymes B2 and C2 <48>; #39# reaction is catalyzed by the
	cathodic pyrazole-sensitive enzyme, no activity with the cathodic
	pyrazole-insensitive enzyme and by the anodic pyrazole-insensitive
	enzyme <25>) <13,14,25,47,48,49,60,61,75,77,78,95,101>
SP	#5,8,9,19,33,39,60,62,71,74,76# cyclohexanol + NAD+ = cyclohexanone +
	NADH (#19# no activity <75>; #5# oxidized by isoenzyme A2, no activity
	with isoenzymes B2 and C2 <48>; #39# reaction is catalyzed by the
	cathodic pyrazole-sensitive enzyme, no activity with the cathodic
	pyrazole-insensitive enzyme and by the anodic pyrazole-insensitive
	enzyme <25>) {} <13,14,25,47,48,49,60,61,75,77,78,95,101>
SP	#5,8,9,19,34,38,39,62,63,76# octan-1-ol + NAD+ = n-octanal + NADH (#63#
	weak activity <84>; #38# activity with ADH I, no activity with ADH II
	<68>) <11,13,14,21,25,48,49,60,68,75,84,85,101>
SP	#50# 1,2-propanediol + NAD+ = hydroxyacetone + NADH + H+ <145>
SP	#50# glycerol + NAD+ = dihydroxyacetone + NADH + H+ <145>
SP	#51# 1,2-propanediol + NAD+ = hydroxyacetone + NADH <145>
SP	#51# 1-propanol + NAD+ = propanal + NADH <145>
SP	#51,82# glycerol + NAD+ = dihydroxyacetone + NADH <104,145>
SP	#53# butylaldehyde + NADH = n-butanol + NAD+ (#53# best substrate for
	isozyme ADH II <112>) {r} <112>
SP	#6# 1-(4'-chlorophenyl)ethanol + NAD+ = 1-(4'-chlorophenyl)ethanone +
	NADH + H+ (#6# 26% of the activity with (S)-(-)-1-phenylethanol <167>)
	<167>
SP	#6# 1-(4-fluorophenyl)ethanol + NAD+ = 1-(4-fluorophenyl)ethanone +
	NADH + H+ (#6# 45% of the activity with (S)-(-)-1-phenylethanol <167>)
	<167>
SP	#6# 1-phenyl-1,2-propanedione + NADH + H+ = ? (#6# activity is 1.46fold
	higher than with 2,2,2-trifluoroacetophenone <167>) <167>
SP	#6# 1-phenyl-1-propanol + NAD+ = 1-phenyl-1-propanone + NADH + H+ (#6#
	59% of the activity with (S)-(-)-1-phenylethanol <167>) <167>
SP	#6# 2,2,2-trifluoroacetophenone + NADH + H+ =
	(R)-alpha-(trifluoromethyl)benzyl alcohol + NAD+ (#6# 93% enantiomeric
	excess <167>) <167>
SP	#6# 2,2-dichloroacetophenone + NADH + H+ = 2,2-dichloro-1-phenylethanol
	+ NAD+ (#6# 32% of the activity with 2,2,2-trifluoroacetophenone <167>)
	<167>
SP	#6# 2-methoxybenzaldehyde + NADH + H+ = 2-methoxybenzylalcohol + NAD+
	(#6# 13% of the activity with 2,2,2-trifluoroacetophenone <167>) <167>
SP	#6# 2-methoxybenzyl alcohol + NAD+ = 2-methoxybenzaldehyde + NADH + H+
	(#6# 25% of the activity with (S)-(-)-1-phenylethanol <167>) <167>
SP	#6# 3-methoxybenzaldehyde + NADH + H+ = 3-methoxybenzylalcohol + NAD+
	(#6# 14% of the activity with 2,2,2-trifluoroacetophenone <167>) <167>
SP	#6# 4-chlorobutyrophenone + NADH + H+ = 1-(4-chlorophenyl)butan-1-ol +
	NAD+ (#6# 10% of the activity with 2,2,2-trifluoroacetophenone <167>)
	<167>
SP	#6# 4-methoxybenzaldehyde + NADH + H+ = 4-methoxybenzylalcohol + NAD+
	(#6# 13% of the activity with 2,2,2-trifluoroacetophenone <167>) <167>
SP	#6# acetophenone + NADH + H+ = (S)-(-)-1-phenylethanol + NAD+ (#6# more
	than 99% enantiomeric excess <167>) {r} <167>
SP	#6# alpha-tetralone + NADH + H+ = (S)-alpha-tetralol + NAD+ (#6# more
	than 99% enantiomeric excess <167>) <167>
SP	#6# ethyl benzoylformate + NADH + H+ = ethyl (R)-(-)-mandelate + NAD+
	(#6# 95% enantiomeric excess <167>) <167>
SP	#6# methyl benzoylformate + NADH + H+ = methyl (R)-(-)-mandelate + NAD+
	(#6# 92% enantiomeric excess <167>) <167>
SP	#6# methylbenzoylformate + NADH + H+ = ? (#6# 13% of the activity with
	2,2,2-trifluoroacetophenone <167>) <167>
SP	#6# trans-cinnamyl alcohol + NAD+ = (2E)-3-phenylprop-2-enal + NADH +
	H+ (#6# activity is 3.9fold higher than with (S)-(-)-1-phenylethanol
	<167>) <167>
SP	#6# (S)-(+)-1-indanol + NAD+ = indanone + NADH + H+ <167>
SP	#6,10,84,85,90,105# 2-propanol + NAD+ = acetone + NADH + H+ (#90# about
	50% of activity with ethanol, ADH1 <170>) <136,142,167,170,200>
SP	#6,10,84,85,90,105# 2-propanol + NAD+ = acetone + NADH + H+ (#90# about
	50% of activity with ethanol, ADH1 <170>) {?} <136,142,167,170,200>
SP	#6,10,84,85,90,105# 2-propanol + NAD+ = acetone + NADH + H+ (#90# about
	50% of activity with ethanol, ADH1 <170>) {r} <136,142,167,170,200>
SP	#6,10,84,85,90,105# 2-propanol + NAD+ = acetone + NADH + H+ (#90# about
	50% of activity with ethanol, ADH1 <170>) {ir} <136,142,167,170,200>
SP	#6,104# 1-indanol + NAD+ = 1-indanone + NADH + H+ |#104# 1% activity
	compared to cyclohexanone <195>| <167,195>
SP	#6,104# 1-indanol + NAD+ = 1-indanone + NADH + H+ |#104# 1% activity
	compared to cyclohexanone <195>| {r} <167,195>
SP	#6,104# 1-phenyl-2-propanol + NAD+ = 1-phenyl-2-propanone + NADH + H+
	(#6# 16% of the activity with (S)-(-)-1-phenylethanol <167>; #104# 3%
	activity compared to cyclohexanol <195>) <167,195>
SP	#6,104# 1-phenyl-2-propanol + NAD+ = 1-phenyl-2-propanone + NADH + H+
	(#6# 16% of the activity with (S)-(-)-1-phenylethanol <167>; #104# 3%
	activity compared to cyclohexanol <195>) {r} <167,195>
SP	#6,25,42,48,88,93# benzaldehyde + NADH + H+ = benzyl alcohol + NAD+
	(#48# 1.2% of the activity with acetaldehyde <149>; #88# 3% activity
	compared to benzyl alcohol <154>; #6# 14% of the activity with
	2,2,2-trifluoroacetophenone <167>; #25# 21% of activity with
	N-benzyl-3-pyrrolidinone <186>; #93# 74% of the activity with
	N-benzyl-3-pyrrolidinone <183>) <149,154,156,167,183,186>
SP	#6,25,42,48,88,93# benzaldehyde + NADH + H+ = benzyl alcohol + NAD+
	(#48# 1.2% of the activity with acetaldehyde <149>; #88# 3% activity
	compared to benzyl alcohol <154>; #6# 14% of the activity with
	2,2,2-trifluoroacetophenone <167>; #25# 21% of activity with
	N-benzyl-3-pyrrolidinone <186>; #93# 74% of the activity with
	N-benzyl-3-pyrrolidinone <183>) {r} <149,154,156,167,183,186>
SP	#6,42# 3-methoxybenzyl alcohol + NAD+ = 3-methoxybenzaldehyde + NADH +
	H+ (#6# 13% of the activity with (S)-(-)-1-phenylethanol <167>)
	<151,167>
SP	#6,42,97# 4-methoxybenzyl alcohol + NAD+ = 4-methoxybenzaldehyde + NADH
	+ H+ (#6# 99% of the activity with (S)-(-)-1-phenylethanol <167>) {r}
	<151,152,167,205>
SP	#6,42,97# 4-methoxybenzyl alcohol + NAD+ = 4-methoxybenzaldehyde + NADH
	+ H+ (#6# 99% of the activity with (S)-(-)-1-phenylethanol <167>) {r}
	<151,152,167,205>
SP	#6,42,97# 4-methoxybenzyl alcohol + NAD+ = 4-methoxybenzaldehyde + NADH
	+ H+ (#6# 99% of the activity with (S)-(-)-1-phenylethanol <167>)
	<151,152,167,205>
SP	#6,42,97,104# cyclohexanol + NAD+ = cyclohexanone + NADH + H+ (#104#
	100% activity <195>; #6# 13% of the activity with
	(S)-(-)-1-phenylethanol <167>) |#104# 100% activity <195>|
	<151,152,161,167,195,205>
SP	#6,42,97,104# cyclohexanol + NAD+ = cyclohexanone + NADH + H+ (#104#
	100% activity <195>; #6# 13% of the activity with
	(S)-(-)-1-phenylethanol <167>) |#104# 100% activity <195>| {r}
	<151,152,161,167,195,205>
SP	#6,8,10,13,14,25,33,37,38,42,46,47,48,53,54,71,80,82,84,85,88,90,93,98
	101,102,104,106# More = ? (#14# broad substrate specificity <125>; #10#
	constitutive enzyme <94>; #38# key enzyme in ethanol production <68>;
	#46# one constitutive enzyme, ADH-MI and one inducible enzyme, ADH-MII
	<82>; #47# enzyme may be involved in the metabolism of dietary wax
	esters in salmonid fish <59>; #71# the enzyme oxidizes alcohols to
	aldehydes or ketones both for detoxification and metabolic purposes
	<38>; #33# involvement in the development of male hamster reproductive
	system <47>; #80# enzyme shows high substrate specificity towards
	primary aliphatic alcohols, no activity with 2-butanol, tert-butanol,
	isoamyl alcohol, isobutyl alcohol, 1,6-hexadiol, and mono-, di-, and
	triethanolamine <117>; #82# no activity with methanol, 2-propanol, and
	isoamyl alcohol <104>; #10# substrate specificity and
	stereospecificity, substrate binding pocket structure of the 3
	isozymes, involving Met294, Trp57, and Trp93 <119>; #53# substrate
	specificity of the 2 isozmyes with various substrates, overview,
	isozymes are highly specific for the (R)-stereoisomers and
	enantioselctive for the R(-)isomers <112>; #42# the enzyme undergoes a
	substantial conformational change in the apo-holo transition,
	accompanied by loop movements at the domain interface <107>; #54#
	alcohol dehydrogenase activity may not limit alcohol supply for ester
	production during ripening <144>; #48# Cm-ADH2 cannot reduce branched
	aldehydes <149>; #10# effects of pressure on deuterium isotope effects
	of yeast alcohol dehydrogenase using alternative substrates <137>; #84#
	no activity with methanol <142>; #85# the enzyme does not act on
	short-chain normal alkyl alcohols, including methanol and ethanol
	<136>; #88# no activity towards methanol, ethanol, 1-propanol,
	triethylene glycol, polyethylene glycol 400, polyethylene glycol 1000,
	D-sorbitol, D-sorbose, formaldehyde, acetaldehyde, propionaldehyde,
	butyraldehyde, and valeraldehyde <154>; #90# ADH1 preferrs primary
	alcohols containing C3-C8 carbons to secondary alcohols such as
	2-propanol and 2-butanol. ADH1 possesses specific carboxylate
	ester-forming activity <170>; #93# no activity detected with:
	N-benzyl-2-pyrrolidinone, 2-pyrrolidinone, 3-hexanone,
	4-hydroxy-2-butanone, (R)-N-benzyl-3-pyrrolidinol, ethanol,
	1,3-propanediol, 1-butanol, 1,4-butanediol, 1,2,3-butanetriol,
	1,2,4-butanetriol, acetol, 2-phenyl-1-propanol, 3-phenyl-1-propanol,
	benzyl alcohol and glycerol. No activity with NADP+ or NADPH <183>; #6#
	preference for reduction of aromatic ketones and alpha-keto esters, and
	poor activity on aromatic alcohols and aldehydes <167>; #25# when NADH
	is replaced with NADPH, the reaction rate is reduced by 0.6% <186>;
	#37# activity is severely reduced towards aliphatic alcohols of more
	than 8 carbon atoms for the free enzyme, but not so with immobilized
	HLAD, exhibiting an activity towards C22 and C24 aliphatic alcohols
	higher than 50% of the highest value, obtained with C8 <202>; #8#
	differences in the activities of total ADH and class I ADH isoenzyme
	between cancer liver tissues and healthy hepatocytes may be a factor in
	ethanol metabolism disorders, which can intensify carcinogenesis <178>;
	#104# TADH is a NAD(H)-dependent enzyme and shows a very broad
	substrate spectrum producing exclusively the (S)-enantiomer in high
	enantiomeric excess (more than 99%) during asymmetric reduction of
	ketones <195>; #98# 1-octanal is no substrate for isozyme ADH1C <212>;
	#98# 1-octanal is no substrate for isozyme ADH2 <212>; #101# 1-octanal
	is no substrate for isozyme ADH4 <212>; #104# ADH exhibits a clear
	preference for primary alcohols and corresponding aldehydes for
	aliphatic substrates, in the oxidative direction activity steeply
	increases with chain length until 1-propanol and then decreases
	slightly again with growing chain length, alpha,beta-unsaturated
	ketones like 3-penten-2-one and cyclohexenone are not converted by ADH,
	almost no conversion of methanol (0.2%) and (+)-carvone (0.4%) is
	detected <195>; #13# no activity is detected using 1 mM NADP+ <209>;
	#102# no activity towards methanol <208>; #106# substrates are a broad
	range of alkyl alcohols from ethanol to 1-triacontanol <213>) {}
	<38,47,59,68,82,94,104,107,112,117,119,125,136,137,142,144,149,154,167
	170,178,183,186,195,202,208,209,212,213>
SP	#6,8,10,13,14,25,33,37,38,42,46,47,48,53,54,71,80,82,84,85,88,90,93,98
	101,102,104,106# More = ? (#14# broad substrate specificity <125>; #10#
	constitutive enzyme <94>; #38# key enzyme in ethanol production <68>;
	#46# one constitutive enzyme, ADH-MI and one inducible enzyme, ADH-MII
	<82>; #47# enzyme may be involved in the metabolism of dietary wax
	esters in salmonid fish <59>; #71# the enzyme oxidizes alcohols to
	aldehydes or ketones both for detoxification and metabolic purposes
	<38>; #33# involvement in the development of male hamster reproductive
	system <47>; #80# enzyme shows high substrate specificity towards
	primary aliphatic alcohols, no activity with 2-butanol, tert-butanol,
	isoamyl alcohol, isobutyl alcohol, 1,6-hexadiol, and mono-, di-, and
	triethanolamine <117>; #82# no activity with methanol, 2-propanol, and
	isoamyl alcohol <104>; #10# substrate specificity and
	stereospecificity, substrate binding pocket structure of the 3
	isozymes, involving Met294, Trp57, and Trp93 <119>; #53# substrate
	specificity of the 2 isozmyes with various substrates, overview,
	isozymes are highly specific for the (R)-stereoisomers and
	enantioselctive for the R(-)isomers <112>; #42# the enzyme undergoes a
	substantial conformational change in the apo-holo transition,
	accompanied by loop movements at the domain interface <107>; #54#
	alcohol dehydrogenase activity may not limit alcohol supply for ester
	production during ripening <144>; #48# Cm-ADH2 cannot reduce branched
	aldehydes <149>; #10# effects of pressure on deuterium isotope effects
	of yeast alcohol dehydrogenase using alternative substrates <137>; #84#
	no activity with methanol <142>; #85# the enzyme does not act on
	short-chain normal alkyl alcohols, including methanol and ethanol
	<136>; #88# no activity towards methanol, ethanol, 1-propanol,
	triethylene glycol, polyethylene glycol 400, polyethylene glycol 1000,
	D-sorbitol, D-sorbose, formaldehyde, acetaldehyde, propionaldehyde,
	butyraldehyde, and valeraldehyde <154>; #90# ADH1 preferrs primary
	alcohols containing C3-C8 carbons to secondary alcohols such as
	2-propanol and 2-butanol. ADH1 possesses specific carboxylate
	ester-forming activity <170>; #93# no activity detected with:
	N-benzyl-2-pyrrolidinone, 2-pyrrolidinone, 3-hexanone,
	4-hydroxy-2-butanone, (R)-N-benzyl-3-pyrrolidinol, ethanol,
	1,3-propanediol, 1-butanol, 1,4-butanediol, 1,2,3-butanetriol,
	1,2,4-butanetriol, acetol, 2-phenyl-1-propanol, 3-phenyl-1-propanol,
	benzyl alcohol and glycerol. No activity with NADP+ or NADPH <183>; #6#
	preference for reduction of aromatic ketones and alpha-keto esters, and
	poor activity on aromatic alcohols and aldehydes <167>; #25# when NADH
	is replaced with NADPH, the reaction rate is reduced by 0.6% <186>;
	#37# activity is severely reduced towards aliphatic alcohols of more
	than 8 carbon atoms for the free enzyme, but not so with immobilized
	HLAD, exhibiting an activity towards C22 and C24 aliphatic alcohols
	higher than 50% of the highest value, obtained with C8 <202>; #8#
	differences in the activities of total ADH and class I ADH isoenzyme
	between cancer liver tissues and healthy hepatocytes may be a factor in
	ethanol metabolism disorders, which can intensify carcinogenesis <178>;
	#104# TADH is a NAD(H)-dependent enzyme and shows a very broad
	substrate spectrum producing exclusively the (S)-enantiomer in high
	enantiomeric excess (more than 99%) during asymmetric reduction of
	ketones <195>; #98# 1-octanal is no substrate for isozyme ADH1C <212>;
	#98# 1-octanal is no substrate for isozyme ADH2 <212>; #101# 1-octanal
	is no substrate for isozyme ADH4 <212>; #104# ADH exhibits a clear
	preference for primary alcohols and corresponding aldehydes for
	aliphatic substrates, in the oxidative direction activity steeply
	increases with chain length until 1-propanol and then decreases
	slightly again with growing chain length, alpha,beta-unsaturated
	ketones like 3-penten-2-one and cyclohexenone are not converted by ADH,
	almost no conversion of methanol (0.2%) and (+)-carvone (0.4%) is
	detected <195>; #13# no activity is detected using 1 mM NADP+ <209>;
	#102# no activity towards methanol <208>; #106# substrates are a broad
	range of alkyl alcohols from ethanol to 1-triacontanol <213>) {}
	<38,47,59,68,82,94,104,107,112,117,119,125,136,137,142,144,149,154,167
	170,178,183,186,195,202,208,209,212,213>
SP	#6,8,10,13,14,25,33,37,38,42,46,47,48,53,54,71,80,82,84,85,88,90,93,98
	101,102,104,106# More = ? (#14# broad substrate specificity <125>; #10#
	constitutive enzyme <94>; #38# key enzyme in ethanol production <68>;
	#46# one constitutive enzyme, ADH-MI and one inducible enzyme, ADH-MII
	<82>; #47# enzyme may be involved in the metabolism of dietary wax
	esters in salmonid fish <59>; #71# the enzyme oxidizes alcohols to
	aldehydes or ketones both for detoxification and metabolic purposes
	<38>; #33# involvement in the development of male hamster reproductive
	system <47>; #80# enzyme shows high substrate specificity towards
	primary aliphatic alcohols, no activity with 2-butanol, tert-butanol,
	isoamyl alcohol, isobutyl alcohol, 1,6-hexadiol, and mono-, di-, and
	triethanolamine <117>; #82# no activity with methanol, 2-propanol, and
	isoamyl alcohol <104>; #10# substrate specificity and
	stereospecificity, substrate binding pocket structure of the 3
	isozymes, involving Met294, Trp57, and Trp93 <119>; #53# substrate
	specificity of the 2 isozmyes with various substrates, overview,
	isozymes are highly specific for the (R)-stereoisomers and
	enantioselctive for the R(-)isomers <112>; #42# the enzyme undergoes a
	substantial conformational change in the apo-holo transition,
	accompanied by loop movements at the domain interface <107>; #54#
	alcohol dehydrogenase activity may not limit alcohol supply for ester
	production during ripening <144>; #48# Cm-ADH2 cannot reduce branched
	aldehydes <149>; #10# effects of pressure on deuterium isotope effects
	of yeast alcohol dehydrogenase using alternative substrates <137>; #84#
	no activity with methanol <142>; #85# the enzyme does not act on
	short-chain normal alkyl alcohols, including methanol and ethanol
	<136>; #88# no activity towards methanol, ethanol, 1-propanol,
	triethylene glycol, polyethylene glycol 400, polyethylene glycol 1000,
	D-sorbitol, D-sorbose, formaldehyde, acetaldehyde, propionaldehyde,
	butyraldehyde, and valeraldehyde <154>; #90# ADH1 preferrs primary
	alcohols containing C3-C8 carbons to secondary alcohols such as
	2-propanol and 2-butanol. ADH1 possesses specific carboxylate
	ester-forming activity <170>; #93# no activity detected with:
	N-benzyl-2-pyrrolidinone, 2-pyrrolidinone, 3-hexanone,
	4-hydroxy-2-butanone, (R)-N-benzyl-3-pyrrolidinol, ethanol,
	1,3-propanediol, 1-butanol, 1,4-butanediol, 1,2,3-butanetriol,
	1,2,4-butanetriol, acetol, 2-phenyl-1-propanol, 3-phenyl-1-propanol,
	benzyl alcohol and glycerol. No activity with NADP+ or NADPH <183>; #6#
	preference for reduction of aromatic ketones and alpha-keto esters, and
	poor activity on aromatic alcohols and aldehydes <167>; #25# when NADH
	is replaced with NADPH, the reaction rate is reduced by 0.6% <186>;
	#37# activity is severely reduced towards aliphatic alcohols of more
	than 8 carbon atoms for the free enzyme, but not so with immobilized
	HLAD, exhibiting an activity towards C22 and C24 aliphatic alcohols
	higher than 50% of the highest value, obtained with C8 <202>; #8#
	differences in the activities of total ADH and class I ADH isoenzyme
	between cancer liver tissues and healthy hepatocytes may be a factor in
	ethanol metabolism disorders, which can intensify carcinogenesis <178>;
	#104# TADH is a NAD(H)-dependent enzyme and shows a very broad
	substrate spectrum producing exclusively the (S)-enantiomer in high
	enantiomeric excess (more than 99%) during asymmetric reduction of
	ketones <195>; #98# 1-octanal is no substrate for isozyme ADH1C <212>;
	#98# 1-octanal is no substrate for isozyme ADH2 <212>; #101# 1-octanal
	is no substrate for isozyme ADH4 <212>; #104# ADH exhibits a clear
	preference for primary alcohols and corresponding aldehydes for
	aliphatic substrates, in the oxidative direction activity steeply
	increases with chain length until 1-propanol and then decreases
	slightly again with growing chain length, alpha,beta-unsaturated
	ketones like 3-penten-2-one and cyclohexenone are not converted by ADH,
	almost no conversion of methanol (0.2%) and (+)-carvone (0.4%) is
	detected <195>; #13# no activity is detected using 1 mM NADP+ <209>;
	#102# no activity towards methanol <208>; #106# substrates are a broad
	range of alkyl alcohols from ethanol to 1-triacontanol <213>) {}
	<38,47,59,68,82,94,104,107,112,117,119,125,136,137,142,144,149,154,167
	170,178,183,186,195,202,208,209,212,213>
SP	#60,74# 3-methylbutanol + NAD+ = ? + NADH <77,78>
SP	#60,74# cyclopentanol + NAD+ = ? + NADH <77,78>
SP	#60,74# D-glucitol + NAD+ = ? + NADH <77,78>
SP	#63# 2-ethylhexan-1-ol + NAD+ = 2-ethylhexanal + NADH (#63# weak
	activity <84>) <84>
SP	#71# phenylethanol + NAD+ = phenylacetaldehyde + NADH (#71#
	R-(+)-phenylethanol and S-(-)-phenylethanol <61>) <61>
SP	#71# 2-methylbutan-1-ol + NAD+ = ? + NADH <61>
SP	#71# 3-methylbutan-2-ol + NAD+ = 3-methylbutan-2-one + NADH (#71#
	R-(-)-3-methylbutan-2-ol and S-(+)-3-methylbutan-2-ol <61>) <61>
SP	#71# 4-methyl-1-pentanol + NAD+ = 4-methyl-1-pentanal + NADH <61>
SP	#71# hexan-2-ol + NAD+ = 2-hexanone + NADH <61>
SP	#71# trans-4-methylcyclohexanol + NAD+ = 4-methylcyclohexanone + NADH
	<61>
SP	#71# cis-4-methylcyclohexanol + NAD+ = 4-methylcyclohexanone + NADH <61>
SP	#71# heptan-2-ol + NAD+ = heptan-2-one + NADH <61>
SP	#71# heptan-4-ol + NAD+ = heptan-4-one + NADH <61>
SP	#71# R-(+)-cis-verbenol + NAD+ = ? + NADH <61>
SP	#71# R-(+)-trans-bicyclo(2.2.1)-heptanol + NAD+ =
	R-(+)-trans-bicyclo(2.2.1)-heptanal + NADH (#71#
	R-(+)-trans-bicyclo(2.2.1)-heptanol and
	S-(-)-trans-bicyclo(2.2.1)-heptanol <61>) <61>
SP	#71# S-(-)-cis-bicyclo(2.2.1)-heptanol + NAD+ =
	S-(-)-cis-bicyclo(2.2.1)-heptanal + NADH <61>
SP	#71# R-(+)-1-phenylethanol + NAD+ = 1-phenylethanone + NADH {} <61>
SP	#71# S-(-)-1-phenylethanol + NAD+ = 1-phenylethanone + NADH {} <61>
SP	#8# 3-phenyl-1-propanol + NAD+ = 3-phenyl-1-propanone + NADH <13>
SP	#8# isobutyl alcohol + NAD+ = ? + NADH <20>
SP	#8# isopentenyl alcohol + NAD+ = isopentanone + NADH <20>
SP	#8# 16-hydroxyhexadecanoate + NAD+ = 16-oxohexadecanoic acid + NADH
	<13,14>
SP	#8# vanillyl alcohol + NAD+ = vanillin + NADH <14,16>
SP	#8# tryptophol + NAD+ = ? + NADH <14>
SP	#8# 2-deoxy-D-ribose + NAD+ = ? + NADH <14>
SP	#8# 17beta-hydroxyetiocholan-3-one + NAD+ = ethiocholan-3,17-dione +
	NADH <16>
SP	#8# phenylalaninol + NAD+ = ? + NADH <16>
SP	#8# digitose + NAD+ = ? + NADH <16>
SP	#8# 3-pyridylcarbinol + NAD+ = pyridine-3-carbaldehyde + NADH <18>
SP	#8# trans-4-(N,N-dimethylamino)-cinnamaldehyde + NADH =
	trans-4-(N,N-dimethylamino)-cinnamyl alcohol + NAD+ <19>
SP	#8# retinol + NAD+ = retinal + NADH <114>
SP	#8# 5alpha-pregnan-3beta-ol-20-one + NAD+ = 5alpha-pregnan-3,20-dione +
	NADH (#8# low activity <115>) <115>
SP	#8# isobutyramide + NAD+ = ? {r} <123>
SP	#8# 3,4-dihydro-retinol + NAD+ = 3,4-dihydro-retinal {r} <106>
SP	#8# 4-hydroxy-retinol + NAD+ = 4-oxo-retinal + NADH {r} <106>
SP	#8# 5beta-cholanic acid-3-one + NADH = 5beta-cholanic acid-3-ol + NAD+
	(#8# low activity <115>) <115>
SP	#8# 5beta-pregnan-3,20-dione + NADH = ? <115>
SP	#8# 5beta-pregnan-3beta-ol-20-one + NAD+ = 5beta-pregnan-3,20-dione +
	NADH <115>
SP	#8# cyclohexanone + NADH = cyclohexanal + NAD+ <115>
SP	#8# hexanol + NAD+ = hexanal + NADH <118>
SP	#8# 4-hydroxynonenal + NADH + H+ = 4-hydroxynonenol + NAD+ (#8#
	substrate of isozyme ADH4 <192>) {r} <192>
SP	#8# 4-methoxy-1-naphthaldehyde + NAD+ = 4-methoxy-1-naphthyl alcohol +
	NADH + H+ (#8# substrate for class I ADH <178>) {?} <178>
SP	#8# 4-methoxy-1-naphthaldehyde + NADH + H+ = 4-methoxy-1-naphthyl
	alcohol + NAD+ (#8# substrate for class I ADH <204>) {r} <204>
SP	#8# 6-methoxy-2-naphthaldehyde + NAD+ = 6-methoxy-2-naphthyl alcohol +
	NADH + H+ (#8# substrate for class II ADH <178>) {?} <178>
SP	#8# 6-methoxy-2-naphthaldehyde + NADH + H+ = 6-methoxy-2-naphthyl
	alcohol + NAD+ (#8# substrate for class II ADH <204>) {r} <204>
SP	#8# m-nitrobenzaldehyde + NAD+ = m-nitrobenzyl alcohol + NADH + H+ (#8#
	substrate of class IV ADH <178>) {?} <178>
SP	#8# m-nitrobenzaldehyde + NADH + H+ = m-nitrobenzyl alcohol + NAD+ (#8#
	substrate of class IV ADH isozyme <204>) {r} <204>
SP	#8# n-butanol + NAD+ = butylaldehyde + NADH + H+ {?} <178,204>
SP	#8# n-butanol + NAD+ = butylaldehyde + NADH + H+ {r} <178,204>
SP	#8# p-nitrobenzaldehyde + NADH + H+ = p-nitrobenzyl alcohol + NAD+ (#8#
	substrate of isozyme ADH4 <192>) {r} <192>
SP	#8# retinal + NADH + H+ = retinol + NAD+ (#8# substrate of isozyme ADH4
	<192>) {r} <192>
SP	#8,10# n-butanol + NAD+ = n-butanal + NADH <119,184>
SP	#8,10# n-butanol + NAD+ = n-butanal + NADH {r} <119,184>
SP	#8,10,37,42,43,50,64,87,88,97,104,105# benzyl alcohol + NAD+ =
	benzaldehyde + NADH + H+ (#88# 100% activity <154>; #43# 199% of the
	activity with 2-phenylethanol <147>; #104# 47% activity compared to
	cyclohexanol <195>) |#104# 154% activity compared to cyclohexanone
	<195>; #104# 178% activity compared to cyclohexanone <195>| {?}
	<145,147,151,152,154,157,178,195,200,203,205>
SP	#8,10,37,42,43,50,64,87,88,97,104,105# benzyl alcohol + NAD+ =
	benzaldehyde + NADH + H+ (#88# 100% activity <154>; #43# 199% of the
	activity with 2-phenylethanol <147>; #104# 47% activity compared to
	cyclohexanol <195>) |#104# 154% activity compared to cyclohexanone
	<195>; #104# 178% activity compared to cyclohexanone <195>| {r}
	<145,147,151,152,154,157,178,195,200,203,205>
SP	#8,10,37,42,43,50,64,87,88,97,104,105# benzyl alcohol + NAD+ =
	benzaldehyde + NADH + H+ (#88# 100% activity <154>; #43# 199% of the
	activity with 2-phenylethanol <147>; #104# 47% activity compared to
	cyclohexanol <195>) |#104# 154% activity compared to cyclohexanone
	<195>; #104# 178% activity compared to cyclohexanone <195>|
	<145,147,151,152,154,157,178,195,200,203,205>
SP	#8,10,37,42,43,50,64,87,88,97,104,105# benzyl alcohol + NAD+ =
	benzaldehyde + NADH + H+ (#88# 100% activity <154>; #43# 199% of the
	activity with 2-phenylethanol <147>; #104# 47% activity compared to
	cyclohexanol <195>) |#104# 154% activity compared to cyclohexanone
	<195>; #104# 178% activity compared to cyclohexanone <195>| {r}
	<145,147,151,152,154,157,178,195,200,203,205>
SP	#8,37# 5beta-androstan-3beta-ol-17-one + NAD+ =
	5beta-androstan-3,17-dione + NADH <115>
SP	#8,37# 5beta-androstan-17beta-ol-3-one + NAD+ =
	5beta-androstan-3,17-dione + NADH (#8# low activity <115>) <115>
SP	#8,37,63,71# octan-2-ol + NAD+ = octan-2-one + NADH (#63# weak activity
	<84>; #37# (R)-2-octanol and (S)-2-octanol <31>) <16,31,61,84>
SP	#8,38# furfuryl alcohol + NAD+ = furfural + NADH (#38# activity with
	ADH I, no activity with ADH II <68>) <16,68>
SP	#8,38# furfuryl alcohol + NAD+ = furfural + NADH (#38# activity with
	ADH I, no activity with ADH II <68>) {r} <16,68>
SP	#8,9,12,19,20,34,38,60,61,62,71,74# pentanol + NAD+ = n-pentanal + NADH
	(#38# activity with ADH I, no activity with ADH II <68>)
	<11,45,49,60,61,68,69,71,75,77,78,85>
SP	#8,9,33,62# 12-hydroxydodecanoate + NAD+ = 12-oxododecanoic acid + NADH
	(#33# oxidized at pH 10, not oxidized at pH 7.5 <47>)
	<11,14,16,47,49,53,60,95,96>
SP	#8,9,33,62# 12-hydroxydodecanoate + NAD+ = 12-oxododecanoic acid + NADH
	(#33# oxidized at pH 10, not oxidized at pH 7.5 <47>) {}
	<11,14,16,47,49,53,60,95,96>
SP	#8,9,62# octanal + NADH = octanol + NAD+ <16,49,60>
SP	#80# 2,2,2-trichloroethanol + NAD+ = trichloroacetaldehyde + NADH + H+
	<117>
SP	#80# n-butanol + NAD+ = butanal + NADH (#80# low activity <117>) <117>
SP	#80# n-propanol + NAD+ = propionaldehyde + NADH <117>
SP	#81# 3,4-methylenedioxyphenyl acetone + NADH =
	(S)-(3,4-methylenedioxyphenyl)-2-propanol + NAD+ + H+ {} <131>
SP	#82# butanol + NAD+ = butanal + NADH <104>
SP	#84# 2-decanol + NAD+ = 2-decanone + NADH + H+ (#84# weak activity
	<142>) {r} <142>
SP	#84# 2-nonanol + NAD+ = 2-nonanone + NADH + H+ (#84# weak activity
	<142>) {r} <142>
SP	#84# allylalcohol + NAD+ = prop-2-enal + NADH + H+ <142>
SP	#84,104# 2-heptanol + NAD+ = 2-heptanone + NADH + H+ (#84# weak
	activity <142>; #104# 63% activity compared to cyclohexanol <195>)
	|#104# 5% activity compared to cyclohexanone <195>| {r} <142,195>
SP	#84,104# 2-heptanol + NAD+ = 2-heptanone + NADH + H+ (#84# weak
	activity <142>; #104# 63% activity compared to cyclohexanol <195>)
	|#104# 5% activity compared to cyclohexanone <195>| {r} <142,195>
SP	#84,104# 2-hexanol + NAD+ = 2-hexanone + NADH + H+ (#84# weak activity
	<142>; #104# 64% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| {r} <142,195>
SP	#84,104# 2-hexanol + NAD+ = 2-hexanone + NADH + H+ (#84# weak activity
	<142>; #104# 64% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| {r} <142,195>
SP	#84,104# 2-octanol + NAD+ = 2-octanone + NADH + H+ (#84# weak activity
	<142>; #104# 43% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| {r} <142,195>
SP	#84,104# 2-octanol + NAD+ = 2-octanone + NADH + H+ (#84# weak activity
	<142>; #104# 43% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| {r} <142,195>
SP	#84,85,88,90,102,103,104# 1-hexanol + NAD+ = hexanal + NADH + H+ (#85#
	44% of the activity with 2-propanol, in the reverse reaction 1029% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 61%
	activity compared to benzyl alcohol <154>; #90# about 90% of activity
	with ethanol, ADH1 <170>; #104# 109% activity compared to cyclohexanol
	<195>; #103# 15.3% activity compared to ethanol <211>) {r}
	<136,142,154,170,195,208,211>
SP	#84,85,88,90,102,103,104# 1-hexanol + NAD+ = hexanal + NADH + H+ (#85#
	44% of the activity with 2-propanol, in the reverse reaction 1029% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 61%
	activity compared to benzyl alcohol <154>; #90# about 90% of activity
	with ethanol, ADH1 <170>; #104# 109% activity compared to cyclohexanol
	<195>; #103# 15.3% activity compared to ethanol <211>) {?}
	<136,142,154,170,195,208,211>
SP	#84,85,88,90,102,103,104# 1-hexanol + NAD+ = hexanal + NADH + H+ (#85#
	44% of the activity with 2-propanol, in the reverse reaction 1029% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 61%
	activity compared to benzyl alcohol <154>; #90# about 90% of activity
	with ethanol, ADH1 <170>; #104# 109% activity compared to cyclohexanol
	<195>; #103# 15.3% activity compared to ethanol <211>)
	<136,142,154,170,195,208,211>
SP	#84,85,88,90,102,103,104# 1-hexanol + NAD+ = hexanal + NADH + H+ (#85#
	44% of the activity with 2-propanol, in the reverse reaction 1029% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 61%
	activity compared to benzyl alcohol <154>; #90# about 90% of activity
	with ethanol, ADH1 <170>; #104# 109% activity compared to cyclohexanol
	<195>; #103# 15.3% activity compared to ethanol <211>) {r}
	<136,142,154,170,195,208,211>
SP	#84,85,88,90,98,102,104# 1-octanol + NAD+ = octanal + NADH + H+ (#85#
	33% of the activity with 2-propanol, in the reverse reaction 435% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 11%
	activity compared to benzyl alcohol <154>; #90# about 85% of activity
	with ethanol, ADH1 <170>; #104# 57% activity compared to cyclohexanol
	<195>; #98# substrate for isozyme ADH3 <212>) {r}
	<136,142,154,170,195,208,212>
SP	#84,85,88,90,98,102,104# 1-octanol + NAD+ = octanal + NADH + H+ (#85#
	33% of the activity with 2-propanol, in the reverse reaction 435% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 11%
	activity compared to benzyl alcohol <154>; #90# about 85% of activity
	with ethanol, ADH1 <170>; #104# 57% activity compared to cyclohexanol
	<195>; #98# substrate for isozyme ADH3 <212>) {?}
	<136,142,154,170,195,208,212>
SP	#84,85,88,90,98,102,104# 1-octanol + NAD+ = octanal + NADH + H+ (#85#
	33% of the activity with 2-propanol, in the reverse reaction 435% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 11%
	activity compared to benzyl alcohol <154>; #90# about 85% of activity
	with ethanol, ADH1 <170>; #104# 57% activity compared to cyclohexanol
	<195>; #98# substrate for isozyme ADH3 <212>)
	<136,142,154,170,195,208,212>
SP	#84,85,88,90,98,102,104# 1-octanol + NAD+ = octanal + NADH + H+ (#85#
	33% of the activity with 2-propanol, in the reverse reaction 435% of
	the activity with phenyl trifluoromethyl ketone <136>; #88# 11%
	activity compared to benzyl alcohol <154>; #90# about 85% of activity
	with ethanol, ADH1 <170>; #104# 57% activity compared to cyclohexanol
	<195>; #98# substrate for isozyme ADH3 <212>) {r}
	<136,142,154,170,195,208,212>
SP	#84,88# 1-decanol + NAD+ = decanal + NADH + H+ (#88# 13% activity
	compared to benzyl alcohol <154>) {r} <142,154>
SP	#84,88# 1-decanol + NAD+ = decanal + NADH + H+ (#88# 13% activity
	compared to benzyl alcohol <154>) <142,154>
SP	#84,88# 1-nonanol + NAD+ = nonanal + NADH + H+ (#88# 12% activity
	compared to benzyl alcohol <154>) {r} <142,154>
SP	#84,88# 1-nonanol + NAD+ = nonanal + NADH + H+ (#88# 12% activity
	compared to benzyl alcohol <154>) <142,154>
SP	#84,88,102,104# 1-heptanol + NAD+ = heptanal + NADH + H+ (#88# 25%
	activity compared to benzyl alcohol <154>; #104# 80% activity compared
	to cyclohexanol <195>) {r} <142,154,195,208>
SP	#84,88,102,104# 1-heptanol + NAD+ = heptanal + NADH + H+ (#88# 25%
	activity compared to benzyl alcohol <154>; #104# 80% activity compared
	to cyclohexanol <195>) {?} <142,154,195,208>
SP	#84,88,102,104# 1-heptanol + NAD+ = heptanal + NADH + H+ (#88# 25%
	activity compared to benzyl alcohol <154>; #104# 80% activity compared
	to cyclohexanol <195>) <142,154,195,208>
SP	#84,88,102,104# 1-heptanol + NAD+ = heptanal + NADH + H+ (#88# 25%
	activity compared to benzyl alcohol <154>; #104# 80% activity compared
	to cyclohexanol <195>) {r} <142,154,195,208>
SP	#84,88,90,102,103,104# 1-pentanol + NAD+ = pentanal + NADH + H+ (#88#
	152% activity compared to benzyl alcohol <154>; #90# about 85% of
	activity with ethanol, ADH1 <170>; #104# 121% activity compared to
	cyclohexanol <195>; #103# 19.1% activity compared to ethanol <211>) {r}
	<142,154,170,195,208,211>
SP	#84,88,90,102,103,104# 1-pentanol + NAD+ = pentanal + NADH + H+ (#88#
	152% activity compared to benzyl alcohol <154>; #90# about 85% of
	activity with ethanol, ADH1 <170>; #104# 121% activity compared to
	cyclohexanol <195>; #103# 19.1% activity compared to ethanol <211>)
	{?} <142,154,170,195,208,211>
SP	#84,88,90,102,103,104# 1-pentanol + NAD+ = pentanal + NADH + H+ (#88#
	152% activity compared to benzyl alcohol <154>; #90# about 85% of
	activity with ethanol, ADH1 <170>; #104# 121% activity compared to
	cyclohexanol <195>; #103# 19.1% activity compared to ethanol <211>)
	<142,154,170,195,208,211>
SP	#84,88,90,102,103,104# 1-pentanol + NAD+ = pentanal + NADH + H+ (#88#
	152% activity compared to benzyl alcohol <154>; #90# about 85% of
	activity with ethanol, ADH1 <170>; #104# 121% activity compared to
	cyclohexanol <195>; #103# 19.1% activity compared to ethanol <211>)
	{r} <142,154,170,195,208,211>
SP	#84,90,92,93,104# 2-butanol + NAD+ = 2-butanone + NADH + H+ (#84# weak
	activity <142>; #90# about 25% of activity with ethanol, ADH1 <170>;
	#93# activity is 3.7fold higher than with (S)-N-benzyl-3-pyrrolidinol
	<183>; #104# 39% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| <142,169,170,183,195>
SP	#84,90,92,93,104# 2-butanol + NAD+ = 2-butanone + NADH + H+ (#84# weak
	activity <142>; #90# about 25% of activity with ethanol, ADH1 <170>;
	#93# activity is 3.7fold higher than with (S)-N-benzyl-3-pyrrolidinol
	<183>; #104# 39% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| {r} <142,169,170,183,195>
SP	#84,90,92,93,104# 2-butanol + NAD+ = 2-butanone + NADH + H+ (#84# weak
	activity <142>; #90# about 25% of activity with ethanol, ADH1 <170>;
	#93# activity is 3.7fold higher than with (S)-N-benzyl-3-pyrrolidinol
	<183>; #104# 39% activity compared to cyclohexanol <195>) |#104# 4%
	activity compared to cyclohexanone <195>| {r} <142,169,170,183,195>
SP	#85# (R)-2-heptanol + NAD+ = 2-heptanone + NADH + H+ (#85# 2469% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# (R)-2-hexanol + NAD+ = 2-hexanone + NADH + H+ (#85# 1906% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# (R)-2-octanol + NAD+ = 2-octanone + NADH + H+ (#85# 2406% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# (S)-2-heptanol + NAD+ = 2-heptanone + NADH + H+ (#85# 331% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# (S)-2-hexanol + NAD+ = 2-hexanone + NADH + H+ (#85# 38% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# (S)-2-octanol + NAD+ = 2-octanone + NADH + H+ (#85# 81% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# 1,1-dichloroacetone + NADH + H+ = 1,1-dichloropropan-2-ol + NADH
	(#85# 1078% of the activity with phenyl trifluoromethyl ketone <136>)
	<136>
SP	#85# 1-heptanol + NAD+ = heptanol + NADH + H+ (#85# 56% of the activity
	with 2-propanol, in the reverse reaction 755% of the activity with
	phenyl trifluoromethyl ketone <136>) {r} <136>
SP	#85# 1-phenyl-3-butanone + NADH + H+ = 1-phenylbutan-3-ol + NAD+ (#85#
	353% of the activity with phenyl trifluoromethyl ketone <136>) <136>
SP	#85# 2,3'-dichloroacetophenone + NADH + H+ =
	1-(2,3-dichlorophenyl)ethanol + NAD+ (#85# 67% of the activity with
	phenyl trifluoromethyl ketone <136>) <136>
SP	#85# 2-heptanone + NADH + H+ = (R)-2-heptanol + NAD+ (#85# 229% of the
	activity with phenyl trifluoromethyl ketone <136>) |#85# 99%
	enantiomeric excess <136>| <136>
SP	#85# 3',4'dimethoxyphenylacetone + NADH + H+ =
	1-(3,4-dimethoxyphenyl)ethanol + NAD+ (#85# 24% of the activity with
	phenyl trifluoromethyl ketone <136>) <136>
SP	#85# 3'-bromoacetophenone + NADH + H+ = 1-(3-bromophenyl)ethanol + NAD+
	(#85# 151% of the activity with phenyl trifluoromethyl ketone <136>)
	<136>
SP	#85# 3'-chloroacetophenone + NADH + H+ = 1-(3-chlorophenyl)ethanol +
	NAD+ (#85# 70% of the activity with phenyl trifluoromethyl ketone
	<136>) <136>
SP	#85# 3'-methoxyacetophenone + NADH + H+ = 1-(3-methoxyphenyl)ethanol +
	NAD+ (#85# 51% of the activity with phenyl trifluoromethyl ketone
	<136>) <136>
SP	#85# 3-chloro-2-butanone + NADH + H+ = 3-chlorobutan-2-ol + NAD+ (#85#
	151% of the activity with phenyl trifluoromethyl ketone <136>) <136>
SP	#85# 3-heptanol + NAD+ = 3-heptanone + NADH + H+ (#85# 93% of the
	activity with 2-propanol <136>) {r} <136>
SP	#85# 3-phenylpropionaldehyde + NADH = 3-phenylpropan-1-ol + NAD+ (#85#
	1218% of the activity with phenyl trifluoromethyl ketone <136>) <136>
SP	#85# 4'-bromoacetophenone + NADH + H+ = 1-(4-bromophenyl)ethanol + NAD+
	(#85# 77% of the activity with phenyl trifluoromethyl ketone <136>)
	<136>
SP	#85# 4'-chloroacetophenone + NADH + H+ = 1-(4-chlorophenyl)ethanol +
	NAD+ (#85# 60% of the activity with phenyl trifluoromethyl ketone
	<136>) <136>
SP	#85# 4-hydroxy-2-butanone + NADH + H+ = 2,4-dihydroxybutane + NAD+
	(#85# 26% of the activity with phenyl trifluoromethyl ketone <136>)
	<136>
SP	#85# acetophenone + NADH + H+ = (R)-1-phenylethanol + NAD+ (#85# 6% of
	the activity with phenyl trifluoromethyl ketone, in the reverse
	reaction 87% of the activity with 2-propanol <136>) |#85# 99%
	enantiomeric excess <136>| <136>
SP	#85# butanal + NADH = 1-butanol + NAD+ + H+ (#85# % of the activity
	with phenyl trifluoromethyl ketone <136>) {ir} <136>
SP	#85# ethyl 3-methyl-2-oxobutyrate + NADH + H+ =
	ethyl-2-hydroxy-3-methylbutyrate + NAD+ (#85# 33% of the activity with
	phenyl trifluoromethyl ketone <136>) <136>
SP	#85# ethyl 3-oxobutanoate + NADH + H+ = ethyl 3-hydroxybutanoate + NAD+
	(#85# 309% of the activity with phenyl trifluoromethyl ketone <136>)
	<136>
SP	#85# ethyl 4-bromo-3-oxobutanoate + NADH + H+ = ethyl
	4-bromo-3-hydroxybutanoate (#85# 511% of the activity with phenyl
	trifluoromethyl ketone <136>) <136>
SP	#85# ethyl 4-chloro-3-oxobutanoate + NADH + H+ = ethyl
	4-chloro-3-hydroxybutanoate + NAD+ (#85# 809% of the activity with
	phenyl trifluoromethyl ketone <136>) <136>
SP	#85# ethyl pyruvate + NADH + H+ = ethyl 2-hydroxypropanoate + NAD+
	(#85# 488% of the activity with phenyl trifluoromethyl ketone <136>)
	<136>
SP	#85# methyl 3-oxobutanoate + NADH + H+ = methyl 3-hydroxybutanoate +
	NAD+ (#85# 130% of the activity with phenyl trifluoromethyl ketone
	<136>) <136>
SP	#85# methyl 4-bromo-3-oxobutanoate + NADH + H+ = methyl
	4-bromo-3-hydroxybutanoate + NAD+ (#85# 164% of the activity with
	phenyl trifluoromethyl ketone <136>) <136>
SP	#85# pentanal + NADH = 1-pentanol + NAD+ + H+ (#85# 132% of the
	activity with phenyl trifluoromethyl ketone, in the reverse reaction 5%
	of the activity with 2-propanol <136>) <136>
SP	#85# phenyl trifluoromethyl ketone + NADH + H+ =
	(S)-1-phenyltrifluoroethanol + NAD+ |#85# more than 99% enantiomeric
	excess <136>| <136>
SP	#85# tert-butyl 3-oxobutanoate + NADH + H+ = tert butyl
	3-hydroxybutanoate + NAD+ (#85# 568% of the activity with phenyl
	trifluoromethyl ketone <136>) <136>
SP	#85,97# (R)-2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#85# 75% of
	the activity with 2-propanol <136>) {r} <136,205>
SP	#85,97# (R)-2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#85# 75% of
	the activity with 2-propanol <136>) {r} <136,205>
SP	#85,97# (S)-2-butanol + NAD+ = 2-butanone + NADH + H+ (#85# 275% of the
	activity with 2-propanol <136>) {r} <136,205>
SP	#85,97# (S)-2-butanol + NAD+ = 2-butanone + NADH + H+ (#85# 275% of the
	activity with 2-propanol <136>) {ir} <136,205>
SP	#85,97# (S)-2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#85# 25% of
	the activity with 2-propanol <136>) {r} <136,205>
SP	#85,97# (S)-2-pentanol + NAD+ = 2-pentanone + NADH + H+ (#85# 25% of
	the activity with 2-propanol <136>) {r} <136,205>
SP	#85,97# trans-cinnamaldehyde + NADH + H+ = cinnamyl alcohol + NAD+
	(#85# % of the activity with phenyl trifluoromethyl ketone <136>) {r}
	<136,205>
SP	#85,97# trans-cinnamaldehyde + NADH + H+ = cinnamyl alcohol + NAD+
	(#85# % of the activity with phenyl trifluoromethyl ketone <136>)
	<136,205>
SP	#86# iso-propanol + NAD+ = isopropanal + NADH + H+ <160>
SP	#86,92# n-propanol + NAD+ = propanal + NADH + H+ <160,169>
SP	#86,92# n-propanol + NAD+ = propanal + NADH + H+ {r} <160,169>
SP	#88# 4-nitrobenzyl alcohol + NAD+ = 4-nitrobenzaldehyde + NADH + H+
	(#88# 94% activity compared to benzyl alcohol <154>) <154>
SP	#88# choline + NAD+ = ? + NADH + H+ (#88# 3% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# decyl aldehyde + NADH + H+ = 1-decanol + NAD+ (#88# 21% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# heptaldehyde + NADH + H+ = ? + NAD+ (#88# 33% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# hexaldehyde + NADH + H+ = 1-heptanol + NAD+ (#88# 7% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# hydrocinnamaldehyde + NADH + H+ = hydrocinnamyl alcohol + NAD+
	(#88# 12% activity compared to benzyl alcohol <154>) {r} <154>
SP	#88# hydrocinnamyl alcohol + NAD+ = hydrocinnamaldehyde + NADH + H+
	(#88# 31% activity compared to benzyl alcohol <154>) {r} <154>
SP	#88# nonyl aldehyde + NADH + H+ = 1-nonanol + NAD+ (#88# 25% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# nonylphenol polyethoxylate 9 + NAD+ = ? + NADH (#88# 7% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# octyl aldehyde + NADH + H+ = 1-octanol + NAD+ (#88# 29% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# octylphenol polyethoxylate 2 + NAD+ = ? + NADH (#88# 59% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# octylphenol polyethoxylate 8 + NAD+ = ? + NADH (#88# 7% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# polyoxyethylene 8 decyl ether + NAD+ = ? + NADH (#88# 12% activity
	compared to benzyl alcohol <154>) <154>
SP	#88# Triton X-100 + NAD+ = ? + NADH (#88# 7% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# Triton X-114 + NAD+ = ? + NADH (#88# 3% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# Triton X-165 + NAD+ = ? + NADH (#88# 24% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# Triton X-35 + NAD+ = ? + NADH (#88# 43% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# Triton X-405 + NAD+ = ? + NADH (#88# 19% activity compared to
	benzyl alcohol <154>) <154>
SP	#88# Triton X-45 + NAD+ = ? + NADH (#88# 7% activity compared to benzyl
	alcohol <154>) <154>
SP	#89# acetophenone + NADPH + H+ = 1-phenylethanol + NADP+ (#89# 5.1% of
	the activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# 2-butanone + NADPH + H+ = butan-2-ol + NADP+ (#89# 12.1% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# 2-heptanone + NADPH + H+ = heptan-2-ol + NADP+ (#89# 6.8% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# 2-hexanone + NADPH + H+ = hexan-2-ol + NADP+ (#89# 5.9% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# 2-hydroxyacetophenone + NADH + H+ = (S)-1-phenyl-1,2-ethanediol +
	NAD+ (#89# 2.4% of the activity with NADPH <166>) <166>
SP	#89# 2-hydroxyacetophenone + NADPH + H+ = (S)-1-phenyl-1,2-ethanediol +
	NADP+ <166>
SP	#89# 2-octanone + NADPH + H+ = octan-2-ol + NADP+ (#89# 11.9% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# 2-pentanone + NADPH + H+ = pentan-2-ol + NADP+ (#89# 11.9% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# 3-pentanone + NADPH + H+ = pentan-3-ol + NADP+ (#89# 7.1% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# acetone + NADPH + H+ = propan-2-ol + NADP+ (#89# 14.7% of the
	activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# benzoylformic acid + NADPH + H+ = mandelate + NADP+ (#89# 2.4% of
	the activity with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# ethyl 4-chloroacetoacetate + NADPH = ? (#89# activity is 1.48fold
	higher than with 2-hydroxyacetophenone and NADPH <166>) <166>
SP	#89# ethyl trifluoroacetoacetate + NADPH + H+ =
	1-ethoxy-2,2,2-trifluoroethanol + NADP+ (#89# 4.3% of the activity with
	2-hydroxyacetophenone and NADPH <166>) <166>
SP	#9# 5alpha-androstan-17beta-ol-3-one + NADH + H+ =
	3beta,17beta-dihydroxy-5alpha-androstan + NAD+ <51>
SP	#9# 3beta,7alpha-dihydroxy-5beta-cholanoic acid + NAD+ = ? + NADH <51>
SP	#9# 3beta,12alpha-dihydroxy-5beta-cholanoic acid + NAD+ = ? + NADH <51>
SP	#9# 3beta,7alpha,12alpha-trihydroxy-5beta-cholanoic acid + NAD+ = ? +
	NADH <51>
SP	#9# m-nitrobenzaldehyde + NAD+ = m-nitrobenzyl alcohol + NADH {} <49>
SP	#9,19# 2-butene-1-ol + NAD+ = ? + NADH <49,75>
SP	#9,37# 3-oxo-5beta-androstan-17beta-ol + NADH =
	3beta,17beta-dihydroxy-5beta-androstane + NAD+ <28,42,49>
SP	#91# ethanol + NADP+ = acetaldehyde + NADPH + H+ (#91# 8.5% of the
	activity with ethanol and NAD+ <171>) <171>
SP	#91# 2,3-butanediol + H2O = ? <171>
SP	#91# 2-aminoethanol + NAD+ = ? <171>
SP	#92# 2-propanol + NAD+ = propanone + NADH + H+ {r} <169>
SP	#92# n-pentanol + NAD+ = pentanal + NADH + H+ <169>
SP	#92# n-butanal + NADH + H+ = n-butanol + NAD+ <169>
SP	#92# n-butanol + NAD+ = n-butanal + NADH + H+ <169>
SP	#93# 1,2-butanediol + NAD+ = ? (#93# 35% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 1,3-butanediol + NAD+ = ? (#93# 39% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 1,2-hexanediol + NAD+ = ? (#93# 20% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 1,2-pentanediol + NAD+ = ? (#93# 12% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 1-hexanol + NAD+ = ? (#93# 15% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 1-hydroxy-2-butanone + NADH + H+ = butane-1,2-diol + NAD+ (#93#
	59% of the activity with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# 1-pentanol + NAD+ = pentanal + NADH + H* (#93# 8% of the activity
	with (S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 1-phenyl-1-propanol + NAD+ = ? (#93# 31% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 2,3-butanediol + NAD+ = ? (#93# 83% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 2,3-butanedione + NADH + H+ = ? (#93# activity is 1.6fold higher
	than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# 2-butanone + NADH + H+ = 2-butanol + NAD+ (#93# 40% of the
	activity with N-benzyl-3-pyrrolidinone <183>) {r} <183>
SP	#93# 2-hexanone + NADH + H+ = ? (#93# activity is 1.6fold higher than
	with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# 2-hexcanol + NAD+ = 2-hexanone + NADH + H+ (#93# activity is
	11.2fold higher than with (S)-N-benzyl-3-pyrrolidinol <183>) <183>
SP	#93# 3,4-hexanedione + NADH + H+ = ? (#93# 77% of the activity with
	N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# acetophenone + NADH + H+ = + NAD+ (#93# 40% of the activity with
	N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# acetylacetone + NADH + H+ = ? (#93# 63% of the activity with
	N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# benzylacetone + NADH + H+ = 4-phenylbutan-2-ol + NAD+ (#93#
	activity is 1.3fold higher than with N-benzyl-3-pyrrolidinone <183>)
	<183>
SP	#93# cyclohexanone + NADH + H+ = ? (#93# activity is 2.1fold higher
	than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# hydoxyacetone + NADH + H+ = propane-1,2-diol + NAD+ (#93# 27% of
	the activity with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# N-benzyl-3-pyrrolidinol + NAD+ = 1-benzylpyrrolidin-3-one + NADH +
	H+ (#93# 33% of the activity with (S)-N-benzyl-3-pyrrolidinol <183>)
	<183>
SP	#93# n-butylaldehyde + NADH + H+ = butanal + NAD+ (#93# activity is
	1.8fold higher than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# n-hexylaldehyde + NADH + H+ = hexanal + NAD+ (#93# activity is
	1.6fold higher than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# n-octylaldehyde + NADH + H+ = octanal + NAD+ (#93# activity is
	1.7fold higher than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# n-valeraldehyde + NADH + H+ = n-pentanol + NAD+ (#93# activity is
	2.8fold higher than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93# propionaldehyde + NADH + H+ = ? (#93# activity is 1.1fold higher
	than with N-benzyl-3-pyrrolidinone <183>) <183>
SP	#93,104# 2,4-pentanediol + NAD+ = ? (#93# 21% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>; #104# 4% activity compared to
	cyclohexanol <195>) <183,195>
SP	#93,104# 2,4-pentanediol + NAD+ = ? (#93# 21% of the activity with
	(S)-N-benzyl-3-pyrrolidinol <183>; #104# 4% activity compared to
	cyclohexanol <195>) {?} <183,195>
SP	#97# 1-heptanol + NAD+ = 1-heptanal + NADH + H+ {r} <205>
SP	#97# 1-hexanol + NAD+ = 1-hexanal + NADH + H+ {r} <205>
SP	#97# 1-pentanol + NAD+ = 1-pentanal + NADH + H+ {r} <205>
SP	#97# 2-ethoxyethanol + NAD+ = 2-ethoxyacetaldehyde + NADH + H+ {r}
	<205>
SP	#97# isobutyraldehyde + NADH + H+ = isobutanol + NAD+ {r} <205>
SP	#97# n-butanol + NAD+ = butyraldehyde + NADH + H+ {r} <205>
SP	#97# pentan-3-ol + NAD+ = 3-pentanone + NADH + H+ {r} <205>
SP	#97,104# 3-pentanol + NAD+ = 3-pentanone + NADH + H+ (#104# 2% activity
	compared to cyclohexanol <195>) |#104# 2% activity compared to
	cyclohexanone <195>| {r} <195,205>
SP	#97,104# 3-pentanol + NAD+ = 3-pentanone + NADH + H+ (#104# 2% activity
	compared to cyclohexanol <195>) |#104# 2% activity compared to
	cyclohexanone <195>| {r} <195,205>
SP	#98,101# 1-hydroxymethyl-6-methylpyrene + NAD+ =
	1-formyl-6-methylpyrene + NADH + H+ {r} <212>
SP	#98,101# 1-hydroxymethyl-8-methylpyrene + NAD+ =
	1-formyl-8-methylpyrene + NADH + H+ {r} <212>
SP	#98,101# 1-hydroxymethylpyrene + NAD+ = 1-formylpyrene + NADH + H+ {r}
	<212>
SP	#98,101# 2-hydroxymethylpyrene + NAD+ = 2-formylpyrene + NADH + H+ {r}
	<212>
SP	#98,101# 4-hydroxymethylpyrene + NAD+ = 4-formylpyrene + NADH + H+ {r}
	<212>

TURNOVER_NUMBER
TN	#10# 1.15 {ethanol}  (#10# 10°C, pH 9.0 <142>) <142>
TN	#10# 0.152 {ethanol}  (#10# 20°C, pH 9.0 <142>) <142>
TN	#10# 143 {ethanol}  (#10# in 50 mM Tris-HCl, pH 8.0 at 25°C <207>)
	<207>
TN	#10# 251.3 {ethanol}  (#10# 10°C, pH 9.0 <142>) <142>
TN	#10# 432.3 {ethanol}  (#10# 20°C, pH 9.0 <142>) <142>
TN	#10# 786.1 {ethanol}  (#10# 30°C, pH 9.0 <142>) <142>
TN	#10# 895.4 {ethanol}  (#10# 40°C, pH 9.0 <142>) <142>
TN	#106# 43.9 {NADP+}  (#106# cosubstrate ethanol, pH 8.0, 60°C <213>)
	<213>
TN	#106# 638.7 {ethanol}  (#106# cosubstrate NAD+, pH 8.0, 60°C <213>)
	<213>
TN	#106# 404.8 {acetaldehyde}  (#106# cosubstrate NADH, pH 8.0, 60°C
	<213>) <213>
TN	#106# 443.1 {NAD+}  (#106# cosubstrate ethanol, pH 8.0, 60°C <213>)
	<213>
TN	#106# 1646 {NADH}  (#106# cosubstrate acetaldehyde, pH 8.0, 60°C
	<213>) <213>
TN	#107# 38.5 {NAD+}  (#107# cosubstrate 1-octanol, pH 8.0, 60°C <213>)
	<213>
TN	#107# 138.1 {acetaldehyde}  (#107# cosubstrate NADPH, pH 8.0, 60°C
	<213>) <213>
TN	#107# 283.1 {NADP+}  (#107# cosubstrate 1-octanol, pH 8.0, 60°C <213>)
	<213>
TN	#107# 4808 {NADPH}  (#107# cosubstrate octanal, pH 8.0, 60°C <213>)
	<213>
TN	#107# 136.2 {ethanol}  (#107# cosubstrate NADP+, pH 8.0, 60°C <213>)
	<213>
TN	#107# 260.7 {1-Octanol}  (#107# cosubstrate NADP+, pH 8.0, 60°C <213>)
	<213>
TN	#107# 518.4 {Octanal}  (#107# cosubstrate NADPH, pH 8.0, 60°C <213>)
	<213>
TN	#26# 4.5 {ethylene glycol}  <128>
TN	#29# 0.3 {acetaldehyde}  (#29# 40°C, pH 9.0, 50 mM Tris-HCl, 4 M NaCl
	<179>) <179>
TN	#29# 5.4 {acetaldehyde}  (#29# 70°C, pH 9.0, 50 mM Tris-HCl, 4 M NaCl
	<179>) <179>
TN	#29# 8.2 {ethanol}  (#29# 70°C, pH 9.0, 50 mM Tris-HCl, 4 M NaCl
	<179>) <179>
TN	#29,72# 0.4 {ethanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>;
	#29# 40°C, pH 9.0, 50 mM Tris-HCl, 4 M NaCl <179>) <24,179>
TN	#33# 8 {ethanol}  <47>
TN	#33# 1.3 {all-trans Retinol}  (#33# isoenzyme TT-ADH <95>) <47,95>
TN	#33# 2.2 {12-hydroxydodecanoate}  (#33# isoenzyme BB-ADH <95>) <95>
TN	#33# 2.8 {n-Hexanol}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 3 {methylcrotonyl alcohol}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 1.03 {12-hydroxydodecanoate}  (#33# isoenzyme TT-ADH <95>) <95>
TN	#33# 1.37 {benzyl alcohol}  <47>
TN	#33# 1.9 {all-trans Retinol}  (#33# isoenzyme BB-ADH <95>) <95>
TN	#33# 2.83 {ethanol}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 7.5 {1-Butanol}  <47>
TN	#33# 2.4 {Cyclohexanol}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 8.5 {Cyclohexanol}  (#33# isoenzyme TT-ADH <95>) <95>
TN	#33# 3.33 {n-Butanol}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 0.35 {all-trans Retinol}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 8.58 {methylcrotonyl alcohol}  (#33# isoenzyme TT-ADH <95>) <95>
TN	#33# 2.03 {Cyclohexanol}  <47>
TN	#33# 2.35 {n-Hexanol}  (#33# isoenzyme BB-ADH <95>) <95>
TN	#33# 2.43 {12-hydroxydodecanoate}  <47>
TN	#33# 2.58 {n-Butanol}  (#33# isoenzymee BB-ADH <95>) <95>
TN	#33# 2.63 {methylcrotonyl alcohol}  (#33# isoenzyme BB-ADH <95>) <95>
TN	#33# 2.77 {12-hydroxydodecanoate}  (#33# isoenzyme AA-ADH <95>) <95>
TN	#33# 3.03 {1-Hexanol}  <47>
TN	#33# 3.38 {ethanol}  (#33# isoenzyme BB-ADH <95>) <95>
TN	#33# 4.08 {n-Hexanol}  (#33# isoenzyme TT-ADH <95>) <95>
TN	#33# 4.75 {2-Butanol}  <47>
TN	#33# 7.18 {n-Butanol}  (#33# isoenzyme TT-ADH <95>) <95>
TN	#33# 7.75 {NAD+}  (#33# oxidation of ethanol <47>) <47>
TN	#33# 9.58 {ethanol}  (#33# isoenzyme TT-ADH <95>) <95>
TN	#37# 0.99 {hexyl alcohol}  <42>
TN	#37# 1 {(S)-2-butanol}  <31>
TN	#37# 0.9 {5beta-Pregnan-21-ol-3,20-dione hemisuccinate}  <42>
TN	#37# 2 {(R)-2-butanol}  <31>
TN	#37# 2.05 {3-Oxo-5beta-androstan-17beta-ol}  <42>
TN	#37# 0.24 {p-nitrophenyl octanoate}  <39>
TN	#37# 2.5 {all-trans-Retinal}  (#37# reduction with NADH <93>) <93>
TN	#37# 1.17 {Propyl alcohol}  <42>
TN	#37# 0.78 {benzyl alcohol}  <42>
TN	#37# 0.87 {(S)-2-pentanol}  <31>
TN	#37# 1.01 {(R)-2-pentanol}  <31>
TN	#37# 0.08 {3-methyl-1-butanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 5.8 {Propan-2-ol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 0.12 {2-Butanone}  <31>
TN	#37# 0.025 {9-cis-retinol}  (#37# oxidation with NAD+ <93>) <93>
TN	#37# 1.27 {ethanol}  <42>
TN	#37# 1.55 {All-trans-Retinol}  (#37# oxidation with NAD+ <93>) <93>
TN	#37# 5.9 {Cyclohexanone}  <42>
TN	#37# 6.7 {4-Methyl-1-pentanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 0.018 {13-cis-retinol}  (#37# oxidation with NAD+ <93>) <93>
TN	#37# 0.018 {13-cis-retinal}  (#37# reduction with NADH <93>) <93>
TN	#37# 0.36 {3-Pentanone}  <31>
TN	#37# 0.021 {11-cis-retinal}  (#37# reduction with NADH <93>) <93>
TN	#37# 133 {cinnamyl alcohol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 0.053 {(R)-2-octanol}  <31>
TN	#37# 308 {ethanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 98 {cinnamyl alcohol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 102 {ethanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 11.9 {butan-2-ol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 0.31 {butan-2-ol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 29.6 {Hexanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 1.52 {(S)-2-octanol}  <31>
TN	#37# 118 {Butanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 18.6 {4-Methyl-1-pentanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 23.9 {Hexanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 0.022 {11-cis-retinol}  (#37# oxidation with NAD+ <93>) <93>
TN	#37# 0.022 {all-trans-Retinal}  (#37# oxidation with NAD+ <93>) <93>
TN	#37# 123 {ethanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 0.27 {3-methyl-1-butanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 0.33 {acetone}  <31>
TN	#37# 53.1 {Propan-2-ol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#37# 28.7 {Propanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 56.6 {hexaldehyde}  <42>
TN	#37# 0.023 {9-cis-retinal}  (#37# reduction with NADH <93>) <93>
TN	#37# 0.0713 {2-Pentanone}  <31>
TN	#37# 0.58 {Isopropanol}  <31>
TN	#37# 0.94 {Butyl alcohol}  <42>
TN	#37# 2.26 {3-Pentanol}  <31>
TN	#37# 18.4 {Pentanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 29.5 {benzaldehyde}  <42>
TN	#37# 31.8 {acetaldehyde}  <42>
TN	#37# 32.7 {Butanol}  (#37# mutant enzyme W54L <92>) <92>
TN	#37# 35.4 {Butyraldehyde}  <42>
TN	#37# 41.9 {propionaldehyde}  <42>
TN	#37# 56.2 {Pentanol}  (#37# wild-type enzyme Adh 1 <92>) <92>
TN	#4,5,8,37,68# -999 {more}  (#8# turnover-numbers for the class I
	isoenzymes with the substrates ethanol, methanol, ethylene glycol,
	benzyl alcohol, octanol, cyclohexanol and 16-hydroxyhexadecanoic acid
	<13>; #37# Km-values of active-site Co(II)substituted enzyme <31>;
	#4,68# kinetics of ethanol oxidation <63>; #5# kcat for isozymes ADH1,
	and ADH4 for all retinoid substrates in forward and reverse reaction
	<118>; #8# kcat for isozymes ADH1B1, ADH1B2, and ADH4 for all retinoid
	substrates in forward and reverse reaction <118>; #5# effects of
	tert-butanol, butyramide, valeramide and capronamide on turnover-number
	of ethanol <139>) <13,28,31,63,118,139>
TN	#42# 3.3 {4-Methoxybenzaldehyde}  (#42# wild type enzyme, at 65°C
	<152>) <152>
TN	#42# 3.3 {4-Methoxybenzyl alcohol}  (#42# wild type enzyme, at 65°C
	<152>) <152>
TN	#42# 0.5 {ethanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
TN	#42# 1.1 {4-bromobenzyl alcohol}  (#42# native enzyme, at 55°C <151>)
	<151>
TN	#42# 1.1 {4-bromobenzylalcohol}  (#42# in the presence of 3 mM NAD+, in
	0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
TN	#42# 3.5 {benzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5) containing
	0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at 55°C <151>)
	<151,161>
TN	#42# 3.5 {4-bromobenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
TN	#42# 15.9 {Cyclohexanol}  (#42# mutant enzyme N249Y, at 65°C <152>)
	<152>
TN	#42# 1.5 {4-Methoxybenzyl alcohol}  (#42# native enzyme, at 55°C
	<151>) <151>
TN	#42# 1.5 {4-methoxybenzylalcohol}  (#42# in the presence of 3 mM NAD+,
	in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
TN	#42# 2.6 {1-Propanol}  (#42# wild type enzyme, at 65°C <152>) <152>
TN	#42# 0.7 {4-carboxybenzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5)
	containing 0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at
	55°C <151>) <151,161>
TN	#42# 2 {NADH}  (#42# carboxymethylated enzyme, at 55°C <151>) <151>
TN	#42# 2 {3-bromobenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
TN	#42# 2.2 {1-Propanol}  (#42# carboxymethylated enzyme, at 55°C <151>)
	<151>
TN	#42# 3.1 {methanol}  <66>
TN	#42# 1.4 {3-Methoxybenzyl alcohol}  (#42# native enzyme, at 55°C
	<151>) <151>
TN	#42# 1.4 {benzyl alcohol}  (#42# native enzyme, at 55°C <151>) <151>
TN	#42# 1.4 {benzylalcohol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>) <161>
TN	#42# 1.4 {NAD+}  (#42# in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>;
	#42# native enzyme, at 55°C <151>) <151,161>
TN	#42# 1.4 {3-methoxybenzylalcohol}  (#42# in the presence of 3 mM NAD+,
	in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
TN	#42# 16 {3-Methoxybenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
TN	#42# 0.65 {Cyclohexanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
TN	#42# 21.7 {benzyl alcohol}  (#42# mutant enzyme N249Y, at 65°C <152>)
	<152>
TN	#42# 0.6 {4-Methoxybenzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5)
	containing 0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at
	55°C <151>) <151,161>
TN	#42# 50 {NAD+}  (#42# mutant enzyme N249Y, at 65°C, in the presence of
	benzyl alcohol <152>) <152>
TN	#42# 20.5 {4-Methoxybenzaldehyde}  (#42# mutant enzyme N249Y, at 65°C
	<152>) <152>
TN	#42# 20.5 {4-Methoxybenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
TN	#42# 0.45 {2-Propanol}  (#42# carboxymethylated enzyme, at 55°C <151>)
	<151>
TN	#42# 4.6 {4-Nitrobenzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5)
	containing 0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at
	55°C <151>) <151,161>
TN	#42# 1.2 {1-Propanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
TN	#42# 1.2 {3-methoxybenzylalcohol}  (#42# in the presence of 5 mM
	benzylalcohol, in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
TN	#42# 1.2 {3-bromobenzyl alcohol}  (#42# native enzyme, at 55°C <151>)
	<151>
TN	#42# 1.2 {3-bromobenzylalcohol}  (#42# in the presence of 3 mM NAD+, in
	0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
TN	#42# 4.5 {NADH}  (#42# in 50 mM Tris-HCl (pH 7.5) containing 0.25 mM
	benzaldehyde, at 65°C <161>; #42# native enzyme, at 55°C <151>)
	<151,161>
TN	#42# 1.8 {benzaldehyde}  (#42# carboxymethylated enzyme, at 55°C
	<151>) <151>
TN	#42# 2.17 {3-methylcyclohexanone}  <66>
TN	#42# 1.02 {Cyclopentanone}  <66>
TN	#42# 0.25 {2-Propanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
TN	#42# 25.5 {4-Methoxybenzyl alcohol}  (#42# mutant enzyme N249Y, at
	65°C <152>) <152>
TN	#42# 25.5 {benzaldehyde}  (#42# mutant enzyme N249Y, at 65°C <152>)
	<152>
TN	#42# 0.85 {ethanol}  (#42# carboxymethylated enzyme, at 55°C <151>)
	<151>
TN	#42# 0.317 {acetone}  <66>
TN	#42# 14.5 {benzyl alcohol}  (#42# carboxymethylated enzyme, at 55°C
	<151>) <151>
TN	#42# 7.72 {3-methyl-cyclohexanol}  <66>
TN	#42# 0.983 {Anisaldehyde}  <66>
TN	#42# 1.22 {3-methylbutan-2-one}  <66>
TN	#42# 1.68 {benzyl alcohol}  <66>
TN	#42# 1.88 {ethanol}  <66>
TN	#42# 1.93 {Butan-2-one}  <66>
TN	#42# 1.97 {butan-1-ol}  <66>
TN	#42# 2.92 {pentan-3-ol}  <66>
TN	#42# 3.55 {butan-2-ol}  <66>
TN	#42# 3.82 {pentan2-ol}  <66>
TN	#42# 4.03 {propan-1-ol}  <66>
TN	#42# 6.92 {Propan-2-ol}  <66>
TN	#42# 16.6 {1-Propanol}  (#42# mutant enzyme N249Y, at 65°C <152>) <152>
TN	#42# 25.3 {NADH}  (#42# mutant enzyme N249Y, at 65°C, in the presence
	of benzaldehyde <152>) <152>
TN	#42# 18.5 {NAD+}  (#42# carboxymethylated enzyme, at 55°C <151>) <151>
TN	#42,97# 3.4 {NAD+}  (#42# wild type enzyme, at 65°C, in the presence
	of benzyl alcohol <152>; #97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <152,205>
TN	#42,97# 11.3 {benzaldehyde}  (#42# wild type enzyme, at 65°C <152>;
	#97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C
	<205>) <152,205>
TN	#42,97# 3.6 {benzyl alcohol}  (#42# wild type enzyme, at 65°C <152>;
	#97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C
	<205>) <152,205>
TN	#42,97# 10.3 {NADH}  (#42# wild type enzyme, at 65°C, in the presence
	of benzaldehyde <152>; #97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <152,205>
TN	#42,97# 1.2 {Cyclohexanol}  (#42# carboxymethylated enzyme, at 55°C
	<151>; #42# wild type enzyme, at 65°C <152>; #97# wild type enzyme, in
	0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <151,152,205>
TN	#5# 0.45 {Hexanol}  (#5# recombinant isozyme ADH1, pH 7.5, 25°C <118>)
	<118>
TN	#5# 3.83 {Hexanol}  (#5# recombinant isozyme ADH1, pH 10.5, 25°C
	<118>) <118>
TN	#5# 1.92 {ethanol}  (#5# recombinant isozyme ADH1, pH 7.5, 25°C <118>)
	<118>
TN	#5# 4.42 {ethanol}  (#5# recombinant isozyme ADH1, pH 10.5, 25°C
	<118>) <118>
TN	#5# 30.8 {Hexanol}  (#5# recombinant isozyme ADH4, pH 7.5, 25°C <118>)
	<118>
TN	#5# 41.3 {ethanol}  (#5# recombinant isozyme ADH4, pH 7.5, 25°C <118>)
	<118>
TN	#5# 215 {ethanol}  (#5# recombinant isozyme ADH4, pH 10.5, 25°C <118>)
	<118>
TN	#5# 86.5 {Hexanol}  (#5# recombinant isozyme ADH4, pH 10.5, 25°C
	<118>) <118>
TN	#6# 1.1 {(S)-(-)-1-phenylethanol}  (#6# 65°C <167>) <167>
TN	#6# 1.6 {4-Methoxybenzyl alcohol}  (#6# 65°C <167>) <167>
TN	#6# 3.1 {3-Methoxybenzaldehyde}  (#6# 65°C <167>) <167>
TN	#6# 0.84 {NAD+}  (#6# 65°C <167>) <167>
TN	#6# 7.7 {alpha-tetralone}  (#6# 65°C <167>) <167>
TN	#6# 45.7 {1-Indanol}  (#6# 65°C <167>) <167>
TN	#6# 8.3 {1-Indanone}  (#6# 65°C <167>) <167>
TN	#6# 52.4 {NADH}  (#6# 65°C <167>) <167>
TN	#6# 57 {(S)-(+)-alpha-tetraol}  (#6# 65°C <167>) <167>
TN	#6# 17.1 {1-phenyl-1,2-propanedione}  (#6# 65°C <167>) <167>
TN	#6# 25.5 {2,2,2-trifluoroacetophenone}  (#6# 65°C <167>) <167>
TN	#6# 38.1 {methylbenzoylformate}  (#6# 65°C <167>) <167>
TN	#6# 50.1 {ethyl benzoylformate}  (#6# 65°C <167>) <167>
TN	#6# 48.1 {alpha-tetralol}  (#6# 65°C <167>) <167>
TN	#6# 61.4 {(S)-(+)-1-indanol}  (#6# 65°C <167>) <167>
TN	#62# 4.92 {ethanol}  (#62# enzyme form ADH-2 <60>) <60>
TN	#62# 17 {Octanal}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 8.88 {NADH}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 0.75 {Cyclohexanol}  (#62# enzyme form ADH-2 <60>) <60>
TN	#62# 7.22 {butan-1-ol}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 1.45 {12-hydroxydodecanoate}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 2.52 {benzyl alcohol}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 1.85 {octan-1-ol}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 4.67 {NAD+}  (#62# enzyme form ADH-2 <60>) <60>
TN	#62# 2.92 {pentan-1-ol}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 3.55 {Cyclohexanol}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 6.18 {NAD+}  (#62# enzyme form ADH-3 <60>) <60>
TN	#62# 6.63 {ethanol}  (#62# enzyme form ADH-3 <60>) <60>
TN	#72# 0.117 {methanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>)
	<24>
TN	#72# 16.7 {acetaldehyde}  (#72# pyrazole-sensitive enzyme, pH 7.0 <24>)
	<24>
TN	#72# 0.45 {Butanol}  (#72# pyrazole-sensitive enzyme and
	pyrazole-insensitive enzyme, pH 10.0 <24>) <24>
TN	#72# 0.45 {ethanol}  (#72# pyrazole-insensitive enzyme, pH 10.0 <24>)
	<24>
TN	#72# 3.33 {acetaldehyde}  (#72# pyrazole-insensitive enzyme, pH 7.0
	<24>) <24>
TN	#72# 0.333 {Pentanol}  (#72# pyrazole-sensitive enzyme, pH 10.0 <24>)
	<24>
TN	#72# 0.35 {Butanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>) <24>
TN	#72# 0.217 {methanol}  (#72# pyrazole-sensitive enzyme, pH 10.0 <24>)
	<24>
TN	#72# 0.567 {ethanol}  (#72# pyrazole-sensitive enzyme <24>) <24>
TN	#72# 0.0833 {Butanol}  (#72# pyrazole-insensitive enzyme, pH 7.5 <24>)
	<24>
TN	#72# 0.0833 {ethanol}  (#72# pyrazole-insensitive enzyme, pH 7.5 <24>)
	<24>
TN	#72# 0.283 {Pentanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>)
	<24>
TN	#76# 1.1 {Butanol}  <101>
TN	#76# 0.05 {methanol}  <101>
TN	#76# 0.15 {Octanol}  <101>
TN	#76# 0.167 {Cyclohexanol}  <101>
TN	#76# 0.167 {Hexanol}  <101>
TN	#76# 0.467 {ethanol}  <101>
TN	#8# 0.55 {all-trans-Retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B2 <106>)
	<106>
TN	#8# 0.4 {All-trans-Retinol}  <53>
TN	#8# 8 {Pentanol}  <14>
TN	#8# 0.7 {Butanol}  (#8# pH 7.5, anodic enzyme form <18>) <18>
TN	#8# 0.7 {ethanol}  (#8# pH 7.5, anodic enzyme form <18>) <18>
TN	#8# 0.9 {All-trans-Retinol}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
TN	#8# 0.04 {Octanol}  (#8# recombinant allozyme Val308, pH 7.5, 25°C
	<114>) <114>
TN	#8# 16 {Pentanol}  <53>
TN	#8# 2.5 {ethanol}  (#8# per active site <12>) <12>
TN	#8# 2.5 {3,4-dihydro-retinol}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
TN	#8# 6.17 {16-hydroxyhexadecanoate}  <14>
TN	#8# 20 {4-oxo-retinal}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>) <106>
TN	#8# 4 {ethanol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
TN	#8# 4 {12-hydroxydodecanoate}  <14>
TN	#8# 0.11 {Retinol}  (#8# recombinant allozyme Val308, pH 7.5, 25°C
	<114>) <114>
TN	#8# 3.83 {ethanol}  (#8# isoenzyme gamma1,gamma1 <13>) <13>
TN	#8# 4.33 {Octanol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
TN	#8# 0.167 {ethanol}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C
	<114>) <114>
TN	#8# 0.167 {4-oxo-retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B1 <106>)
	<106>
TN	#8# 0.183 {1-Pentanol}  <11>
TN	#8# 0.583 {Cyclohexanol}  <14>
TN	#8# 0.75 {2-Propanol}  <14>
TN	#8# 0.75 {ethylene glycol}  <14>
TN	#8# 2.83 {1-Octanol}  <11>
TN	#8# 2.83 {2-deoxy-D-ribose}  <14>
TN	#8# 2.83 {4-hydroxy-retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B2 <106>)
	<106>
TN	#8# 7.5 {3-Phenyl-1-propanol}  <14>
TN	#8# 3.33 {Octanal}  <16>
TN	#8# 7.33 {Octanol}  <16>
TN	#8# 0.333 {12-Hydroxydodecanoic acid}  <11>
TN	#8# 2.17 {(S)-2-butanol}  <53>
TN	#8# 0.018 {all-trans-Retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B1
	<106>) <106>
TN	#8# 0.092 {4-hydroxy-retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B1
	<106>) <106>
TN	#8# 0.25 {All-trans-Retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B2 <106>)
	<106>
TN	#8# 0.667 {Pentanol}  (#8# pH 7.5, anodic enzyme form <18>) <18>
TN	#8# 0.038 {Octanol}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C
	<114>) <114>
TN	#8# 2.95 {12-hydroxydodecanoate}  <53>
TN	#8# 8.33 {Octanol}  <14>
TN	#8# 9.17 {benzyl alcohol}  <14>
TN	#8# 0.22 {3,4-dihydro-retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B2
	<106>) <106>
TN	#8# 4.67 {benzyl alcohol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
TN	#8# 17.2 {Propanol}  <53>
TN	#8# 0.245 {Pentanol}  <16>
TN	#8# 0.717 {NAD+}  (#8# pH 7.5, anodic enzyme form <18>) <18>
TN	#8# 1.83 {all-trans-Retinal}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
TN	#8# 1.83 {tryptophol}  <14>
TN	#8# 0.102 {methanol}  <12>
TN	#8# 0.467 {Vanillyl alcohol}  <16>
TN	#8# 0.683 {3-Pyridylcarbinol}  (#8# pH 7.5, anodic enzyme form <18>)
	<18>
TN	#8# 1.22 {3,4-dihydro-retinal}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
TN	#8# 3.03 {12-hydroxydodecanoate}  <16>
TN	#8# 7.83 {ethanol}  <14>
TN	#8# 7.83 {4-oxo-retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B2 <106>)
	<106>
TN	#8# 8.67 {Vanillyl alcohol}  <14>
TN	#8# 10.2 {ethanol}  (#8# pH 10.0, anodic enzyme form <18>) <18>
TN	#8# 19.5 {Hexanol}  <53>
TN	#8# 30.7 {ethanol}  <53>
TN	#8# 34.8 {Butanol}  <53>
TN	#8# 0.175 {ethanol}  (#8# recombinant allozyme Val308, pH 7.5, 25°C
	<114>) <114>
TN	#8# 0.028 {All-trans-Retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B1
	<106>) <106>
TN	#8# 0.087 {Retinol}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C
	<114>) <114>
TN	#8# 34.2 {4-hydroxy-retinol}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
TN	#8# 0.088 {3,4-dihydro-retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B2
	<106>) <106>
TN	#84# 34 {ethanol}  (#84# 20°C, pH 9.0 <142>) <142>
TN	#84# 10 {ethanol}  (#84# 40°C, pH 9.0 <142>) <142>
TN	#84# 39.9 {ethanol}  (#84# 10°C, pH 9.0 <142>) <142>
TN	#84# 62.48 {ethanol}  (#84# 20°C, pH 9.0 <142>) <142>
TN	#84# 109.5 {ethanol}  (#84# 30°C, pH 9.0 <142>) <142>
TN	#84# 160.8 {ethanol}  (#84# 40°C, pH 9.0 <142>) <142>
TN	#84# 262.3 {ethanol}  (#84# 50°C, pH 9.0 <142>) <142>
TN	#84# 474.9 {ethanol}  (#84# 60°C, pH 9.0 <142>) <142>
TN	#9# 0.833 {1-Butanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 1 {1-Octanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 1 {benzyl alcohol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 1 {ethanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 1.5 {Cyclohexanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 1.17 {1-Pentanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 20 {12-hydroxydodecanoate}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9# 1.67 {2-Buten-1-ol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
TN	#9# 3.83 {12-hydroxydodecanoate}  (#9# isoenzyme ADH-12, pH 10.0 <49>)
	<49>
TN	#9# 1.27 {12-hydroxydodecanoate}  (#9# isoenzyme ADH-3, pH 10.0 <49>)
	<49>
TN	#9# 5.83 {2-Buten-1-ol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
TN	#9# 2.33 {1-Octanol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
TN	#9# 0.383 {Cyclohexanol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
TN	#9# 213 {2-Buten-1-ol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9# 3.53 {1-Pentanol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
TN	#9# 48.8 {1-Butanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9# 48.8 {1-Pentanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9# 60.8 {1-Octanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9# 62.7 {ethanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9# 89.7 {benzyl alcohol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
TN	#9,33# 1.75 {Cyclohexanol}  (#33# isoenzyme BB-ADH <95>; #9# isoenzyme
	ADH-1, pH 10.0 <49>) <49,95>
TN	#91# 0.00086 {ethanol}  <171>
TN	#97# 0.52 {NAD+}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.1 {(R)-2-pentanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1 {(R)-2-butanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.5 {3-Pentanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 2.6 {(S)-2-pentanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.6 {1-Heptanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.6 {2-ethoxyethanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 2 {1-Hexanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 2.1 {trans-cinnamaldehyde}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.21 {trans-cinnamaldehyde}  (#97# mutant enzyme W95L,, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.53 {1-Pentanol}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 3.1 {1-Butanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 3.1 {ethanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.7 {(R)-2-butanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 2.9 {4-Methoxybenzyl alcohol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 21 {NAD+}  (#97# Km above 50 mM, mutant enzyme W95L/N249Y, in 0.1
	M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 2.5 {1-Pentanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 2.5 {1-Propanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.82 {Isobutyraldehyde}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 16.3 {1-Pentanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 20 {benzyl alcohol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 4.8 {(S)-2-butanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.9 {(R)-2-pentanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 13.1 {benzaldehyde}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 15.1 {1-Butanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 16.8 {4-Methoxybenzyl alcohol}  (#97# mutant enzyme W95L/N249Y, in
	0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 18.1 {Isobutyraldehyde}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.38 {NADH}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 1.2 {(S)-2-butanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 29 {Isobutyraldehyde}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.37 {4-Methoxybenzyl alcohol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 12.4 {Cyclohexanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.35 {benzyl alcohol}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 6.7 {(S)-2-pentanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 13.3 {1-Hexanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.36 {benzaldehyde}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.36 {Butyraldehyde}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.42 {1-Hexanol}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 11.9 {1-Heptanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 18.9 {trans-cinnamaldehyde}  (#97# mutant enzyme W95L/N249Y, in
	0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 4.1 {ethanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 34.8 {NADH}  (#97# mutant enzyme W95L/N249Y, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 19.7 {Butyraldehyde}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>; #97# wild type enzyme,
	in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 15.7 {1-Propanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
TN	#97# 0.51 {1-Heptanol}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>

KM_VALUE
KM	#10# 17 {ethanol}  (#10# in presence of 1 mM SDS <190>) <190>
KM	#10# 11 {p-methoxybenzyl alcohol}  (#10# isozyme ADH1, in the presence
	of 2 mM NAD+, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA
	buffer, pH 7.3, at 30°C <200>) <200>
KM	#10# 0.059 {NAD+}  <87>
KM	#10# 14 {benzaldehyde}  (#10# isozyme ADH2, in the presence of 0.25 mM
	NADH, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer,
	pH 7.3, at 30°C <200>) <200>
KM	#10# 14 {ethanol}  (#10# in presence of 3 mM SDS <190>) <190>
KM	#10# 50 {ethanol}  (#10# in presence of 50 mM SDS <190>) <190>
KM	#10# 2.9 {p-Methoxybenzaldehyde}  (#10# isozyme ADH1, in the presence
	of 0.1 mM NADH, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM
	EDTA buffer, pH 7.3, at 30°C <200>) <200>
KM	#10# 33 {benzaldehyde}  (#10# isozyme ADH1, in the presence of 0.25 mM
	NADH, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer,
	pH 7.3, at 30°C <200>) <200>
KM	#10# 34 {benzyl alcohol}  (#10# isozyme ADH1, in the presence of 2 mM
	NAD+, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer,
	pH 7.3, at 30°C <200>) <200>
KM	#10# 12.1 {ethanol}  (#10# 40°C, pH 9.0 <142>) <142>
KM	#10# 49 {benzyl alcohol}  (#10# isozyme ADH2, in the presence of 2 mM
	NAD+, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer,
	pH 7.3, at 30°C <200>) <200>
KM	#10# 53 {ethanol}  (#10# pH 7.5, 25°C, native Zn-ADH <121>) <121>
KM	#10# 350 {beta-NAD+}  (#10# in presence of 1 mM SDS <190>) <190>
KM	#10# 0.122 {NADH}  <87>
KM	#10# 5.9 {p-Methoxybenzaldehyde}  (#10# isozyme ADH2, in the presence
	of 0.1 mM NADH, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM
	EDTA buffer, pH 7.3, at 30°C <200>) <200>
KM	#10# 39 {ethanol}  (#10# pH 7.5, 25°C, Cu-ADH <121>) <121>
KM	#10# 16.7 {ethanol}  <87>
KM	#10# 41 {ethanol}  (#10# in presence of 15 mM SDS <190>) <190>
KM	#10# 240 {beta-NAD+}  (#10# in presence of 0.5 mM SDS <190>) <190>
KM	#10# 6.9 {p-methoxybenzyl alcohol}  (#10# isozyme ADH2, in the presence
	of 2 mM NAD+, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA
	buffer, pH 7.3, at 30°C <200>) <200>
KM	#10# 2.83 {acetaldehyde}  <87>
KM	#10# 710 {beta-NAD+}  (#10# in presence of 3 mM SDS <190>) <190>
KM	#10# 8.56 {ethanol}  (#10# 30°C, pH 9.0 <142>) <142>
KM	#10# 7.75 {ethanol}  (#10# in 50 mM Tris-HCl, pH 8.0 at 25°C <207>)
	<207>
KM	#10# 9.03 {ethanol}  (#10# 10°C, pH 9.0 <142>) <142>
KM	#10# 243 {beta-NAD+}  (#10# in presence of 0.5 mM SDS <190>) <190>
KM	#10# 2290 {beta-NAD+}  (#10# in presence of 15 mM SDS <190>) <190>
KM	#10# 1230 {beta-NAD+}  (#10# in presence of 50 mM SDS <190>) <190>
KM	#10# 24.45 {phenylglyoxylic acid}  (#10# soluble enzyme <180>) <180>
KM	#10# 37.55 {phenylglyoxylic acid}  (#10# enzyme covalently immobilized
	to magnetic Fe3O4 nanoparticles via glutaraldehyde <180>) <180>
KM	#10,103# 5.7 {ethanol}  (#10# 20°C, pH 9.0 <142>; #103# in 100 mM
	Tris-HCl, at pH 5.0 and 75°C <211>) <142,211>
KM	#10,60,74# 12 {ethanol}  (#10# pH 7.5, 25°C, Co-ADH <121>) <77,78,121>
KM	#10,82# 13 {ethanol}  (#82# pH 8.5 <104>; #10# in presence of 0.5 mM
	SDS <190>) <104,190>
KM	#101# 0.00028 {1-hydroxymethyl-6-methylpyrene}  (#101# isozyme ADH4, at
	21-23°C <212>) <212>
KM	#101# 0.033 {2-hydroxymethylpyrene}  (#101# isozyme ADH4, at 21-23°C
	<212>) <212>
KM	#101# 0.0016 {1-hydroxymethyl-8-methylpyrene}  (#101# isozyme ADH4, at
	21-23°C <212>) <212>
KM	#101# 0.00092 {1-formylpyrene}  (#101# isozyme ADH4, at 21-23°C <212>)
	<212>
KM	#101# 0.0029 {4-hydroxymethylpyrene}  (#101# isozyme ADH4, at 21-23°C
	<212>) <212>
KM	#101# 0.0069 {2-formylpyrene}  (#101# isozyme ADH4, at 21-23°C <212>)
	<212>
KM	#101# 3.6 {ethanol}  (#101# isozyme ADH4, at 21-23°C <212>) <212>
KM	#101# 3.5e-05 {1-formyl-8-methylpyrene}  (#101# isozyme ADH4, at
	21-23°C <212>) <212>
KM	#101# 12.7 {acetaldehyde}  (#101# isozyme ADH4, at 21-23°C <212>) <212>
KM	#101# 0.0283 {1-hydroxymethylpyrene}  (#101# isozyme ADH4, at 21-23°C
	<212>) <212>
KM	#101# 0.00048 {4-formylpyrene}  (#101# isozyme ADH4, at 21-23°C <212>)
	<212>
KM	#101# 3.6e-05 {1-formyl-6-methylpyrene}  (#101# isozyme ADH4, at
	21-23°C <212>) <212>
KM	#104# 0.13 {NAD+}  (#104# in 200 mM bicine, pH 9.0, at 60°C <195>)
	<195>
KM	#104# 2.09 {Cyclohexanol}  (#104# in 200 mM bicine, pH 9.0, at 60°C
	<195>) <195>
KM	#104# 3.68 {Cyclohexanone}  (#104# in 200 mM bicine, pH 6.0, at 60°C
	<195>) <195>
KM	#105# 24 {benzyl alcohol}  (#105# in the presence of 2 mM NAD+, in 83
	mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer, pH 7.3, at
	30°C <200>) <200>
KM	#105# 2-3 {benzaldehyde}  (#105# in the presence of 0.25 mM NADH, in 83
	mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer, pH 7.3, at
	30°C <200>) <200>
KM	#105# 3.4 {p-Methoxybenzaldehyde}  (#105# in the presence of 0.1 mM
	NADH, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer,
	pH 7.3, at 30°C <200>) <200>
KM	#105# 22 {p-methoxybenzyl alcohol}  (#105# in the presence of 2 mM
	NAD+, in 83 mM potassium phosphate, 40 mM KCl, and 0.25 mM EDTA buffer,
	pH 7.3, at 30°C <200>) <200>
KM	#106# 0.28 {NADP+}  (#106# cosubstrate ethanol, pH 8.0, 60°C <213>)
	<213>
KM	#106# 1.4 {NADH}  (#106# cosubstrate acetaldehyde, pH 8.0, 60°C <213>)
	<213>
KM	#106# 4.71 {acetaldehyde}  (#106# cosubstrate NADH, pH 8.0, 60°C
	<213>) <213>
KM	#106# 1.51 {NAD+}  (#106# cosubstrate ethanol, pH 8.0, 60°C <213>)
	<213>
KM	#106# 7.55 {ethanol}  (#106# cosubstrate NAD+, pH 8.0, 60°C <213>)
	<213>
KM	#107# 2.4 {NADP+}  (#107# cosubstrate 1-octanol, pH 8.0, 60°C <213>)
	<213>
KM	#107# 1.15 {Octanal}  (#107# cosubstrate NADPH, pH 8.0, 60°C <213>)
	<213>
KM	#107# 0.84 {NADPH}  (#107# cosubstrate octanal, pH 8.0, 60°C <213>)
	<213>
KM	#107# 2.25 {acetaldehyde}  (#107# cosubstrate NADPH, pH 8.0, 60°C
	<213>) <213>
KM	#107# 37.6 {ethanol}  (#107# cosubstrate NADP+, pH 8.0, 60°C <213>)
	<213>
KM	#107# 3.88 {1-Octanol}  (#107# cosubstrate NADP+, pH 8.0, 60°C <213>)
	<213>
KM	#107# 1.44 {NAD+}  (#107# cosubstrate 1-octanol, pH 8.0, 60°C <213>)
	<213>
KM	#12# 3.33 {ethanol}  (#12# pH 7.5 <45>) <45>
KM	#12# 0.00694 {NAD+}  (#12# pH 7.5 <45>) <45>
KM	#12# 0.0531 {NAD+}  (#12# pH 10.8 <45>) <45>
KM	#13# 3.1 {ethanol}  (#13# at pH 9.0 in bis-Tris propane buffer <209>)
	<209>
KM	#13# 0.39 {NAD+}  (#13# at pH 7.0 and 25°C <209>) <209>
KM	#13# 20.3 {Isopropanol}  (#13# at pH 7.0 and 25°C <209>) <209>
KM	#13# 197 {Isopentanol}  (#13# at pH 7.0 and 25°C <209>) <209>
KM	#14# 5.11 {ethanol}  <125>
KM	#15# 1.3 {ethanol}  <81>
KM	#15# 1.3 {Propan-2-ol}  <81>
KM	#15# 0.9 {NAD+}  (#15# reduction of ethanol <81>) <81>
KM	#15# 0.35 {NADH}  <81>
KM	#15# 0.053 {acetaldehyde}  <81>
KM	#15# 550 {NAD+}  (#15# reduction of propan-2-ol <81>) <81>
KM	#17# 3.5 {ethanol}  (#17# isoenzyme III from leaf <79>) <79>
KM	#17# 25 {NADH}  (#17# isoenzyme III from leaf <79>) <79>
KM	#17# 70 {NADH}  (#17# isoenzyme II from leaf <79>) <79>
KM	#17# 30 {NAD+}  (#17# isoenzyme II from leaf <79>) <79>
KM	#17# 31 {NAD+}  (#17# isoenzyme III from leaf <79>) <79>
KM	#17# 73 {NAD+}  (#17# isoenzyme I from leaf <79>) <79>
KM	#17# 7.2 {ethanol}  (#17# isoenzyme II from leaf <79>) <79>
KM	#17# 1.45 {acetaldehyde}  (#17# isoenzyme I <79>) <79>
KM	#17# 27.5 {ethanol}  (#17# isoenzyme I from leaf <79>) <79>
KM	#17# 121 {NADH}  (#17# isoenzyme I from leaf <79>) <79>
KM	#17,61# 1.25 {acetaldehyde}  (#17# isoenzyme II <79>) <69,79>
KM	#19# 0.038 {NAD+}  (#19# mutant enzyme ADH1-1S1108 <97>) <97>
KM	#19# 24 {ethanol}  (#19# wild-type enzyme ADH1-1S <97>) <97>
KM	#19# 0.042 {NADH}  (#19# mutant enzyme ADH1-1S1108 <97>) <97>
KM	#19# 0.085 {NADH}  (#19# wild-type enzyme ADH1-1S <97>) <97>
KM	#19# 0.037 {NAD+}  (#19# wild-type enzyme ADH1-1S <97>) <97>
KM	#19# 70 {acetaldehyde}  (#19# mutant enzyme ADH1-1S1108 <97>) <97>
KM	#19# 85 {acetaldehyde}  (#19# wild-type enzyme ADH1-1S <97>) <97>
KM	#19,37# 22 {ethanol}  (#37# pH 7.6 <28>; #19# mutant enzyme ADH1S-1108
	<97>) <28,97>
KM	#20,37# 16 {ethanol}  (#37# pH 8.8 <28>) <28,71>
KM	#21# 0.6 {acetaldehyde}  <72>
KM	#21# 35 {Methylglyoxal}  <72>
KM	#25# 0.58 {N-benzyl-3-pyrrolidinone}  <186>
KM	#26# 200 {ethylene glycol}  (#26# above <128>) <128>
KM	#26# 1.64 {ethanol}  <134>
KM	#27# 20 {ethanol}  (#27# 23°C <74>) <74>
KM	#27# 0.185 {NAD+}  (#27# 33°C <74>) <74>
KM	#27# 0.136 {NAD+}  (#27# 23°C <74>) <74>
KM	#27# 25 {ethanol}  (#27# 27°C <74>) <74>
KM	#27# 0.155 {NAD+}  (#27# 27°C <74>) <74>
KM	#27# 30 {ethanol}  (#27# 33°C <74>) <74>
KM	#27# 0.224 {NAD+}  (#27# 43°C <74>) <74>
KM	#27# 41.3 {ethanol}  (#27# 43°C <74>) <74>
KM	#29# 0.013 {acetaldehyde}  (#29# 70°C, pH 9.0, 50 mM Tris-HCl, 4 M
	NaCl <179>) <179>
KM	#29# 0.34 {ethanol}  (#29# 40°C, pH 9.0, 50 mM Tris-HCl, 4 M NaCl
	<179>) <179>
KM	#29# 0.059 {acetaldehyde}  (#29# 40°C, pH 9.0, 50 mM Tris-HCl, 4 M
	NaCl <179>) <179>
KM	#32# 29.9 {ethanol}  <134>
KM	#33# 0.03 {n-Butanol}  (#33# isoenzyme BB-ADH <95>) <95>
KM	#33# 0.05 {All-trans-Retinol}  (#33# isoenzyme AA-ADH <95>) <95>
KM	#33# 0.05 {12-hydroxydodecanoate}  (#33# isoenzyme BB-ADH and isoenzyme
	ADH-TT <95>) <95>
KM	#33# 0.06 {12-hydroxydodecanoate}  (#33# isoenzyme AA-ADH <95>) <95>
KM	#33# 0.26 {n-Hexanol}  (#33# isoenzyme TT-ADH <95>) <95>
KM	#33# 0.04 {Cyclohexanol}  (#33# isoenzyme BB-ADH <95>) <95>
KM	#33# 0.04 {n-Hexanol}  (#33# isoenzyme BB-ADH <95>) <95>
KM	#33# 0.5 {ethanol}  (#33# isoenzyme AA-ADH <95>) <95>
KM	#33# 0.02 {All-trans-Retinol}  (#33# isoenzyme TT-ADH <95>) <95>
KM	#33# 0.02 {n-Hexanol}  (#33# isoenzyme TT-ADH <95>) <95>
KM	#33# 0.02 {12-hydroxydodecanoate}  (#33# isoenzyme BB-ADH <95>) <95>
KM	#33# 0.07 {n-Butanol}  (#33# isoenzyme AA-ADH <95>) <95>
KM	#33# 2.3 {12-hydroxydodecanoate}  (#33# isoenzyme TT-ADH <95>) <95>
KM	#33# 0.76 {Cyclohexanol}  (#33# isoenzyme AA-ADH <95>) <95>
KM	#33# 2.6 {n-Butanol}  (#33# isoenzyme TT-ADH <95>) <95>
KM	#33# 320 {Cyclohexanol}  (#33# isoenzyme TT-ADH <95>) <95>
KM	#34# 0.076 {NAD+}  <85>
KM	#34# 0.194 {acetaldehyde}  <85>
KM	#34# 4.68 {ethanol}  <85>
KM	#34,42# 0.036 {NADH}  <70,85>
KM	#37# 0.03 {Hexanol}  <42>
KM	#37# 0.06 {Butyraldehyde}  <42>
KM	#37# 0.16 {9-cis-retinal}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 0.3 {9-cis-retinol}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 0.18 {(S)-2-octanol}  <31>
KM	#37# 0.26 {all-trans-Retinal}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 0.003 {5beta-Androstan-3beta-ol-17-one}  (#37# pH 7.3, 37°C,
	recombinant enzyme <115>) <115>
KM	#37# 0.012 {hexaldehyde}  <42>
KM	#37# 0.008 {5beta-cholanic acid-3-one}  (#37# pH 7.3, 37°C,
	recombinant enzyme <115>) <115>
KM	#37# 7 {ethanol}  (#37# pH 10.0 <28>) <28>
KM	#37# 0.11 {13-cis-retinal}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 0.2 {11-cis-retinal}  (#37# reduction with NADH <93>) <93>
KM	#37# 0.28 {11-cis-retinol}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 0.137 {13-cis-retinal}  (#37# reduction with NADH <93>) <93>
KM	#37# 0.011 {5beta-Androstan-17beta-ol-3-one}  (#37# pH 7.3, 37°C,
	recombinant enzyme <115>) <115>
KM	#37# 1.5 {cinnamyl alcohol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 0.046 {benzyl alcohol}  <42>
KM	#37# 0.39 {Allyl alcohol}  (#37# pH 7.3, 37°C <116>) <116>
KM	#37# 0.34 {all-trans-Retinal}  (#37# reduction with NADH <93>) <93>
KM	#37# 0.71 {crotyl alcohol}  (#37# pH 7.3, 37°C <116>) <116>
KM	#37# 9 {Isopropanol}  <31>
KM	#37# 0.031 {3-Oxo-5beta-androstan-17beta-ol}  <42>
KM	#37# 0.091 {Butanol}  <42>
KM	#37# 1.6 {3-Pentanol}  <31>
KM	#37# 0.059 {All-trans-Retinol}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 0.73 {(S)-2-pentanol}  <31>
KM	#37# 14 {Cyclohexanone}  <28>
KM	#37# 40 {ethanol}  <42>
KM	#37# 0.047 {5beta-Pregnan-21-ol-3,20-dione hemisuccinate}  <42>
KM	#37# 2.9 {Propanol}  <42>
KM	#37# 6 {acetaldehyde}  <28,42>
KM	#37# 15 {2-Butanone}  <31>
KM	#37# 1.35 {(S)-2-butanol}  <31>
KM	#37# 6.7 {4-Methyl-1-pentanol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 7.5 {(R)-2-butanol}  <31>
KM	#37# 1.24 {propionaldehyde}  <42>
KM	#37# 42 {ethanol}  (#37# pH 7.0 <28>) <28>
KM	#37# 6.5 {Hexanol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 75 {3-Pentanone}  <31>
KM	#37# 2.46 {ethanol}  (#37# pH 7.3, 37°C <116>) <116>
KM	#37# 0.148 {benzaldehyde}  <42>
KM	#37# 13.4 {ethanol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 0.242 {9-cis-retinal}  (#37# reduction with NADH <93>) <93>
KM	#37# 14.1 {Cyclohexanone}  <42>
KM	#37# 11.8 {Pentanol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 29.4 {Butanol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 1.92 {(R)-2-octanol}  <31>
KM	#37# 13.6 {Propanol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 14.2 {2-Pentanone}  <31>
KM	#37# 13.8 {Hexanol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 0.257 {13-cis-retinol}  (#37# oxidation with NAD+ <93>) <93>
KM	#37# 4.58 {cinnamyl alcohol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 31.7 {(R)-2-pentanol}  <31>
KM	#37# 43.9 {Propanol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 53.8 {4-Methyl-1-pentanol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 53.9 {Butanol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 56.2 {Pentanol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 93.3 {butan-2-ol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37# 118 {ethanol}  (#37# pH 6.1 <28>) <28>
KM	#37# 135 {acetone}  <31>
KM	#37# 193 {Propan-2-ol}  (#37# mutant enzyme W54L <92>) <92>
KM	#37# 268 {2-Propanol}  (#37# wilde-type enzyme ADh1 <92>) <92>
KM	#37,72# 4 {ethanol}  (#72# pyrazole-insensitive enzyme, pH 7.5 <24>;
	#37# wild-type enzyme Adh1 <92>) <24,92>
KM	#38# 1.3 {acetaldehyde}  (#38# enzyme form ADH II <68>) <68>
KM	#38# 0.012 {NADH}  (#38# enzyme form ADH II <68>) <68>
KM	#38# 0.027 {NADH}  (#38# enzyme form ADH I <68>) <68>
KM	#38# 0.11 {NAD+}  (#38# enzyme form ADH II <68>) <68>
KM	#38# 0.086 {acetaldehyde}  (#38# enzyme form ADH I <68>) <68>
KM	#38# 4.8 {ethanol}  (#38# enzyme form ADH I <68>) <68>
KM	#38# 0.073 {NAD+}  (#38# enzyme form ADH I <68>) <68>
KM	#38# 27 {ethanol}  (#38# enzyme form ADH II <68>) <68>
KM	#4# 0.26 {NAD+}  <64>
KM	#4# 0.86 {butan-2-ol}  <64>
KM	#4# 1.87 {Propan-2-ol}  <64>
KM	#4# 3.31 {butan-1-ol}  <64>
KM	#4# 3.42 {Propan-2-ol}  <64>
KM	#4# 8.92 {ethanol}  <64>
KM	#4,5,8,10,19,37,64,68,71,75,82# -999 {more}  (#37,64# kinetics
	<116,120>; #10# pH-dependence of Km-value <89>; #4,68# kinetics of
	ethanol oxidation <63>; #37# kinetics of native and modified enzyme
	with coenzyme analogues <54>; #37# Km-values of active-site
	Co(II)substituted enzyme <31>; #8# Km values for the class I isoenzymes
	with the substrates ethanol, methanol, ethylene glycol, benzyl alcohol,
	octanol, cyclohexanol and 16-hydroxyhexadecanoic acid <13>; #8#
	steady-state kinetics <115>; #37# detailed kinetic mechanism,
	steady-state kinetics for wild-type and mutant enzymes, investigation
	of pH-dependency <110>; #71# detailed kinetics, computational analysis
	of the reaction mechanism <129>; #5# Km for isozymes ADH1, and ADH4 for
	all retinoid substrates in forward and reverse reaction <118>; #8# Km
	for isozymes ADH1B1, ADH1B2, and ADH4 for all retinoid substrates in
	forward and reverse reaction <118>; #82# Michaelis-Menten kinetics
	<104>; #8# steady-state kinetics, kinetic mechanism <123>; #8#
	steady-state kinetics, MW 25 kDa <114>; #10# wild-type and mutant forms
	of the 3 isozymes, steady-state kinetics, detailed kinetic analysis, at
	different pH values and temperatures <119>; #5# effects of
	tert-butanol, butyramide, valeramide and capronamide on KM-value for
	ethanol <139>)
	<13,22,23,31,54,63,75,83,89,104,110,114,115,116,118,119,120,123,129,139>
KM	#41# 7.05 {acetaldehyde}  <6>
KM	#41# 31.1 {NADH}  <6>
KM	#41# 47.3 {ethanol}  <6>
KM	#41# 51.7 {NAD+}  <6>
KM	#42# 0.045 {Cyclohexanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
KM	#42# 0.05 {pentan-2-ol}  <66>
KM	#42# 0.3 {benzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5) containing
	0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at 55°C <151>)
	<151,161>
KM	#42# 0.26 {benzaldehyde}  (#42# mutant enzyme N249Y, at 65°C <152>)
	<152>
KM	#42# 0.26 {ethanol}  <66>
KM	#42# 0.6 {1-Propanol}  (#42# wild type enzyme, at 65°C <152>) <152>
KM	#42# 0.6 {2-Propanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
KM	#42# 1.3 {Cyclopentanone}  <66>
KM	#42# 1.3 {4-methoxybenzylalcohol}  (#42# in the presence of 3 mM NAD+,
	in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
KM	#42# 0.013 {NADH}  (#42# wild type enzyme, at 65°C, in the presence of
	benzaldehyde <152>) <152>
KM	#42# 0.04 {NADH}  (#42# carboxymethylated enzyme, at 55°C <151>) <151>
KM	#42# 0.21 {NADH}  (#42# mutant enzyme N249Y, at 65°C, in the presence
	of benzaldehyde <152>) <152>
KM	#42# 0.5 {Propan-2-ol}  <66>
KM	#42# 1.7 {1-Propanol}  (#42# mutant enzyme N249Y, at 65°C <152>) <152>
KM	#42# 0.09 {Anisaldehyde}  <70>
KM	#42# 0.021 {2-Methylcyclohexanol}  <66>
KM	#42# 0.2 {benzaldehyde}  (#42# carboxymethylated enzyme, at 55°C
	<151>) <151>
KM	#42# 0.4 {4-bromobenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
KM	#42# 2 {benzyl alcohol}  (#42# carboxymethylated enzyme, at 55°C
	<151>) <151>
KM	#42# 0.12 {4-bromobenzyl alcohol}  (#42# native enzyme, at 55°C <151>)
	<151>
KM	#42# 0.12 {4-bromobenzylalcohol}  (#42# in the presence of 3 mM NAD+,
	in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
KM	#42# 0.25 {(+)-2-methylcyclohexanone}  <66>
KM	#42# 0.28 {4-carboxybenzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5)
	containing 0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at
	55°C <151>) <151,161>
KM	#42# 0.9 {3-bromobenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
KM	#42# 0.0025 {Anisaldehyde}  <66>
KM	#42# 0.14 {4-Methoxybenzaldehyde}  (#42# in 50 mM Tris-HCl (pH 7.5)
	containing 0.2 mM NADH + H+, at 65°C <161>; #42# native enzyme, at
	55°C <151>) <151,161>
KM	#42# 0.14 {3-bromobenzyl alcohol}  (#42# native enzyme, at 55°C <151>)
	<151>
KM	#42# 0.14 {3-bromobenzylalcohol}  (#42# in the presence of 3 mM NAD+,
	in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
KM	#42# 0.8 {benzyl alcohol}  (#42# native enzyme, at 55°C <151>) <151>
KM	#42# 0.8 {benzylalcohol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>) <161>
KM	#42# 1.4 {4-Methoxybenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
KM	#42# 2.4 {1-Propanol}  (#42# carboxymethylated enzyme, at 55°C <151>)
	<151>
KM	#42# 0.23 {4-Methoxybenzyl alcohol}  (#42# wild type enzyme, at 65°C
	<152>) <152>
KM	#42# 0.23 {Cyclohexanol}  (#42# carboxymethylated enzyme, at 55°C
	<151>) <151>
KM	#42# 1.2 {3-Methoxybenzyl alcohol}  (#42# native enzyme, at 55°C
	<151>) <151>
KM	#42# 1.2 {3-methoxybenzylalcohol}  (#42# in the presence of 3 mM NAD+,
	in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>; #42# in the presence of
	5 mM benzylalcohol, in 0.1 M glycine-NaOH, pH 9.2, at 65°C <161>) <161>
KM	#42# 1.5 {benzyl alcohol}  (#42# mutant enzyme N249Y, at 65°C <152>)
	<152>
KM	#42# 1.9 {Cyclohexanol}  (#42# mutant enzyme N249Y, at 65°C <152>)
	<152>
KM	#42# 3.3 {3-Methoxybenzyl alcohol}  (#42# carboxymethylated enzyme, at
	55°C <151>) <151>
KM	#42# 0.055 {butan-1-ol}  <66>
KM	#42# 0.33 {1-Propanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <151,161>
KM	#42# 0.35 {butan-2-ol}  <66>
KM	#42# 0.024 {4-Methoxybenzaldehyde}  (#42# wild type enzyme, at 65°C
	<152>) <152>
KM	#42# 0.86 {4-Methoxybenzaldehyde}  (#42# mutant enzyme N249Y, at 65°C
	<152>) <152>
KM	#42# 14 {Butan-2-one}  <66>
KM	#42# 0.019 {propan-1-ol}  <66>
KM	#42# 7.5 {3-methylbutan-2-one}  <66>
KM	#42# 1.24 {4-Methoxybenzyl alcohol}  (#42# mutant enzyme N249Y, at
	65°C <152>) <152>
KM	#42# 0.225 {pentan-3-ol}  <66>
KM	#42# 53 {2-Propanol}  (#42# carboxymethylated enzyme, at 55°C <151>)
	<151>
KM	#42# 27 {methanol}  <66>
KM	#42# 6.6 {acetone}  <66>
KM	#42# 12.4 {NAD+}  (#42# mutant enzyme N249Y, at 65°C, in the presence
	of benzyl alcohol <152>) <152>
KM	#42# 184 {ethanol}  (#42# carboxymethylated enzyme, at 55°C <151>)
	<151>
KM	#42,47# 0.7 {ethanol}  (#42# in the presence of 3 mM NAD+, in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <59,151,161>
KM	#42,53,82# 0.03 {NADH}  (#82# pH 8.5 <104>; #53# isozyme ADH II, pH
	6.0, 25°C <112>; #42# in 50 mM Tris-HCl (pH 7.5) containing 0.25 mM
	benzaldehyde, at 65°C <161>; #42# native enzyme, at 55°C <151>)
	<104,112,151,161>
KM	#42,62# 0.013 {benzyl alcohol}  (#62# enzyme form ADH-2 <60>) <60,66>
KM	#42,97# 0.03 {benzaldehyde}  (#42# wild type enzyme, at 65°C <152>;
	#97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C
	<205>) <152,205>
KM	#42,97# 0.03 {Cyclohexanol}  (#42# wild type enzyme, at 65°C <152>;
	#97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C
	<205>) <152,205>
KM	#42,97# 0.26 {benzyl alcohol}  (#42# wild type enzyme, at 65°C <152>;
	#97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C
	<205>) <152,205>
KM	#42,97# 1.3 {4-Methoxybenzyl alcohol}  (#42# native enzyme, at 55°C
	<151>; #97# mutant enzyme W95L/N249Y, in 0.1 M glycine-NaOH buffer (pH
	10.5), at 65°C <205>) <151,205>
KM	#42,97# 0.5 {NAD+}  (#42# carboxymethylated enzyme, at 55°C <151>;
	#42# wild type enzyme, at 65°C, in the presence of benzyl alcohol
	<152>; #97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5),
	at 65°C <205>) <151,152,205>
KM	#43# 0.26 {Phenylacetaldehyde}  <147>
KM	#43# 0.012 {benzyl alcohol}  <147>
KM	#43# 0.02 {(R)-2-phenylpropanol}  <147>
KM	#43# 0.025 {1-phenylethanol}  <147>
KM	#43# 0.033 {3-phenylpropanol}  <147>
KM	#43# 0.157 {(S)-2-phenylpropanol}  <147>
KM	#43# 0.864 {2-phenylpropionaldehyde}  <147>
KM	#45# 0.06 {ethanol}  <134>
KM	#46# 0.487 {NAD+}  <82>
KM	#46# 0.195 {NAD+}  <82>
KM	#47# 40 {NAD+}  (#47# enzyme from liver <59>) <59>
KM	#47# 60 {NAD+}  (#47# enzyme from caecum <59>) <59>
KM	#49# 0.02 {NADH}  (#49# reduction of acetaldehyde <99>) <99>
KM	#49# 0.28 {propan-1-ol}  <99>
KM	#49# 1.8 {acetaldehyde}  <99>
KM	#49# 0.15 {ethanol}  <99>
KM	#49# 50 {formaldehyde}  <99>
KM	#5# 1.9 {Hexanol}  (#5# recombinant isozyme ADH1, pH 10.5, 25°C <118>)
	<118>
KM	#5# 0.085 {Hexanol}  (#5# recombinant isozyme ADH1, pH 7.5, 25°C
	<118>) <118>
KM	#5# 0.006 {Hexanol}  (#5# recombinant isozyme ADH4, pH 7.5, 25°C
	<118>) <118>
KM	#5# 0.63 {Hexanol}  (#5# recombinant isozyme ADH4, pH 10.5, 25°C
	<118>) <118>
KM	#5# 0.83 {ethanol}  (#5# recombinant isozyme ADH1, pH 10.5, 25°C
	<118>) <118>
KM	#5# 0.48 {ethanol}  (#5# recombinant isozyme ADH1, pH 7.5, 25°C <118>)
	<118>
KM	#5# 255 {ethanol}  (#5# recombinant isozyme ADH4, pH 10.5, 25°C <118>)
	<118>
KM	#5# 1625 {ethanol}  (#5# recombinant isozyme ADH4, pH 7.5, 25°C <118>)
	<118>
KM	#50# 0.78 {methanol}  <145>
KM	#50# 1.65 {1,2-Propanediol}  <145>
KM	#50# 3.09 {1-Propanol}  <145>
KM	#50# 2.58 {glycerol}  <145>
KM	#50# 3.42 {2-Propanol}  <145>
KM	#50# 5.38 {ethanol}  <145>
KM	#50# 4.46 {formaldehyde}  <145>
KM	#50# 7.72 {benzyl alcohol}  <145>
KM	#50# 25.78 {1-Butanol}  <145>
KM	#51# 6.66 {ethanol}  <145>
KM	#51# 3.54 {1-Propanol}  <145>
KM	#51# 18.6 {glycerol}  <145>
KM	#51# 9.69 {methanol}  <145>
KM	#51# 15.84 {1,2-Propanediol}  <145>
KM	#51# 11.46 {2-Propanol}  <145>
KM	#51# 19.96 {benzyl alcohol}  <145>
KM	#51# 19.93 {1-Butanol}  <145>
KM	#53# 0.3 {acetaldehyde}  (#53# isozyme ADH I, pH 5.5, 25°C <112>) <112>
KM	#53# 0.2 {NADH}  (#53# isozyme ADH I, pH 5.5, 25°C <112>) <112>
KM	#53# 24 {acetaldehyde}  (#53# isozyme ADH II, pH 6.0, 25°C <112>) <112>
KM	#53# 1.2 {NAD+}  (#53# isozyme ADH I, pH 8.5, 25°C <112>) <112>
KM	#53# 2.3 {ethanol}  (#53# isozyme ADH I, pH 8.5, 25°C <112>) <112>
KM	#53# 7.3 {ethanol}  (#53# isozyme ADH II, pH 8.5, 25°C <112>) <112>
KM	#59# 8.7 {ethanol}  <134>
KM	#6# 1 {ethyl benzoylformate}  (#6# 65°C <167>) <167>
KM	#6# 5.3 {alpha-tetralol}  (#6# 65°C <167>) <167>
KM	#6# 5.8 {alpha-tetralone}  (#6# 65°C <167>) <167>
KM	#6# 0.035 {NADH}  (#6# 65°C <167>) <167>
KM	#6# 2.7 {methylbenzoylformate}  (#6# 65°C <167>) <167>
KM	#6# 4.2 {(S)-(+)-1-indanol}  (#6# 65°C <167>) <167>
KM	#6# 4.2 {(S)-(+)-alpha-tetraol}  (#6# 65°C <167>) <167>
KM	#6# 0.24 {NAD+}  (#6# 65°C <167>) <167>
KM	#6# 5.1 {1-Indanol}  (#6# 65°C <167>) <167>
KM	#6# 4.4 {3-Methoxybenzaldehyde}  (#6# 65°C <167>) <167>
KM	#6# 5.9 {1-phenyl-1,2-propanedione}  (#6# 65°C <167>) <167>
KM	#6# 11.2 {2,2,2-trifluoroacetophenone}  (#6# 65°C <167>) <167>
KM	#6# 61 {4-Methoxybenzyl alcohol}  (#6# 65°C <167>) <167>
KM	#6# 18.1 {(S)-(-)-1-phenylethanol}  (#6# 65°C <167>) <167>
KM	#6# 27.6 {1-Indanone}  (#6# 65°C <167>) <167>
KM	#61# 0.11 {NADH}  <69>
KM	#61# 0.125 {NAD+}  <69>
KM	#61# 22.2 {ethanol}  <69>
KM	#62# 0.04 {12-hydroxydodecanoate}  (#62# enzyme form ADH-3 <60>) <60>
KM	#62# 0.2 {pentan-1-ol}  (#62# enzyme form ADH-3 <60>) <60>
KM	#62# 2 {butan-1-ol}  (#62# enzyme form ADH-3 <60>) <60>
KM	#62# 0.23 {NAD+}  (#62# oxidation of ethanol <60>) <60>
KM	#62# 0.011 {octan-1-ol}  (#62# enzyme form ADH-3 <60>) <60>
KM	#62# 0.0051 {NADH}  (#62# reduction of octanal <60>) <60>
KM	#62# 0.043 {Octanal}  (#62# enzyme form ADH-2 <60>) <60>
KM	#62# 5.2 {Cyclohexanol}  (#62# enzyme form ADH-3 <60>) <60>
KM	#62# 8.1 {ethanol}  (#62# enzyme form ADH-3 <60>) <60>
KM	#63# 0.17 {NAD+}  <84>
KM	#63# 0.021 {NADH}  <84>
KM	#63# 2.5 {ethanol}  <84>
KM	#63# 0.0086 {acetaldehyde}  <84>
KM	#63# 64 {ethanol}  <84>
KM	#63# 64 {Propan-2-ol}  <84>
KM	#65# 1.6 {butan-2-ol}  <64>
KM	#65# 1.99 {Propan-2-ol}  <64>
KM	#65# 4.16 {Propan-2-ol}  <64>
KM	#65# 6.44 {ethanol}  <64>
KM	#68# 0.41 {butan-2-ol}  <64>
KM	#68# 0.19 {NAD+}  <64>
KM	#68# 3.33 {Propan-2-ol}  <64>
KM	#68# 0.93 {Propan-2-ol}  <64>
KM	#68# 3.01 {butan-1-ol}  <64>
KM	#68# 5.22 {ethanol}  <64>
KM	#7,8# 10.6 {ethanol}  (#8# recombinant allozyme Val308, pH 7.5, 25°C
	<114>) <114,134>
KM	#71# 1 {cis-4-methylcyclohexanol}  <61>
KM	#71# 0.028 {NAD+}  (#71# oxidation of propan-2-ol <61>) <61>
KM	#71# 0.011 {NAD+}  (#71# oxidation of ethanol <61>) <61>
KM	#71# 1.2 {R-(+)-cis-verbenol}  <61>
KM	#71# 1.5 {R-(+)-trans-bicyclo(2.2.1)-heptanol}  <61>
KM	#71# 1.9 {butan-1-ol}  <61>
KM	#71# 1.9 {propan-1-ol}  <61>
KM	#71# 0.81 {4-methylpentan-1-ol}  <61>
KM	#71# 1.1 {2-Propanol}  <61>
KM	#71# 1.1 {trans-4-methylcyclohexanol}  <61>
KM	#71# 2.7 {2-methylpropan-1-ol}  <61>
KM	#71# 0.85 {S-(-)-trans-bicyclo(2.2.1)-heptanol}  <61>
KM	#71# 4.1 {pentan-1-ol}  <61>
KM	#71# 3.9 {S-(-)-1-phenylethanol}  <61>
KM	#71# 3.4 {R-(+)-1-phenylethanol}  <61>
KM	#71# 6 {ethanol}  <61>
KM	#71# 3.8 {S-(-)-cis-bicyclo(2.2.1)-heptanol}  <61>
KM	#71# 0.95 {S-(-)-2-methylbutan-1-ol}  <61>
KM	#71# 7.4 {hexan-1-ol}  <61>
KM	#71# 6.2 {ethanol}  <61>
KM	#71# 6.6 {heptan-4-ol}  <61>
KM	#71# 0.72 {Cyclohexanol}  <61>
KM	#72# 0.06 {Butanol}  (#72# pyrazole-insensitive enzyme, pH 7.5 <24>)
	<24>
KM	#72# 0.1 {acetaldehyde}  (#72# pyrazole-sensitive enzyme, pH 7.0 <24>)
	<24>
KM	#72# 0.18 {ethanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>) <24>
KM	#72# 0.012 {Butanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>) <24>
KM	#72# 0.012 {Pentanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>)
	<24>
KM	#72# 0.018 {Pentanol}  (#72# pyrazole-sensitive enzyme, pH 10.0 <24>)
	<24>
KM	#72# 0.02 {Butanol}  (#72# pyrazole-sinensitive enzyme, pH 10.0 <24>)
	<24>
KM	#72# 0.09 {Butanol}  (#72# pyrazole-sensitive enzyme, pH 10.0 <24>) <24>
KM	#72# 12 {methanol}  (#72# pyrazole-sensitive enzyme, pH 7.5 <24>) <24>
KM	#72# 5 {ethanol}  (#72# pyrazole-insensitive enzyme, pH 10.0 <24>) <24>
KM	#72# 14 {methanol}  (#72# pyrazole-sensitive enzyme, pH 10.0 <24>) <24>
KM	#72# 11.5 {acetaldehyde}  (#72# pyrazole-insensitive enzyme, pH 7.0
	<24>) <24>
KM	#76# 0.0014 {Octanol}  <101>
KM	#76# 0.0007 {Hexanol}  <101>
KM	#76# 0.35 {Butanol}  <101>
KM	#76# 0.39 {Cyclohexanol}  <101>
KM	#76# 5 {methanol}  <101>
KM	#76# 1.23 {ethanol}  <101>
KM	#8# 0.06 {16-hydroxyhexadecanoate}  <14>
KM	#8# 0.063 {NAD+}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C
	<114>) <114>
KM	#8# 0.18 {NAD+}  (#8# isoenzyme beta1,beta1 <16>) <16>
KM	#8# 0.55 {1-Octanol}  <11>
KM	#8# 0.004 {4-hydroxy-retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B1
	<106>) <106>
KM	#8# 0.012 {all-trans-Retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B2
	<106>) <106>
KM	#8# 0.012 {Retinol}  (#8# recombinant allozyme Val308, pH 7.5, 25°C
	<114>) <114>
KM	#8# 0.008 {Cyclohexanol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
KM	#8# 0.013 {NAD+}  (#8# isoenzyme alpha,alpha <16,17>) <16,17>
KM	#8# 0.049 {ethanol}  (#8# isoenzyme beta1,beta1 <17>) <15,17>
KM	#8# 0.015 {4-hydroxy-retinol}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
KM	#8# 0.018 {11-cis-retinol}  (#8# isozyme ADH1B2, pH 7.5, 25°C <118>)
	<118>
KM	#8# 0.022 {NAD+}  <12>
KM	#8# 0.027 {5beta-Pregnan-3beta-ol-20-one}  (#8# pH 7.3, 37°C, ADH1C*2
	(gamma2gamma2) <115>) <115>
KM	#8# 0.027 {4-oxo-retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B2 <106>)
	<106>
KM	#8# 0.032 {3-Phenyl-1-propanol}  <14>
KM	#8# 0.09 {Pentanol}  <14>
KM	#8# 0.025 {NAD+}  <16>
KM	#8# 0.025 {4-oxo-retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B1 <106>)
	<106>
KM	#8# 0.025 {3,4-dihydro-retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B2
	<106>) <106>
KM	#8# 0.2 {tryptophol}  <14>
KM	#8# 1 {ethanol}  (#8# isoenzyme gamma1,gamma1 <15>) <15>
KM	#8# 0.009 {All-trans-Retinol}  <53>
KM	#8# 0.009 {Octanol}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C
	<114>) <114>
KM	#8# 0.023 {All-trans-Retinol}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
KM	#8# 0.023 {9-cis-retinol}  (#8# isozyme ADH1B2, pH 7.5, 25°C <118>)
	<118>
KM	#8# 0.25 {5beta-cholanic acid-3-one}  (#8# pH 7.3, 37°C, ADH1C*2
	(gamma2gamma2) <115>) <115>
KM	#8# 0.28 {Pentanol}  <53>
KM	#8# 0.0025 {NADH}  <16>
KM	#8# 0.8 {Octanol}  <21>
KM	#8# 2.4 {Octanal}  <16>
KM	#8# 1.8 {ethanol}  <10>
KM	#8# 0.23 {12-hydroxydodecanoate}  <14>
KM	#8# 0.028 {3,4-dihydro-retinol}  (#8# pH 7.5, 25°C, isozyme ADH4
	<106>) <106>
KM	#8# 0.15 {benzyl alcohol}  <96>
KM	#8# 0.0036 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	ADH1C*2 (gamma2gamma2) <115>) <115>
KM	#8# 0.0036 {5beta-pregnan-3,20-dione}  (#8# pH 7.3, 37°C, ADH1C*2
	(gamma2gamma2) <115>) <115>
KM	#8# 0.011 {all-trans-Retinal}  (#8# pH 7.5, 25°C, isozyme ADH1B1
	<106>) <106>
KM	#8# 0.011 {NADH}  (#8# isoenzyme alpha,alpha <16>) <16>
KM	#8# 0.011 {Retinol}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C
	<114>) <114>
KM	#8# 0.011 {9-cis-retinol}  (#8# isozyme ADH1B1, pH 7.5, 25°C <118>)
	<118>
KM	#8# 0.011 {4-hydroxy-retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B2
	<106>) <106>
KM	#8# 1.2 {Octanol}  <16>
KM	#8# 1.5 {ethanol}  (#8# isoenzyme alpha,alpha <17>) <17>
KM	#8# 4.3 {acetaldehyde}  (#8# isoenzyme alpha,alpha <15>) <15>
KM	#8# 0.007 {benzyl alcohol}  <14>
KM	#8# 0.007 {NADH}  (#8# isoenzyme gamma1,gamma1 <16>) <16>
KM	#8# 0.007 {Octanol}  <14>
KM	#8# 0.033 {All-trans-Retinol}  (#8# isozyme ADH1B2, pH 7.5, 25°C
	<118>; #8# pH 7.5, 25°C, isozyme ADH1B2 <106>) <106,118>
KM	#8# 0.034 {all-trans-Retinal}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>)
	<106>
KM	#8# 0.034 {Vanillyl alcohol}  <14>
KM	#8# 0.08 {Octanol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
KM	#8# 0.085 {acetaldehyde}  (#8# isoenzyme beta1,beta1 <15,20>) <15,20>
KM	#8# 0.84 {ethanol}  (#8# isoenzyme beta2,beta2 <20>) <20>
KM	#8# 0.017 {4-oxo-retinal}  (#8# pH 7.5, 25°C, isozyme ADH4 <106>) <106>
KM	#8# 0.046 {5beta-Androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	ADH1C*2 (gamma2gamma2) <115>) <115>
KM	#8# 0.33 {acetaldehyde}  (#8# isoenzyme gamma1,gamma1 <15>) <15>
KM	#8# 0.13 {Hexanol}  <53>
KM	#8# 0.34 {NAD+}  <96>
KM	#8# 0.024 {3,4-dihydro-retinol}  (#8# pH 7.5, 25°C, isozyme ADH1B2
	<106>) <106>
KM	#8# 0.035 {11-cis-retinol}  (#8# isozyme ADH1B1, pH 7.5, 25°C <118>)
	<118>
KM	#8# 0.048 {12-hydroxydodecanoate}  <53>
KM	#8# 9 {ethanol}  (#8# recombinant allozyme Ile308, pH 7.5, 25°C <114>)
	<114>
KM	#8# 17 {Hexanol}  <21>
KM	#8# 0.026 {3,4-dihydro-retinal}  (#8# pH 7.5, 25°C, isozyme ADH4
	<106>) <106>
KM	#8# 0.63 {ethanol}  (#8# isoenzyme gamma2,gamma2 <15>) <15>
KM	#8# 11 {Vanillyl alcohol}  <16>
KM	#8# 1.6 {ethanol}  (#8# isoenzyme beta1,beta1 <17>) <17>
KM	#8# 4.2 {ethanol}  (#8# isoenzyme alpha,alpha <15,17>) <15,17>
KM	#8# 0.016 {Octanol}  (#8# recombinant allozyme Val308, pH 7.5, 25°C
	<114>) <114>
KM	#8# 0.105 {NADH}  (#8# isoenzyme beta2,beta2 <16>) <16>
KM	#8# 0.056 {12-Hydroxydodecanoic acid}  <11>
KM	#8# 0.91 {Propanol}  <96>
KM	#8# 50 {ethylene glycol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
KM	#8# 260 {NADH}  (#8# isoenzyme beta3,beta3 <20>) <20>
KM	#8# 0.047 {12-hydroxydodecanoate}  <96>
KM	#8# 150 {methanol}  (#8# isoenzyme alpha,gamma1 <13>) <13>
KM	#8# 0.24 {acetaldehyde}  (#8# isoenzyme gamma2,gamma2 <15>; #8#
	isoenzymes beta2,beta2 <15,20>) <15,20>
KM	#8# 0.24 {Butanol}  <96>
KM	#8# 0.94 {ethanol}  (#8# isoenzyme beta2,beta2 <15>) <15>
KM	#8# 10.4 {methanol}  <12>
KM	#8# 3.4 {acetaldehyde}  (#8# isoenzyme beta3,beta3 <20>) <20>
KM	#8# 6.4 {NADH}  (#8# isoenzyme beta1,beta1 <20>) <20>
KM	#8# 0.044 {Pentanol}  <96>
KM	#8# 0.058 {5beta-Androstan-3beta-ol-17-one}  (#8# pH 7.3, 37°C,
	ADH1C*2 (gamma2gamma2) <115>) <115>
KM	#8# 0.0064 {NADH}  (#8# isoenzyme beta1,beta1 <16>) <16>
KM	#8# 36 {ethanol}  (#8# isoenzyme beta3,beta3 <20>) <20>
KM	#8# 120 {ethanol}  <14>
KM	#8# 120 {(S)-2-butanol}  <53>
KM	#8# 7.4 {NAD+}  (#8# isoenzyme beta1,beta1 <20>) <20>
KM	#8# 18 {ethanol}  <96>
KM	#8# 23 {Cyclohexanol}  (#8# isoenzyme beta1,beta1 <13>) <13>
KM	#8# 27 {1-Pentanol}  <11>
KM	#8# 210 {Cyclohexanol}  <14>
KM	#8# 290 {ethylene glycol}  <14>
KM	#8# 0.0074 {NAD+}  (#8# isoenzyme beta1,beta1 <17>; #8# isoenzyme
	beta2,beta2 <16>) <16,17>
KM	#8# 0.0087 {NAD+}  (#8# isoenzyme gamma2,gamma2 <16,17>) <16,17>
KM	#8# 0.79 {Butanol}  <53>
KM	#8# 180 {NAD+}  (#8# isoenzyme beta2,beta2 <20>) <20>
KM	#8# 310 {2-deoxy-D-ribose}  <14>
KM	#8# 1.39 {Propanol}  <53>
KM	#8# 0.0079 {NAD+}  (#8# isoenzyme gamma1,gamma1 <16,17>) <16,17>
KM	#8# 105 {NADH}  (#8# isoenzyme beta2,beta2 <20>) <20>
KM	#8# 560 {2-Propanol}  <14>
KM	#8# 710 {NAD+}  (#8# isoenzyme beta3,beta3 <20>) <20>
KM	#8,12# 0.45 {ethanol}  (#12# pH 10.8 <45>) <12,45>
KM	#8,13# 3.2 {ethanol}  (#8# isoenzyme gamma1,gamma1 <17>; #13# at pH 7.0
	and 25°C <209>) <17,209>
KM	#8,17# 1.7 {ethanol}  (#17# isoenzyme III <79>; #8# isoenzyme
	alpha,gamma1 <13>; #8# isoenzyme gamma2,gamma2 <17>) <13,17,79>
KM	#8,29# 0.022 {ethanol}  (#8# isoenzyme beta1,beta1 <20>; #29# 70°C, pH
	9.0, 50 mM Tris-HCl, 4 M NaCl <179>) <20,179>
KM	#8,33# 0.03 {All-trans-Retinol}  (#33# isoenzyme BB-ADH <95>; #8#
	isozyme ADH1B1, pH 7.5, 25°C <118>; #8# pH 7.5, 25°C, isozyme ADH1B1
	<106>) <95,106,118>
KM	#8,33# 28 {ethanol}  (#33# isoenzyme TT-ADH <95>) <53,95>
KM	#8,49# 0.074 {NAD+}  (#49# oxidation of ethanol <99>; #8# recombinant
	allozyme Val308, pH 7.5, 25°C <114>) <99,114>
KM	#8,9# 0.1 {12-hydroxydodecanoate}  (#9# isoenzyme ADH-1, pH 10.0 <49>)
	<16,49>
KM	#80# 24.2 {ethanol}  (#80# pH 10.0, 50°C <117>) <117>
KM	#82# 1.9 {acetaldehyde}  (#82# pH 8.5 <104>) <104>
KM	#82# 1.12 {NAD+}  (#82# pH 8.5 <104>) <104>
KM	#84# 0.147 {ethanol}  (#84# 20°C, pH 9.0 <142>) <142>
KM	#84# 0.19 {ethanol}  (#84# 10°C, pH 9.0 <142>) <142>
KM	#84# 0.43 {ethanol}  (#84# 50°C, pH 9.0 <142>) <142>
KM	#84# 0.168 {ethanol}  (#84# 30°C, pH 9.0 <142>) <142>
KM	#84# 0.248 {ethanol}  (#84# 40°C, pH 9.0 <142>) <142>
KM	#84# 1.04 {ethanol}  (#84# 60°C, pH 9.0 <142>) <142>
KM	#85# 0.12 {NAD+}  (#85# 25°C, pH 7.0 <136>) <136>
KM	#85# 0.048 {NADH}  (#85# 25°C, pH 7.0 <136>) <136>
KM	#85# 57.5 {2-Propanol}  (#85# 25°C, pH 7.0 <136>) <136>
KM	#85# 13.6 {phenyl trifluoromethyl ketone}  (#85# 25°C, pH 7.0 <136>)
	<136>
KM	#86# 0.19 {n-Propanol}  (#86# 2 mM zinc sulfate in 100 mM glycine-NaOH
	(pH 10.5) at 65°C <160>) <160>
KM	#86# 2.4 {iso-propanol}  (#86# 2 mM zinc sulfate in 100 mM glycine-NaOH
	(pH 10.5) at 65°C <160>) <160>
KM	#86# 1.33 {ethanol}  (#86# 2 mM zinc sulfate in 100 mM glycine-NaOH (pH
	10.5) at 65°C <160>) <160>
KM	#86# 0.44 {benzylalcohol}  (#86# 2 mM zinc sulfate in 100 mM
	glycine-NaOH (pH 10.5) at 65°C <160>) <160>
KM	#87# 0.0145 {benzylalcohol}  (#87# in 50 mM glycine-NaOH at pH 10.0
	<157>) <157>
KM	#87# 0.0172 {ethanol}  (#87# in 50 mM glycine-NaOH at pH 10.0 <157>)
	<157>
KM	#9# 0.05 {benzyl alcohol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
KM	#9# 0.05 {NAD+}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 0.057 {NAD+}  (#9# isoenzyme 1 <51>) <51>
KM	#9# 0.1 {1-Octanol}  (#9# isoenzyme ADH-2 <49>) <49>
KM	#9# 0.16 {3beta,12alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 3
	<51>) <51>
KM	#9# 0.16 {3beta,7alpha,12alpha-trihydroxy-5beta-cholanoate}  (#9#
	isoenzyme 2 <51>) <51>
KM	#9# 0.17 {1-Butanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
KM	#9# 0.3 {Octanal}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 0.31 {acetaldehyde}  (#9# isoenzyme 1 <51>) <51>
KM	#9# 0.31 {3beta,12alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme I
	<51>) <51>
KM	#9# 0.013 {12-hydroxydodecanoate}  (#9# isoenzyme ADH-3, pH 10.0 <49>)
	<49>
KM	#9# 0.04 {5alpha-androstan-17beta-ol-3-one}  (#9# isoenzyme 1 <51>) <51>
KM	#9# 0.217 {acetaldehyde}  (#9# isoenzyme 3 <51>) <51>
KM	#9# 0.5 {1-Octanol}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 0.027 {5alpha-androstan-17beta-ol-3-one}  (#9# isoenzyme 4 <51>)
	<51>
KM	#9# 0.032 {3beta-7alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 3
	<51>) <51>
KM	#9# 0.021 {5alpha-androstan-17beta-ol-3-one}  (#9# isoenzyme 2 <51>)
	<51>
KM	#9# 0.025 {1-Octanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
KM	#9# 0.025 {5alpha-androstan-17beta-ol-3-one}  (#9# isoenzyme 2 <51>)
	<51>
KM	#9# 0.25 {NAD+}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 2.2 {Cyclohexanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
KM	#9# 0.14 {5beta-androstan-3beta-ol-17 one}  (#9# isoenzyme 3 <51>) <51>
KM	#9# 0.182 {3beta,7alpha,12alpha-trihydroxy-5beta-cholanoate}  (#9#
	isoenzyme 3 <51>) <51>
KM	#9# 1.4 {benzyl alcohol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 1.4 {ethanol}  (#9# isoenzyme ADH-3, pH 10.0 and pH 7.5 <49>) <49>
KM	#9# 1.4 {m-nitrobenzaldehyde}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 1.4 {12-hydroxydodecanoate}  (#9# isoenzyme ADH-1, pH 10.0 <49>)
	<49>
KM	#9# 3.1 {1-Pentanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 0.23 {acetaldehyde}  (#9# isoenzyme 2 <51>) <51>
KM	#9# 0.0017 {NADH}  (#9# isoenzyme ADH-2, pH 7.5 <49>) <49>
KM	#9# 2.5 {2-Buten-1-ol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 3 {Butanal}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 0.08 {1-Pentanol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
KM	#9# 0.125 {5beta-androstan-3beta-ol-17 one}  (#9# isoenzyme 2 <51>) <51>
KM	#9# 0.35 {2-Buten-1-ol}  (#9# isoenzyme ADH-3, pH 10.0 <49>) <49>
KM	#9# 0.35 {3beta,7alpha-12alpha-trihydroxy-5beta-cholanoate}  (#9#
	isoenzyme 4 <51>) <51>
KM	#9# 0.076 {NADH}  (#9# isoenzyme 1 <51>) <51>
KM	#9# 1.41 {ethanol}  (#9# isoenzyme 4 <51>) <51>
KM	#9# 0.071 {NADH}  (#9# isoenzyme 2 <51>) <51>
KM	#9# 0.071 {3beta-7alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 4
	<51>) <51>
KM	#9# 0.066 {3beta-7alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 1
	<51>) <51>
KM	#9# 17 {1-Butanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 0.091 {NADH}  (#9# isoenzyme 3 <51>) <51>
KM	#9# 1.6 {Octanol}  (#9# isoenzyme ADH-2, pH 7.5 <49>) <49>
KM	#9# 3.5 {Octanal}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 0.064 {3beta-7alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 2
	<51>) <51>
KM	#9# 0.115 {NAD+}  (#9# isoenzyme 2 <51>) <51>
KM	#9# 1.87 {ethanol}  (#9# isoenzyme 3 <51>) <51>
KM	#9# 60 {2-Buten-1-ol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
KM	#9# 0.044 {NAD+}  (#9# isoenzyme 4 <51>) <51>
KM	#9# 0.051 {NADH}  (#9# isoenzyme 4 <51>) <51>
KM	#9# 0.51 {1-Octanol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
KM	#9# 0.128 {3beta,12alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 2
	<51>) <51>
KM	#9# 220 {Cyclohexanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 230 {1-Butanol}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9# 1.37 {ethanol}  (#9# isoenzyme 1 <51>) <51>
KM	#9# 0.248 {3beta,12alpha-dihydroxy-5beta-cholanoate}  (#9# isoenzyme 4
	<51>) <51>
KM	#9# 78 {1-Pentanol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
KM	#9# 0.123 {5beta-androstan-3beta-ol-17 one}  (#9# isoenzyme 4 <51>) <51>
KM	#9# 0.099 {NAD+}  (#9# isoenzyme 2 <51>) <51>
KM	#9# 0.149 {3beta,7alpha,12alpha-trihydroxy-5beta-cholanoate}  (#9#
	isoenzyme I <51>) <51>
KM	#9# 0.276 {acetaldehyde}  (#9# isoenzyme 4 <51>) <51>
KM	#9# 340 {ethanol}  (#9# isoenzyme ADH-1, pH 10.0 <49>) <49>
KM	#9# 0.164 {5beta-androstan-3beta-ol-17 one}  (#9# isoenzyme 1 <51>) <51>
KM	#9# 1900 {Cyclohexanol}  (#9# isoenzyme ADH-2, pH 10.0 <49>) <49>
KM	#9# 5000 {ethanol}  (#9# isoenzyme ADH-1, pH 7.5 <49>) <49>
KM	#9,13,60,74# 0.1 {NAD+}  (#9# isoenzyme ADH-3 <49>; #13# at pH 9.0 in
	bis-Tris propane buffer <209>) <49,77,78,209>
KM	#9,33# 0.76 {ethanol}  (#9# isoenzyme 2 <51>; #33# isoenzyme BB-ADH
	<95>) <51,95>
KM	#9,42,65# 0.2 {NAD+}  (#9# isoenzyme ADH-1, pH 7.5 <49>; #42# in 0.1 M
	glycine-NaOH, pH 9.2, at 65°C <161>; #42# native enzyme, at 55°C
	<151>) <49,64,151,161>
KM	#9,53# 0.04 {NAD+}  (#9# isoenzyme ADH-2, pH 10.0 and pH 7.5 <49>; #53#
	isozyme ADH II, pH 8.5, 25°C <112>) <49,112>
KM	#9,72# 0.8 {ethanol}  (#72# pyrazole-sensitive enzyme, pH 10.0 <24>)
	<10,24>
KM	#91# 0.056 {ethanol}  <171>
KM	#92# 0.59 {propanal}  (#92# 33°C, pH 7 <169>) <169>
KM	#92# 6.8 {ethanol}  (#92# 33°C, pH 8 <169>) <169>
KM	#92# 11.9 {2-Butanol}  (#92# 33°C, pH 8 <169>) <169>
KM	#92# 0.92 {acetaldehyde}  (#92# 33°C, pH 7 <169>) <169>
KM	#92# 10.3 {n-Pentanal}  (#92# 33°C, pH 8 <169>) <169>
KM	#92# 2.01 {propanone}  (#92# 33°C, pH 7 <169>) <169>
KM	#92# 19.6 {2-Propanol}  (#92# 33°C, pH 8 <169>) <169>
KM	#92# 35.1 {n-Butanol}  (#92# 33°C, pH 8 <169>) <169>
KM	#92# 4.24 {Butanal}  (#92# 33°C, pH 7 <169>) <169>
KM	#92# 3.04 {methanol}  (#92# 33°C, pH 8 <169>) <169>
KM	#92# 7.49 {n-Propanol}  (#92# 33°C, pH 8 <169>) <169>
KM	#93# 0.87 {NADH}  (#93# pH 6.0 <183>) <183>
KM	#93# 0.13 {N-benzyl-3-pyrrolidinone}  (#93# pH 6.0 <183>) <183>
KM	#93# 0.79 {NAD+}  (#93# pH 8.0 <183>) <183>
KM	#93# 8.47 {(S)-N-benzyl-3-pyrrolidinol}  (#93# pH 8.0 <183>) <183>
KM	#97# 66 {ethanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.26 {1-Pentanol}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.26 {Isobutyraldehyde}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.41 {(R)-2-butanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.012 {(S)-2-butanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.008 {NADH}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.04 {1-Hexanol}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.21 {1-Heptanol}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.027 {1-Pentanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.038 {1-Heptanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.09 {trans-cinnamaldehyde}  (#97# mutant enzyme W95L,, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.07 {4-Methoxybenzyl alcohol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.07 {benzaldehyde}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.07 {Butyraldehyde}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.07 {(S)-2-pentanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.009 {trans-cinnamaldehyde}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.12 {4-Methoxybenzyl alcohol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.12 {benzyl alcohol}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.25 {2-ethoxyethanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.28 {benzaldehyde}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 4.6 {ethanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.22 {(R)-2-pentanol}  (#97# wild type enzyme, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.67 {1-Heptanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.23 {trans-cinnamaldehyde}  (#97# mutant enzyme W95L/N249Y, in
	0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 1.9 {1-Pentanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.08 {1-Butanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.33 {Isobutyraldehyde}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 4 {NAD+}  (#97# mutant enzyme W95L, in 0.1 M glycine-NaOH buffer
	(pH 10.5), at 65°C <205>) <205>
KM	#97# 0.13 {Butyraldehyde}  (#97# mutant enzyme W95L, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.035 {1-Hexanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 4.5 {Cyclohexanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.27 {3-Pentanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.27 {Butyraldehyde}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 1.6 {1-Butanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.75 {NADH}  (#97# mutant enzyme W95L/N249Y, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 50 {NAD+}  (#97# Km above 50 mM, mutant enzyme W95L/N249Y, in 0.1
	M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 8.8 {(S)-2-pentanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.24 {1-Propanol}  (#97# wild type enzyme, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.76 {Isobutyraldehyde}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 29.8 {(S)-2-butanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 3.8 {benzyl alcohol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 0.88 {1-Hexanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 6.5 {1-Propanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 11.7 {(R)-2-pentanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97# 37.4 {(R)-2-butanol}  (#97# mutant enzyme W95L/N249Y, in 0.1 M
	glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
KM	#97,104# 0.01 {NADH}  (#104# in 200 mM bicine, pH 6.0, at 60°C <195>;
	#97# wild type enzyme, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C
	<205>) <195,205>
KM	#98# 0.00024 {1-formyl-8-methylpyrene}  (#98# isozyme ADH2, at 21-23°C
	<212>) <212>
KM	#98# 0.0005 {1-formylpyrene}  (#98# isozyme ADH1C, at 21-23°C <212>)
	<212>
KM	#98# 0.0009 {1-formyl-6-methylpyrene}  (#98# isozyme ADH1C, at 21-23°C
	<212>) <212>
KM	#98# 0.001 {4-formylpyrene}  (#98# isozyme ADH1C, at 21-23°C <212>)
	<212>
KM	#98# 0.001 {4-hydroxymethylpyrene}  (#98# isozyme ADH1C, at 21-23°C
	<212>) <212>
KM	#98# 0.012 {1-formylpyrene}  (#98# isozyme ADH2, at 21-23°C <212>)
	<212>
KM	#98# 0.04 {4-hydroxymethylpyrene}  (#98# isozyme ADH2, at 21-23°C
	<212>) <212>
KM	#98# 0.009 {2-formylpyrene}  (#98# isozyme ADH3, at 21-23°C <212>)
	<212>
KM	#98# 0.00055 {1-formylpyrene}  (#98# isozyme ADH3, at 21-23°C <212>)
	<212>
KM	#98# 0.0021 {2-formylpyrene}  (#98# isozyme ADH1C, at 21-23°C <212>)
	<212>
KM	#98# 0.0021 {4-formylpyrene}  (#98# isozyme ADH3, at 21-23°C <212>)
	<212>
KM	#98# 0.00031 {1-hydroxymethyl-8-methylpyrene}  (#98# isozyme ADH3, at
	21-23°C <212>) <212>
KM	#98# 0.39 {1-Octanol}  (#98# isozyme ADH3, at 21-23°C <212>) <212>
KM	#98# 0.076 {1-hydroxymethylpyrene}  (#98# isozyme ADH2, at 21-23°C
	<212>) <212>
KM	#98# 0.77 {ethanol}  (#98# isozyme ADH1C, at 21-23°C <212>) <212>
KM	#98# 0.00057 {1-hydroxymethyl-6-methylpyrene}  (#98# isozyme ADH3, at
	21-23°C <212>) <212>
KM	#98# 0.34 {acetaldehyde}  (#98# isozyme ADH1C, at 21-23°C <212>) <212>
KM	#98# 0.0029 {2-formylpyrene}  (#98# isozyme ADH2, at 21-23°C <212>)
	<212>
KM	#98# 0.059 {1-hydroxymethyl-8-methylpyrene}  (#98# isozyme ADH1C, at
	21-23°C <212>) <212>
KM	#98# 26 {acetaldehyde}  (#98# isozyme ADH2, at 21-23°C <212>) <212>
KM	#98# 0.0044 {2-hydroxymethylpyrene}  (#98# isozyme ADH2, at 21-23°C
	<212>) <212>
KM	#98# 33 {ethanol}  (#98# isozyme ADH2, at 21-23°C <212>) <212>
KM	#98# 0.0064 {1-hydroxymethyl-6-methylpyrene}  (#98# isozyme ADH2, at
	21-23°C <212>) <212>
KM	#98# 0.0064 {1-hydroxymethyl-8-methylpyrene}  (#98# isozyme ADH2, at
	21-23°C <212>) <212>
KM	#98# 0.0038 {4-formylpyrene}  (#98# isozyme ADH2, at 21-23°C <212>)
	<212>
KM	#98# 0.0038 {1-formyl-6-methylpyrene}  (#98# isozyme ADH3, at 21-23°C
	<212>) <212>
KM	#98# 9.6 {Octanal}  (#98# isozyme ADH3, at 21-23°C <212>) <212>
KM	#98# 0.106 {2-hydroxymethylpyrene}  (#98# isozyme ADH3, at 21-23°C
	<212>) <212>
KM	#98# 0.00059 {1-hydroxymethylpyrene}  (#98# isozyme ADH3, at 21-23°C
	<212>) <212>
KM	#98# 0.00032 {1-formyl-6-methylpyrene}  (#98# isozyme ADH2, at 21-23°C
	<212>) <212>
KM	#98# 0.00075 {1-hydroxymethylpyrene}  (#98# isozyme ADH1C, at 21-23°C
	<212>) <212>
KM	#98# 0.00131 {1-formyl-8-methylpyrene}  (#98# isozyme ADH1C, at
	21-23°C <212>) <212>
KM	#98# 0.00048 {2-hydroxymethylpyrene}  (#98# isozyme ADH1C, at 21-23°C
	<212>) <212>
KM	#98# 0.00037 {4-hydroxymethylpyrene}  (#98# isozyme ADH3, at 21-23°C
	<212>) <212>
KM	#98# 0.00115 {1-hydroxymethyl-6-methylpyrene}  (#98# isozyme ADH1C, at
	21-23°C <212>) <212>
KM	#98# 0.00149 {1-formyl-8-methylpyrene}  (#98# isozyme ADH3, at 21-23°C
	<212>) <212>

PH_OPTIMUM
PHO	#10# 8.3 (#10# alcohol dehydrogenase IV <87>) <87>
PHO	#10,61,97# 6.8 (#10# soluble enzyme <180>; #61# oxidation of NADH <69>;
	#97# for the reduction reaction with benzaldehyde <205>) <69,180,205>
PHO	#10,64,91# 7.8 (#10,64# assay at <120>) <120,171>
PHO	#103# 5 <211>
PHO	#14,19,29,40,42,104# 9 (#42# wild type enzyme <152>; #14# recombinant
	enzyme <125>; #19# oxidation of ethanol <97>; #40# oxidation <113>;
	#104# the optimal pH for oxidation is at a pH of 9.0 <195>)
	<97,113,125,152,163,179,195>
PHO	#15# 8.1 (#15# reduction of propan-2-ol or ethanol <81>) <81>
PHO	#16# 3.8 (#16# -4.3 <133>) <133>
PHO	#17# 8.6-8.8 (#17# reduction of acetaldehyde, isoenzyme I <79>) <79>
PHO	#19# 8.7 <76>
PHO	#20,36# 6.7 (#20# reduction of acetaldehyde <71>) <71,130>
PHO	#21# 8.9 (#21# oxidation of ethanol <72>) <72>
PHO	#21,25# 5.7 (#21# reduction of acetaldehyde <72>) <72,186>
PHO	#26,37# 8.8 (#26# assay at <128>; #37# activity for both free and
	immobilized HLAD increases with pH up to 8.8 <202>) <128,202>
PHO	#3,5,8,10,42,49,68# 7.5 (#5,8# assay at <106,123,198>; #49# reduction
	of acetaldehyde <99>; #3# reduction of substrate <4>; #68# and second
	optimum at pH 9.9 <64>; #42# reduction of anisaldehyde <66>; #8#
	kinetic analysis assay at <114>; #10# Zn-ADH, Co-ADH, and Cu-ADH <121>;
	#10# enzyme covalently immobilized to magnetic Fe3O4 nanoparticles via
	glutaraldehyde <180>; #10# immobilized enzyme, at 25°C <194>)
	<4,64,66,99,106,114,121,123,180,194,198>
PHO	#3,8,19,42,53,82# 8.5 (#3# oxidation of substrate <4>; #19# wild-type
	enzyme ADH1-1S <97>; #42# oxidation of benzyl alcohol <66>; #8#
	isoenzyme beta2,beta2 <20>; #53# assay at, forward reaction, ADH I and
	ADH II <112>; #8# isozyme ADH1B2, assay at <118>; #42# mutant enzyme
	N249Y <152>) <4,20,66,97,104,112,118,152>
PHO	#34# 8-8.5 <85>
PHO	#38,40,41,62# 6.5 (#41# reduction of acetaldehyde <6>; #62# reduction
	of octanal <60>; #38# reduction of acetaldehyde, enzyme form ADH II
	<68>; #40# reduction <113>) <6,60,68,113>
PHO	#38,89# 4.5 (#38# reduction of acetaldehyde, enzyme form ADH I <68>)
	<68,166>
PHO	#39# 11.2 (#39# oxidation of ethanol, pyrazole-sensitive enzyme form
	<25>) <25>
PHO	#39,72# 10.6 (#72# and a second optimum at pH 8.2, oxidation of
	ethanol, pyrazole-sensitive enzyme <24>; #39# pyrazole-sensitive enzyme
	<25>) <24,25>
PHO	#4,19,24,37,65,106,107# 8 (#37# assay at <110>; #4,65# and a second
	optimum at pH 9.5 <64>; #19# mutant enzyme ADH1-1S1108 <97>)
	<64,97,105,110,213>
PHO	#4,9,23,38,41,49,65,85,97# 9.5 (#23# assay at <127>; #9,41,49#
	oxidation of ethanol <6,51,99>; #4,65# and a second optimum at pH 8.0
	<64>; #9# isoenzyme 1 <51>; #38# enzyme form ADH-I, oxidation of
	ethanol <67,68>; #85# oxidative reaction <136>; #97# for the oxidation
	reaction, ADH activity shows a slight dependence on pH, displaying a
	broad peak with a maximum around 9.5 <205>)
	<6,51,64,67,68,99,127,136,205>
PHO	#42# 8.5-9.1 <151>
PHO	#42# 6.9-7.5 (#42# apparent optimal pH for the benzaldehyde reduction
	<152>) <152>
PHO	#43,50,53,84,85,104# 6 (#84# reduction of acetaldehyde <142>; #53#
	assay at, reverse reaction, ADH II <112>; #43# reduction of
	phenylacetaldehyde <147>; #85# reductive reaction <136>; #104# the
	optimal pH for reduction is at a pH of 6.0 <195>)
	<112,136,142,145,147,195>
PHO	#5,71# -999 (#5# enzyme is strongly pH-dependent <109>; #71# pH
	dependence of the reaction mechanism and enzyme-substrate interaction,
	overview <129>) <109,129>
PHO	#5,8,9,66# 10.5 (#5# assay at <118>; #66# oxidation of ethanol <2>; #8#
	isoenzyme beta1,beta1 <20>; #8# isozyme ADH1B1, ADH4, assay at <118>)
	<2,10,20,118>
PHO	#53# 5.5 (#53# assay at, reverse reaction, ADH I <112>) <112>
PHO	#6,20,33# 9-10 (#20# oxidation of acetaldehyde <71>; #6# substrate:
	(S)-(-)-1-phenylethanol and 3 mM NAD+ or methyl benzoylformate + NADH
	<167>) <47,71,167>
PHO	#61# 9.1 (#61# reduction of NAD+ <69>) <69>
PHO	#63# 8-8.4 (#63# reduction of aldehyde <84>) <84>
PHO	#63# 5.6-6.5 (#63# oxidation of ethanol <84>) <84>
PHO	#68# 9.9 (#68# and second optimum at pH 7.5 <64>) <64>
PHO	#72,75# 8.2 (#72# and a second optimum at pH 10.6, oxidation of
	ethanol, pyrazole-sensitive enzyme <24>) <24,83>
PHO	#8# 7.4 (#8# acetaldehyde reduction of isoenzyme beta2,beta2 <15>) <15>
PHO	#8# 8.5-8.8 (#8# ethanol oxidation, isoenzyme beta2,beta2, beta2,beta1,
	alpha,beta2 and beta2gamma1 <15>) <15>
PHO	#8# 10-10.5 (#8# and a second optimum at pH 10.0-10.5, ADH Indianapolis
	form 2 and 3 <22>) <22>
PHO	#8,10,46,81# 7 (#8# isoenzyme beta3,beta3 <20>; #8# ADH Indianapolis
	form 1 <22>; #10# free enzyme, at 25°C <194>) <20,22,82,131,194>
PHO	#8,12# 10.8 (#12# and a second lower maximum at pH 7.5 <45>) <12,45>
PHO	#8,13# 7-7.5 (#8# and a second optimum at pH 10.0-10.5, ADH
	Indianapolis form 2 and 3 <22>; #13# for ethanol oxidation <209>)
	<22,209>
PHO	#8,19,38,80# 10 (#38# enzyme form ADH-II, oxidation of ethanol <67,68>;
	#8# standard assay at <114>) <67,68,75,96,114,117>
PHO	#8,28# 5.9 (#8# acetaldehyde reduction, isoenzyme beta1,beta1 <15>)
	<15,132>
PHO	#8,37# 7.3 (#8,37# assay at <115,116>) <115,116>
PHO	#8,43# 10.4 (#43# oxidation of 2-phenylethanol <147>) <14,147>
PHO	#84# 6.7-7 (#84# oxidation of ethanol <142>) <142>
PHO	#9# 10.7 (#9# oxidation of ethanol, isoenzyme 2, 3 and 4 <49>) <49>
PHO	#9,62,72# 11 (#72# oxidation of ethanol, pyrazole-insensitive enzyme
	<24>; #62# ethanol oxidation, enzyme form ADH-2 and ADH-3 <60>; #9#
	oxidation of octanol <49>) <24,49,60>
PHO	#92# 7.7-8.6 (#92# reaction with ethanol + NAD+ <169>) <169>
PHO	#92# 6.7-7.3 (#92# reaction with acetaldehyde + NADH <169>) <169>
PHO	#93# 6-7 (#93# reduction of N-benzyl-3-pyrrolidinone <183>) <183>

PH_RANGE
PHR	#10# 5-9 <194>
PHR	#10# 8.2-9.5 (#10# pH 8.2: about 10% of maximal activity, pH 9.5: about
	40% of maximal activity <87>) <87>
PHR	#10,106,107# 6-9 <121,213>
PHR	#103# 2-8 <211>
PHR	#24,37# 6-10 <105,110>
PHR	#39# 9-12 (#39# pH 9.0: about 25% of maximal activity, pH 12.0: about
	80% of maximal activity, pyrazole-sensitive enzyme <25>) <25>
PHR	#39# 10-11 (#39# pH 10.0: about 50% of maximal activity, pH 11.0: about
	75% of maximal activity, pyrazole-insensitive enzyme <25>) <25>
PHR	#42# 8.8-9.6 <161>
PHR	#43# 5-8 (#43# pH 5.0: about 50% of maximal activity, pH 8.0: about 40%
	of maximal activity, reduction of phenylacetaldehyde <147>) <147>
PHR	#50# 4-8 (#50# pH 4.0: about 35% of maximal activity, pH 8.0: about 70%
	of maximal activity <145>) <145>
PHR	#62# 9.5-11.5 (#62# pH 9.5: about 40% of maximal activity, pH 11.5:
	about 85% of maximal activity, ethanol oxidation enzyme form ADH-3
	<60>) <60>
PHR	#63# 5.2-6.8 (#63# pH 5.2: about 35% of maximal activity, pH 6.8: about
	55% of maximal activity, oxidation of ethanol <84>) <84>
PHR	#63# 7.2-9.2 (#63# pH 7.2: about 50% of maximal activity, pH 9.2: about
	60% of maximal activity <84>) <84>
PHR	#8# 8-10.5 (#8# pH 8.0: about 40% of maximal activity, pH 10.5: about
	85% of maximal activity <96>) <96>
PHR	#8,29,43# 8-12 (#8# about 30% of maximal activity at pH 8.0 and at pH
	12.0 <14>; #43# pH 8.0: about 50% of maximal activity, pH 12.0: about
	50% of maximal activity, oxidation of 2-phenylethanol <147>; #29# pH
	8.0: about 70% of maximal activity, pH 12: about 60% of maximal
	activity <179>) <14,147,179>
PHR	#89# 4-7.5 (#89# pH 4.0: about 80% of maximal activity, pH 7.5: about
	60% of maximal activity <166>) <166>
PHR	#91# 7-8 (#91# pH 7: 41% of maximal activity, pH 8: 59% of maximal
	activity <171>) <171>

SPECIFIC_ACTIVITY
SA	#1,12,15,19,37,53,61,74,77,82# -999.0 (#53# activity of the 2 isozmyes
	with various substrates, overview <112>; #77# wild-type and mutant
	enzymes <124>) <35,44,46,69,75,77,81,104,112,124>
SA	#10# 5.18 (#10# pH 6.7, 30°C, mutant enzyme S109P/L116S/Y294C <191>)
	<191>
SA	#103# 17.6 (#103# crude extract Ta1316 ADH with ethanol as a substrate,
	at pH 5.0 and 75°C <211>) <211>
SA	#103# 628.7 (#103# purified Ta1316 ADH with ethanol as a substrate, at
	pH 5.0 and 75°C <211>) <211>
SA	#104# 20.6 (#104# after 1.4fold purifictaion <195>) <195>
SA	#104# 15.0 (#104# crude enzyme, after heat treatment at 75°C for 20
	min <195>) <195>
SA	#106# 447.0 (#106# substrate ethanol, pH 8.0, 60°C <213>) <213>
SA	#12# 2.69 <45>
SA	#19# 70.0 (#19# wild-type enzyme Adh1-1S <97>) <97>
SA	#19# 65.0 (#19# mutant enzyme Adh1-1S1108 <97>) <97>
SA	#21# 17.17 <72>
SA	#23# 0.092 (#23# partially purified enzyme <127>) <127>
SA	#25# 3.12 <186>
SA	#33# 2.1 (#33# isoenzyme AA-ADH <95>) <95>
SA	#33# 4.0 <47>
SA	#33,51# 2.5 (#33# isoenzyme BB-ADH <95>) <95,145>
SA	#34# 79.1 <85>
SA	#37# 2.0 <27>
SA	#37# 3.2 (#37# reduction of 3-oxo-5beta-androstan-17beta-ol <42>) <42>
SA	#37,97# 4.2 (#37# reduction of cyclohexanone <42>; #97# purified wild
	type enzyme, using benzyl alcohol as substrate, in 0.1 M glycine-NaOH
	buffer (pH 10.5), at 65°C <205>) <42,205>
SA	#38# 93.0 (#38# enzyme form ADHI <68>) <68>
SA	#38# 470.0 (#38# enzyme form ADHII <68>) <68>
SA	#4# 55.0 <65>
SA	#42# 3.92 <66>
SA	#42# 0.01 (#42# wild type recombinant enzyme, from crude extract, at
	65°C <163>) <163>
SA	#42# 4.5 (#42# wild type recombinant enzyme, after 450fold
	purification, at 65°C <163>) <163>
SA	#42# 5.2 (#42# mutant recombinant enzyme E97C, after 260fold
	purification, at 65°C <163>) <163>
SA	#42# 5.3 <70>
SA	#42# 10.1 (#42# after 12.9fold purification, at pH 10.0 <157>) <157>
SA	#42# 4.1 (#42# wild type enzyme, at 65°C <152>) <152>
SA	#42# 0.02 (#42# mutant recombinant enzyme E97C, from crude extract, at
	65°C <163>) <163>
SA	#42# 4.03 (#42# recombinant wild type enzyme, after 6fold purification,
	at 65°C <161>) <161>
SA	#42# 0.78 (#42# crude extract, at pH 10.0 <157>) <157>
SA	#42# 0.64 (#42# wild type enzyme, crude extract, at 65°C <161>) <161>
SA	#42# 26.1 (#42# mutant enzyme N249Y, at 65°C <152>) <152>
SA	#42,84# 43.0 (#42# mutant enzyme N249Y, after 6fold purification, at
	65°C <161>) <142,161>
SA	#46# 49.3 <82>
SA	#49# 31.8 <99>
SA	#5# 1.36 (#5# isoenzyme A2 <48>) <48>
SA	#5# 64.0 (#5# isoenzyme C2 <48>) <48>
SA	#5# 8.08 (#5# isoenzyme B2 <48>) <48>
SA	#50# 2.3 <145>
SA	#53# 361.0 (#53# purified ADH II <112>) <112>
SA	#53# 597.0 (#53# purified ADH I <112>) <112>
SA	#6# 151.1 <167>
SA	#60# 55900.0 <78>
SA	#63# 196.3 <84>
SA	#8# 3.3 <12>
SA	#8# 0.6 <16>
SA	#8# 0.65 <21>
SA	#8# 1.47 <14>
SA	#8,9# 1.3 (#9# ADH-3 <49>) <18,49>
SA	#80# 1.28 (#80# purified enzyme <117>) <117>
SA	#85# 10.3 <136>
SA	#86# 0.75 (#86# purified enzyme, using benzylalcohol as substrate, at
	80°C <160>) <160>
SA	#86# 0.18 (#86# after 5.67fold purification, using benzylalcohol as
	substrate, at 65°C <160>) <160>
SA	#86# 0.03 (#86# crude extract, using benzylalcohol as substrate, at
	65°C <160>) <160>
SA	#87# 0.22 (#87# crude extract, at pH 10.0 <157>) <157>
SA	#87# 2.88 (#87# after 12.9fold purification, at pH 10.0 <157>) <157>
SA	#9# 0.2 (#9# isoenzyme 3 <49>) <49>
SA	#9# 0.1 (#9# isoenzyme 4 <49>) <49>
SA	#9# 32.5 (#9# ADH-1 <49>) <49>
SA	#9# 0.12 (#9# isoenzyme 1 <49>) <49>
SA	#9# 1.14 (#9# ADH-2 <49>) <49>
SA	#9,73# 0.62 (#9# isoenzyme 2 <49>) <49,52>
SA	#91# 0.225 <171>
SA	#93# 31.0 <183>
SA	#97# 0.5 (#97# purified mutant enzyme W95L, using benzyl alcohol as
	substrate, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>) <205>
SA	#97# 18.6 (#97# purified mutant enzyme W95L/N249Y, using benzyl alcohol
	as substrate, in 0.1 M glycine-NaOH buffer (pH 10.5), at 65°C <205>)
	<205>
SA	#99# 2.6 (#99# in Tris-HCl buffer (pH 7.6), 5 mM dithiothreitol, 0.2 mM
	NADH, and 10 mM acetaldehyde at 65°C <193>) <193>

TEMPERATURE_OPTIMUM
TO	#10# 25-30 (#10# assay at <119>) <119>
TO	#10# 45-50 <3>
TO	#10,26,49# 40 (#26# assay at <128>; #10# Cu-ADH <121>; #10# enzyme
	covalently immobilized to magnetic Fe3O4 nanoparticles via
	glutaraldehyde <180>) <99,121,128,180>
TO	#10,63,93# 30 (#10# soluble enzyme <180>; #93# reduction of
	N-benzyl-3-pyrrolidinone <183>; #10# approximately 30°C <203>)
	<84,142,180,183,203>
TO	#10,89# 35 (#10# immobilized enzyme <194>; #10# Zn-ADH and Co-ADH
	<121>) <121,166,194>
TO	#103# 75 <211>
TO	#106,107# 60 <213>
TO	#14,29,37,46,80,84# 70 (#46# above <82>; #14# recombinant enzyme <125>;
	#37# approximately 70°C <203>) <82,117,125,142,179,203>
TO	#16,28# 33 <132,133>
TO	#23# 22 (#23# assay at room temperature <127>) <127>
TO	#25# 55 <186>
TO	#34# 50-55 <85>
TO	#37# 37 (#37# assay at <116>) <116>
TO	#40# 30-50 <113>
TO	#5,8,10,24,36,53# 25 (#5,8,10# assay at <106,114,118,120,123>; #53#
	assay at, forward and reverse reaction <112>; #10# free enzyme, at
	25°C <194>) <105,106,112,114,118,120,123,130,194>
TO	#6# 73 <167>
TO	#64# 85 (#64# approximately 85°C <203>) <203>
TO	#64# 65 (#64# assay at <120>) <120>
TO	#8,37# 30-37 (#8,37# assay at <115>) <115>
TO	#85,92# 50 (#92# reaction with ethanol + NAD+ <169>) <136,169>
TO	#91# 83 <171>

TEMPERATURE_RANGE
TR	#10# 15-50 <121,194>
TR	#10# 20-85 (#10# 20°C: about 65% of maximal activity, 85°C: about 90%
	of maximal activity <142>) <142>
TR	#103# 25-90 <211>
TR	#25# 30-65 (#25# 30°C: 36% of maximal activity, 65°C: 24% of maximal
	activity <186>) <186>
TR	#27# 10-45 (#27# activity increases from 10°C to 45°C <74>) <74>
TR	#29# 50-80 (#29# 50°C: 45% of maximal activity, 80°C: about 60% of
	maximal activity <179>) <179>
TR	#42# 45-95 (#42# continous increase in activity from 40°C to 95°C
	<66>) <66>
TR	#43# 60 <147>
TR	#63# 10-60 (#63# 10°C: about 65% of maximal activity, 50°C: about 40%
	of maximal activity <84>) <84>
TR	#80# 30-85 (#80# maximal activity at 70°C, 60% of maximal activity at
	85°C <117>) <117>
TR	#81# 33-35 <131>
TR	#84# 0-60 (#84# 0°C: about 70% of maximal activity, about 45% of
	maximal activity <142>) <142>
TR	#85# 20-70 (#85# 20°C: 23% of maximal activity, 70°C: 40% of maximal
	activity <136>) <136>
TR	#89,93# 20-50 (#89# 20°C: about 80% of maximal activity, 50°C: about
	55% of maximal activity <166>; #93# 20°C: about 80% of maximal
	activity, 50°C: about 60% of maximal activity, reduction of
	N-benzyl-3-pyrrolidinone <183>) <166,183>
TR	#91# 75-90 (#91# 75°C: about 45% of maximal activity, 90°C: about 45%
	of maximal activity <171>) <171>

COFACTOR
CF	#1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,26,27,30
	31,32,33,34,35,37,38,39,40,41,42,43,45,46,47,49,52,53,54,56,57,59,60,61
	62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,82,83,84,85,86
	87,88,90,97,98,99,100,101,102,103,104,105,106,107# NAD+
	(#14,23,40,53,102,104# dependent on <112,113,125,127,195,208>; #13#
	specific for NAD+ <209>; #42,87# dependent <151,152,157>; #37# kinetics
	of coenzyme binding in the pH-range 10-12 <26>; #4#
	NAD+-plus-acetone-induced conversion <62>; #37# NAD+ acts as an
	activator which induces an active form of the enzyme <34>; #37#
	preferred substrate <42>; #77# activity with mutants G223D/T224I and
	G223D/T224I/H225N <124>; #10# cofactor binding mode <119>; #14#
	dependent on, cofactor binding mechanism and conformation from crystal
	structure analysis <111>; #79# the monomer consists of a catalytic and
	a cofactor-binding domain, the cofactor is bound between 2 domains in a
	cleft <126>; #7,26,32,45,59# strongly preferred as cofactor <134>; #84#
	specific for NAD+, no activity with NADP+, pro-R stereospecificity for
	hydrogen transfer <142>; #90# ADH1 preferrs NAD+ 205fold better than
	NADP+ as cofactor <170>; #16# ADH3 does not react with NADP+ <170>; #6#
	strict requirement for NAD(H) as the coenzyme. Critical role of the D37
	residue in discriminating NAD(H) from NADP(H) <167>; #103# shows NAD+
	as the preferred co-factor over NADP+ <211>; #37# the binding of NAD+
	is kinetically limited by a unimolecular isomerization (corresponding
	to the conformational change) that is controlled by deprotonation of
	the catalytic zinc-water to produce a negatively-charged
	zinc-hydroxide, which can attract the positively-charged nicotinamide
	ring <196>; #106# NAD+ is prefered over NADP+ <213>; #107# NADP+ is
	prefered over NAD+ <213>)
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26
	27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50
	51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74
	75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98
	99,100,101,102,104,109,110,111,112,113,114,115,117,119,120,123,124,125
	126,127,128,129,134,135,136,137,139,141,142,144,146,147,150,151,152,154
	155,156,157,159,160,161,162,163,167,170,178,192,193,194,195,196,198,199
	200,201,202,203,204,205,206,207,208,209,210,211,212,213>
CF	#1,2,3,4,5,6,8,9,10,11,12,15,16,17,18,19,20,21,22,23,26,27,28,30,31,33
	34,35,36,37,38,39,40,41,42,43,46,47,48,49,52,53,56,57,60,61,62,63,65,66
	67,68,69,70,71,72,73,74,75,76,77,80,81,82,85,107# NADH (#40,53#
	dependent on <112,113>; #42# dependent <153>; #37# kinetics of coenzyme
	binding in the pH range 10-12 <26>; #37# preferred coenzyme <42>; #77#
	activity with mutants G223D/T224I and G223D/T224I/H225N <124>; #10#
	cofactor binding mode <119>; #6# strict requirement for NAD(H) as the
	coenzyme. Critical role of the D37 residue in discriminating NAD(H)
	from NADP(H) <167>)
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26
	27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50
	51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74
	75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98
	99,100,101,102,104,109,112,113,117,119,122,123,124,128,130,131,132,133
	136,138,147,149,153,155,156,159,161,167,198,213>
CF	#10,12,15,33,37,49,61,64,77,106,107# NADP+ (#12,15,33,61# no activity
	as coenzyme <45,47,69,81>; #37# also utilized as coenzyme by the SS
	isoenzyme <28>; #49# at 1.5% of the activity with NAD+ <99>; #77#
	specific for, residues Gly223, Thr224, His225, Leu200, and Lys228 are
	involved in cofactor binding pocket formation <124>; #106# NAD+ is
	prefered over NADP+ <213>; #107# NADP+ is prefered over NAD+ <213>)
	<28,45,47,69,81,99,120,124,213>
CF	#10,37,43,71# more (#10# kinetic study on the binding of monomeric and
	polymeric derivatives of NAD+ <88>; #37# kinetics of native and
	modified enzyme with coenzyme analogues <54>; #71# crystallographic
	study of the coenzyme binding mode <38>; #43# NADP+ shows less than
	0.1% of the activity with NAD+ <147>) <38,54,88,147>
CF	#15,37,48,49,77,85,107# NADPH (#49# at 1.6% of the activity with NADH
	<99>; #15# no activity as coenzyme <81>; #37# also utilized as coenzyme
	by the SS isoenzyme <28>; #77# specific for, residues Gly223, Thr224,
	His225, Leu200, and Lys228 are involved in cofactor binding pocket
	formation <124>; #48# about 20% of the activity with NADH <149>; #85#
	weak activity <136>) <28,81,99,124,136,149,213>
CF	#37# 3-benzoylpyridine-adenine dinucleotide (#37# can be used as
	coenzyme <33>) <33>

ACTIVATING_COMPOUND
AC	#10# Glutaraldehyde (#10# treating with 0.5% glutaraldehyde solution,
	the activity of the immobilized enzyme is at maximum <194>) <194>
AC	#104# Triton X-100 (#104# 201% relative activity at 10% (v/v) <195>)
	<195>
AC	#104# Urea (#104# 130% relative activity at 1 M <195>) <195>
AC	#25# iodoacetate (#25# 1 mM, 1.1fold activation <186>) <186>
AC	#37# Acetylsalicylate (#37# enhances activity <141>) <141>
AC	#37# more (#37# isonicotinimidylation and methylation increases
	activity <35>) <35>
AC	#37# tert-butyl hydroperoxide (#37# stimulation up to 100 mM <86>) <86>
AC	#42# iodoacetamide (#42# 1 mM activates up to 25fold <161>) <161>
AC	#5# butyramide (#5# activates ADH3 <139>) <139>
AC	#5# Valeramide (#5# activates ADH3 <139>) <139>
AC	#5# tert-butanol (#5# activates ADH3 <139>) <139>
AC	#5# S-nitrosoglutathione (#5# ADH3-mediated alcohol oxidation is
	promoted in the presence of S-nitrosoglutathione <198>) <198>
AC	#5# capronamide (#5# activates ADH3 <139>) <139>
AC	#6,46,106# EDTA (#46# enhances activity <82>; #6# 10 mM, 1.65fold
	activation <167>; #106# 1 mM, 105% of initial activity <213>)
	<82,167,213>

INHIBITORS
IN	#10# 2-fluoroethanol <94>
IN	#10# acetamide <94>
IN	#10# butyramide <91>
IN	#10# Glutaraldehyde (#10# 71% relative activity in the presence of 10
	mM glutaraldehyde <194>) <194>
IN	#10# mithramycin <207>
IN	#10# NaCN <94>
IN	#10# tert-butyl hydroperoxide (#10# irreversible, inactivation is
	associated with -SH group oxidation <86>) <86>
IN	#10# heptafluorobutanol <91>
IN	#10# chromomycin A3 <207>
IN	#10,11,18,19,20,22,37,41,42,45,57# more (#37# design of inhibitors
	<31>; #11,18,19,20,22,41,57# inactivator from rice seedlings <80>; #10#
	use of competitive dead-end inhibitors to determine the chemical
	mechanism of action of yeast alcohol dehydrogenase <94>; #37# thiols
	and dithiols have their main effect, at the enzyme-NAD+-thiol complex
	level, by competition with alcohol for the catalytic zinc <98>; #45# no
	inhibition by 4-methylpyrazole <134>; #42# not affected by Cu2+ <161>)
	<31,80,94,98,134,161>
IN	#10,37# H2O2 (#37# inactivation is caused by oxidation of its
	functional Cys residues, coenzyme protects from inactivation <40>)
	<40,187>
IN	#10,71,94# 2,2,2-Trifluoroethanol (#71# competitive towards ethanol
	<61>; #94# 95 mM, 74% inhibition <172>) <61,94,172>
IN	#10,84,91,104# SDS (#84# 1 mM, 91% inhibition <142>; #91# 10% (w/v),
	95% inhibition <171>; #10# in the presence of the surfactant the
	initial reaction rates are consistently lower than in pure buffer at
	all the surfactant concentrations considered (0.5-50 mM). This effect
	is mainly due to an increase in the dissociation constant of beta-NAD+
	which reaches its maximum value (7.1 mM) at the critical micelle
	concentration. Above the critical micelle concentration the effect of
	the surfactant is mainly due to an increase in the Michaels constants
	of the alcohol, with values of 41 mM for 15 mM SDS and 50 mM for 50 mM
	SDS <190>; #104# 0.4% relative activity at 10% (v/v) <195>)
	<142,171,190,195>
IN	#106,107# sodium dodecylsulfate (#106# 1 mM, 3% residual activity
	<213>; #107# 1 mM, no residual activity <213>) <213>
IN	#107# Ca2+ (#107# 1 mM, no residual activity <213>) <213>
IN	#12# Ag+ <45>
IN	#12,19,29,46,49,50,51,104,106,107# Zn2+ (#46# 0.1 mM, 20% decrease of
	activity <82>; #51# 5 mM, 17% loss of activity <145>; #50# 5 mM, 29%
	loss of activity <145>; #104# 91% relative activity at 10 mM <195>;
	#107# 1 mM, 14.1% residual activity <213>; #106# 1 mM, 30.5% residual
	activity <213>) <45,76,82,99,145,179,195,213>
IN	#12,19,34,38,43,49,84,93# PCMB (#19# no effect <76>; #93# 0.1 mM,
	complete inhibition <183>; #43,84# 1 mM, complete inhibition <142,147>)
	<45,68,75,76,85,99,142,147,183>
IN	#12,19,42# Hg2+ (#19# no effect <75>) <45,75,161>
IN	#12,19,49,84# NEM (#84# 1 mM, complete inhibition <142>) <45,75,99,142>
IN	#12,19,89,106,107# Cu2+ (#19# no effect <75>; #89# 1 mM, 99% loss of
	activity <166>; #107# 1 mM, 14.0% residual activity <213>; #106# 1 mM,
	44.2% residual activity <213>) <45,75,166,213>
IN	#12,34,84,93# iodoacetic acid (#93# 1 mM, 10% inhibition <183>; #84# 1
	mM, 96% inhibition <142>) <45,85,142,183>
IN	#12,37,60# glutathione (#37# competitive <98>) <45,78,98>
IN	#12,49# 2,2'-dipyridyl <45,99>
IN	#14,71,80# imidazole (#80# weak inhibition <117>; #71# pure competitive
	inhibition towards ethanol and (R)-(+)-phenylethanol <61>) <61,117,125>
IN	#14,80# Pyridine <117,125>
IN	#19# p-hydroxymercuribenzoate <75>
IN	#19# PMSF <75>
IN	#19# B4O72- <76>
IN	#19,106,107# Mg2+ (#107# 1 mM, 0.3% residual activity <213>; #106# 1
	mM, 74.3% residual activity <213>) <76,213>
IN	#19,61# iodoacetamide <69,75,76>
IN	#23# cyclopropyl carbinol (#23# complete inhibition in vitro at 1820
	nM, anti-amoebic activity on trophozoites by growth inhibition of
	recombinant Escherichia coli cells <122>) <122>
IN	#23# cyclobutyl carbinol (#23# complete inhibition in vitro at 890 nM,
	anti-amoebic activity on trophozoites by growth inhibition of
	recombinant Escherichia coli cells <122>) <122>
IN	#25# 2,4-Dinitrophenol (#25# 1 mM, complete inhibition <186>) <186>
IN	#25# FeSO4 (#25# 1 mM, complete inhibition <186>) <186>
IN	#25# N-ethylmaleimide (#25# 1 mM, 11% inhibition <186>) <186>
IN	#25# 5,5'-dinitrobis(2-nitrobenzoate) (#25# 1 mM, complete inhibition
	<186>) <186>
IN	#25,104# dithiothreitol (#25# 1 mM, 6% inhibition <186>; #104# 14%
	relative activity at 10 mM <195>) <186,195>
IN	#25,37,60# 2-mercaptoethanol (#37# competitive <98>; #25# 1 mM, 19%
	inhibition <186>) <78,98,186>
IN	#25,43# BaCl2 (#25# 1 mM, complete inhibition <186>; #43# 1 mM, 95%
	inhibition <147>) <147,186>
IN	#25,43,85# PbCl2 (#25# 1 mM, complete inhibition <186>; #43# 1 mM, 24%
	inhibition <147>; #85# 1 mM, 63% inhibition <136>) <136,147,186>
IN	#25,85# AgNO3 (#25# 1 mM, 37% inhibition <186>; #85# 0.1 mM, 66%
	inhibition <136>) <136,186>
IN	#25,93,104# 2,2'-Bipyridyl (#25# 1 mM, 11% inhibition <186>; #93# 1 mM,
	78% inhibition <183>; #104# 91% relative activity at 10 mM <195>)
	<183,186,195>
IN	#3# pyridoxal 5'-phosphate (#3# inactivates by modifying its
	epsilon-amino group, NAD+ protects <4>) <4>
IN	#33# Biochanin A (#33# inhibition of isoenzyme BB-ADH, no inhibition of
	isoenzyme AA-ADH and TT-ADH <95>) <95>
IN	#33# daidzein (#33# inhibition of isoenzyme BB-ADH, no inhibition of
	isoenzyme AA-ADH and TT-ADH <95>) <95>
IN	#33# genistein (#33# inhibition of isoenzyme BB-ADH, no inhibition of
	isoenzyme AA-ADH and TT-ADH <95>) <95>
IN	#33# testosterone (#33# inhibition of isoenzyme BB-ADH, no inhibition
	of isoenzyme AA-ADH and TT-ADH <95>) <95>
IN	#33# 12-hydroxydodecanoate <47>
IN	#34,80,82# acetaldehyde (#34# linear noncompetitive inhibition <85>;
	#80# strong product inhibition <117>; #82# product inhibition, 50%
	inhibition at 16 mM <104>) <85,104,117>
IN	#37# 1,2-Ethanedithiol (#37# competitive <98>) <98>
IN	#37# 1,4-Butanedithiol (#37# competitive <98>) <98>
IN	#37# 1,4-dithiothreitol (#37# competitive <98>) <98>
IN	#37# 1-thioglycerol (#37# competitive <98>) <98>
IN	#37# 2-mercaptobenzothiazole (#37# competitive <98>) <98>
IN	#37# 6-Thioguanine (#37# competitive <98>) <98>
IN	#37# Captopril (#37# competitive <98>) <98>
IN	#37# Coenzyme A (#37# competitive <98>) <98>
IN	#37# Cys (#37# competitive <98>) <98>
IN	#37# cysteamine (#37# competitive <98>) <98>
IN	#37# diethyldithiocarbamate (#37# competitive <98>) <98>
IN	#37# Dimethyl sulfoxide <173>
IN	#37# Disulfiram (#37# competitive <98>) <98>
IN	#37# NO (#37# Cys residues contained within the zinc/thiolate active
	center may be primary sites of NO interaction <102>) <102>
IN	#37# p-nitrophenol (#37# noncompetitive inhibition of the hydrolysis of
	p-nitrophenyl octanoate <39>) <39>
IN	#37# Penicillamine (#37# competitive <98>) <98>
IN	#37# Thiophenol (#37# competitive <98>) <98>
IN	#37# Thiourea (#37# competitive <98>) <98>
IN	#37# S-2-Chloro-3-(imidazol-5-yl)propionate (#37# inactivation at pH
	8.2, R-2-chloro-3-(imidazol-5-yl)propionate has no effect <29>) <29>
IN	#37# 1,2-dithioglycerol (#37# competitive <98>) <98>
IN	#37# 1,3-propanedithiol (#37# competitive <98>) <98>
IN	#37# 1,4-dithioerythritol (#37# competitive <98>) <98>
IN	#37# 1-hydroxypyridine-2-thione (#37# competitive <98>) <98>
IN	#37# 1-thio-1-phenylmethane (#37# competitive <98>) <98>
IN	#37# 1-thioacetamide (#37# competitive <98>) <98>
IN	#37# 1-thioacetate (#37# competitive <98>) <98>
IN	#37# 1-thiobutane (#37# competitive <98>) <98>
IN	#37# 1-thioethane (#37# competitive <98>) <98>
IN	#37# 1-thiopropane (#37# competitive <98>) <98>
IN	#37# 1-thiosorbitol (#37# competitive <98>) <98>
IN	#37# 2-mercapto-1-methylimidazole (#37# competitive <98>) <98>
IN	#37# 2-mercaptobenzimidazole (#37# competitive <98>) <98>
IN	#37# 2-mercaptoimidazole (#37# competitive <98>) <98>
IN	#37# 2-phenylethanethiol (#37# competitive <98>) <98>
IN	#37# 2-pyridylethanethiol (#37# competitive <98>) <98>
IN	#37# 2-thioacetate (#37# competitive <98>) <98>
IN	#37# 2-thiobutane (#37# competitive <98>) <98>
IN	#37# 2-thiopropane (#37# competitive <98>) <98>
IN	#37# 2-thiopyridine (#37# competitive <98>) <98>
IN	#37# 2-thiopyrimidine (#37# competitive <98>) <98>
IN	#37# 3-mercapto-1,2,4-triazole (#37# competitive <98>) <98>
IN	#37# 3-thiopropionate (#37# competitive <98>) <98>
IN	#37# 5-beta-D-ribofuranosylnicotinamide adenine dinucleotide (#37#
	potent and specific inhibitor <55>) <55>
IN	#37# 6-thioguanosine (#37# competitive <98>) <98>
IN	#38# cyanide (#38# competitive with nicotinamide nucleotides. NADH
	increases cyanide-resistance of ADH II <138>) <138>
IN	#4,34,71# NADH (#4,71# competitive towards NAD+ <61,63>; #34# linear
	competitive inhibition <85>) <43,61,63,85>
IN	#4,91# acetone (#4# product inhibition <43>; #91# 50% (v/v), 82% loss
	of activity <171>) <43,171>
IN	#42# Guanidine hydrochloride <152>
IN	#42# Iodine <161>
IN	#42# o-phenanthroline (#42# loses 30% of its activity immediately on
	addition of o-phenanthroline <161>) <161>
IN	#42# sodium iodoacetate (#42# increasing concentrations od sodium
	iodoacetate produce a slight decrease in activity <151>) <151>
IN	#43,84,93# NiCl2 (#93# 1 mM, complete inhibition <183>; #43# 1 mM, 93%
	inhibition <147>; #84# 1 mM, 79% inhibition <142>) <142,147,183>
IN	#49# p-chloromercuribenzene sulfonate <99>
IN	#49,106,107# Co2+ (#106# 1 mM, 51.9% residual activity <213>; #107# 1
	mM, 68.7% residual activity <213>) <99,213>
IN	#49,106,107# Mn2+ (#106# 1 mM, 14.3% residual activity <213>; #107# 1
	mM, 23.4% residual activity <213>) <99,213>
IN	#49,91,106,107# Ni2+ (#91# 10 mM, 46% loss of activity <171>; #107# 1
	mM, 18.2% residual activity <213>; #106# 1 mM, 72.7% residual activity
	<213>) <99,171,213>
IN	#5# caffeic acid (#5# mixed type of inhibition <210>) <210>
IN	#5# Dodecanoic acid (#5# inhibits ADH3 irrespective of substrate <198>)
	<198>
IN	#5# Ellagic acid (#5# mixed type of inhibition <210>) <210>
IN	#5# Vanillin (#5# mixed type of inhibition <210>) <210>
IN	#5# syringaldehyde (#5# mixed type of inhibition <210>) <210>
IN	#5# cyclohexylformamide (#5# dead-end inhibition pattern <109>) <109>
IN	#5,37,79# Octanoic acid (#37# competitive inhibition of the hydrolysis
	of p-nitrophenyl octanoate <39>; #5# dead-end inhibition pattern <109>;
	#79# interacts with the catalytic zinc ion, binding structure <126>)
	<39,109,126>
IN	#5,7,8,26,32,33,37,39,42,59,66,72,98,101# 4-Methylpyrazole (#42#
	competitive inhibitor <161>; #8# 1 mM, 31% inhibition <23>; #8# class
	III enzyme is completely insensitive to inhibition <11,16>; #8# poor
	inhibitor, class II isoenzyme <14>; #8# no inhibition by 12 mM <21>;
	#8# competitive against ethanol <96>; #33# isoenzyme AA-ADH, BB-ADH and
	TT-ADH <95>; #5# inhibits cell protein carbonylation following exposure
	to crotyl alcohol <116>) <2,11,14,16,21,23,24,25,95,96,116,134,161,212>
IN	#5,8,12,19,25,33,38,39,61,66,72,84,93# 1,10-phenanthroline (#93# 1 mM,
	complete inhibition <183>; #33# mixed type inhibition <47>; #84# 1 mM,
	38% inhibition <142>; #5# inhibition of isoenzyme A2 and C2, no
	inhibition of isoenzyme B2 <48>; #38# 0.2 mM, strong inhibition <68>;
	#25# 1 mM, 6% inhibition <186>)
	<2,14,21,24,25,45,47,48,68,69,75,95,142,183,186>
IN	#5,8,9,10,12,20,39,42,62,71,72,80# pyrazole (#71# competitive <38>;
	#80# strong inhibition <117>; #8# 0.05 mM, 50% inhibition <10>; #42#
	competitive inhibitor <161>; #71# competitive towards ethanol <61>; #9#
	0.1-10 mM, ADH-2 is practically insensitive, ADH-3 is very sensitive
	<49>; #9# 0.05 mM, complete inhibition <10>; #8# no inhibition at 1.0
	mM <23>; #39,72# organism has a pyrazole-sensitive isoenzyme and a
	pyrazole-insensitive enzyme <24,25>; #62# pyrazole-sensitive enzyme
	forms ADH-1, ADH-2, ADH-3 and the pyrazole-insensitive form ADH-An
	<60>; #5# inhibition of isoenzyme A2 and C2. Isoenzyme B2 is
	insensitive to pyrazole inhibition with trans-2-hexen-1-ol as substrate
	<48>) <10,12,23,24,25,38,45,48,49,60,61,71,94,117,161,210>
IN	#50,51# Ba2+ (#51# 5 mM, 95% inhibition <145>; #50# 5 mM, 94%
	inhibition <145>) <145>
IN	#50,51# Cr3+ (#51# 5 mM, 88% loss of activity <145>; #50# 5 mM, 84%
	loss of activity <145>) <145>
IN	#50,51# Fe2+ (#50# 5 mM, 48% inhibition <145>; #51# 5 mM, 61%
	inhibition <145>) <145>
IN	#50,51# Li+ (#50# 5 mM, 28% inhibition <145>; #51# 5 mM, 32% inhibition
	<145>) <145>
IN	#50,51# Pb2+ (#51# 5 mM, 96% inhibition <145>; #50# 5 mM, 98%
	inhibition <145>) <145>
IN	#50,51# Zr2+ (#50# 5 mM, 78% inhibition <145>; #51# 5 mM, 72%
	inhibition <145>) <145>
IN	#6# CaCl2 (#6# 100 mM, 30% inhibition <167>) <167>
IN	#6# 1-butyl-3-methylimidazolium tetrafluoroborate (#6# 2 mM, 65%
	inhibition <167>) <167>
IN	#6,25,43,84,85,93# HgCl2 (#25,43,84,93# 1 mM, complete inhibition
	<142,147,183,186>; #85# 0.1 mM, 85% inhibition <136>; #6# 1 mM, 67%
	inhibition <167>) <136,142,147,167,183,186>
IN	#6,43,84,93# CuCl2 (#43,93# 1 mM, complete inhibition <147,183>; #6# 1
	mM, 24% inhibition <167>; #84# 1 mM, 68% inhibition <142>)
	<142,147,167,183>
IN	#6,93# MgCl2 (#93# 1 mM, 10% inhibition <183>; #6# 100 mM, 33%
	inhibition <167>) <167,183>
IN	#61# NaN3 <69>
IN	#71# 2-Chloroethanol (#71# competitive towards ethanol <61>) <61>
IN	#71# Cibacron blue (#71# competitive towards NAD+ <61>) <61>
IN	#71# isoburyramide (#71# competitive towards ethanol and butan-2-ol
	<61>) <61>
IN	#8# 4-androsten-3,17-dione (#8# competitive against substrate
	cyclohexanone <115>) <115>
IN	#8# 5alpha-androstan-17beta-ol-3-one (#8# i.e.
	5alpha-dihydrotestosterone, allosteric, competitive against substrate
	cyclohexanone, noncompetitive against NAD+ nd ethanol <115>) <115>
IN	#8# 8-Amino-6-methoxyquinoline <12>
IN	#8# all-trans-Retinal (#8# product inhibition <123>) <123>
IN	#8# all-trans-retinoic acid (#8# weak feedback inhibition <123>) <123>
IN	#8# NADP+ <21>
IN	#8# 4-bromopyrazole <23>
IN	#8# 4-cyanopyrazole <23>
IN	#8# 4-nitropyrazole <23>
IN	#8# 4-octylpyrazole <12>
IN	#8# 4-pentylpyrazole <12,23>
IN	#8# 4-propylpyrazole <23>
IN	#8# sulfonic acid <21>
IN	#8# 3-butylthiolan 1-oxide (#8# dead-end inhibitor to the
	enzyme-cofactor complex, inhibition of oxidation reaction <115>) <115>
IN	#8# N-cyclopentyl-N-cyclobutylformamide (#8# inhibits isozyme
	alphaalpha, complex structure <108>) <108>
IN	#8# N-benzylformamide (#8# inhibits isozyme beta(1)beta(1) <108>) <108>
IN	#8# N-heptylformamide (#8# inhibits isozyme beta(1)beta(1) <108>) <108>
IN	#8# N-1-methylheptylformamide (#8# inhibits isozyme gamma(2)gamma(2)
	<108>) <108>
IN	#8,10# trifluoroethanol (#8# competitive against retinol,
	noncompetitive against NAD+ <123>) <91,123>
IN	#8,10,72# dipicolinic acid (#10# Zn2+ chelator and inhibitor of ADH
	<207>) <21,24,207>
IN	#8,19,25,39,42,49,50,51,53,72,104# EDTA (#25# 1 mM, 31% inhibition
	<186>; #42# 15 mM, 85% inhibition <66>; #53# 67% inhibition of ADH II
	at 5 mM, 45% inhibition of ADH I at 1 mM, irreversible inhibition,
	addition of Mg2+ and Zn2+ increase the inhibitory effect <112>; #51#
	25% inhibition at 10.5 mM, 44% inhibition at 21 mM <145>; #50# 31%
	inhibition at 10.5 mM, 92% inhibition at 21 mM <145>; #42# loses 30% of
	its activity immediately on addition of EDTA <161>; #104# 2.3% relative
	activity at 10 mM <195>) <14,24,25,66,76,99,112,145,161,186,195>
IN	#8,37# Isobutyramide (#8# substrate inhibition, competitive against
	retinol, noncompetitive against NADH <123>) <123,173>
IN	#8,39# 2,2'-Bipyridine <14,25>
IN	#8,42# 4-iodopyrazole (#42# competitive inhibitor <161>) <23,161>
IN	#8,72# 8-hydroxyquinoline 5-sulfonic acid <21,24>
IN	#8,9,10,12,33# 4-methoxypyrazole (#33# competitive <47>; #8# 1 mM, 28%
	inhibition <23>; #12# class I ADHs migrate towards cathode on starch
	gel and are very sensitive to 4-methylpyrazole inhibition, class II ADH
	migrates slowly towards anode and is less sensitive to
	4-methylpyrazole, class II ADH migrates rapidly towards anode and is
	insensitive to 4-methylpyrazole <46>; #9# 0.1-10 mM, ADH-2 is
	practically insensitive, ADH-3 is very sensitive <49>; #9# competitive
	inhibitor of all four isoenzymes <51>) <23,45,46,47,49,51,53,91>
IN	#8,91,104# Tween 80 (#8# competitive, stabilizes the retinoid
	compounds, elevates the Km values of the substrates, most effective at
	0.1% w/v <106>; #91# 10% (w/v), 89% inhibition <171>; #104# 13%
	relative activity at 10% (v/v) <195>) <106,171,195>
IN	#80# trichloroethanol (#80# weak inhibition <117>) <117>
IN	#82# NAD+ (#82# substrate inhibition above 5 mM <104>) <104>
IN	#82,91,98,101# ethanol (#82# substrate inhibition above 0.5 M <104>;
	#91# 50% (v/v), 59% loss of activity <171>; #98# ethanol competitively
	inhibits the oxidation of 1-hydroxymethylpyrene by ADH1C and ADH3
	<212>; #101# ethanol competitively inhibits the oxidation of
	1-hydroxymethylpyrene by ADH4 <212>) <104,171,212>
IN	#84# FeCl2 (#84# 1 mM, 57% inhibition <142>) <142>
IN	#84# Hydroxylamine hydrochloride (#84# 1 mM, 34% inhibition <142>) <142>
IN	#84# hexadecyltrimethyl-ammonium bromide (#84# 1 mM, 79% inhibition
	<142>) <142>
IN	#84# polyoxyethylene octylphenyl ether (#84# 1 mM, 43% inhibition
	<142>) <142>
IN	#85# KCN (#85# 1 mM, 41% inhibition <136>) <136>
IN	#85,93# FeCl3 (#85# 1 mM, 34% inhibition <136>; #93# 0.1 mM, 13%
	inhibition <183>) <136,183>
IN	#91# CHAPS (#91# 10% (w/v), 59% inhibition <171>) <171>
IN	#91# Heptane (#91# 50% (v/v), 99% loss of activity <171>) <171>
IN	#91# Isopropanol (#91# 50% (v/v), 88% loss of activity <171>) <171>
IN	#91# Na+ (#91# 10 mM, 13% loss of activity <171>) <171>
IN	#91# Toluene (#91# 50% (v/v), 97% loss of activity <171>) <171>
IN	#91# Triton X-100 (#91# 10% (w/v), 78% inhibition <171>) <171>
IN	#91# Tween 20 (#91# 10% (w/v), 82% inhibition <171>) <171>
IN	#91# tert-butanol (#91# 50% (v/v), 92% loss of activity <171>) <171>
IN	#91# methanol (#91# 50% (v/v), 30% loss of activity <171>) <171>
IN	#91# pefabloc (#91# 10 mM, 32% inhibition <171>) <171>
IN	#91# hexadecane (#91# 50% (v/v), 71% loss of activity <171>) <171>
IN	#91# isooctane (#91# 50% (v/v), 98% loss of activity <171>) <171>
IN	#91,104# Urea (#91# 5 M, 41% inhibition <171>; #104# 1% relative
	activity at 5 M <195>) <171,195>
IN	#91,106,107# Al3+ (#91# 10 mM, 30% loss of activity <171>; #107# 1 mM,
	14.7% residual activity <213>; #106# 1 mM, 18.9% residual activity
	<213>) <171,213>
IN	#91,106,107# K+ (#91# 10 mM, 29% loss of activity <171>; #106# 1 mM,
	70.3% residual activity <213>; #107# 1 mM, 82.3% residual activity
	<213>) <171,213>
IN	#91,98,101# DMSO (#91# 50% (v/v), 29% loss of activity <171>; #98# DMSO
	inhibits isozyme ADH2-catalysed oxidation in an uncompetitive mode and
	reduction in a mixed mode <212>; #98# DMSO inhibits isozymes
	ADH1C-catalysed oxidation in an uncompetitive mode and reduction in a
	mixed mode, no inhibition is detected with isozyme ADH3 <212>; #101#
	DMSO inhibits isozymes ADH4-catalysed oxidation in an uncompetitive
	mode and reduction in a mixed mode <212>) <171,212>
IN	#93# CoCl2 (#93# 1 mM, 37% inhibition <183>) <183>
IN	#93# ZnSO4 (#93# 1 mM, complete inhibition <183>) <183>
IN	#94# Antimycin (#94# 0.0017 mM, 95% inhibition <172>) <172>

KI_VALUE
KI	#10# 0.025 {mithramycin}  (#10# in 50 mM Tris-HCl, pH 8.0 at 25°C
	<207>) <207>
KI	#10# 0.038 {mithramycin}  (#10# in 50 mM Tris-HCl, pH 8.0 at 25°C
	<207>) <207>
KI	#101# 3.3 {ethanol}  (#101# isozyme ADH4, using 1-hydroxymethylpyrene
	as substrate <212>) <212>
KI	#26# 6.64 {4-Methylpyrazole}  <134>
KI	#32# 0.47 {4-Methylpyrazole}  <134>
KI	#42# 0.13 {pyrazole}  (#42# apparent value <161>) <161>
KI	#42# 0.009 {4-Methylpyrazole}  (#42# apparent value <161>) <161>
KI	#42# 0.0032 {4-iodopyrazole}  (#42# apparent value <161>) <161>
KI	#5# 0.026 {Octanoic acid}  (#5# pH 7.5, 25°C, wild-type enzyme, versus
	NAD+ <109>) <109>
KI	#5# 0.072 {cyclohexylformamide}  (#5# pH 7.5, 25°C, wild-type enzyme,
	versus NADH <109>) <109>
KI	#5# 8e-05 {caffeic acid}  (#5# at 37°C in 0.1 M Na-K phosphate buffer
	(pH 7.4) <210>) <210>
KI	#5# 0.0051 {pyrazole}  (#5# at 37°C in 0.1 M Na-K phosphate buffer (pH
	7.4) <210>) <210>
KI	#5# 0.022 {Ellagic acid}  (#5# at 37°C in 0.1 M Na-K phosphate buffer
	(pH 7.4) <210>) <210>
KI	#5# 0.035 {cyclohexylformamide}  (#5# pH 7.5, 25°C, wild-type enzyme,
	versus benzaldehyde <109>) <109>
KI	#5# 0.037 {Octanoic acid}  (#5# pH 7.5, 25°C, wild-type enzyme, versus
	octanol <109>) <109>
KI	#5# 0.0079 {Vanillin}  (#5# at 37°C in 0.1 M Na-K phosphate buffer (pH
	7.4) <210>) <210>
KI	#5# 0.0156 {syringaldehyde}  (#5# at 37°C in 0.1 M Na-K phosphate
	buffer (pH 7.4) <210>) <210>
KI	#59# 6.4 {4-Methylpyrazole}  <134>
KI	#7# 18.26 {4-Methylpyrazole}  <134>
KI	#8# 0.014 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	versus ethanol <115>) <115>
KI	#8# 0.028 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	versus NAD+ <115>) <115>
KI	#8# 0.0047 {4-androsten-3,17-dione}  (#8# pH 7.3, 37°C, versus
	cyclohexanone <115>) <115>
KI	#8# 0.0047 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	versus cyclohexanone <115>) <115>
KI	#8,23# -999 {more}  (#8# inhibition kinetics <115>) <115,122,123>
KI	#98# 1.7 {ethanol}  (#98# isozyme ADH1C, using 1-hydroxymethylpyrene as
	substrate <212>) <212>
KI	#98# 1470 {ethanol}  (#98# isozyme ADH3, using 1-hydroxymethylpyrene as
	substrate <212>) <212>

METALS_IONS
ME	#10# Co2+ (#10# construction of an active metal-substituted mutant by
	substituting Zn2+ for Cu2+ or Co2+, which maintain the same
	configuration as the native zinc ion, but possessing a wider pH range
	and a lower activity and substrate affinity than the wild-type enzyme,
	overview <121>) <121>
ME	#10,25# Cu2+ (#10# construction of an active metal-substituted mutant
	by substituting Zn2+ for Cu2+ or Co2+, which maintain the same
	configuration as the native zinc ion, but possessing a wider pH range
	and a lower activity and substrate affinity than the wild-type enzyme,
	overview <121>; #25# 1 mM CuSO4, 1.7fold activation <186>) <121,186>
ME	#103,104,106,107# more (#103# Mg2+ does not have any effect on activity
	<211>; #104# not stimulated by 10 mM Li+, Mg2+, Co2+, and Ca2+ <195>;
	#106,107# enzyme contains neither Fe nor other metals, and Fe is not
	required for the activity, although sequence analysis reveals that ADH1
	belongs to the Fe-containing/activated long-chain alcohol
	dehydrogenases <213>) <195,211,213>
ME	#13,46# Mg2+ (#46# enhances activity <82>; #13# essential for activity,
	in the absence of Mg2+ in the kinetic assay no ADH activity is detected
	<209>) <82,209>
ME	#25# Ni2+ (#25# 1 mM NiSO4, 1.2fold activation <186>) <186>
ME	#29# KCl (#29# most active at 5 M NaCl or 4 M KCl <179>) <179>
ME	#29# NaCl (#29# most active at 5 M NaCl or 4 M KCl <179>) <179>
ME	#39# Copper (#39# contains 0.5 mol of copper per mol of enzyme <25>)
	<25>
ME	#46,106,107# Fe2+ (#46# enhances activity <82>; #106# 1 mM, 136% of
	initial activity <213>; #107# 1 mM, 168% of initial activity <213>)
	<82,213>
ME	#5,6,8,10,13,14,25,26,37,40,42,53,79,86,102,103# Zn2+ (#10# activates
	<87>; #102# dependent on <208>; #42# zinc-containing metalloenzyme
	<162>; #5,37,79# catalytic zinc ion <109,110,126>; #42# zinc-containing
	enzyme <159>; #5# 1 catalytic and 1 structural zinc ion per subunit
	<118>; #26# 1 catalytic and 1 structural zinc ion per subunit,
	coordination complex geometry <128>; #14# 1 catalytic zinc ion and 1
	structural zinc ion per enzyme subunit <111>; #40# 1 tightly bound ion
	per subunit <113>; #53# ADH I contains 1 Zn2+ per subunit, while ADH II
	does not contains any metal ions <112>; #10# all isozymes, amino acid
	residues involved in zinc in binding are Cys46, Cys174, His67, Glu68,
	Asp49, and Thr48, binding mode <119>; #8# catalytic zinc <108>; #10#
	included into the crystal strcuture <103>; #10# native enzyme contains
	catalytic zinc ions <121>; #42# the catalytic active site zinc ion is
	bound to Glu69 in the apoenzyme state, but not in the ternary complex
	state <107>; #86# ADH is a putative zinc-dependent alcohol
	dehydrogenase <160>; #42# contains a zinc ion which is directly
	involved in the structural stabilization of enzyme molecule <153>; #42#
	contains eight zinc atoms per tetramer <161>; #6# 1 mM ZnSO4, 1.14fold
	activation <167>; #25# 1 mM ZnSO4, 1.3fold activation <186>; #5# 2
	atoms are included in each 40 kDa subunit, while one of the zinc ions
	is considered to serve a structural function only, the other zinc ion
	functions as a Lewis acid and activates the substrate in the active
	site, which is located in a cleft between the catalytic and the
	coenzyme binding domain <198>; #13# 20% of activity is obtained when
	replacing Mg2+ with 5 mM ZnSO4 <209>; #10# contains Zn2+ <207>; #103#
	maximum activity is reached at 0.5 mM Zn2+,Ta1316 ADH is able to
	tolerate high concentrations of Zn2+ <211>; #37# zinc metalloenzyme
	with two zinc atoms per subunit <199>)
	<87,103,107,108,109,110,111,112,113,118,119,121,126,128,153,159,160,161
	162,167,186,198,199,207,208,209,211>
ME	#5,8,9,12,15,19,33,37,38,39,42,49,61,72,95,96# Zinc (#19# required for
	activity, tightly bound within the enzyme <75>; #5# isoenzyme A2
	contains 2.7 mol of zinc per mol of enzyme, isoenzyme b2 contains 1.9
	mol of zinc per mol of enzyme, isoenzyme C2 contains 3.2 mol of zinc
	per mol of enzyme. A and C subunits each contain two atoms of zinc,
	with at least one being involved catalytically, the b subunit probably
	contains a single non-catalytic zinc atom <48>; #9# ADH-1 contains 3.9
	mol of zinc per mol of subunit, ADH-2 contains 4.2 mol of zinc per mol
	of subunit <49>; #8# enzyme contains 7.59 zinc atoms per molecule <96>;
	#72# contains 3.9 gatom of zinc per mol of enzyme <24>; #42# 2 mM
	required for optimal activity <66>; #37# substitution of catalytic and
	/or noncatalytic zinc ions by cobaltous ions <36>; #37# contains 4 zinc
	atoms per molecule <42>; #8,12# contains 3.8 mol of Zn per mol of
	protein <16,45>; #38# enzyme form ADH I and ADH II contain one zinc
	atom per subunit <67>; #15# contains 1 zinc atom per subunit <81>; #33#
	isoenzyme AA-ADH contains 4.3 zinc atoms per dimeric molecule,
	isoenzyme BB-ADH contains 3.7 zinc atoms per dimeric molecule,
	isoenzyme AA-ADH contains 4.1 zinc atoms per dimeric molecule <95>;
	#49# contains 1.2 Zn atom per subunit <99>; #61# contains 4 zinc atoms
	per dimer <69>; #8# zinc containing enzyme <12>; #8# from beta1gamma1
	and gamma1gamma1 isoenzyme the active-site zinc is extracted much more
	slowly than from beta1beta1 isoenzyme. Characterization of
	active-site-specific zinc-depleted and reconstituted cobalt(II) alcohol
	dehydrogenase <19>; #8# contains 3.7 gatom of zinc per mol of enzyme
	<23>; #8# 3.6-4.2 gatom of zinc per mol <21>; #39# contains 3.7-4.2 mol
	of zinc per mol of enzyme <25>; #95# KmADH3 appears to belong to the
	zinc-containing Adh family <175>; #96# KmADH4 appears to belong to the
	zinc-containing Adh family <175>)
	<12,16,19,21,23,24,25,36,42,45,48,49,66,67,69,70,75,81,95,96,99,175>
ME	#6# K+ (#6# 100 mM KCl, 1.9fold activation <167>) <167>
ME	#6,106# Na+ (#6# 100 mM NaCl, 1.8fold activation <167>; #106# 1 mM,
	110% of initial activity <213>) <167,213>
ME	#6,25# Li+ (#25# 1 mM LiCl, 1.1fold activation <186>; #6# 100 mM LiCl,
	1.8fold activation <167>) <167,186>
ME	#84# Zn (#84# the enzyme contains 2 gram-atoms Zn per subunit <142>)
	<142>

MOLECULAR_WEIGHT
MW	#10# 60000-80000 (#10# gel filtration <87>) <87>
MW	#104# 37200 (#104# calculated molecular weight <195>) <195>
MW	#106# 380000 (#106# PAGE <213>) <213>
MW	#107# 90000 (#107# PAGE <213>) <213>
MW	#12# 72000 (#12# gel filtration <45>) <45>
MW	#12# 74500 (#12# gel filtration <46>) <46>
MW	#13# 37000 (#13# SDS-PAGE <209>) <209>
MW	#15# 290000 (#15# gel filtration <81>) <81>
MW	#17# 89000-91000 (#17# gel filtration <79>) <79>
MW	#19,42,53# 70000 (#19# gel filtration <75>; #42# gel filtration,
	sucrose density gradient centrifugation <66>; #53# ADH II, grl
	filtration <112>) <66,75,112>
MW	#20,42# 74000 (#42# gel filtration, sucrose density gradient
	centrifugation <70>; #20# gel filtration sedimentation equilibrium
	centrifugation <71>) <70,71>
MW	#21# 68000 (#21# gel filtration <72>) <72>
MW	#25# 58000 (#25# gel filtration <186>) <186>
MW	#30# 150000 (#30# gel filtration <73>) <73>
MW	#34# 152000 (#34# gel filtration <85>) <85>
MW	#38# 95000 (#38# enzyme form ADHII, gel filtration <68>) <68>
MW	#38# 145000 (#38# enzyme form ADH-I, glycerol density gradient
	centrifugation <67>) <67>
MW	#38# 67000 (#38# enzyme form ADH-II, glycerol density gradient
	centrifugation <67>) <67>
MW	#39# 76000-77000 (#39# equilibrium sedimentation <25>) <25>
MW	#4# 55600 (#4# gel filtration <64>) <64>
MW	#41# 86000 <6>
MW	#42# 135000 (#42# SDS-PAGE <161>) <161>
MW	#42# 150300 (#42# electrospray mass spectrometry <152>) <152>
MW	#42,87# 140000 (#42,87# gel filtration <157>) <157>
MW	#43# 29000 (#43# gel filtration <147>) <147>
MW	#46# 180000 (#46# gel filtration <82>) <82>
MW	#49# 320000 (#49# gel filtration <99>) <99>
MW	#5# 85000 (#5# isoenzyme C2, gel filtration <48>) <48>
MW	#5# 83000 (#5# isoenzyme A2, gel filtration <48>) <48>
MW	#5# 79000 (#5# isoenzyme B2, gel filtration <48>) <48>
MW	#50# 45000 (#50# gel filtration <145>) <145>
MW	#51# 25000 (#51# gel filtration <145>) <145>
MW	#53# 130000 (#53# ADH I, gel filtration <112>) <112>
MW	#6# 105000 (#6# buffer containing 25 mM NaCl, gel filtration <167>)
	<167>
MW	#60,74# 116000 (#60,74# gel filtration <77,78>) <77,78>
MW	#61# 94000 (#61# gel filtration <69>) <69>
MW	#62# 82750 (#62# enzyme form ADH-3, equilibrium sedimentation <60>) <60>
MW	#63# 176000 (#63# non-denaturing PAGE <84>) <84>
MW	#65# 54600 (#65# gel filtration <64>) <64>
MW	#68# 57600 (#68# gel filtration <64>) <64>
MW	#71# 56000 (#71# gel filtration <61>) <61>
MW	#72# 77330 (#72# equilibrium sedimentation <24>) <24>
MW	#8# 78000 (#8# ultracentrifugation under non-denaturing conditions
	<23>) <23>
MW	#8# 78000-85000 (#8# amino acid analysis, ultracentrifugation <18>) <18>
MW	#8# 79000-84000 (#8# ultracentrifugal analysis <21>) <21>
MW	#8# 82700 (#8# equilibrium sedimentation <16>) <16>
MW	#80# 88000 (#80# approximately, gel filtration <117>) <117>
MW	#84# 160000 (#84# gel filtration <142>) <142>
MW	#85# 110000 (#85# gel filtration <136>) <136>
MW	#86# 36000 (#86# deduced from amino acid sequence <160>) <160>
MW	#88# 57000 (#88# SDS-PAGE <154>) <154>
MW	#88# 56700 (#88# deduced from amino acid sequence <154>) <154>
MW	#89# 30000 (#89# gel filtration <166>) <166>
MW	#9,33,38,47# 80000 (#9,33,47# gel filtration <47,49,59,95>; #38# enzyme
	form ADHI, gel filtration <68>) <47,49,59,68,95>
MW	#92# 81500 (#92# gel filtration <169>) <169>
MW	#98# 39500 (#98# isozyme ADH3, apparent molecular weight deduced from
	electrophoretic mobility <212>) <212>
MW	#98# 39870 (#98# isozyme ADH1C, calculated from amino acid sequence
	<212>) <212>
MW	#98# 39720 (#98# isozyme ADH3, calculated from amino acid sequence
	<212>) <212>
MW	#98# 40220 (#98# isozyme ADH2, calculated from amino acid sequence
	<212>) <212>
MW	#98,101# 40500 (#98# isozyme ADH1C, apparent molecular weight deduced
	from electrophoretic mobility <212>; #101# isozyme ADH4, apparent
	molecular weight deduced from electrophoretic mobility <212>) <212>
MW	#98,101,104# 40000 (#104# SDS-PAGE <195>; #98# isozyme ADH2, apparent
	molecular weight deduced from electrophoretic mobility <212>; #101#
	isozyme ADH4, calculated from amino acid sequence <212>) <195,212>
MW	#99# 100000 (#99# SDS-PAGE <193>) <193>

POSTTRANSLATIONAL_MODIFICATION
PM	#42# more (#42# carboxymethylation with sodium iodoacetate <151>) <151>

SUBUNITS
SU	#1,8,15,16,23,24,29,66,73,90# ? (#8# x * 42000, SDS-PAGE <14>; #66# x *
	28000, SDS-PAGE <2>; #1,8,73# x * 40000, SDS-PAGE <11,44,52>; #23# x *
	96000, SDS-PAGE <127>; #15# x * 37500, SDS-PAGE <81>; #24# x * 31997,
	amino acid sequence calculation <105>; #90# x * 37443, ADH1, calculated
	from sequence <170>; #16# x * 37983, ADH3, calculated from sequence
	<170>; #29# x * 41300, SDS-PAGE <179>)
	<2,11,14,44,52,81,105,127,170,179>
SU	#106# octamer (#106# 8 * 45000, SDS-PAGE, 8 * 41664, calculated <213>)
	<213>
SU	#3,4,5,8,9,10,12,17,19,20,21,25,33,37,38,40,41,42,47,53,60,61,62,65,68
	71,72,74,80,92# dimer (#17# 2 * 45000, SDS-PAGE <79>; #25,71# 2 *
	28000, SDS-PAGE <61,186>; #60,74# 2 * 58000, SDS-PAGE <77,78>; #19# 2 *
	35000, SDS-PAGE <75>; #40# 2 * 38000, SDS-PAGE <113>; #8,10,33,47,72# 2
	* 40000, SDS-PAGE <16,23,24,59,87,95>; #33# 2 * 41000, SDS-PAGE <47>;
	#61# 2 * 42000, SDS-PAGE <69>; #41# 2 * 46000, SDS-PAGE <6>; #80# 2 *
	43000, SDS-PAGE <117>; #12# 2 * 36000, SDS-PAGE <45>; #21,42# 2 *
	37000, SDS-PAGE <66,70,72,163>; #38# 2 * 38000, enzyme form ADHII,
	SDS-PAGE <68>; #8# 2 * 41000, class III isoenzyme chi ADH, SDS-PAGE
	<16>; #9# 2 * 43000, ADH-1, SDS-PAGE <49>; #8# 2 * 42000, anodic enzyme
	form, SDS-PAGE <18>; #62# 2 * 42000, enzyme form ADH-2 and ADH-3,
	SDS-PAGE <60>; #5# 2 * 47000, isoenzyme C2, SDS-PAGE <48>; #5# 2 *
	39000, isoenzyme B2, SDS-PAGE <48>; #9# 2 * 40000, ADH-3, SDS-PAGE
	<49>; #9# 2 * 39000, ADH-2, SDS-PAGE <49>; #12# 2 * 41700, enzyme form
	CM-I: a polypeptide chain + C polypeptide chain, enzyme form CM-II:
	B-chain + C-chain, enzyme form CM III, homodimer of C chains, SDS-PAGE
	<46>; #5# 2 * 43000, isoenzyme A2, SDS-PAGE <48>; #38# 2 * 40000,
	enzyme form ADHI <68>; #4,65,68# 2 * 27800, SDS-PAGE <64>; #38# 2 *
	34700, enzyme form ADH-I, SDS-PAGE <67>; #3# 2 * 30000 <4>; #38# 2 *
	31100, enzyme form ADH-II, SDS-PAGE <67>; #53# 2 * 31000, ADH II,
	SDS-PAGE <112>; #42# dimer of dimers, X-ray crystallography <159>; #92#
	2 * 36900, SDS-PAGE <169>)
	<4,6,16,18,21,23,24,45,46,47,48,49,59,60,61,64,66,67,68,69,70,71,72,75
	77,78,79,87,95,112,113,117,159,163,169,186,192,203>
SU	#42,87,103# homotetramer (#42# x-ray crystallography <159>; #42,87# 4 *
	35000, gel filtration <157>; #42# 4 * 37585, electrospray mass
	spectrometry <152>; #103# 4 * 36000, Ta1316 ADH, SDS-PAGE <211>; #103#
	4 * 36010, Ta1316 ADH, calculated from amino acid sequence <211>)
	<152,157,159,211>
SU	#43,50,51,89# monomer (#50# 1 * 45000, SDS-PAGE <145>; #43# 1 * 39000,
	SDS-PAGE <147>; #89# 1 * 31000, SDS-PAGE <166>; #51# 1 * 24600,
	SDS-PAGE <145>) <145,147,166>
SU	#49# decamer (#49# 10 * 43000, SDS-PAGE <99>) <99>
SU	#53# trimer (#53# 3 * 42000, ADH I, SDS-PAGE <112>) <112>
SU	#6,10,14,34,42,46,63,64,79,84,85# tetramer (#63# 4 * 42000, SDS-PAGE
	<84>; #46# 4 * 45000, SDS-PAGE <82>; #85# 4 * 26000, SDS-PAGE <136>;
	#84# 4 * 40000, SDS-PAGE <142>; #34# 4 * 38000, SDS-PAGE <85>; #42#
	x-ray crystallography <155,162>; #79# the monomer consista of a
	catalytic and a cofactor-binding domain, the cofactor is bound between
	2 domains in a cleft <126>; #42# 4 * 37588, calculated from amino acid
	sequence <161>; #42# 4 * 37591, electrospray mass spectrometry <161>;
	#42# crosslinking of ADH with dimethylsuberimidate and ethylene glycol
	bis [succinimidylsuccinate] produces mainly dimers and tetramers,
	suggesting a dimer of dimers assembly <161>; #6# 4 * 26961, calculated
	from sequence <167>) <82,84,85,111,126,136,142,155,161,162,167,203>
SU	#8,26# More (#26# quaternary organization and stability, overview
	<128>; #8# structure modelling <114>) <114,128>
SU	#91# dodecamer (#91# 12 * 35000, SDS-PAGE <171>) <171>

PI_VALUE
PI	#103# 5.5 (#103# Ta1316 ADH, calculated from amino acid sequence <211>)
	<211>
PI	#16# 8.3 (#16# calculated from sequence <170>) <170>
PI	#80# 6 <117>
PI	#90# 6.3 (#90# calculated from sequence, ADH1 <170>) <170>

APPLICATION
AP	#10,16,28,36,40,81,85# synthesis (#40# enzyme can be used in
	preparative scale enantioselective oxidation of sec-alcohol in
	asymmetric reduction of ketones, using acetone and 2-propanol,
	respectively, as cosubstrates for cofactor-regeneration via a
	coupled-substrate approach <113>; #28# production of
	(3R,5S)-6-benzyloxy-3,5-dihydroxy-hexanoic acid ethyl ester, which is a
	key chiral intermediate for anticholesterol drugs that act by
	inhibition of hydroxy methyl glutaryl coenzyme A reductase <132>; #16#
	production of
	(4S,6S)-5,6-dihydro-4-hydroxy-6-methyl-4H-thieno[2,3b]thiopyran-7
	7dioxide, which is an intermediate in the synthesis of the carbonic
	anhydrase inhibitor trusopt. Trusopt is a novel, topically active
	treatment for glaucoma <133>; #36# production of
	(S)-1-Phenyl-2-propanol, which is used as an intermediate for the
	synthesis of amphetamines and as a precursor for anti-hypertensive
	agents and spasmolytics or anti-epileptics <130>; #81# production of
	(S)-4-(3,4-methylenedioxyphenyl)-2-propanol, which is converted to
	LY300164, an orally active benzodiazepine <131>; #85# LSADH catalyzed
	the enantioselective reduction of some ketones with high enantiomeric
	excesses: phenyl trifluoromethyl ketone to (S)-1-phenyltrifluoroethanol
	(>99% e.e.), acetophenone to (R)-1-phenylethanol (99% e.e.), and
	2-heptanone to (R)-2-heptanol (>99% e.e.) in the presence of 2-propanol
	without an additional NADH regeneration system. Therefore, it would be
	a useful biocatalyst <136>; #10# the photochemical and enzymatic
	synthesis of methanol from formaldehyde with alcohol dehydrogenase and
	NAD+ photoreduction by the visible-light photosensitization of zinc
	tetraphenylporphyrin tetrasulfonate in the presence of methylviologen,
	diaphorase, and triethanolamine is developed <185>)
	<113,130,131,132,133,136,185>
AP	#14# biotechnology (#14# possible usage of the enzyme in bioindustrial
	processes and as biosensor <125>) <125>
AP	#23# medicine (#23# isozyme ADH2 is a target for anti-amoebic agents
	<122>) <122>

ENGINEERING
EN	#10# H47R (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# M294L (#10# 7-10fold increase in reactivity, V/Km, with butanol,
	pentanol and hexanol <91>; #10# increased activity compared to the
	wild-type enzyme <119>) <91,119>
EN	#10# T48A (#10# inactive mutant <119>) <119>
EN	#10# W57M (#10# slightly reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# W57L (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# W93A (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# D49N (#10# highly reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# E68Q (#10# highly reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# T48S (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# T48S/T93A (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# T48S/W57M/W93A (#10# reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# T48C (#10# inactive mutant <119>) <119>
EN	#10# H51E (#10# highly reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# S198F (#10# highly reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# G224I (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# G225R (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# D223G (#10# highly reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# D223G/G225R (#10# nearly inactive mutant <119>) <119>
EN	#10# L203A (#10# reduced activity compared to the wild-type enzyme
	<119>) <119>
EN	#10# L203A/T178S (#10# reduced activity compared to the wild-type
	enzyme <119>) <119>
EN	#10# G204A (#10# nearly inactive mutant <119>) <119>
EN	#10# DELTAA200/A201L (#10# highly reduced activity compared to the
	wild-type enzyme <119>) <119>
EN	#10# S269I (#10# nearly inactive mutant <119>) <119>
EN	#10,37# H51Q (#10# reduced activity compared to the wild-type enzyme
	<119>; #37# site-directed mutagenesis, shifting of pH dependency,
	increased activity at pH 8.0, decrease of the rate of isomerization of
	the enzyme-NAD+ complex, which becomes the limiting step for ethanol
	oxidation <110>) <110,119>
EN	#37# W54L (#37# less active than the wild-type enzyme with ethanol,
	1-propanol and 1-butanol. With 1-pentanol and 1-hexanol the mutant
	enzyme is a better catalyst than the wild-type enzyme <92>) <92>
EN	#37# H51Q/K228R (#37# site-directed mutagenesis, kinetic effects <110>)
	<110>
EN	#42# N249Y (#42# mutant exhibits increased catalytic activity compared
	to the wild type enzyme <155>; #42# mutant shows increased thermal
	stability and increased catalytic activity compared to the wild type
	enzyme <152>; #42# shows 7fold higher specific activity compared to the
	wild type enzyme, is active up to 95°C and more stable than the native
	enzyme, has acquired an improved resistance to proteolysis by
	thermolysin and shows a decreased activating effect by treatment with
	denaturants at moderate concentration <161>) <152,155,161>
EN	#42# E97C (#42# shows the same activity but a reduced thermostability
	with respect to the wild type recombinant protein <163>) <163>
EN	#5# P47H (#5# site-directed mutagenesis, about 100fold increased
	activity compared to the wild-type enzyme <109>) <109>
EN	#5# P47A (#5# site-directed mutagenesis, about 100fold increased
	activity compared to the wild-type enzyme <109>) <109>
EN	#5# P47Q (#5# site-directed mutagenesis, about 100fold increased
	activity compared to the wild-type enzyme <109>) <109>
EN	#77# G223D (#77# unaltered cofactor specificity compared to the
	wild-type enzyme <124>) <124>
EN	#77# T224I (#77# unaltered cofactor specificity compared to the
	wild-type enzyme <124>) <124>
EN	#77# H225N (#77# unaltered cofactor specificity compared to the
	wild-type enzyme <124>) <124>
EN	#77# G223D/T224I/H225N (#77# altered cofactor specificity, highly
	reduced activity with NADP+ compared to the wild-type enzyme,
	wild-type-like activity with NAD+ <124>) <124>
EN	#77# G223D/T224I (#77# highly reduced activity with NADP+ compared to
	the wild-type enzyme, wild-type-like activity with NAD+ <124>) <124>
EN	#8# A93F (#8# isozyme alphaalpha, altered active site structure and
	inhibitor binding <108>) <108>
EN	#8# S48T (#8# isozyme gamma(2)gamma(2), altered active site structure
	and inhibitor binding <108>) <108>
EN	#8# V141L (#8# isozyme gamma(2)gamma(2), altered active site structure
	and inhibitor binding <108>) <108>
EN	#97# W95L (#97# the mutant displays no apparent activity with
	short-chain primary and secondary alcohols and poor activity with
	aromatic substrates and coenzyme, the substitution affects the
	structural stability of the archaeal ADH, decreasing its thermal
	stability without relevant changes in secondary structure, optimum pH
	is at about pH 10 <205>) <205>
EN	#97# W95L/N249Y (#97# the mutant exhibits higher activity but decreased
	affinity toward aliphatic alcohols, aldehydes as well as NAD+ and NADH
	compared to the wild type enzyme, optimum pH is at about pH 8.6 <205>)
	<205>

CLONED
CL	#5# (class III enzyme) <9>
CL	#5# (expression of isozymes in Escherichia coli strain BL21) <118>
CL	#6# (overexpressed in Escherichia coli) <167>
CL	#8# (class IV enzyme, expression in Escherichia coli) <53>
CL	#8# (5-7 genes encoding ADH, DNA and amino acid sequence determination
	and analysis, polymorphism and allelic frequencies analysis, gene ADH2
	possesses 2 allelic forms with Ile308 or Val308, expression of ADH2
	alloenzymes in Escherichia coli) <114>
CL	#8# (expression of ADH1C*2 in Escherichia coli) <115>
CL	#8# (expression of ADH4 in Escherichia coli) <123>
CL	#8# (expression of isozymes in Escherichia coli strain BL21) <118>
CL	#10# <87,91>
CL	#10# (expressed in Escherichia coli DH5alpha cells) <200>
CL	#10# (expressed in Hep-G2 cells) <207>
CL	#10# (mutant enzyme S109P/L116S/Y294) <191>
CL	#10# (overexpression in Saccharomyces bayanus) <168>
CL	#13# (expressed in Escherichia coli BL21DE3pLysS cells) <209>
CL	#14# (overexpression as GST-fusion protein in Escherichia coli) <125>
CL	#16# (ADH3 is expressed in recombinant Escherichia coli) <170>
CL	#23# (expression in Escherichia coli) <122>
CL	#24# (DNA and amino acid sequence determination and analysis,
	functional expression in Escherichia coli using a rhamnose-inducible
	system) <105>
CL	#26# (expression in Escherichia coli strain TG-1) <128>
CL	#29# (gene encoding for ADH of the haloalkaliphilic archaeon
	Natronomonas pharaonis, which has a 1,068-bp open reading frame that
	encodes a protein of 355 amino acids, is cloned into the pET28b vector
	and is expressed in Escherichia coli) <179>
CL	#31# <91>
CL	#42# (expressed in Escherichia coli) <155,157>
CL	#42# (expressed in Escherichia coli JM109(DE3) cells) <163>
CL	#42# (expressed in Escherichia coli RB791 cells) <152,159>
CL	#42# (expressed in Escherichia coli strain RB791) <161>
CL	#48# (expression in yeast) <149>
CL	#84# <142>
CL	#86# (expressed in Escherichia coli BL21 Star (DE3) cells) <160>
CL	#87# (expressed in Escherichia coli) <157>
CL	#88# (expressed in Escherichia coli BL21(DE3) cells) <154>
CL	#89# <166>
CL	#90# (ADH1 is expressed in recombinant Escherichia coli) <170>
CL	#91# (expression in Escherichia coli) <171>
CL	#92# (expression in Escherichia coli) <169>
CL	#95# <175>
CL	#96# <175>
CL	#97# (expressed in Escherichia coli RB791 cells) <205>
CL	#99# (expressed in Escherichia coli BL21(DE3) cells) <193>
CL	#102# (expressed in Escherichia coli DH5alpha cells) <208>
CL	#103# (expressed in Escherichia coli BL21 (DE3) pLysS cells) <211>
CL	#104# (expressed in Escherichia coli BL21 (DE3) cells) <195>
CL	#105# (expressed in Escherichia coli DH5alpha cells) <200>
CL	#106# (expression in Escherichia coli) <213>
CL	#107# (expression in Escherichia coli) <213>

CRYSTALLIZATION
CR	#8# <12>
CR	#8# (isozyme alphaalpha in complex with inhibitor
	N-cyclopentyl-N-cyclobutylformamide, isozyme beta(1)beta(1) in complex
	with inhibitors N-benzylformamide and N-heptylformamide, and isozyme
	gamma(2)gamma(2) in complex with inhibitor N-1-methylheptylformamide,
	X-ray diffraction structure determination and analysis at 1.45-2.5 A
	resolution, structure modeling) <108>
CR	#10# (isozyme YADH-1, crystal structure analysis) <119>
CR	#10# (trigonal crystal form alcohol dehydrogenase I: evidence for the
	existence of Zn ions in the crystal, from 20% PEG 4000, 20% 2-propanol,
	0.1 M sodium citrate, pH 5.6, and 1 mM NAD+, X-ray diffraction
	structure determination and analysis at 3.0 A resolution) <103>
CR	#14# (enzyme in complex with trifluoroethanol and without NAD+, X-ray
	diffraction structure determination and analysis at 2.35 A resolution)
	<111>
CR	#26# (ternary complex of enzyme with NADH and ethylene glycol, X-ray
	diffraction structure determination and analysis at 2.3 A resolution,
	molecular replacement method) <128>
CR	#37# <30,34,35>
CR	#37# (10 mg/ml purified double mutant H51Q/K228R in complex with NAD+
	and 2,3- or 2,4-difluorobenzyl alcohol, in 50 mM ammonium
	N-[tris(hydroxymethyl)-methyl]-2-aminoethanesulfonate, pH 7.0, 5°C, 1
	mM NAD+, 10 mM 2,3-difluorobenzyl alcohol or 2,4-difluorobenzyl
	alcohol, equilibrated against increasing concentrations of
	2-methyl-2,4-pentanediole, crystal formation at 12%
	2-methyl-2,4-pentanediole, X-ray diffraction structure determination
	and analysis) <110>
CR	#37# (1 A resolution crystal structures of liver alcohol dehydrogenase
	in complex with NADH and two inhibitors: dimethyl sulfoxide and
	isobutyramide) <173>
CR	#42# (holo-enzyme form and apo-enzyme form) <56>
CR	#42# (apoenzyme and ternary complex of enzyme with NADH and
	2-ethoxyethanol bound to each subunit, X-ray diffraction structure
	determination and analysis at 2.3 A resolution) <107>
CR	#42# (microbatch method) <155>
CR	#42# (microbatch method in 100 mM Tris-HCl (pH 7.8), 10 mM
	dithiotreitol with the same volume of 12% (w/v) PEG 4000, 12% (v/v)
	2-propanol, 100 mM sodium citrate (pH 5.6) at 20°C) <159>
CR	#42# (twinned crystals are grown with the sitting drop vapour diffusion
	method using 2-methyl-2,4-pentanediol (50% v/v), Tris/HCl buffer (150
	mM, pH 8.4), and NADH (1 mM), prismatic crystals are grown at 4°C and
	20°C by microbatch and free interface diffusion methods with Tris/HCl
	buffer (130 mM, pH 8.0), NADH (2 mM), polyethyleneglycol 4000 (16%
	w/v), propan-2-ol or propan-1-ol (16% v/v) in trisodium citrate (100
	mM, pH 4.8-5.6)) <150>
CR	#71# <38>
CR	#77# (enzyme-NADP+-cofactor complex, X-ray diffraction strcuture
	determination and analysis, computational structure modeling) <124>
CR	#79# (multiple anomalous dispersion techniques, X-ray diffraction
	structure determination and analysis at 1.62 A resolution) <126>
CR	#97# <205>

PURIFICATION
PU	#1# <44>
PU	#2# <1>
PU	#4# <8,65>
PU	#4# (alleloenzymes Adhf and Adhus) <58>
PU	#4# (alleloenzyme Adh71k) <63>
PU	#5# (liver isoenzyme A2 and B2 and stomach isoenzyme C2) <48>
PU	#5# (recombinant isozymes from Escherichia coli strain BL21) <118>
PU	#6# <167>
PU	#8# <12,15>
PU	#8# (class I isoenzymes) <13>
PU	#8# (anodic enzyme form) <18>
PU	#8# (isoenzyme beta3,beta3) <20>
PU	#8# (class III isoenzyme chi-ADH) <16>
PU	#8# (class II isoenzyme: pi-ADH) <14>
PU	#8# (recombinant ADH2 alloenzymes from Escherichia coli by DEAE and AMP
	or blue Sepharose chromatography, and ultrafiltration) <114>
PU	#8# (recombinant enzyme from Escherichia coli by DEAE ion exchange,
	5'-AMP-resin affinity, and Mono Q ion exchange chromatography) <123>
PU	#8# (recombinant isozymes from Escherichia coli strain BL21) <118>
PU	#9# (ADH-1, ADH-2 and ADH-3) <49>
PU	#9# (isoenzyme 1, 2, 3, and 4) <51>
PU	#10# <3,87>
PU	#10# (mutant enzyme S109P/L116S/Y294) <191>
PU	#10# (DEAE-Sepharose CL-4B column chromatograhy and octyl-Sepharose
	column chromatography) <200>
PU	#12# <45>
PU	#12# (class I isoenzyme) <46>
PU	#13# (Talon Co2+-affinity column chromatography) <209>
PU	#14# (reombinant fusion enzyme by glutathione affinity chromatography,
	cleavage of GST fusion tag by thrombin, further purification of the
	active enzyme) <125>
PU	#15# <81>
PU	#19# <75,76>
PU	#19# (wild-type enzyme Adh1-1S and mutant enzyme Adh1-1S1108) <97>
PU	#20# <71>
PU	#21# <72>
PU	#23# (partial by isopycnic sucrose gradient centrifugation) <127>
PU	#25# <186>
PU	#29# (recombinant enzyme) <179>
PU	#30# <73>
PU	#33# <47>
PU	#34# <85>
PU	#35# <3>
PU	#37# <26,42,92>
PU	#37# (SS-isoenzyme) <28>
PU	#38# <67,68>
PU	#39# <25>
PU	#40# <113>
PU	#41# <6>
PU	#42# <66,70,150,155,159>
PU	#42# (Blue A column chromatography) <151>
PU	#42# (DEAE-Sepharose Fast Flow column chromatography and G75 gel
	filtration) <152>
PU	#42# (DEAE-Sepharose Fast Flow column chromatography, Matrex Gel Red A
	column chromatography, and Blue A column chromatography) <161>
PU	#42# (HiLoad Superdex 200 gel filtration) <157>
PU	#42# (HiTrap heparin-Sepharose column chromatography, DEAE-Sepharose
	fast-flow column chromatography, and HiLoad Superdex S-75 gel
	filtration) <158>
PU	#42# (Toyopearl Butyl 650 S column chromatography, Q Sepharose fast
	flow column chromatography, Superose 12 prep-grade gel filtration, and
	TosoHaas G 2000 SWXL gel filtration) <163>
PU	#43# <147>
PU	#46# (ADH-MII) <82>
PU	#48# <149>
PU	#49# <99>
PU	#50# <145>
PU	#51# <145>
PU	#52# <5>
PU	#53# (2 isozymes from cytosol by DEAE ion exchange, hydroxyl apatite,
	and gel filtration chromatography, ADH I 35fold, ADH II 21fold) <112>
PU	#60# <78>
PU	#61# (partial) <69>
PU	#62# (ADH-2 and ADH-3) <60>
PU	#63# <84>
PU	#65# <8>
PU	#68# <8,63>
PU	#69# <8>
PU	#70# <8>
PU	#71# <8>
PU	#72# <24>
PU	#74# (3 isoenzymes) <77>
PU	#75# (partial) <83>
PU	#76# <101>
PU	#80# (128fold to homogeneity by adenosine 5'-monophosphate affinity and
	Mono-Q ion exchange chromatography) <117>
PU	#84# <142>
PU	#85# <136>
PU	#86# (HIS-Select High Flow cartridge chromatography) <160>
PU	#87# (HiLoad Superdex 200 gel filtration) <157>
PU	#89# <166>
PU	#91# <171>
PU	#92# <169>
PU	#93# <183>
PU	#97# <205>
PU	#99# (DEAE-Sepharose column chromatography) <193>
PU	#103# (Sephacryl S-100 gel filtration) <211>
PU	#104# (ultracentrifugation and Sepabeads EB-QA405 chromatography) <195>
PU	#105# (DEAE-Sepharose CL-4B column chromatograhy and octyl-Sepharose
	column chromatography) <200>

RENATURED
RN	#10# (Zn2+ withdrawal by inactivation with Chelex 100, reactivation of
	the apoenzyme by addition of CuSO4, 1 h at 25°C, pH 7.6) <121>

GENERAL_STABILITY
GS	#10# (even at 50°C the stabilization effect of lipid membranes on the
	tertiary and quaternary structures of the liposomal YADH allows the
	enzyme to form its thermostable complex with NAD+ in liposomes) <177>
GS	#10# (enzyme covalently immobilized to magnetic Fe3O4 nanoparticles via
	glutaraldehyde shows enhanced thermal stability and good durability in
	the repeated use after recovered by magnetic separations. Within 7
	cycles of usage, the remaining activity is about 100%, 89.15%, 79.42%,
	69.50%, 62.80%, 56.48%, and 48.26% of the first use) <180>
GS	#10# (the recycling stability of YADH in silica-coated alginate gel
	beads is found to be increased significantly mainly due to the
	effective inhibition of enzyme leakage by compact silica film) <182>
GS	#10# (sucrose, glucose, and betaine stabilize ADH substantially while
	D-ribose and sarcosine destabilize the enzyme) <201>
GS	#10# (ADH immobilized on derived attapulgite nanofibers via
	glutaraldehyde covalent binding retains higher activity over wider
	ranges of pH and temperature than those of the free enzyme. After
	shaking at 125 rpm at 35°C for 32 h, a rapid loss in activity is
	observed, and almost complete activity of immobilized enzyme is lost in
	52 h. The activity of immobilized ADH decreases to 80% of its initial
	value after four cycles of operation and afterwards gradually decreases
	with every reuse, but it retains 42% activity after eight cycles for
	bioreduction of ethyl 3-oxobutyrate.) <194>
GS	#104# (the presence of a second phase of a water-insoluble solvent like
	hexane or octane has only minor effects on the enzyme, which retains
	80% of its activity, allowing the use of these solvents in
	aqueous/organic mixtures to increase the availability of low-water
	soluble substrates) <195>
GS	#12# (dialysis against 50 mM Tris-HCl buffer, stable after 5 h, 3% loss
	of activity after 1 day, 82% loss of activity after 6 days) <45>
GS	#12# (dithiothreitol stabilizes activity at all stages of purification)
	<46>
GS	#14# (highly stable against 0.1 M urea and 0.05% SDS) <125>
GS	#37# (the catalytic zinc ions have an important stabilizing effect on
	the tertiary and quaternary structure of the immobilized enzyme) <36>
GS	#38# (enzyme form ADH I is more stable during purification than enzyme
	form ADH-II) <67>
GS	#42# (does not require the presence of reducing agents to mantain its
	stability even at high temperature, evidently due to the lack in free
	cysteines) <161>
GS	#53# (isozymes are stabilized by MgCl2 and DTT during purification)
	<112>
GS	#8# (100fold purified enzyme is destroyed by freezing) <12>

ORGANIC_SOLVENT_STABILITY
OSS	#10,64# Pyridine (#10# inactivation <120>; #64# active, from 25°C up
	to 90°C, 3 h <120>) <120>
OSS	#10,64# toluene (#10# active, from 25°C up to 75°C, 3 h,
	stabilization of the enzyme at elevated temperature <120>; #64# active,
	from 25°C up to 90°C, 3 h <120>) <120>
OSS	#10,64# dioxane (#10# 50% v/v, 50% remaining activity at 4°C after 100
	min, 10% remaining activity after 100 min at 25°C <120>; #64# 50% v/v,
	about 95% remaining activity at 4°C or 25°C after 1-100 min <120>)
	<120>
OSS	#10,64# dimethylformamide (#64# 50% v/v, 20% remaining activity at 4°C
	or 25°C after 1-100 min <120>; #10# 50% v/v, 75% remaining activity at
	4°C after 100 min, 15% remaining activity after 100 min at 25°C
	<120>) <120>
OSS	#10,64# octane (#10# active, from 25°C up to 75°C, 3 h, stabilization
	of the enzyme at elevated temperature <120>; #64# active, from 25°C up
	to 90°C, 3 h <120>) <120>
OSS	#10,64# dodecane (#10# active, from 25°C up to 75°C, 3 h,
	stabilization of the enzyme at elevated temperature <120>; #64# active,
	from 25°C up to 90°C, 3 h <120>) <120>
OSS	#40# more (#40# chemotolerant enzyme <113>) <113>
OSS	#40# Acetone (#40# 50% v/v, stable at <113>) <113>
OSS	#40# 2-propanol (#40# 80% v/v, stable at <113>) <113>
OSS	#98,101# DMSO (#98,101# DMSO is not an ideal substrate-delivering
	solvent for ADH-catalysed reactions <212>) <212>

OXIDATION_STABILITY
OS	#10# (among all the cysteine residues, Cys43 is the most susceptible to
	H2O2 oxidation, and the major oxidation products of this cysteine are
	Cys-SO2H and Cys-SO3H. The oxidation of Cys43 might be responsible for
	the inactivation of the enzyme upon H2O2 treatment) <187>
OS	#10# (Adh1p is oxidatively modified during ageing and, consequently,
	its activity becomes reduced) <188>
OS	#49# (pronounced oxygen lability at pH 9, even at pH 7, 2 h under air,
	80% loss of activity) <99>

PH_STABILITY
PHS	#10# 6-8 (#10# at pH 6.0 and 8.0, the activity of free ADH decreases
	dramatically during the incubation, and 90 min later most of the
	activity is lost, the immobilized form retains 81% of activity at pH
	8.0 <194>) <194>
PHS	#10# 6.5-9 (#10# native Zn-ADH enzyme <121>) <121>
PHS	#10# 6.5 (#10# below, Cu-ADH and Co-ADH <121>) <121>
PHS	#13# 7-9 (#13# with 100 mM diphosphate buffer at pH 9.0, the enzyme
	only exhibits 49% of activity, a 50% decrease is obtained using 50 mM
	bis-Tris propane buffer at pH 7.0-7.5 and 9.0, whereas at pH 8 and 8.5
	only a 10% reduction is found <209>) <209>
PHS	#19# 6-9 (#19# isoenzyme 2 and isoenzyme 3 <75>) <75>
PHS	#27# 6.5-7 (#27# most stable at <74>) <74>
PHS	#29# 4 (#29# 30°C, 1 h, 30% loss of activity <179>) <179>
PHS	#29# 5 (#29# 30°C, 1 h, 20% loss of activity <179>) <179>
PHS	#29# 6-11 (#29# 30°C, 1 h, less than 10% loss of activity <179>) <179>
PHS	#29# 1-2 (#29# 30°C, 1 h, 15% loss of activity <179>) <179>
PHS	#38# 7.5 (#38# 4°C, stable for 2 days <68>) <68>
PHS	#8# 7-10.6 (#8# stable <12>) <12>
PHS	#85# 5-9.5 (#85# 25°C, 1 h, stable <136>) <136>
PHS	#89# 4-8 (#89# 4°C, 48 h, stable <166>) <166>

STORAGE_STABILITY
SS	#104# (-20°C, several months, no loss of activity) <195>
SS	#12# (4°C, in presence of 1.0 mM dithiothreitol, stable for 10 days)
	<45>
SS	#13# (-20°C, in the presence of 50% (v/v) glycerol and at highly
	concentrated solutions (0.75-1 mg protein/ml), 3 days, 40-50% loss of
	activity) <209>
SS	#13# (4°C, in 3.2 M ammonium sulfate or 50% glycerol, 1 day, rapid
	loss of activity) <209>
SS	#19# (-20°C, isoenzyme 2 is stable in 50% ethylene glycol for at least
	3 months, isoenzyme 1 and 3 maintain less than 50% of their original
	activity after 2 weeks) <75>
SS	#38# (4°C, most stable at pH 7.5 during storage for 2 days) <68>
SS	#40# (very stable during storage) <113>
SS	#42# (-20°C, 1 M NaCl in 20 mM Tris-HCl (pH 8.4) in the presence of an
	equal volume of glycerol, 12 months, no loss of activity) <161>
SS	#42# (4°C, 1 M NaCl in 20 mM Tris-HCl (pH 8.4) in the absence of
	glycerol, 4 months, 60% loss of activity) <161>
SS	#8# (4°C, pH 7.5, stable for 2-3 weeks) <14>
SS	#8# (4°C, 10 mM HEPES buffer, 1 mM dithioerythritol, pH 7.5, stable
	for 2 weeks) <16>
SS	#8# (4°C, 5 mM Na phosphate, pH 7.5, the half-life is 24 h. 0.01 mM
	ethanol effectively stabilizes for several weeks) <18>
SS	#8# (4°C, 5 mM Na-phosphate, pH 7.5, 50% loss of activity after 1 day.
	Enzyme can be stabilized for up to 2 weeks by storage in buffer
	containing 10 mM ethanol) <23>
SS	#84# (-20°C, 10 mM potassium phosphate buffer, pH 7.0, containing 0.5
	mM NAD+ without loss of activity for several months) <142>

TEMPERATURE_STABILITY
TS	#10# 56 (#10# native Zn-ADH enzyme <121>; #10# thermal aggregation
	occurs at 56°C, the thermal denaturation of ADH is irreversible <197>)
	<121,197>
TS	#10# 50-60 (#10# thermal unfolding of ADH is not observed below 60°C
	while the kinetic deactivation is observed even at 50°C <201>) <201>
TS	#10# 30-55 (#10# the specific activity of ADH decreases rapidly above
	30°C, ADH is almost completely inactive after a 36 min incubation at
	55°C <203>) <203>
TS	#10# 35-60 (#10# 58% of the original activity is retained after
	incubation of the immobilized enzyme at 35°C for 32 h, free enzyme
	loses 68% activity over a 60 min incubation at 60°C, whereas
	immobilized ADH retains 44% over a 60 min incubation at 60°C <194>)
	<194>
TS	#10# 69 (#10# Cu-ADH enzyme <121>) <121>
TS	#10,19,25,29,40,42,43,84,85,89,91# 50 (#43# 30 min, 50% loss of
	activity <147>; #42# 24 h, 30% loss of activity <66>; #29# 1 h, 15%
	loss of activity <179>; #19# wild-type enzyme Adh1-1S is more stable
	than mutant enzyme Adh1-1S1108 <97>; #89# 60 min, about 50% loss of
	activity <166>; #40# half-life: 35 h <113>; #10# stable up to, about
	20% remaining activity after 3 h <120>; #85# 1 h in 20 mM Tris-HCl
	buffer, pH 7.0, retains 70% of its activity <136>; #84# half-life: 304
	min in absence of NAD+ <142>; #25# 1 h, 90 mM potassium phosphate
	buffer, pH 6.5, complete loss of activity <186>; #91# half-life: 96 min
	<171>) <66,97,113,120,136,142,147,166,171,179,186>
TS	#10,25# 45 (#25# 1 h, 90 mM potassium phosphate buffer, pH 6.5, 70%
	loss of activity <186>; #10# 2 h, free YADH is increasingly deactivated
	during its incubation with decrease of the enzyme concentration from
	3.3 to 0.01 mg/ml because of the dissociation of tetrameric YADH into
	its subunits <177>) <177,186>
TS	#10,27,29,42,84,85,89,91,106,107# 60 (#89# 60 min, complete loss of
	activity <166>; #42# half-life: 20 h <66>; #27# denaturation above
	<74>; #29# 1 h, 20% loss of activity <179>; #85# 1 h in 20 mM Tris-HCl
	buffer, pH 7.0, retains 24% of its activity <136>; #10# half-life: 2
	min in absence of NAD+ <142>; #84# half-life: 50 min in absence of
	NAD+, 143 min in presence of 0.01 mM NAD+ <142>; #91# half-life: 55 min
	<171>; #10# 60 min, about 35% loss of activity, soluble enzyme and
	enzyme covalently immobilized to magnetic Fe3O4 nanoparticles via
	glutaraldehyde <180>; #106,107# 14 h, more than 50% of initial activity
	<213>) <66,74,136,142,166,171,179,180,213>
TS	#10,29,42,80,84,85,91# 70 (#91# half-life: 42 min <171>; #42#
	half-life: 5 h <66>; #29# 1 h, 40% loss of activity <179>; #10# above,
	Co-ADH enzyme <121>; #80# stable upt to <117>; #85# 1 h in 20 mM
	Tris-HCl buffer, pH 7.0, complete loss of activity <136>; #84#
	half-life: 6 min in absence of NAD+ <142>; #42# remains quite stable at
	70°C in the absence of chelating agents <161>)
	<66,117,121,136,142,161,171,179>
TS	#10,38,42,84# 65 (#38# inactivation constant for ADHI: 1.23 per min,
	inactivation constant for ADH II: 0.13 per min <68>; #42# pH 8.0,
	protein concentration 2.5 mg/ml, 16 h, stable. 50% loss of activity
	after 8 h at protein concentration of 0.5 mg/ml <70>; #84# half-life:
	20 min in absence of NAD+ <142>; #42# at 65°C the half-lives of the
	native and carboxymethylated enzymes are 9 h and 4 h, respectively
	<151>; #42# the activity of the recombinant wild type enzyme slowly
	decreases to 50% after 16 h at 65°C <163>; #10# 60 min, about 80% loss
	of activity of soluble enzyme, about 55% loss of activity of enzyme
	covalently immobilized to magnetic Fe3O4 nanoparticles via
	glutaraldehyde <180>) <68,70,142,151,163,180>
TS	#10,80# 75 (#10# inactivation <120>; #80# and above, rapid loss of
	activity <117>) <117,120>
TS	#14# 68 (#14# purified recombinant enzyme, most stable at <125>) <125>
TS	#14,42,80# 85 (#42# pH 8.0, protein concentration 0.5 mg/ml, 3 h, 50%
	loss of activity <70>; #14# remaining activity <125>; #80# slight
	residual activity <117>) <70,117,125>
TS	#19,37,42,64# 55 (#19# 60 min, 73% loss of activity of enzyme 1, 10%
	loss of activity of enzyme 2, 21% loss of activity of enzyme 3 <75>;
	#42# the native enzyme remains completely stable after heating for 3 h
	at 55°C while the carboxymethylated enzyme loses 10% of activity under
	the same conditions <151>; #64# ADH is insensitive to thermal stress at
	55°C and remains fully active after a 36 min incubation at 55°C
	<203>; #37# ADH loses less than 30% of its initial activity after a 36
	min incubation at 55°C <203>) <75,151,203>
TS	#25,85,91# 30 (#91# half-life: 114 min <171>; #85# 1 h in 20 mM
	Tris-HCl buffer, pH 7.0, stable below <136>; #25# 1 h, 90 mM potassium
	phosphate buffer, pH 6.5, stable <186>) <136,171,186>
TS	#29,34,41,85,89,91# 40 (#34# stable below <85>; #29# 1 h, stable <179>;
	#89# 60 min, stable up to <166>; #91# half-life: 110 min <171>; #41# 60
	min, stable <6>; #85# 1 h in 20 mM Tris-HCl buffer, pH 7.0, retains 80%
	of its activity <136>) <6,85,136,166,171,179>
TS	#29,42,64,91# 90 (#64# stable up to <120>; #91# half-life: 4 min <171>;
	#42# at 90°C the specific activity is about three times as high as
	that measured at 65°C <161>; #29# 1 h, 95% loss of activity <179>)
	<120,161,171,179>
TS	#29,91# 80 (#29# 1 h, 50% loss of activity <179>; #91# half-life: 18
	min <171>) <171,179>
TS	#34# -20 (#34# loss of activity after 24 h <85>) <85>
TS	#37,43# 35 (#43# 30 min, no significant loss of activity <147>; #37#
	HLAD is a mesophilic enzyme whose activity and stability are
	significantly impaired at temperatures over 35°C <202>) <147,202>
TS	#42# 70-80 (#42# wild type and mutant enzyme N249Y are stable at 70°C,
	the mutant enzyme seems more thermoresistant than the wild type enzyme
	up to a temperature of 80°C, after which its activity decreases
	abruptly <152>) <152>
TS	#42,86# 95 (#86# activity increases with temperature up to 95°C <160>;
	#42# stable and active up to 95°C <150>) <150,160>
TS	#42,87# 85-90 (#87# half-life of 3 h at 85°C and 1 h at 90°C <157>;
	#42# half-life of 3 h at 85°C and 1 h at 90°C, the catalytic
	efficiency is considerably higher at temperatures below 90°C <157>)
	<157>
TS	#6# 73 (#6# inactivation above <167>) <167>
TS	#8# 23 (#8# unstable at room temperature and above <12>) <12>
TS	#8,10,14,37# -999 (#37# distinct subunits have different deactivation
	properties <37>; #10# effect of salts in the high concentration range
	on the thermal stability <146>; #37# alpha-cyclodextrin causes thermal
	stabilization and delays the onset of secondary structural unfolding
	and aggregation by approx. 10°C and the midpoint temperatures by more
	than 5°C. alpha-Cyclodextrin diminishes the deactivation of the
	enzyme, decreasing the deactivation constant by more than 50%, and
	clearly reveals the stabilization of the enzyme not only structurally
	but also kinetically at higher temperatures <176>) <37,111,114,146,176>
TS	#97# 65-88 (#97# the single and double mutant are less thermoresistant
	than the wild type enzyme, displaying a transition temperature of 78
	and 88°C, respectively, which are 17 and 7°C lower than that of the
	wild-type enzyme. At 65°C the single mutant W95L is 10fold less active
	and the double mutant W95L/N249Y is about 6fold more active than wild
	type enzyme, the reaction rate catalyzed by the double mutant
	W95L/N249Y increases more markedly than that of the wild type enzyme up
	to a temperature of about 83°C and then decreases rapidly due to
	thermal inactivation. The reaction rate of the single mutant W95L
	increases more slowly up to about 80°C and then decreases rapidly. At
	65°C the single mutant is 10fold less active and the double mutant is
	about 6fold more active than wild type enzyme. <205>) <205>

REFERENCE
RF	<1> Talbot, B.G.; Qureshi, A.A.; Cohen, R.; Thirion, J.P.: Purification
	and properties of two distinct groups of ADH isozymes from Chinese
	hamster liver. Biochem. Genet. (1981) 19, 813-829. {Pubmed:6794566}
RF	<2> Fong, W.P.: Isolation and characterization of grass carp
	(Ctenopharyngodon idellus) liver alcohol dehydrogenase. Comp. Biochem.
	Physiol. B (1991) 98, 297-302. {Pubmed:}
RF	<3> Pessione, E.; Pergola, L.; Cavaletto, M.; Giunta, C.; Trotta, A.;
	Vanni, A.: Extraction, purification and characterization of ADH1 from
	the budding yeast Kluyveromyces marxianus. Ital. J. Biochem. (1990) 39,
	71-82. {Pubmed:2193901}
RF	<4> Leblova, S.; El Ahmad, M.: Characterization of alcohol
	dehydrogenase isolated from germinating bean (Vicia faba) seeds.
	Collect. Czech. Chem. Commun. (1989) 54, 2519-2527. {Pubmed:}
RF	<5> Keung, W.M.; Ho, Y.W.; Fong, W.P.; Lee, C.Y.: Isolation and
	characterization of shrew (Suncus murinus) liver alcohol dehydrogenase.
	Comp. Biochem. Physiol. B Comp. Biochem. (1989) 93, 169-173.
	{Pubmed:2666017}
RF	<6> Tong, W.F.; Lin, S.W.: Purification and biochemical properties of
	rice alcohol dehydrogenase. Bot. Bull. Acad. Sin. (1988) 29, 245-253.
	{Pubmed:}
RF	<7> Van Geyt, J.; Jacobs, M.; Triest, L.: Characterization of alcohol
	dehydrogenase in Najas marina L. Aquat. Bot. (1987) 28, 129-141.
	{Pubmed:}
RF	<8> Vilageliu, L.; Juan, E.; Gonzalez-Duarte, R.: Determination of some
	biochemical features of alcohol dehydrogenase from Drosophila
	melanogaster, Drosophila simulans, Drosophila virilis, Drosophila
	funebris, Drosophila imigrans and drosophila lebanonensis. Comparison
	of their properties and estimation of the homology of the ADH enzyme of
	different species. Adv. Genet., Dev., Evol. Drosophila, [Proc. Eur.
	Drosophila Res. Conf.] (Lakovaara, S., ed.) Plenum N.Y. (1982) 7,
	237-250. {Pubmed:}
RF	<9> Edenberg, H.J.; Brown, C.J.; Carr, L.G.; Ho, W.H.; Hu, M.W.:
	Alcohol dehydrogenase gene expression and cloning of the mouse chi-like
	ADH. Adv. Exp. Med. Biol. (1991) 284, 253-262. {Pubmed:2053480}
RF	<10> Herrera, E.; Zorzano, A.; Fresneda, V.: Comparative kinetics of
	human and rat liver alcohol dehydrogenase. Biochem. Soc. Trans. (1983)
	11, 729-730. {Pubmed:} (c,review)
RF	<11> Dafeldecker, W.P.; Vallee, B.L.: Organ-specific human alcohol
	dehydrogenase: isolation and characterization of isozymes from testis.
	Biochem. Biophys. Res. Commun. (1986) 134, 1056-1063. {Pubmed:2936344}
	(c)
RF	<12> Woronick, C.L.: Alcohol dehydrogenase from human liver. Methods
	Enzymol. (1975) 41B, 369-374. {Pubmed:236461} (c,review)
RF	<13> Wagner, F.W.; Burger, A.R.; Vallee, B.L.: Kinetic properties of
	human liver alcohol dehydrogenase: oxidation of alcohols by class I
	isoenzymes. Biochemistry (1983) 22, 1857-1863. {Pubmed:6342669} (c)
RF	<14> Ditlow, C.C.; Holmquist, B.; Morelock, M.M.; Vallee, B.L.:
	Physical and enzymatic properties of a class II alcohol dehydrogenase
	isozyme of human liver: pi-ADH. Biochemistry (1984) 23, 6363-6368.
	{Pubmed:6397223} (c)
RF	<15> Yin, S.J.; Bosron, W.F.; Magnes, L.J.; Li, T.K.: Human liver
	alcohol dehydrogenase: purification and kinetic characterization of the
	beta 2 beta 2, beta 2 beta 1, alpha beta 2, and beta 2 gamma 1 Oriental
	isoenzymes. Biochemistry (1984) 23, 5847-5853. {Pubmed:6395883} (c)
RF	<16> Wagner, F.W.; Pares, X.; Holmquist, B.; Vallee, B.L.: Physical and
	enzymatic properties of a class III isozyme of human liver alcohol
	dehydrogenase: chi-ADH. Biochemistry (1984) 23, 2193-2199.
	{Pubmed:6375718} (c)
RF	<17> Bosron, W.F.; Magnes, L.J.; Li, T.K.: Kinetic and electrophoretic
	properties of native and recombined isoenzymes of human liver alcohol
	dehydrogenase. Biochemistry (1983) 22, 1852-1857. {Pubmed:6342668} (c)
RF	<18> Bosron, W.F.; Li, T.K.: Isolation and characterization of an
	anodic form of human liver alcohol dehydrogenase. Biochem. Biophys.
	Res. Commun. (1977) 74, 85-91. {Pubmed:836289} (c)
RF	<19> Schneider-Bernloehr, H.; Formicka-Kozlowska, G.; Buehler, R.;
	Wartburg, J.P.; Zeppezauer, M.: Active-site-specific zinc-depleted and
	reconstituted cobalt(II) human-liver alcohol dehydrogenase.
	Preparation, characterization and complexation with NADH and
	trans-4-(N,N-dimethylamino)-cinnamaldehyde. Eur. J. Biochem. (1988)
	173, 275-280. {Pubmed:3360008} (c)
RF	<20> Burnell, J.C.; Li, T.K.; Bosron, W.F.: Purification and
	steady-state kinetic characterization of human liver beta 3 beta 3
	alcohol dehydrogenase. Biochemistry (1989) 28, 6810-6815.
	{Pubmed:2819035} (c)
RF	<21> Pares, X.; Vallee, B.L.: New human liver alcohol dehydrogenase
	forms with unique kinetic characteristics. Biochem. Biophys. Res.
	Commun. (1981) 98, 122-130. {Pubmed:7011320} (c)
RF	<22> Bosron, W.F.; Li, T.K.; Vallee, B.L.: New molecular forms of human
	liver alcohol dehydrogenase: isolation and characterization of
	ADHIndianapolis. Proc. Natl. Acad. Sci. USA (1980) 77, 5784-5788.
	{Pubmed:7003596} (c)
RF	<23> Bosron, W.F.; Li, T.K.; Dafeldecker, W.P.; Vallee, B.L.: Human
	liver pig-alcohol dehydrogenase: kinetic and molecular properties.
	Biochemistry (1979) 18, 1101-1105. {Pubmed:427099} (c)
RF	<24> Dafeldecker, W.P.; Pares, X.; Vallee, B.L.; Bosron, W.F.; Li,
	T.K.: Simian liver alcohol dehydrogenase: isolation and
	characterization of isoenzymes from Saimiri sciureus. Biochemistry
	(1981) 20, 856-861. {Pubmed:7011375} (c)
RF	<25> Dafeldecker, W.P.; Meadow, P.E.; Pares, X.; Vallee, B.L.: Simian
	liver alcohol dehydrogenase: isolation and characterization of
	isoenzymes from Macaca mulatta. Biochemistry (1981) 20, 6729-6734.
	{Pubmed:7030395} (c)
RF	<26> Kvassman, J.; Pettersson, G.: Kinetics of coenzyme binding to
	liver alcohol dehydrogenase in the pH range 10-12. Eur. J. Biochem.
	(1987) 166, 167-172. {Pubmed:3595610} (c)
RF	<27> Andersson, L.; Mosbach, K.: Alcohol dehydrogenase from horse liver
	by affinity chromatography. Methods Enzymol. (1982) 89, 435-445.
	{Pubmed:6755178} (c,review)
RF	<28> Pietruszko, R.: Alcohol dehydrogenase from horse liver,
	steroid-active SS isoenzyme. Methods Enzymol. (1982) 89, 429-435.
	{Pubmed:} (c,review)
RF	<29> Dahl, K.H.; Eklund, H.; McKinley-McKee, J.S.: Enantioselective
	affinity labelling of horse liver alcohol dehydrogenase. Correlation of
	inactivation kinetics with the three-dimensional structure of the
	enzyme. Biochem. J. (1983) 211, 391-396. {Pubmed:6347187} (c)
RF	<30> Ramaswamy, S.: Dynamics in alcohol dehydrogenase elucidated from
	crystallographic investigations. Enzymol. Mol. Biol. Carbonyl Metab.
	(1999) 7, 275-284. {Pubmed:10352696} (c)
RF	<31> Adolph, H.W.; Maurer, P.; Schneider-Bernloehr, H.; Sartorius, C.;
	Zeppezauer, M.: Substrate specificity and stereoselectivity of horse
	liver alcohol dehydrogenase. Kinetic evaluation of binding and
	activation parameters controlling the catalytic cycles of unbranched,
	acyclic secondary alcohols and ketones as substrates of the native and
	active-site-specific Co(II)-substituted enzyme. Eur. J. Biochem. (1991)
	201, 615-625. {Pubmed:1935957} (c)
RF	<32> Freudenreich, C.; Samama, J.P.; Biellmann, J.F.: Design of
	inhibitors from the three-dimensional structure of alcohol
	dehydrogenase. Chemical synthesis and enzymatic properties. J. Am.
	Chem. Soc. (1984) 106, 3344-3353. {Pubmed:} (c)
RF	<33> Samama, J.P.; Hirsch, D.; Goulas, P.; Biellmann, J.F.: Dependence
	of the substrate specificity and kinetic mechanism of horse-liver
	alcohol dehydrogenase on the size of the C-3 pyridinium substituent.
	3-Benzoylpyridine-adenine dinucleotide. Eur. J. Biochem. (1986) 159,
	375-380. {Pubmed:3758068} (c)
RF	<34> Eklund, H.: Coenzyme binding in alcohol dehydrogenase. Biochem.
	Soc. Trans. (1989) 17, 293-296. {Pubmed:2753206} (c)
RF	<35> Dworschack, R.T.; Plapp, B.V.: Kinetics of native and activated
	isozymes of horse liver alcohol dehydrogenase. Biochemistry (1977) 16,
	111-116. {Pubmed:831772} (c)
RF	<36> Maret, W.; Andersson, I.; Dietrich, H.; Schneider-Bernloehr, H.;
	Einarsson, R.; Zeppezauer, M.: Site-specific substituted cobalt(II)
	horse liver alcohol dehydrogenases. Preparation and characterization in
	solution, crystalline and immobilized state. Eur. J. Biochem. (1979)
	98, 501-512. {Pubmed:488110} (c)
RF	<37> Skerker, P.S.; Clark, D.S.: Thermostability of alcohol
	dehydrogenase: evidence for distinct subunits with different
	deactivation properties. Biotechnol. Bioeng. (1989) 33, 62-71.
	{Pubmed:18587844} (c)
RF	<38> Benach, J.; Atrian, S.; Gonzalez-Duarte, R.; Ladenstein, R.: The
	catalytic reaction and inhibition mechanism of Drosophila alcohol
	dehydrogenase: observation of an enzyme-bound NAD-ketone adduct at 1.4
	A resolution by X-ray crystallography. J. Mol. Biol. (1999) 289,
	335-355. {Pubmed:10366509} (c)
RF	<39> Tsai, C.S.: Multifunctionality of liver alcohol dehydrogenase:
	kinetic and mechanistic studies of esterase reaction. Arch. Biochem.
	Biophys. (1982) 213, 635-642. {Pubmed:7041828} (c)
RF	<40> Favilla, R.; Cavatorta, P.; Mazzini, A.; Fava, A.: The peroxidatic
	reaction catalyzed by horse liver alcohol dehydrogenase. 2.
	Steady-state kinetics and inactivation. Eur. J. Biochem. (1980) 104,
	223-227. {Pubmed:6989598} (c)
RF	<41> Ryzewski, C.N.; Pietruszko, R.: Kinetic mechanism of horse liver
	alcohol dehydrogenase SS. Biochemistry (1980) 19, 4843-4848.
	{Pubmed:7000185} (c)
RF	<42> Ryzewski, C.N.; Pietruszko, R.: Horse liver alcohol dehydrogenase
	SS: purification and characterization of the homogenous isoenzyme.
	Arch. Biochem. Biophys. (1977) 183, 73-82. {Pubmed:20851} (c)
RF	<43> Winberg, J.O.; McKinley-McKee, J.S.: Drosophila melanogaster
	alcohol dehydrogenase: product-inhibition studies. Biochem. J. (1994)
	301, 901-909.. {Pubmed:8053914} (c)
RF	<44> von Bahr-Lindstroem, H.; Andersson, L.; Mosbach, K.; Joernvall,
	H.: Purification and characterization of chicken liver alcohol
	dehydrogenase. FEBS Lett. (1978) 89, 293-297. {Pubmed:658420} (c)
RF	<45> Hoshino, T.; Ishigura, I.; Ohta, Y.: Rabbit liver alcohol
	dehydrogenase: purification and properties. J. Biochem. (1985) 97,
	1163-1172. {Pubmed:3161873} (c)
RF	<46> Keung, W.M.; Yip, P.K.: Rabbit liver alcohol dehydrogenase:
	isolation and characterization of class I isozymes. Biochem. Biophys.
	Res. Commun. (1989) 158, 445-453. {Pubmed:2916992} (c)
RF	<47> Keung, W.M.: A genuine organ specific alcohol dehydrogenase from
	hamster testes: isolation, characterization and developmental changes.
	Biochem. Biophys. Res. Commun. (1988) 156, 38-45. {Pubmed:3178842} (c)
RF	<48> Algar, E.M.; Seeley, T.L.; Holmes, R.S.: Purification and
	molecular properties of mouse alcohol dehydrogenase isozymes. Eur. J.
	Biochem. (1983) 137, 139-147. {Pubmed:6360682} (c)
RF	<49> Julia, P.; Farres, J.; Pares, X.: Characterization of three
	isoenzymes of rat alcohol dehydrogenase. Tissue distribution and
	physical and enzymatic properties. Eur. J. Biochem. (1987) 162,
	179-189. {Pubmed:3816781} (c)
RF	<50> Pares, X.; Moreno, A.; Cederlund, E.; Hoeoeg, J.O.; Joernvall, H.:
	Class IV mammalian alcohol dehydrogenase. Structural data of the rat
	stomach enzyme reveal a new class well separated from those already
	characterized. FEBS Lett. (1990) 277, 115-118. {Pubmed:2269340} (c)
RF	<51> Mezey, E.; Potter, J.J.: Separation and partial characterization
	of multiple forms of rat liver alcohol dehydrogenase. Arch. Biochem.
	Biophys. (1983) 225, 787-794. {Pubmed:6354095} (c)
RF	<52> Hjelmqvist, L.; Shafqqat, J.; Siddiqi, A.R.; Joernvall, H.:
	Linking of isoenzyme and class variability patterns in the emergence of
	novel alcohol dehydrogenase functions. Characterization of isozymes in
	Uromastix hardwickii. Eur. J. Biochem. (1996) 236, 563-570.
	{Pubmed:8612630} (c)
RF	<53> Kedishvili, N.Y.; Bosron, W.F.; Stone, C.L.; Hurley, T.D.; Peggs,
	C.F.; Thomasson, H.R.; Popov, K.M.; Carr, L.G.; Edenberg, H.J.; Li,
	T.K.: Expression and kinetic characterization of recombinant human
	stomach alcohol dehydrogenase. Active-site amino acid sequence explains
	substrate specificity copared with liver isozymes. J. Biol. Chem.
	(1995) 270, 3625-3630. {Pubmed:7876099} (c)
RF	<54> Plapp, B.V.; Sogin, D.C.; Dworschack, R.T.; Bohlken, D.P.;
	Woenckhaus, C.: Kinetics of native and modified liver alcohol
	dehydrogenase with coenzyme analogues: isomerization of
	enzyme-nicotinamide adenine dinucleotide complex. Biochemistry (1986)
	25, 5396-5402. {Pubmed:3778867}
RF	<55> Li, H.; Hallows, W.H.; Punzi, J.S.; Marquez, V.E.; Carrell, H.L.;
	Pankiewicz, K.W.; Watanabe, K.A.; Goldstein, B.M.: Crystallographic
	studies of two alcohol dehydrogenase-bound analogues of
	thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite
	of the antitumor agent tiazofurin. Biochemistry (1994) 33, 23-32.
	{Pubmed:8286346}
RF	<56> Pearl, L.H.; Demasi, D.; Hemmings, A.M.; Sica, F.; Mazzarella, L.;
	Raia, C.A.; D'Auria, S.; Rossi, M.: Crystallization and preliminary
	X-ray analysis of an NAD(+)-dependent alcohol dehydrogenase fromthe
	extreme thermophilic archaebacterium Sulfolobus solfataricus. J. Mol.
	Biol. (1993) 229, 782-784. {Pubmed:8433371}
RF	<57> Shafqat, J.; Hjelmqvist, L.; Joernvall, H.: Liver class-I alcohol
	dehydrogenase isozyme relationships and constant patterns in a variable
	basic structure. Distinctions from characterization of an ethanol
	dehydrogenase in cobra, Naja naja. Eur. J. Biochem. (1996) 236,
	571-578. {Pubmed:8612631} (c)
RF	<58> Retzios, A.; Thatcher, D.R.: Characterization of the Adhf and
	Adhus alleloenzymes of Drosophila melanogaster (fruitfly) alcohol
	dehydrogenase. Biochem. Soc. Trans. (1981) 9, 298-299. {Pubmed:}
RF	<59> Bauermeister, A.; Sargent, J.: Purification and properties of an
	alcohol dehydrogenase from the liver and intestinal caecum of rainbow
	trout (Salmo gairdnerii). Biochem. Soc. Trans. (1978) 6, 222-224.
	{Pubmed:640168} (c)
RF	<60> Nussrallah, B.A.; Dam, R.; Wagner, F.W.: Characterization of
	Coturnix quail liver alcohol dehydrogenase enzymes. Biochemistry (1989)
	28, 6245-6251. {Pubmed:2789998}
RF	<61> Winberg, J.O.; Hovik, R.; McKinley-McKee, J.S.; Juan, E.;
	Gonzalez-Duarte, R.: Biochemical properties of alcohol dehydrogenase
	from Drosophila lebanonensis. Biochem. J. (1986) 235, 481-490.
	{Pubmed:2943270} (c)
RF	<62> Winberg, J.O.; McKinley-McKee, J.S.: Drosophila melanogaster
	alcohol dehydrogenase. Biochemical properties of the
	NAD+-plus-acetone-induced isoenzyme conversion. Biochem. J. (1988) 251,
	223-227. {Pubmed:3134011} (c)
RF	<63> Heinstra, P.W.H.; Thoerig, G.E.W.; Scharloo, W.; Drenth, W.;
	Nolte, R.J.M.: Kinetics and thermodynamics of ethanol oxidation
	catalyzed by genetic variants of the alcohol dehydrogenase from
	Drosophila melanogaster and D. simulans. Biochim. Biophys. Acta (1988)
	967, 224-233. {Pubmed:3142528} (c)
RF	<64> Juan, E.; Gonzalez-Duarte, R.: Determination of some biochemical
	and structural features of alcohol dehydrogenases from Drosophila
	simulans and Drosophila virilis. Comparison of their properties with
	the Drosophila melanogaster Adhs enzyme. Biochem. J. (1981) 195, 61-69.
	{Pubmed:6796069} (c)
RF	<65> Lee, C.Y.: Alcohol dehydrogenase from Drosophila melanogaster.
	Methods Enzymol. (1982) 89, 445-450. {Pubmed:} (c,review)
RF	<66> Rella, R.; Raia, C.A.; Pensa, M.; Pisani, F.M.; Gambacorta, A.; de
	Rosa, M.; Rossi, M.: A novel archaebacterial NAD+-dependent alcohol
	dehydrogenase. Purification and properties. Eur. J. Biochem. (1987)
	167, 475-479. {Pubmed:3115775} (c)
RF	<67> Wills, C.; Kratofil, P.; Londo, D.; Martin, T.: Characterization
	of the two alcohol dehydrogenases of Zymomonas mobilis. Arch. Biochem.
	Biophys. (1981) 210, 775-785. {Pubmed:7030207} (c)
RF	<68> Kinoshita, S.; Kakizono, T.; Kadota, K.; Das, K.; Taguchi, H.:
	Purification of two alcohol dehydrogenases from Zymomonas mobilis and
	their properties. Appl. Microbiol. Biotechnol. (1985) 22, 249-254.
	{Pubmed:} (c)
RF	<69> Grondal, E.J.M.; Betz, A.; Kreuzberg, K.: Partial purification and
	properties of alcohol dehydrogenase from unicellular green alga
	Chlamydomonas moewusii. Phytochemistry (1983) 22, 1695-1699. {Pubmed:}
	(c)
RF	<70> Ammendola, S.; Raia, C.A.; Caruso, C.; Camardella, L.; D'Auria,
	S.; De Rosa, M.; Rossi, M.: Thermostable NAD(+)-dependent alcohol
	dehydrogenase from Sulfolobus solfataricus: gene and protein sequence
	determination and relationship to other alcohol dehydrogenases.
	Biochemistry (1992) 31, 12514-12523. {Pubmed:1463738} (c)
RF	<71> Tihanyi, K.; Talbot, B.; Brzezinski, R.; Thirion, J.P.:
	Purification and characterization of alcohol dehydrogenase from
	soybean. Phytochemistry (1989) 28, 1335-1338. {Pubmed:} (c)
RF	<72> Liang, Z.Q.; Hayase, F.; Nishimura, T.; Kato, H.: Purification and
	characterization of NAD-dependent alcohol dehydrogenase and
	NADH-dependent 2-oxoaldehyde reductase from parsley. Agric. Biol. Chem.
	(1990) 54, 1717-1719. {Pubmed:} (c)
RF	<73> Hatanaka, A.; Harada, T.: Purification and properties of alcohol
	dehydrogenase from tea seeds. Agric. Biol. Chem. (1972) 36, 2033-2035.
	{Pubmed:} (c)
RF	<74> Stiborova, M.; Leblova, S.: Kinetics of the reaction catalysed by
	rape alcohol dehydrogenase. Phytochemistry (1979) 18, 23-24. {Pubmed:}
	(c)
RF	<75> Lai, Y.K.; Chandlee, J.M.; Scandalios, J.G.: Purification and
	characterization of three non-allelic alcohol dehydrogenase isoenzymes
	in maize. Biochim. Biophys. Acta (1982) 706, 9-18. {Pubmed:} (c)
RF	<76> Leblova, S.; Ehlichova, D.: Purification and some properties of
	alcohol dehydrogenase from maize. Phytochemistry (1972) 11, 1345-1346.
	{Pubmed:} (c)
RF	<77> Langston, P.J.; Pace, C.N.; Hart, G.E.: Wheat alcohol
	dehydrogenase iszymes. Purification, characterization, and gene
	expression. Plant Physiol. (1980) 65, 518-522. {Pubmed:16661226} (c)
RF	<78> Langston, P.J.; Hart, G.E.; Pace, C.N.: Purification and partial
	characterization of alcohol dehydrogenase from wheat. Arch. Biochem.
	Biophys. (1979) 196, 611-618. {Pubmed:485168} (c)
RF	<79> Mayne, M.G.; Lea, P.J.: Properties of three sets of isoenzymes of
	alcohol dehydrogenase isolated from barley (Hordeum vulgare).
	Phytochemistry (1985) 24, 1433-1438. {Pubmed:} (c)
RF	<80> Shimomura, S.; Beevers, H.: Alcohol dehydrogenase inactivator from
	rice seedlings. Properties and intracellular location. Plant Physiol.
	(1983) 71, 742-746. {Pubmed:16662899} (c)
RF	<81> Creaser, E.H.; Porter, R.L.; Britt, K.A.; Pateman, J.A.; Doy,
	C.H.: Purification and preliminary characterization of alcohol
	dehydrogenase from Aspergillus nidulans. Biochem. J. (1985) 225,
	449-454. {Pubmed:3156582} (c)
RF	<82> Yabe, M.; Shitara, K.; Kawashima, J.; Shinoyama, H.; Ando, A.;
	Fujii, T.: Purification and properties of an alcohol dehydrogenase
	isozyme from a methanol-using yeast, Candida sp. N-16. Biosci.
	Biotechnol. Biochem. (1992) 56, 338-339. {Pubmed:} (c)
RF	<83> Morosoli, R.; Begin-Heick, N.: The partial purification and
	characterization of cytosol alcohol dehydrogenase from Astasia.
	Biochem. J. (1974) 141, 469-475. {Pubmed:4455216} (c)
RF	<84> Rudge, J.; Bickerstaff, G.F.: Purification and properties of an
	alcohol dehydrogenase from Sporotrichum pulverulentum. Enzyme Microb.
	Technol. (1986) 8, 120-124. {Pubmed:}
RF	<85> Indrati, R.; Ohita, Y.: Purification and properties of alcohol
	dehydrogenase from a mutant strain of Candida guilliermondii. Can. J.
	Microbiol. (1992) 38, 953-957. {Pubmed:}
RF	<86> Tkachenko, A.G.; Winston, G.W.: Interaction of alcohol
	dehydrogenase with tert-butylhydroperoxide: stimulation of the horse
	liver and inhibition of the yeast enzyme. Arch. Biochem. Biophys.
	(2000) 380, 165-173. {Pubmed:10900146} (c)
RF	<87> Drewke, C.; Ciriacy, M.: Overexpression, purification and
	properties of alcohol dehydrogenase IV from Saccharomyces cerevisiae.
	Biochim. Biophys. Acta (1988) 950, 54-60. {Pubmed:3282541} (c)
RF	<88> Yamazaki, Y.; Maeda, H.; Satoh, A.; Hiromi, K.: A kinetic study on
	the binding of monomeric and polymeric derivatives of NAD+ to yeast
	alcohol dehydrogenase. J. Biochem. (1984) 95, 109-115. {Pubmed:6368531}
	(c)
RF	<89> Mazid, M.A.; Laidler, K.J.: pH Dependence of free and immobilized
	yeast alcohol dehydrogenase kinetics. Can. J. Microbiol. (1982) 60,
	100-107. {Pubmed:7044497}
RF	<90> Dickinson, F.M.; Monger, G.P.: A study of the kinetics and
	mechanism of yeast alcohol dehydrogenase with a variety of substrates.
	Biochem. J. (1973) 131, 261-270. {Pubmed:4352908} (c)
RF	<91> Ganzhorn, A.J.; Green, D.W.; Hershey, A.D.; Gould, R.M.; Plapp,
	B.V.: Kinetic characterization of yeast alcohol dehydrogenases. Amino
	acid residue 294 and substrate specificity. J. Biol. Chem. (1987) 262,
	3754-3761. {Pubmed:3546317}
RF	<92> Weinhold, E.G.; Benner, S.A.: Engineering yeast alcohol
	dehydrogenase. Replacing Trp54 by Leu broadens substrate specificity.
	Protein Eng. (1995) 8, 457-461. {Pubmed:8532667} (c)
RF	<93> Pocker, Y.; Li, H.: Mechanistic enzymology of liver alcohol
	dehydrogenase. Kinetic and stereochemical characterization of retinal
	oxidation and reduction. Enzymol. Mol. Biol. Carbonyl Metab. (1996) 6,
	331-338. {Pubmed:} (c)
RF	<94> Leskovac, V.; Trivic, S.; Anderson, B.M.: Use of competitive
	dead-end inhibitors to determine the chemical mechanism of action of
	yeast alcohol dehydrogenase. Mol. Cell. Biochem. (1998) 178, 219-227.
	{Pubmed:9546603} (c)
RF	<95> Keung, W.M.: Isolation and characterization of three alcohol
	dehydrogenase isozymes from Syrian golden hamster. Alcohol. Clin. Exp.
	Res. (1996) 20, 213-220. {Pubmed:8730210} (c)
RF	<96> Yin, S.J.; Wang, M.F.; Liao, C.S.; Chen, C.M.; Wu, C.W.:
	Identification of a human stomach alcohol dehydrogenase with
	distinctive kinetic properties. Biochem. Int. (1990) 22, 829-835.
	{Pubmed:2099148} (c)
RF	<97> Osterman, J.C.; Chiang, Y.; Markwell, J.: Characterization of
	mutation-induced changes in the maize (Zea mays L.) ADH1-1S1108 alcohol
	dehydrogenase. Biochem. Genet. (1993) 31, 497-506. {Pubmed:8166623} (c)
RF	<98> Langeland, B.T.; Morris, D.L.; McKinley-McKee, J.S.: Metal binding
	properties of thiols: complexes with horse liver alcohol dehydrogenase.
	Comp. Biochem. Physiol. B (1999) 123, 155-162. {Pubmed:10425719} (c)
RF	<99> Hensgens, C.M.H.; Vonck, J.; van Beeumen, J.; Bruggen, E.F.J.;
	Hansen, T.A.: Purification and characterization of an oxygen-labile,
	NAD-dependent alcohol dehydrogenase from Desulfovibrio gigas. J.
	Bacteriol. (1993) 175, 2859-2863. {Pubmed:8491707} (c)
RF	<100> Flores, B.M.; Stanley, S.L.; Yong, T.S.; Ali, M.; Yang, W.;
	Diedrich, D.L.; Torian, B.E.: Surface localization, regulation, and
	biologic properties of the 96-kDA alcohol/aldehyde dehydrogenase
	(EhADH2) of pathogenic Entamoeba histolytica. J. Infect. Dis. (1996)
	173, 226-231. {Pubmed:8537663} (c)
RF	<101> Persson, B.; Bergman, T.; Keung, W.M.; Waldenstroem, U.;
	Holmquist, B.; Vallee, B.L.; Joernvall, H.: Basic features of class-I
	alcohol dehydrogenase variable and constant segments coordinated by
	inter-class and intra-class variabvility. Conclusions from
	characterization of the alligator enzyme. Eur. J. Biochem. (1993) 216,
	49-56. {Pubmed:8365416} (c)
RF	<102> Gergel, D.; Cederbaum, A.I.: Inhibition of the catalytic activity
	of alcohol dehydrogenase by nitric oxide is associated with S
	nitrosylation and the release of zinc. Biochemistry (1996) 35,
	16186-16194. {Pubmed:8973191} (c)
RF	<103> Kim, K.J.; Howard, A.J.: Crystallization and preliminary X-ray
	diffraction analysis of the trigonal crystal form of Saccharomyces
	cerevisiae alcohol dehydrogenase I: evidence for the existence of Zn
	ions in the crystal. Acta Crystallogr. Sect. D (2002) 58, 1332-1334.
	{Pubmed:12136146}
RF	<104> Hadizadeh, M.; Keyhani, E.: Detection and kinetic properties of
	alcohol dehydrogenase in dormant corm of Crocus sativus L. Acta Hort.
	(2004) 650, 127-139. {Pubmed:}
RF	<105> Hildebrandt, P.; Musidlowska, A.; Bornscheuer, U.T.;
	Altenbuchner, J.: Cloning, functional expression and biochemical
	characterization of a stereoselective alcohol dehydrogenase from
	Pseudomonas fluorescens DSM50106. Appl. Microbiol. Biotechnol. (2002)
	59, 483-487. {Pubmed:12172614}
RF	<106> Martras, S.; Alvarez, R.; Gallego, O.; Dominguez, M.; de Lera,
	A.R.; Farres, J.; Pares, X.: Kinetics of human alcohol dehydrogenase
	with ring-oxidized retinoids: effect of Tween 80. Arch. Biochem.
	Biophys. (2004) 430, 210-217. {Pubmed:15369820}
RF	<107> Esposito, L.; Bruno, I.; Sica, F.; Raia, C.A.; Giordano, A.;
	Rossi, M.; Mazzarella, L.; Zagari, A.: Crystal structure of a ternary
	complex of the alcohol dehydrogenase from Sulfolobus solfataricus.
	Biochemistry (2003) 42, 14397-14407. {Pubmed:14661950}
RF	<108> Gibbons, B.J.; Hurley, T.D.: Structure of three class I human
	alcohol dehydrogenases complexed with isoenzyme specific formamide
	inhibitors. Biochemistry (2004) 43, 12555-12562. {Pubmed:15449945}
RF	<109> Stroemberg, P.; Svensson, S.; Berst, K.B.; Plapp, B.V.; Höög,
	J.O.: Enzymatic mechanism of low-activity mouse alcohol dehydrogenase
	2. Biochemistry (2004) 43, 1323-1328. {Pubmed:14756569}
RF	<110> LeBrun, L.A.; Park, D.H.; Ramaswamy, S.; Plapp, B.V.:
	Participation of histidine-51 in catalysis by horse liver alcohol
	dehydrogenase. Biochemistry (2004) 43, 3014-3026. {Pubmed:15023053}
RF	<111> Ceccarelli, C.; Liang, Z.X.; Strickler, M.; Prehna, G.;
	Goldstein, B.M.; Klinman, J.P.; Bahnson, B.J.: Crystal structure and
	amide H/D exchange of binary complexes of alcohol dehydrogenase from
	Bacillus stearothermophilus: insight into thermostability and cofactor
	binding. Biochemistry (2004) 43, 5266-5277. {Pubmed:15122892}
RF	<112> Chinnawirotpisan, P.; Matsushita, K.; Toyama, H.; Adachi, O.;
	Limtong, S.; Theeragool, G.: Purification and characterization of two
	NAD-dependent alcohol dehydrogenases (ADHs) induced in the quinoprotein
	ADH-deficient mutant of Acetobacter pasteurianus SKU1108. Biosci.
	Biotechnol. Biochem. (2003) 67, 958-965. {Pubmed:12834271}
RF	<113> Kosjek, B.; Stampfer, W.; Pogorevc, M.; Goessler, W.; Faber, K.;
	Kroutil, W.: Purification and characterization of a chemotolerant
	alcohol dehydrogenase applicable to coupled redox reactions.
	Biotechnol. Bioeng. (2004) 86, 55-62. {Pubmed:15007841}
RF	<114> Stroemberg, P.; Svensson, S.; Hedberg, J.J.; Nordling, E.; Hoog,
	J.O.: Identification and characterisation of two allelic forms of human
	alcohol dehydrogenase 2. Cell. Mol. Life Sci. (2002) 59, 552-559.
	{Pubmed:11964133}
RF	<115> Plapp, B.V.; Berst, K.B.: Specificity of human alcohol
	dehydrogenase 1C*2 (gamma2gamma2) for steroids and simulation of the
	uncompetitive inhibition of ethanol metabolism. Chem. Biol. Interact.
	(2003) 143-144, 183-193. {Pubmed:12604203}
RF	<116> Fontaine, F.R.; Dunlop, R.A.; Petersen, D.R.; Burcham, P.C.:
	Oxidative bioactivation of crotyl alcohol to the toxic endogenous
	aldehyde crotonaldehyde: association of protein carbonylation with
	toxicity in mouse hepatocytes. Chem. Res. Toxicol. (2002) 15,
	1051-1058. {Pubmed:12184789}
RF	<117> Yoon, S.Y.; Noh, H.S.; Kim, E.H.; Kong, K.H.: The highly stable
	alcohol dehydrogenase of Thermomicrobium roseum: purification and
	molecular characterization. Comp. Biochem. Physiol. B (2002) 132,
	415-422. {Pubmed:12031468}
RF	<118> Martras, S.; Alvarez, R.; Martinez, S.E.; Torres, D.; Gallego,
	O.; Duester, G.; Farres, J.; de Lera, A.R.; Pares, X.: The specificity
	of alcohol dehydrogenase with cis-retinoids. Activity with
	11-cis-retinol and localization in retina. Eur. J. Biochem. (2004) 271,
	1660-1670. {Pubmed:15096205}
RF	<119> Leskovac, V.; Trivic, S.; Pericin, D.: The three zinc-containing
	alcohol dehydrogenases from bakers' yeast, Saccharomyces cerevisiae.
	FEMS Yeast Res. (2002) 2, 481-494. {Pubmed:12702265} (review)
RF	<120> Miroliaei, M.; Nemat-Gorgani, M.: Effect of organic solvents on
	stability and activity of two related alcohol dehydrogenases: a
	comparative study. Int. J. Biochem. Cell Biol. (2002) 34, 169-175.
	{Pubmed:11809419}
RF	<121> Vanni, A.; Anfossi, L.; Pessione, E.; Giovannoli, C.: Catalytic
	and spectroscopic characterisation of a copper-substituted alcohol
	dehydrogenase from yeast. Int. J. Biol. Macromol. (2002) 30, 41-45.
	{Pubmed:11893392}
RF	<122> Espinosa, A.; Clark, D.; Stanley, S.L., Jr.: Entamoeba
	histolytica alcohol dehydrogenase 2 (EhADH2) as a target for
	anti-amoebic agents. J. Antimicrob. Chemother. (2004) 54, 56-59.
	{Pubmed:15150165}
RF	<123> Chou, C.F.; Lai, C.L.; Chang, Y.C.; Duester, G.; Yin, S.J.:
	Kinetic mechanism of human class IV alcohol dehydrogenase functioning
	as retinol dehydrogenase. J. Biol. Chem. (2002) 277, 25209-25216.
	{Pubmed:11997393}
RF	<124> Rosell, A.; Valencia, E.; Ochoa, W.F.; Fita, I.; Pares, X.;
	Farres, J.: Complete reversal of coenzyme specificity by concerted
	mutation of three consecutive residues in alcohol dehydrogenase. J.
	Biol. Chem. (2003) 278, 40573-40580. {Pubmed:12902331}
RF	<125> Shim, E.J.; Jeon, S.H.; Kong, K.H.: Overexpression, purification,
	and biochemical characterization of the thermostable NAD-dependent
	alcohol dehydrogenase from Bacillus stearothermophilus. J. Microbiol.
	Biotechnol. (2003) 13, 738-744. {Pubmed:}
RF	<126> Guy, J.E.; Isupov, M.N.; Littlechild, J.A.: The structure of an
	alcohol dehydrogenase from the hyperthermophilic archaeon Aeropyrum
	pernix. J. Mol. Biol. (2003) 331, 1041-1051. {Pubmed:12927540}
RF	<127> Avila, E.E.; Martinez-Alcaraz, E.R.; Barbosa-Sabanero, G.;
	Rivera-Baron, E.I.; Arias-Negrete, S.; Zazueta-Sandoval, R.:
	Subcellular localization of the NAD+-dependent alcohol dehydrogenase in
	Entamoeba histolytica trophozoites. J. Parasitol. (2002) 88, 217-222.
	{Pubmed:12058720}
RF	<128> Levin, I.; Meiri, G.; Peretz, M.; Burstein, Y.; Frolow, F.: The
	ternary complex of Pseudomonas aeruginosa alcohol dehydrogenase with
	NADH and ethylene glycol. Protein Sci. (2004) 13, 1547-1556.
	{Pubmed:15152088}
RF	<129> Koumanov, A.; Benach, J.; Atrian, S.; Gonzalez-Duarte, R.;
	Karshikoff, A.; Ladenstein, R.: The catalytic mechanism of Drosophila
	alcohol dehydrogenase: evidence for a proton relay modulated by the
	coupled ionization of the active site lysine/tyrosine pair and a NAD+
	ribose OH switch. Proteins (2003) 51, 289-298. {Pubmed:12660997}
RF	<130> Kragl, U.; Kruse, W.; Hummel, W.; Wandrey, C.: Enzyme engineering
	aspects of biocatalysis: Cofactor regeneration as example. Biotechnol.
	Bioeng. (1996) 52, 309-319. {Pubmed:18629898}
RF	<131> Vicenzi, J.T.; Zmijewski, M.J.; Reinhard, M.R.; Landen, B.E.;
	Muth, W.L.; Marler, P.G.: Large-scale stereoselective enzymatic ketone
	reduction with in-situ product removal via polymeric adsorbent resins.
	Enzyme Microb. Technol. (1997) 20, 494-499. {Pubmed:}
RF	<132> Sit, S.Y.; Parker, R.A.; Motoc, I.; Han, W.; Balasubramanian, N.:
	Synthesis, biological profile, and quantitative structure-activity
	relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A
	reductase inhibitors. J. Med. Chem. (1990) 33, 2982-2999.
	{Pubmed:2231596}
RF	<133> Blacklock, T.J.; Sohar, P.; Butcher, J.W.; Lamanec, T.;
	Grabowski, E.J.J.: An enantioselective synthesis of the
	topically-active carbonic anhydrase inhibitor
	MK-0507:5,6-dihydro-(s)-4-(ethylamino)-(s)-6-mehtyl-4H-thieno[2
	3-beta]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride. J. Org. Chem.
	(1993) 58, 1672-1679. {Pubmed:}
RF	<134> Nosova, T.; Jousimies-Somer, H.; Kaihovaara, P.; Jokelainen, K.;
	Heine, R.; Salaspuro, M.: Characteristics of alcohol dehydrogenases of
	certain aerobic bacteria representing human colonic flora. Alcohol.
	Clin. Exp. Res. (1997) 21, 489-494. {Pubmed:9161610} (c)
RF	<135> Duron-Castellanos, A.; Zazueta-Novoa, V.; Silva-Jimenez, H.;
	Alvarado-Caudillo, Y.; Pena Cabrera, E.; Zazueta-Sandoval, R.:
	Detection of NAD+dependent alcohol dehydrogenase activities in YR-1
	strain of Mucor circinelloides, a potential bioremediator of petroleum
	contaminated soils. Appl. Biochem. Biotechnol. (2005) 121-124, 279-288.
	{Pubmed:15917606}
RF	<136> Inoue, K.; Makino, Y.; Itoh, N.: Purification and
	characterization of a novel alcohol dehydrogenase from Leifsonia sp.
	strain S749: a promising biocatalyst for an asymmetric hydrogen
	transfer bioreduction. Appl. Environ. Microbiol. (2005) 71, 3633-3641.
	{Pubmed:16000771}
RF	<137> Park, H.; Kidman, G.; Northrop, D.B.: Effects of pressure on
	deuterium isotope effects of yeast alcohol dehydrogenase using
	alternative substrates. Arch. Biochem. Biophys. (2005) 433, 335-340.
	{Pubmed:15581588}
RF	<138> Kalnenieks, U.; Galinina, N.; Toma, M.M.: Physiological
	regulation of the properties of alcohol dehydrogenase II (ADH II) of
	Zymomonas mobilis: NADH renders ADH II resistant to cyanide and
	aeration. Arch. Microbiol. (2005) 183, 450-455. {Pubmed:16027951}
RF	<139> Haseba, T.; Duester, G.; Shimizu, A.; Yamamoto, I.; Kameyama, K.;
	Ohno, Y.: In vivo contribution of class III alcohol dehydrogenase
	(ADH3) to alcohol metabolism through activation by cytoplasmic solution
	hydrophobicity. Biochim. Biophys. Acta (2006) 1762, 276-283.
	{Pubmed:16431092}
RF	<140> Westerlund, M.; Galter, D.; Carmine, A.; Olson, L.: Tissue- and
	species-specific expression patterns of class I, III, and IV Adh and
	Aldh 1 mRNAs in rodent embryos. Cell Tissue Res. (2005) 322, 227-236.
	{Pubmed:16047160}
RF	<141> Negoro, M.; Wakabayashi, I.: Enhancement of alcohol dehydrogenase
	activity in vitro by acetylsalicylic acid. Eur. J. Pharmacol. (2005)
	523, 25-28. {Pubmed:16226743}
RF	<142> Kazuoka, T.; Oikawa, T.; Muraoka, I.; Kuroda, S.; Soda, K.: A
	cold-active and thermostable alcohol dehydrogenase of a psychrotorelant
	from Antarctic seawater, Flavobacterium frigidimaris KUC-1.
	Extremophiles (2007) 11, 257-267. {Pubmed:17072683}
RF	<143> Mazzoni, C.; Iacchini, S.; Serafini, A.; Falcone, C.:
	Characterization of a Kluyveromyces lactis mutant with altered
	regulation of mitochondrial alcohol dehydrogenases. FEMS Yeast Res.
	(2006) 6, 421-427. {Pubmed:16630282}
RF	<144> Defilippi, B.G.; Dandekar, A.M.; Kader, A.A.: Relationship of
	ethylene biosynthesis to volatile production, related enzymes, and
	precursor availability in apple peel and flesh tissues. J. Agric. Food
	Chem. (2005) 53, 3133-3141. {Pubmed:15826070}
RF	<145> Koutsompogeras, P.; Kyriacou, A.; Zabetakis, I.: Characterizing
	NAD-dependent alcohol dehydrogenase enzymes of Methylobacterium
	extorquens and strawberry (Fragaria x ananassa cv. Elsanta). J. Agric.
	Food Chem. (2006) 54, 235-242. {Pubmed:16390205}
RF	<146> Ikegaya, K.: Kinetic analysis about the effects of neutral salts
	on the thermal stability of yeast alcohol dehydrogenase. J. Biochem.
	(2005) 137, 349-354. {Pubmed:15809336}
RF	<147> Hirano, J.; Miyamoto, K.; Ohta, H.: Purification and
	characterization of the alcohol dehydrogenase with a broad substrate
	specificity originated from 2-phenylethanol-assimilating Brevibacterium
	sp. KU 1309. J. Biosci. Bioeng. (2005) 100, 318-322. {Pubmed:16243283}
RF	<148> Jelski, W.; Chrostek, L.; Markiewicz, W.; Szmitkowski, M.:
	Activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde
	dehydrogenase (ALDH) in the sera of patients with breast cancer. J.
	Clin. Lab. Anal. (2006) 20, 105-108. {Pubmed:16721836}
RF	<149> Manriquez, D.; El-Sharkawy, I.; Flores, F.B.; El-Yahyaoui, F.;
	Regad, F.; Bouzayen, M.; Latche, A.; Pech, J.C.: Two highly divergent
	alcohol dehydrogenases of melon exhibit fruit ripening-specific
	expression and distinct biochemical characteristics. Plant Mol. Biol.
	(2006) 61, 675-685. {Pubmed:16897483}
RF	<150> Sica, F.; Demasi, D.; Mazzarella, D.L.; Zagari, A.; Capasso, S.;
	Pearl, L.H.; D'Auria, S.; Raia, C.A.; Rossi, M.: Elimination of
	twinning in crystals of Sulfolobus sofataricus alcohol dehydrogenase
	holo-enzyme by growth in agarose gels. Acta Crystallogr. Sect. D (1994)
	50, 508-511. {Pubmed:15299411}
RF	<151> Raia, C.A.; Caruso, C.; Marino, M.; Vespa, N.; Rossi, M.:
	Activation of Sulfolobus solfataricus alcohol dehydrogenase by
	modification of cysteine residue 38 with iodoacetic acid. Biochemistry
	(1996) 35, 638-647. {Pubmed:8555238}
RF	<152> Giordano, A.; Cannio, R.; La Cara, F.; Bartolucci, S.; Rossi, M.;
	Raia, C.A.: Asn249Tyr substitution at the coenzyme binding domain
	activates Sulfolobus solfataricus alcohol dehydrogenase and increases
	its thermal stability.. Biochemistry (1999) 38, 3043-3054.
	{Pubmed:10074357}
RF	<153> Trincone, A.; Lama, L.; Rella, R.; D'Auria, S.; Raia, C.A.;
	Nicolaus, B.: Determination of hydride transfer stereospecificity of
	NADH-dependent alcohol-aldehyde/ketone oxidoreductase from Sulfolobus
	solfataricus. Biochim. Biophys. Acta (1990) 1041, 94-96.
	{Pubmed:2121281}
RF	<154> Tasaki, Y.; Yoshikawa, H.; Tamura, H.: Isolation and
	characterization of an alcohol dehydrogenase gene from the octylphenol
	polyethoxylate degrader Pseudomonas putida S-5. Biosci. Biotechnol.
	Biochem. (2006) 70, 1855-1863. {Pubmed:16926497}
RF	<155> Esposito, L.; Bruno, I.; Sica, F.; Raia, C.A.; Giordano, A.;
	Rossi, M.; Mazzarella, L.; Zagari, A.: Structural study of a
	single-point mutant of Sulfolobus solfataricus alcohol dehydrogenase
	with enhanced activity.. FEBS Lett. (2003) 539, 14-18. {Pubmed:12650918}
RF	<156> Cannio, R.; Fiorentino, G.; Rossi, M.; Bartolucci, S.: The
	alcohol dehydrogenase gene: distribution among Sulfolobales and
	regulation in Sulfolobus solfataricus. FEMS Microbiol. Lett. (1999)
	170, 31-39. {Pubmed:9919650}
RF	<157> Cannio, R.; Fiorentino, G.; Carpinelli, P.; Rossi, M.;
	Bartolucci, S.: Cloning and overexpression in Escherichia coli of the
	genes encoding NAD-dependent alcohol dehydrogenase from two Sulfolobus
	species. J. Bacteriol. (1996) 178, 301-305. {Pubmed:8550434}
RF	<158> Fiorentino, G.; Cannio, R.; Rossi, M.; Bartolucci, S.:
	Transcriptional regulation of the gene encoding an alcohol
	dehydrogenase in the archaeon Sulfolobus solfataricus involves multiple
	factors and control elements. J. Bacteriol. (2003) 185, 3926-3934.
	{Pubmed:12813087}
RF	<159> Esposito, L.; Sica, F.; Raia, C.A.; Giordano, A.; Rossi, M.;
	Mazzarella, L.; Zagari, A.: Crystal structure of the alcohol
	dehydrogenase from the hyperthermophilic archaeon Sulfolobus
	solfataricus at 1.85 A resolution. J. Mol. Biol. (2002) 318, 463-477.
	{Pubmed:12051852}
RF	<160> Chong, P.K.; Burja, A.M.; Radianingtyas, H.; Fazeli, A.; Wright,
	P.C.: Proteome and transcriptional analysis of ethanol-grown Sulfolobus
	solfataricus P2 reveals ADH2, a potential alcohol dehydrogenase. J.
	Proteome Res. (2007) 6, 3985-3994. {Pubmed:17824633}
RF	<161> Raia, C.A.; Giordano, A.; Rossi, M.: Alcohol dehydrogenase from
	Sulfolobus solfataricus. Methods Enzymol. (2001) 331, 176-195.
	{Pubmed:11265460}
RF	<162> Casadio, R.; Martelli, P.L.; Giordano, A.; Rossi, M.; Raia, C.A.:
	A low-resolution 3D model of the tetrameric alcohol dehydrogenase from
	Sulfolobus solfataricus. Protein Eng. (2002) 15, 215-223.
	{Pubmed:11932492}
RF	<163> Ammendola, S.; Raucci, G.; Incani, O.; Mele, A.; Tramontano, A.;
	Wallace, A.: Replacing the glutamate ligand in the structural zinc site
	of Sulfolobus solfataricus alcohol dehydrogenase with a cysteine
	decreases thermostability.. Protein Eng. (1995) 8, 31-37.
	{Pubmed:7770449}
RF	<164> Hoellrigl, V.; Otto, K.; Schmid, A.: Electroenzymatic asymmetric
	reduction of rac-3-methylcyclohexanone to (1S,3S)-3-methylcyclohexanol
	in organic/aqueous media catalyzed by a thermophilic alcohol
	dehydrogenase. Adv. Synth. Catal. (2007) 349, 1337-1340. {Pubmed:}
RF	<165> Quintanilla, M.E.; Tampier, L.; Sapag, A.; Gerdtzen, Z.; Israel,
	Y.: Sex differences, alcohol dehydrogenase, acetaldehyde burst, and
	aversion to ethanol in the rat: a systems perspective. Am. J. Physiol.
	Endocrinol. Metab. (2007) 293, E531-E537. {Pubmed:17488809}
RF	<166> Nie, Y.; Xu, Y.; Mu, X.Q.; Wang, H.Y.; Yang, M.; Xiao, R.:
	Purification, characterization, gene cloning, and expression of a novel
	alcohol dehydrogenase with anti-prelog stereospecificity from Candida
	parapsilosis. Appl. Environ. Microbiol. (2007) 73, 3759-3764.
	{Pubmed:17435004}
RF	<167> Pennacchio, A.; Pucci, B.; Secundo, F.; La Cara, F.; Rossi, M.;
	Raia, C.A.: Purification and characterization of a novel recombinant
	highly enantioselective short-chain NAD(H)-dependent alcohol
	dehydrogenase from Thermus thermophilus. Appl. Environ. Microbiol.
	(2008) 74, 3949-3958. {Pubmed:18456852}
RF	<168> Maestre, O.; Garcia-Martinez, T.; Peinado, R.A.; Mauricio, J.C.:
	Effects of ADH2 overexpression in Saccharomyces bayanus during
	alcoholic fermentation. Appl. Environ. Microbiol. (2008) 74, 702-707.
	{Pubmed:18065623}
RF	<169> Kotrbova-Kozak, A.; Kotrba, P.; Inui, M.; Sajdok, J.; Yukawa, H.:
	Transcriptionally regulated adhA gene encodes alcohol dehydrogenase
	required for ethanol and n-propanol utilization in Corynebacterium
	glutamicum R. Appl. Microbiol. Biotechnol. (2007) 76, 1347-1356.
	{Pubmed:17646983}
RF	<170> Park, Y.C.; San, K.Y.; Bennett, G.N.: Characterization of alcohol
	dehydrogenase 1 and 3 from Neurospora crassa FGSC2489. Appl. Microbiol.
	Biotechnol. (2007) 76, 349-356. {Pubmed:17516063}
RF	<171> Hess, M.; Antranikian, G.: Archaeal alcohol dehydrogenase active
	at increased temperatures and in the presence of organic solvents.
	Appl. Microbiol. Biotechnol. (2008) 77, 1003-1013. {Pubmed:17989975}
RF	<172> Crichton, P.G.; Affourtit, C.; Moore, A.L.: Identification of a
	mitochondrial alcohol dehydrogenase in Schizosaccharomyces pombe: new
	insights into energy metabolism. Biochem. J. (2007) 401, 459-464.
	{Pubmed:16999687}
RF	<173> Meijers, R.; Adolph, H.W.; Dauter, Z.; Wilson, K.S.; Lamzin,
	V.S.; Cedergren-Zeppezauer, E.S.: Structural evidence for a ligand
	coordination switch in liver alcohol dehydrogenase. Biochemistry (2007)
	46, 5446-5454. {Pubmed:17429946}
RF	<174> Zhang, X.; Bruice, T.C.: Temperature-dependent structure of the E
	x S complex of Bacillus stearothermophilus alcohol dehydrogenase.
	Biochemistry (2007) 46, 837-843. {Pubmed:17223705}
RF	<175> Lertwattanasakul, N.; Sootsuwan, K.; Limtong, S.; Thanonkeo, P.;
	Yamada, M.: Comparison of the gene expression patterns of alcohol
	dehydrogenase isozymes in the thermotolerant yeast Kluyveromyces
	marxianus and their physiological functions. Biosci. Biotechnol.
	Biochem. (2007) 71, 1170-1182. {Pubmed:17485854}
RF	<176> Barzegar, A.; Moosavi-Movahedi, A.A.; Rezaei-Zarchi, S.; Saboury,
	A.A.; Ganjali, M.R.; Norouzi, P.; Hakimelahi, G.H.; Tsai, F.Y.: The
	mechanisms underlying the effect of alpha-cyclodextrin on the
	aggregation and stability of alcohol dehydrogenase. Biotechnol. Appl.
	Biochem. (2008) 49, 203-211. {Pubmed:17685894}
RF	<177> Yoshimoto, M.; Sato, M.; Yoshimoto, N.; Nakao, K.: Liposomal
	encapsulation of yeast alcohol dehydrogenase with cofactor for
	stabilization of the enzyme structure and activity. Biotechnol. Prog.
	(2008) 24, 576-582. {Pubmed:18335956}
RF	<178> Jelski, W.; Zalewski, B.; Szmitkowski, M.: The activity of class
	I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde
	dehydrogenase (ALDH) in liver cancer. Digest. Dis. Sci. (2008) 53,
	2550-2555. {Pubmed:18224440}
RF	<179> Cao, Y.; Liao, L.; Xu, X.W.; Oren, A.; Wang, C.; Zhu, X.F.; Wu,
	M.: Characterization of alcohol dehydrogenase from the haloalkaliphilic
	archaeon Natronomonas pharaonis. Extremophiles (2008) 12, 471-476.
	{Pubmed:18189118}
RF	<180> Li, G.Y.; Huang, K.L.; Jiang, Y.R.; Yang, D.L.; Ding, P.:
	Preparation and characterization of Saccharomyces cerevisiae alcohol
	dehydrogenase immobilized on magnetic nanoparticles. Int. J. Biol.
	Macromol. (2008) 42, 405-412. {Pubmed:18456317}
RF	<181> Sauvage, F.X.; Pradal, M.; Chatelet, P.; Tesniere, C.: Proteome
	changes in leaves from grapevine (Vitis vinifera L.) transformed for
	alcohol dehydrogenase activity. J. Agric. Food Chem. (2007) 55,
	2597-2603. {Pubmed:17348683}
RF	<182> Xu, S.; Lu, Y.; Li, J.; Zhang, Y.; Jiang, Z.: Preparation of
	novel silica-coated alginate gel beads for efficient encapsulation of
	yeast alcohol dehydrogenase. J. Biomater. Sci. Polym. Ed. (2007) 18,
	71-80. {Pubmed:17274452}
RF	<183> Yamada-Onodera, K.; Fukui, M.; Tani, Y.: Purification and
	characterization of alcohol dehydrogenase reducing
	N-benzyl-3-pyrrolidinone from Geotrichum capitatum. J. Biosci. Bioeng.
	(2007) 103, 174-178. {Pubmed:17368401}
RF	<184> Jelski, W.; Zalewski, B.; Szmitkowski, M.: Alcohol dehydrogenase
	(ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera
	of patients with liver cancer. J. Clin. Lab. Anal. (2008) 22, 204-209.
	{Pubmed:18484658}
RF	<185> Amao, Y.; Watanabe, T.: Photochemical and enzymatic synthesis of
	methanol from formaldehyde with alcohol dehydrogenase from
	Saccharomyces cerevisiae and water-soluble zinc porphyrin. J. Mol.
	Catal. B (2007) 44, 27-31. {Pubmed:}
RF	<186> Kizaki, N.; Yasohara, Y.; Nagashima, N.; Hasegawa, J.:
	Characterization of novel alcohol dehydrogenase of Devosia riboflavina
	involved in stereoselective reduction of 3-pyrrolidinone derivatives.
	J. Mol. Catal. B (2008) 51, 73-80. {Pubmed:}
RF	<187> Men, L.; Wang, Y.: The oxidation of yeast alcohol dehydrogenase-1
	by hydrogen peroxide in vitro. J. Proteome Res. (2007) 6, 216-225.
	{Pubmed:17203966}
RF	<188> Reverter-Branchat, G.; Cabiscol, E.; Tamarit, J.; Sorolla, M.A.;
	Angeles de la Torre, M.; Ros, J.: Chronological and replicative
	life-span extension in Saccharomyces cerevisiae by increased dosage of
	alcohol dehydrogenase 1. Microbiology (2007) 153, 3667-3676.
	{Pubmed:17975074}
RF	<189> Jelski, W.; Chrostek, L.; Szmitkowski, M.: The activity of class
	I, II, III, and IV of alcohol dehydrogenase isoenzymes and aldehyde
	dehydrogenase in pancreatic cancer. Pancreas (2007) 35, 142-146.
	{Pubmed:17632320}
RF	<190> Abuin, E.; Lissi, E.; Leon, L.: Kinetics of ethanol oxidation
	catalyzed by yeast alcohol dehydrogenase in aqueous solutions of sodium
	dodecylsulfate. Protein J. (2008) 27, 247-252. {Pubmed:18317889}
RF	<191> Laadan, B.; Almeida, J.R.; Radstroem, P.; Hahn-Haegerdal, B.;
	Gorwa-Grauslund, M.: Identification of an NADH-dependent
	5-hydroxymethylfurfural-reducing alcohol dehydrogenase in Saccharomyces
	cerevisiae. Yeast (2008) 25, 191-198. {Pubmed:18302314}
RF	<192> Jelski, W.; Szmitkowski, M.: Alcohol dehydrogenase (ADH) and
	aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin. Chim. Acta
	(2008) 395, 1-5. {Pubmed:18505683}
RF	<193> Peng, H.; Wu, G.; Shao, W.: The aldehyde/alcohol dehydrogenase
	(AdhE) in relation to the ethanol formation in Thermoanaerobacter
	ethanolicus JW200. Anaerobe (2008) 14, 125-127. {Pubmed:17981479}
RF	<194> Zhao, Q.; Hou, Y.; Gong, G.H.; Yu, M.A.; Jiang, L.; Liao, F.:
	Characterization of alcohol dehydrogenase from permeabilized brewers
	yeast cells immobilized on the derived attapulgite nanofibers. Appl.
	Biochem. Biotechnol. (2009) 160, 2287-2299. {Pubmed:19578994}
RF	<195> Hoellrigl, V.; Hollmann, F.; Kleeb, A.C.; Buehler, K.; Schmid,
	A.: TADH, the thermostable alcohol dehydrogenase from Thermus sp. ATN1:
	a versatile new biocatalyst for organic synthesis. Appl. Microbiol.
	Biotechnol. (2008) 81, 263-273. {Pubmed:18704396}
RF	<196> Plapp, B.V.: Conformational changes and catalysis by alcohol
	dehydrogenase. Arch. Biochem. Biophys. (2010) 493, 3-12.
	{Pubmed:19583966}
RF	<197> Markossian, K.A.; Golub, N.V.; Khanova, H.A.; Levitsky, D.I.;
	Poliansky, N.B.; Muranov, K.O.; Kurganov, B.I.: Mechanism of thermal
	aggregation of yeast alcohol dehydrogenase I: role of intramolecular
	chaperone. Biochim. Biophys. Acta (2008) 1784, 1286-1293.
	{Pubmed:18515108}
RF	<198> Staab, C.A.; Hellgren, M.; Hoeoeg, J.O.: Medium- and short-chain
	dehydrogenase/reductase gene and protein families: Dual functions of
	alcohol dehydrogenase 3: implications with focus on formaldehyde
	dehydrogenase and S-nitrosoglutathione reductase activities. Cell. Mol.
	Life Sci. (2008) 65, 3950-3960. {Pubmed:19011746}
RF	<199> Bergman, T.; Zhang, K.; Palmberg, C.; Joernvall, H.; Auld, D.S.:
	Zinc binding to peptide analogs of the structural zinc site in alcohol
	dehydrogenase: implications for an entatic state. Cell. Mol. Life Sci.
	(2008) 65, 4019-4027. {Pubmed:18850316}
RF	<200> Pal, S.; Park, D.H.; Plapp, B.V.: Activity of yeast alcohol
	dehydrogenases on benzyl alcohols and benzaldehydes: characterization
	of ADH1 from Saccharomyces carlsbergensis and transition state
	analysis. Chem. Biol. Interact. (2009) 178, 16-23. {Pubmed:19022233}
RF	<201> Miyawaki, O.; Ma, G.; Horie, T.; Hibi, A.; Ishikawa, T.; Kimura,
	S.: Thermodynamic, kinetic, and operational stabilities of yeast
	alcohol dehydrogenase in sugar and compatible osmolyte solutions.
	Enzyme Microb. Technol. (2008) 43, 495-499. {Pubmed:}
RF	<202> Cea, G.; Wilson, L.; Bolivar, J.; Markovits, A.; Illanes, A.:
	Effect of chain length on the activity of free and immobilized alcohol
	dehydrogenase towards aliphatic alcohols. Enzyme Microb. Technol.
	(2009) 44, 135-138. {Pubmed:}
RF	<203> Barzegar, A.; Moosavi-Movahedi, A.; Pedersen, J.; Miroliaei, M.:
	Comparative thermostability of mesophilic and thermophilic alcohol
	dehydrogenases: Stability-determining roles of proline residues and
	loop conformations. Enzyme Microb. Technol. (2009) 45, 73-79. {Pubmed:}
RF	<204> Jelski, W.; Orywal, K.; Panek, B.; Gacko, M.; Mroczko, B.;
	Szmitkowski, M.: The activity of class I, II, III and IV of alcohol
	dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the
	wall of abdominal aortic aneurysms. Exp. Mol. Pathol. (2009) 87, 59-62.
	{Pubmed:19332052}
RF	<205> Pennacchio, A.; Esposito, L.; Zagari, A.; Rossi, M.; Raia, C.A.:
	Role of Tryptophan 95 in substrate specificity and structural stability
	of Sulfolobus solfataricus alcohol dehydrogenase. Extremophiles (2009)
	13, 751-761. {Pubmed:19588068}
RF	<206> Carvalho, E.; Solferini, V.; Matioli, S.: Alcohol dehydrogenase
	activities and ethanol tolerance in Anastrepha (Diptera, Tephritidae)
	fruit-fly species and their hybrids. Genet. Mol. Biol. (2009) 32,
	177-185. {Pubmed:}
RF	<207> Devi, P.G.; Chakraborty, P.K.; Dasgupta, D.: Inhibition of a
	Zn(II)-containing enzyme, alcohol dehydrogenase, by anticancer
	antibiotics, mithramycin and chromomycin A3. J. Biol. Inorg. Chem.
	(2009) 14, 347-359. {Pubmed:19034537}
RF	<208> Jeon, Y.J.; Fong, J.C.; Riyanti, E.I.; Neilan, B.A.; Rogers,
	P.L.; Svenson, C.J.: Heterologous expression of the alcohol
	dehydrogenase (adhI) gene from Geobacillus thermoglucosidasius strain
	M10EXG. J. Biotechnol. (2008) 135, 127-133. {Pubmed:18436321}
RF	<209> Palma-Gutierrez, H.; Rodriguez-Zavala, J.; Jasso-Chavez, R.;
	Moreno-Sanchez, R.; Saavedra, E.: Gene cloning and biochemical
	characterization of an alcohol dehydrogenase from Euglena gracilis. J.
	Eukaryot. Microbiol. (2008) 55, 554-561. {Pubmed:19120802}
RF	<210> Haseba, T.; Sugimoto, J.; Sato, S.; Abe, Y.; Ohno, Y.:
	Phytophenols in whisky lower blood acetaldehyde level by depressing
	alcohol metabolism through inhibition of alcohol dehydrogenase 1 (class
	I) in mice. Metab. Clin. Exp. (2008) 57, 1753-1759. {Pubmed:19013301}
RF	<211> Marino-Marmolejo, E.N.; De Leon-Rodriguez, A.; de la Rosa, A.P.;
	Santos, L.: Heterologous expression and characterization of an alcohol
	dehydrogenase from the archeon Thermoplasma acidophilum. Mol.
	Biotechnol. (2009) 42, 61-67. {Pubmed:19058034}
RF	<212> Kollock, R.; Frank, H.; Seidel, A.; Meinl, W.; Glatt, H.:
	Oxidation of alcohols and reduction of aldehydes derived from methyl-
	and dimethylpyrenes by cDNA-expressed human alcohol dehydrogenases.
	Toxicology (2008) 245, 65-75. {Pubmed:18242813}
RF	<213> Liu, X.; Dong, Y.; Zhang, J.; Zhang, A.; Wang, L.; Feng, L.: Two
	novel metal-independent long-chain alkyl alcohol dehydrogenases from
	Geobacillus thermodenitrificans NG80-2. Microbiology (2009) 155,
	2078-2085. {Pubmed:19383697}

ACTIVATING_COMPOUND
AC	#10# Glutaraldehyde (#10# treating with 0.5% glutaraldehyde solution,
	the activity of the immobilized enzyme is at maximum <194>) <194>
AC	#104# Triton X-100 (#104# 201% relative activity at 10% (v/v) <195>)
	<195>
AC	#104# Urea (#104# 130% relative activity at 1 M <195>) <195>
AC	#25# iodoacetate (#25# 1 mM, 1.1fold activation <186>) <186>
AC	#37# Acetylsalicylate (#37# enhances activity <141>) <141>
AC	#37# more (#37# isonicotinimidylation and methylation increases
	activity <35>) <35>
AC	#37# tert-butyl hydroperoxide (#37# stimulation up to 100 mM <86>) <86>
AC	#42# iodoacetamide (#42# 1 mM activates up to 25fold <161>) <161>
AC	#5# butyramide (#5# activates ADH3 <139>) <139>
AC	#5# Valeramide (#5# activates ADH3 <139>) <139>
AC	#5# tert-butanol (#5# activates ADH3 <139>) <139>
AC	#5# S-nitrosoglutathione (#5# ADH3-mediated alcohol oxidation is
	promoted in the presence of S-nitrosoglutathione <198>) <198>
AC	#5# capronamide (#5# activates ADH3 <139>) <139>
AC	#6,46,106# EDTA (#46# enhances activity <82>; #6# 10 mM, 1.65fold
	activation <167>; #106# 1 mM, 105% of initial activity <213>)
	<82,167,213>

KI_VALUE
KI	#10# 0.025 {mithramycin}  (#10# in 50 mM Tris-HCl, pH 8.0 at 25°C
	<207>) <207>
KI	#10# 0.038 {mithramycin}  (#10# in 50 mM Tris-HCl, pH 8.0 at 25°C
	<207>) <207>
KI	#101# 3.3 {ethanol}  (#101# isozyme ADH4, using 1-hydroxymethylpyrene
	as substrate <212>) <212>
KI	#26# 6.64 {4-Methylpyrazole}  <134>
KI	#32# 0.47 {4-Methylpyrazole}  <134>
KI	#42# 0.13 {pyrazole}  (#42# apparent value <161>) <161>
KI	#42# 0.009 {4-Methylpyrazole}  (#42# apparent value <161>) <161>
KI	#42# 0.0032 {4-iodopyrazole}  (#42# apparent value <161>) <161>
KI	#5# 0.026 {Octanoic acid}  (#5# pH 7.5, 25°C, wild-type enzyme, versus
	NAD+ <109>) <109>
KI	#5# 0.072 {cyclohexylformamide}  (#5# pH 7.5, 25°C, wild-type enzyme,
	versus NADH <109>) <109>
KI	#5# 8e-05 {caffeic acid}  (#5# at 37°C in 0.1 M Na-K phosphate buffer
	(pH 7.4) <210>) <210>
KI	#5# 0.0051 {pyrazole}  (#5# at 37°C in 0.1 M Na-K phosphate buffer (pH
	7.4) <210>) <210>
KI	#5# 0.022 {Ellagic acid}  (#5# at 37°C in 0.1 M Na-K phosphate buffer
	(pH 7.4) <210>) <210>
KI	#5# 0.035 {cyclohexylformamide}  (#5# pH 7.5, 25°C, wild-type enzyme,
	versus benzaldehyde <109>) <109>
KI	#5# 0.037 {Octanoic acid}  (#5# pH 7.5, 25°C, wild-type enzyme, versus
	octanol <109>) <109>
KI	#5# 0.0079 {Vanillin}  (#5# at 37°C in 0.1 M Na-K phosphate buffer (pH
	7.4) <210>) <210>
KI	#5# 0.0156 {syringaldehyde}  (#5# at 37°C in 0.1 M Na-K phosphate
	buffer (pH 7.4) <210>) <210>
KI	#59# 6.4 {4-Methylpyrazole}  <134>
KI	#7# 18.26 {4-Methylpyrazole}  <134>
KI	#8# 0.014 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	versus ethanol <115>) <115>
KI	#8# 0.028 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	versus NAD+ <115>) <115>
KI	#8# 0.0047 {4-androsten-3,17-dione}  (#8# pH 7.3, 37°C, versus
	cyclohexanone <115>) <115>
KI	#8# 0.0047 {5alpha-androstan-17beta-ol-3-one}  (#8# pH 7.3, 37°C,
	versus cyclohexanone <115>) <115>
KI	#8,23# -999 {more}  (#8# inhibition kinetics <115>) <115,122,123>
KI	#98# 1.7 {ethanol}  (#98# isozyme ADH1C, using 1-hydroxymethylpyrene as
	substrate <212>) <212>
KI	#98# 1470 {ethanol}  (#98# isozyme ADH3, using 1-hydroxymethylpyrene as
	substrate <212>) <212>

IC50_VALUE
IC50	#42# 1.7 {Guanidine hydrochloride}  (#42# wild type enzyme <152>) <152>
IC50	#42# 2.2 {Guanidine hydrochloride}  (#42# mutant enzyme N249Y <152>)
	<152>

PI_VALUE
PI	#103# 5.5 (#103# Ta1316 ADH, calculated from amino acid sequence <211>)
	<211>
PI	#16# 8.3 (#16# calculated from sequence <170>) <170>
PI	#80# 6 <117>
PI	#90# 6.3 (#90# calculated from sequence, ADH1 <170>) <170>

IC50_VALUE
IC50	#42# 1.7 {Guanidine hydrochloride}  (#42# wild type enzyme <152>) <152>
IC50	#42# 2.2 {Guanidine hydrochloride}  (#42# mutant enzyme N249Y <152>)
	<152>

///
ID	1.1.1.10
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Cavia porcellus   (#1# SULT1A2 <1,2,6,7>) <1,2,6,7>
PR	#2# Mus musculus   <11,18,19>
PR	#3# Homo sapiens   <11,12,17,18,20,22,29>
PR	#4# Rattus norvegicus   <13,18,20>
PR	#5# Sus scrofa   <18>
PR	#6# Saccharomyces cerevisiae   <5>
PR	#7# Neurospora crassa   <21>
PR	#8# Aspergillus niger   <8,32>
PR	#9# Mesocricetus auratus   <16>
PR	#10# Meyerozyma guilliermondii   <30,31>
PR	#11# Pantoea ananatis   <4>
PR	#12# Erwinia sp.   <3>
PR	#13# Scheffersomyces stipitis   <9,23,24,25,26,27>
PR	#14# hamster   <10>
PR	#15# Candida tenuis   <28>
PR	#16# Homo sapiens Q7Z4W1 SwissProt <14>
PR	#17# Ambrosiozyma monospora Q70FD1 SwissProt <15>
PR	#18# Mus musculus Q91X52 SwissProt <14>
PR	#19# Rattus norvegicus Q920P0 SwissProt <14>
PR	#20# Cavia porcellus Q920N9 SwissProt <14>
PR	#21# Mesocricetus auratus Q91XV4 SwissProt <14>

RECOMMENDED_NAME
RN	L-xylulose reductase


SYSTEMATIC_NAME
SN	xylitol:NADP+ 4-oxidoreductase (L-xylulose-forming)


SYNONYMS
SY	 reductase, L-xylulose
SY	#10,13# xylose reductase <27,30,31>
SY	#13# xylitol dehydrogenase <9>
SY	#13# XDH <23,25>
SY	#13# NADP(+)-dependent xylitol dehydrogenase <23>
SY	#13,15# NAD(P)H-dependent xylose reductase <26,28>
SY	#16# P34H <14>
SY	#2,3,4,16,18,19,20,21# XR <11,12,13,14,17>
SY	#2,3,4,8# More (#8# xylitol:NAD+ 2-oxidoreductase, EC 1.1.1.9, is
	termed as xylitol dehydrogenase <8>; #2,3,4# enzyme belongs to the
	short-chain dehydrogenase/reductase family <11,13,17>) <8,11,13,17>
SY	#3# L-xylulose reductase <22>
SY	#9# dicarbonyl/L-xylulose reductase <16>
SY	#9# DCXR <16>
SY	#9# P31h <16>

CAS_REGISTRY_NUMBER
CR	9028-17-5

REACTION
RE	xylitol + NADP+ = L-xylulose + NADPH + H+ (#14# probably identical with
	EC 1.1.1.5 diacetyl reductase <10>; #3# active site structure <12>; #3#
	active site residues are Cys138, Val143, His146, Trp191, and Met200,
	the catalytic tetrad is formed by Asn107, Ser136, Tyr149, and Lys153,
	substrate binding site structure, enzyme with dual function showing
	L-xylulose reductase activity and dicarbonyl reductase activity, EC
	1.1.1.5 <17>; #18,19,20,21# enzyme with dual function showing
	L-xylulose reductase and dicarbonyl reductase activities <14>; #2,3,16#
	enzyme with dual function showing L-xylulose reductase and dicarbonyl
	reductase activities, it is probably identical with sperm 34 kDa
	protein P34H and diacetyl reductase, EC 1.1.1.5 <11,14>; #4# enzyme
	with dual function showing L-xylulose reductase and dicarbonyl
	reductase activities, it is probably identical with sperm 34 kDa
	protein P34H and diacetyl reductase, EC 1.1.1.5, the amino acid
	residues Ser136, Tyr149, and Lys153 form the catalytic triad <13>; #9#
	immunological analysis revealed that the dicarbonyl/L-xylulose
	reductase is not identical with the sperm protein P26h <16>)

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1,2,3,4,5,14,16,18,19,20,21# liver (#16,19,20,21# high content <14>)
	<1,2,6,7,10,14,18>
ST	#1,2,3,4,5,14,16,18,19,20,21# kidney (#16,18,19,20,21# high content
	<14>; #4# brush border <13>) <7,10,12,13,14,18,19>
ST	#16,18,19,20,21# heart (#16,18,19,21# low expression level <14>) <14>
ST	#16,18,19,20,21# spleen (#16,18,20,21# low expression level <14>) <14>
ST	#16,18,19,20,21# brain (#16,18,19,20,21# low expression level <14>) <14>
ST	#16,18,19,20,21# lung (#20# high content <14>; #16,19,21# low
	expression level <14>) <14>
ST	#16,18,19,20,21# testis (#16,18,19,20,21# low expression level <14>)
	<14>
ST	#3# MOLT-4 cell (#3# expression levels of L-xylulose reductase and its
	mRNA in the T lymphoma cells are markedly enhanced after the exposure
	to 9,10-phenanthrenequinone, and the induction is completely abolished
	by the ROS scavengers. L-Xylulose reductase is upregulated in the
	earlier step of the apoptosis and deteriorates the apoptotic signaling
	through the generation of ROS by the redox cycling of
	9,10-phenanthrenequinone <22>) <22>
ST	#9# epithelium (#9# epididymal <16>) <16>
ST	#9,16,18,19,20,21# epididymis (#18# high content <14>; #19,21# low
	expression level <14>; #9# from caput, corpus, and cauda, activity in
	descending order <16>) <14,16>

LOCALIZATION
LO	#20# cytosol <14>
LO	#3# brush border <12>
LO	#3,4# membrane <12,13>
LO	#9# perinuclear space <16>

NATURAL_SUBSTRATE_PRODUCT
NSP	#17# L-xylulose + NADH = L-xylitol + NAD+ (#17# part of the L-arabinose
	catabolism <15>) {r} <15>
NSP	#2,3,4,5,8# L-xylulose + NADPH + H+ = L-xylitol + NADP+ (#3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #2,3,4,5#
	uronate cycle of glucose metabolism <18>) {r} <8,12,13,17,18>
NSP	#2,3,4,5,8# L-xylulose + NADPH + H+ = L-xylitol + NADP+ (#3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #2,3,4,5#
	uronate cycle of glucose metabolism <18>) <8,12,13,17,18>
NSP	#2,3,4,5,8# L-xylulose + NADPH + H+ = L-xylitol + NADP+ (#3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #2,3,4,5#
	uronate cycle of glucose metabolism <18>) {?} <8,12,13,17,18>
NSP	#4# diacetyl + NAD(P)H = acetoin + NAD(P)+ (#4# detoxification of
	alpha-dicarbonyl compounds <13>) {r} <13>

SUBSTRATE_PRODUCT
SP	#1,2,3,4,5,7,8,10,13,14,15,16,18,19,20,21# L-xylulose + NADPH + H+ =
	L-xylitol + NADP+ (#14# also reduces 2,3-butadione <10>; #3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #3,4#
	L-xylulose reductase activity <13,17>; #16,18,19,20,21# reductase
	activity <14>; #2,3,4,5# uronate cycle of glucose metabolism <18>; #13#
	xylulose reductase has about 50% higher activity during xylose
	consumption than during the coconsumption of glucose and xylose <27>)
	{r} <6,7,8,10,11,12,13,14,17,18,21,25,26,27,28,30,31,32>
SP	#1,2,3,4,5,7,8,10,13,14,15,16,18,19,20,21# L-xylulose + NADPH + H+ =
	L-xylitol + NADP+ (#14# also reduces 2,3-butadione <10>; #3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #3,4#
	L-xylulose reductase activity <13,17>; #16,18,19,20,21# reductase
	activity <14>; #2,3,4,5# uronate cycle of glucose metabolism <18>; #13#
	xylulose reductase has about 50% higher activity during xylose
	consumption than during the coconsumption of glucose and xylose <27>)
	<6,7,8,10,11,12,13,14,17,18,21,25,26,27,28,30,31,32>
SP	#1,2,3,4,5,7,8,10,13,14,15,16,18,19,20,21# L-xylulose + NADPH + H+ =
	L-xylitol + NADP+ (#14# also reduces 2,3-butadione <10>; #3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #3,4#
	L-xylulose reductase activity <13,17>; #16,18,19,20,21# reductase
	activity <14>; #2,3,4,5# uronate cycle of glucose metabolism <18>; #13#
	xylulose reductase has about 50% higher activity during xylose
	consumption than during the coconsumption of glucose and xylose <27>)
	{?} <6,7,8,10,11,12,13,14,17,18,21,25,26,27,28,30,31,32>
SP	#1,3,4,8,11,12,13,14# xylitol + NADP+ = L-xylulose + NADPH + H+ |#11#
	strain DM101 and DM122, product identification is not exact, could also
	be D-xylulose <4>| {r} <1,2,3,4,6,7,8,9,10,20>
SP	#1,3,4,8,11,12,13,14# xylitol + NADP+ = L-xylulose + NADPH + H+ |#11#
	strain DM101 and DM122, product identification is not exact, could also
	be D-xylulose <4>| <1,2,3,4,6,7,8,9,10,20>
SP	#1,4,8,11,16,17,18,19,20,21# More = ? (#8# minimal reductive activity
	also with D-xylulose, D-erythrose and dihydroxyacetone <8>; #1# no
	activity in the mitochondrial fraction with D-xylulose, D-sorbose,
	L-sorbose, L-erythrulose, D-fructose, D-sorbitol, L-arabitol,
	D-gulitol, D-talitol <7>; #11# minimal oxidative activity with
	D-arabitol, mannitol, 1,2-propanediol and 2,3-butanediol <4>; #17#
	NADH-linked enzyme form, no activity with NADPH and NADP+, no activity
	with L-arabinitol, adonitol or ribitol, dulcitol or galactitol,
	D-mannitol, and D-sorbitol, no activity with D-sorbose, L-sorbose,
	D-psicose, and D-fructose <15>; #16,18,19,20,21# substrate specificity
	for dicarbonyl reductase activity, overview <14>; #4# the size and
	hydrophobicity of the amino acid residues involved in substrate
	recognition, i.e. Q137, L143, H146, N190, and W191, is important,
	mutants N190V, N190V/W191S, Q137M/L143F/H146L, and
	N190V/W191S/Q137M/L143F/H146L show reductive activity with
	4-nitroacetophenone, 5beta-androstane-3,17-dione,
	5beta-androstan-17beta-ol-3-one, and
	5beta-androstane-3alpha,17beta-diol, overview <13>; #8# no substrate:
	D-fructose, D-sorbose, L-sorbose, xylitol, D-arabitol, L-arabitol,
	ribitol, D-sorbitol and galactitol <32>) {} <4,7,8,13,14,15,32>
SP	#1,4,8,11,16,17,18,19,20,21# More = ? (#8# minimal reductive activity
	also with D-xylulose, D-erythrose and dihydroxyacetone <8>; #1# no
	activity in the mitochondrial fraction with D-xylulose, D-sorbose,
	L-sorbose, L-erythrulose, D-fructose, D-sorbitol, L-arabitol,
	D-gulitol, D-talitol <7>; #11# minimal oxidative activity with
	D-arabitol, mannitol, 1,2-propanediol and 2,3-butanediol <4>; #17#
	NADH-linked enzyme form, no activity with NADPH and NADP+, no activity
	with L-arabinitol, adonitol or ribitol, dulcitol or galactitol,
	D-mannitol, and D-sorbitol, no activity with D-sorbose, L-sorbose,
	D-psicose, and D-fructose <15>; #16,18,19,20,21# substrate specificity
	for dicarbonyl reductase activity, overview <14>; #4# the size and
	hydrophobicity of the amino acid residues involved in substrate
	recognition, i.e. Q137, L143, H146, N190, and W191, is important,
	mutants N190V, N190V/W191S, Q137M/L143F/H146L, and
	N190V/W191S/Q137M/L143F/H146L show reductive activity with
	4-nitroacetophenone, 5beta-androstane-3,17-dione,
	5beta-androstan-17beta-ol-3-one, and
	5beta-androstane-3alpha,17beta-diol, overview <13>; #8# no substrate:
	D-fructose, D-sorbose, L-sorbose, xylitol, D-arabitol, L-arabitol,
	ribitol, D-sorbitol and galactitol <32>) {} <4,7,8,13,14,15,32>
SP	#11# DL-threitol + NAD+ = D-threose + NADH {r} <4>
SP	#14# DL-threitol + NADP+ = D-erythrulose + NADPH (#14# probably
	identical with erythrulose reductase, EC 1.1.1.162 and diacetyl
	reductase,  EC 1.1.1.5 <10>) {r} <10>
SP	#16,18,19,20,21# 1,4-dibromo-2,3-butanedione + NAD(P)H = ? + NAD(P)+
	(#16,18,19,20,21# dicarbonyl reductase activity, best substrate, NADPH
	is the preferred cofactor, forward reaction is preferred <14>) {r} <14>
SP	#16,18,19,20,21# D-erythrose + NADPH = ? (#16,18,19,20,21# reductase
	activity <14>) {r} <14>
SP	#16,18,19,20,21# D-threose + NADPH = D-threitol + NADP+
	(#16,18,19,20,21# reductase activity <14>) {r} <14>
SP	#16,18,19,20,21# D-xylulose + NADPH + H+ = D-xylitol + NADP+
	(#16,18,19,20,21# reductase activity <14>) {r} <14>
SP	#16,18,19,20,21# DL-glyceraldehyde + NADPH = dihydroxyacetone + NADP+
	(#16,18,19,20,21# reductase activity, forward reaction is highly
	preferred <14>) {r} <14>
SP	#16,18,19,20,21# L-erythrulose + NADPH = ? (#16,18,19,20,21# reductase
	activity <14>) {r} <14>
SP	#16,18,19,20,21# L-threose + NADPH = L-threitol + NADP+
	(#16,18,19,20,21# reductase activity <14>) {r} <14>
SP	#17# L-xylulose + NADH = L-xylitol + NAD+ (#17# part of the L-arabinose
	catabolism <15>) {r} <15>
SP	#17# D-ribulose + NADH = D-arabinitol + NAD+ {r} <15>
SP	#17# D-xylulose + NADH + H+ = D-arabinitol + NAD+ (#17# about 100fold
	lower activity compared to L-xylulose <15>) {r} <15>
SP	#2,3,4,16,18,19,20,21# diacetyl + NAD(P)H = acetoin + NAD(P)+ (#4#
	detoxification of alpha-dicarbonyl compounds <13>; #2,3,4# dicarbonyl
	reductase activity <11,13,17>; #16,18,19,20,21# dicarbonyl reductase
	activity, NADPH is the preferred cofactor <14>) {r} <11,13,14,17>
SP	#3# diacetyl + NADPH + H+ = acetoin + NADP+ {?} <29>
SP	#4# 1,4-dibromo-2,3-butanedione + NADPH = ? + NADP+ (#4# dicarbonyl
	reductase activity <13>) {r} <13>
SP	#7,16,18,19,20,21# D-ribulose + NADPH = D-ribitol + NADP+
	(#16,18,19,20,21# reductase activity <14>) <14,21>
SP	#7,16,18,19,20,21# D-ribulose + NADPH = D-ribitol + NADP+
	(#16,18,19,20,21# reductase activity <14>) {r} <14,21>
SP	#8# D-sorbitol + NADP+ = ? <8>
SP	#8# D-ribulose + NADPH + H+ = D-ribitol + NADP+ <32>

TURNOVER_NUMBER
TN	#16# 0.52 {D-ribulose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.52 {DL-glyceraldehyde}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.52 {L-threose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 3.8 {NADH}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.1 {D-xylulose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 1.5 {NAD+}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 1.5 {NADPH}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 1.6 {Diacetyl}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.65 {acetoin}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.65 {L-xylulose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.65 {NADP+}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.82 {D-threose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.6 {L-Erythrulose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.6 {xylitol}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.43 {D-Erythrose}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.48 {D-Threitol}  (#16# pH 7.0, 25°C <14>) <14>
TN	#16# 0.23 {Dihydroxyacetone}  (#16# pH 7.0, 25°C <14>) <14>
TN	#18# 3.3 {Dihydroxyacetone}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 15 {NADP+}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 34 {NADPH}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 3 {acetoin}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 55 {NAD+}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 7.4 {D-xylulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 17 {xylitol}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 41 {Diacetyl}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 41 {NADH}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 26 {D-ribulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 24 {DL-glyceraldehyde}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 23 {L-Erythrulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 23 {D-threose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18,19# 18 {D-Erythrose}  (#18,19# pH 7.0, 25°C <14>) <14>
TN	#18,19# 16 {L-threose}  (#18,19# pH 7.0, 25°C <14>) <14>
TN	#18,20# 37 {L-xylulose}  (#18,20# pH 7.0, 25°C <14>) <14>
TN	#18,21# 16 {D-Threitol}  (#18,21# pH 7.0, 25°C <14>) <14>
TN	#19# 2-8 {D-threose}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 18 {D-xylulose}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 21 {DL-glyceraldehyde}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 39 {L-xylulose}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 10 {xylitol}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 10 {NADP+}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 25 {Diacetyl}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 19 {D-ribulose}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 41 {NAD+}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 12 {D-Threitol}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 5.1 {Dihydroxyacetone}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19# 23 {NADH}  (#19# pH 7.0, 25°C <14>) <14>
TN	#19,20,21# 6.9 {acetoin}  (#19,20,21# pH 7.0, 25°C <14>) <14>
TN	#19,21# 25 {L-Erythrulose}  (#19,21# pH 7.0, 25°C <14>) <14>
TN	#20# 3.8 {Dihydroxyacetone}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 2-8 {D-Erythrose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 15 {D-Threitol}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 27 {L-threose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 20 {DL-glyceraldehyde}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 20 {xylitol}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 76 {NADH}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 19 {D-xylulose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 26 {NADPH}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 24 {Diacetyl}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 24 {L-Erythrulose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 23 {NADP+}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 32 {D-threose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 7.8 {D-ribulose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#21# 22 {DL-glyceraldehyde}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 27 {NADPH}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 8.7 {Dihydroxyacetone}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 30 {Diacetyl}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 44 {NAD+}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 26 {NADP+}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 31 {D-ribulose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 31 {D-threose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 6.9 {D-xylulose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 23 {D-Erythrose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 23 {L-threose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#3# 0.009 {Diacetyl}  (#3# pH 7.0, 25°C, mutant N107D <17>) <17>
TN	#3# 0.0008 {Diacetyl}  (#3# pH 7.0, 25°C, mutant N107L <17>) <17>
TN	#3# 1.57 {Diacetyl}  (#3# pH 7.0, 25°C, wild-type enzyme <17>) <17>
TN	#4# 0.0005 {NADPH}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
TN	#4# 9.5 {NADP+}  (#4# pH 7.0, 25°C, wild-type enzyme <13>) <13>
TN	#4# 0.0009 {NADPH}  (#4# pH 7.0, 25°C, mutant Y149F <13>) <13>
TN	#4# 0.0006 {NADPH}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
TN	#4,19# 25 {NADPH}  (#19# pH 7.0, 25°C <14>; #4# pH 7.0, 25°C,
	wild-type enzyme <13>) <13,14>
TN	#7# 5.6 {xylitol}  <21>
TN	#7# 119 {D-ribulose}  <21>
TN	#9# 3-6 {L-xylulose}  (#9# pH 7.0, 25°C <14>) <14>
TN	#9# 2-8 {NADH}  (#9# pH 7.0, 25°C <14>) <14>
TN	#9# 2-8 {xylitol}  (#9# pH 7.0, 25°C <14>) <14>

KM_VALUE
KM	#1# 0.29 {L-xylulose}  <1>
KM	#11# 48 {xylitol}  <4>
KM	#12# 72 {xylitol}  <3>
KM	#16# 1.5 {acetoin}  (#16# pH 7.0, 25°C <14>) <14>
KM	#16# 2.5 {L-Erythrulose}  (#16# pH 7.0, 25°C <14>) <14>
KM	#16# 5 {D-ribulose}  (#16# pH 7.0, 25°C <14>) <14>
KM	#16# 25 {xylitol}  (#16# pH 7.0, 25°C <14>) <14>
KM	#16# 18 {D-Threitol}  (#16# pH 7.0, 25°C <14>) <14>
KM	#17# 4.7 {D-ribulose}  (#17# pH 7.0, 30°C, purified recombinant enzyme
	<15>) <15>
KM	#17# 2.7 {D-Arabinitol}  (#17# pH 9.0, 30°C, purified recombinant
	enzyme <15>) <15>
KM	#17# 9.6 {L-xylulose}  (#17# pH 7.0, 30°C, purified recombinant enzyme
	<15>) <15>
KM	#17# 7.2 {L-xylitol}  (#17# pH 9.0, 30°C, purified recombinant enzyme
	<15>) <15>
KM	#18# 9 {acetoin}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 6 {DL-glyceraldehyde}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 15 {xylitol}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 37 {D-Threitol}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 47 {Dihydroxyacetone}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18,21# 12 {D-xylulose}  (#18,21# pH 7.0, 25°C <14>) <14>
KM	#19# 1.5 {NAD+}  (#19# pH 7.0, 25°C <14>) <14>
KM	#19# 4 {D-threose}  (#19# pH 7.0, 25°C <14>) <14>
KM	#19# 11 {xylitol}  (#19# pH 7.0, 25°C <14>) <14>
KM	#19# 16 {D-Threitol}  (#19# pH 7.0, 25°C <14>) <14>
KM	#19# 6 {D-Erythrose}  (#19# pH 7.0, 25°C <14>) <14>
KM	#19# 5.5 {L-Erythrulose}  (#19# pH 7.0, 25°C <14>) <14>
KM	#19,20# 18 {D-xylulose}  (#19,20# pH 7.0, 25°C <14>) <14>
KM	#19,21# 60 {Dihydroxyacetone}  (#19,21# pH 7.0, 25°C <14>) <14>
KM	#2# 0.22 {NADH}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 0.67 {Diacetyl}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 2.4 {D-threose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 5.7 {D-Erythrose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 5.7 {D-ribulose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 4.8 {L-Erythrulose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 5.6 {L-threose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 0.24 {L-xylulose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 0.99 {NAD+}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2,20# 0.005 {NADPH}  (#2,20# pH 7.0, 25°C <14>) <14>
KM	#2,4,9# 0.003 {NADP+}  (#4# pH 7.0, 25°C, wild-type enzyme <13>;
	#2,4,9# pH 7.0, 25°C <14>) <13,14>
KM	#20# 0.05 {L-xylulose}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 0.002 {NADP+}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 2 {L-Erythrulose}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 2 {D-threose}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 1.4 {DL-glyceraldehyde}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 10 {xylitol}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 0.59 {D-Erythrose}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 0.69 {NADH}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 14 {D-Threitol}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 2.9 {L-threose}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 0.52 {Diacetyl}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 36 {Dihydroxyacetone}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 13 {acetoin}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 7.8 {D-ribulose}  (#20# pH 7.0, 25°C <14>) <14>
KM	#21# 40 {xylitol}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21# 34 {D-Threitol}  (#21# pH 7.0, 25°C <14>) <14>
KM	#3# 0.17 {NADH}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.001 {NADP+}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.21 {L-xylulose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.22 {Diacetyl}  (#3# mutant enzyme C138A, in 10 mM potassium
	phosphate buffer <29>) <29>
KM	#3# 2.4 {D-Erythrose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 1.2 {DL-glyceraldehyde}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 1.9 {D-threose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 4.8 {D-xylulose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.85 {NAD+}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 1.6 {Dihydroxyacetone}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 4.2 {L-threose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 26 {Diacetyl}  (#3# pH 7.0, 25°C, mutant N107D <17>) <17>
KM	#3# 0.077 {Diacetyl}  (#3# pH 7.0, 25°C, wild-type enzyme <17>; #3# pH
	7.0, 25°C <14>) <14,17>
KM	#3# 31 {Diacetyl}  (#3# pH 7.0, 25°C, mutant N107L <17>) <17>
KM	#3# 95 {NADPH}  (#3# pH 7.0, 25°C, mutant N107D <17>) <17>
KM	#3# 97 {NADPH}  (#3# pH 7.0, 25°C, mutant N107L <17>) <17>
KM	#3# 0.0945 {Diacetyl}  (#3# wild type enzyme, in 10 mM potassium
	phosphate buffer <29>) <29>
KM	#3,4# 0.002 {NADPH}  (#3# pH 7.0, 25°C, wild-type enzyme <17>; #3# pH
	7.0, 25°C <14>; #4# pH 7.0, 25°C, mutant Y149F <13>) <13,14,17>
KM	#4# 0.05 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, mutant
	S136A <13>) <13>
KM	#4# 0.1 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, mutant K153M
	<13>) <13>
KM	#4# 0.31 {L-xylulose}  (#4# pH 7.0, 25°C, mutant N190V <13>) <13>
KM	#4# 0.013 {L-xylitol}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
KM	#4# 0.005 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, wild-type
	enzyme <13>) <13>
KM	#4# 0.0046 {NADPH}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
KM	#4# 0.14 {L-xylulose}  (#4# pH 7.0, 25°C, wild-type enzyme and mutant
	L143F <13>) <13>
KM	#4# 0.78 {Diacetyl}  (#4# pH 7.0, 25°C, wild-type enzyme <13>) <13>
KM	#4# 0.23 {L-xylulose}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 0.011 {L-xylitol}  (#4# pH 7.0, 25°C, wild-type enzyme <13>) <13>
KM	#4# 1.2 {Diacetyl}  (#4# pH 7.0, 25°C, mutant H146L <13>) <13>
KM	#4# 3 {Diacetyl}  (#4# pH 7.0, 25°C, mutant Q137M <13>) <13>
KM	#4# 0.007 {NADPH}  (#4# pH 7.0, 25°C, wild-type enzyme <13>; #4# pH
	7.0, 25°C <14>) <13,14>
KM	#4# 0.085 {L-xylitol}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
KM	#4# 0.33 {L-xylulose}  (#4# pH 7.0, 25°C, mutant Q137M <13>) <13>
KM	#4# 0.0013 {NADP+}  (#4# pH 7.0, 25°C, mutant Y149F <13>) <13>
KM	#4# 0.36 {NADH}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 8.3 {L-threose}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 1.1 {Diacetyl}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 2.7 {Diacetyl}  (#4# pH 7.0, 25°C, mutant
	N190V/W191S/Q137M/L143F/H146L <13>) <13>
KM	#4# 2.7 {DL-glyceraldehyde}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 11 {Diacetyl}  (#4# pH 7.0, 25°C, mutant Q137M/L143F <13>) <13>
KM	#4# 0.053 {NADPH}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
KM	#4# 16 {Diacetyl}  (#4# pH 7.0, 25°C, mutant N190V/W191S <13>) <13>
KM	#4# 2.6 {Diacetyl}  (#4# pH 7.0, 25°C, mutant N190V <13>) <13>
KM	#4# 0.092 {L-xylulose}  (#4# pH 7.0, 25°C, mutant H146L <13>) <13>
KM	#4# 3.6 {L-xylulose}  (#4# pH 7.0, 25°C, mutant Q137M/L143F <13>) <13>
KM	#4# 42 {Diacetyl}  (#4# pH 7.0, 25°C, mutant W191S <13>) <13>
KM	#4# 9.6 {Diacetyl}  (#4# pH 7.0, 25°C, mutant Q137M/L143F/H146L <13>)
	<13>
KM	#4# 5.2 {Diacetyl}  (#4# pH 7.0, 25°C, mutant W191F <13>) <13>
KM	#4# 6.2 {Diacetyl}  (#4# pH 7.0, 25°C, mutant L143F <13>) <13>
KM	#4# 7.2 {L-xylulose}  (#4# pH 7.0, 25°C, mutant W191F <13>) <13>
KM	#4# 0.0099 {L-xylitol}  (#4# pH 7.0, 25°C, mutant Y149F <13>) <13>
KM	#4# 0.139 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, mutant
	Y149F <13>) <13>
KM	#4# 0.117 {NADP+}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
KM	#4# 6.9 {acetoin}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 0.00067 {NADP+}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
KM	#4,9# 6.3 {D-ribulose}  (#4,9# pH 7.0, 25°C <14>) <14>
KM	#7# 0.0026 {NADPH}  <21>
KM	#7# 150 {D-ribulose}  <21>
KM	#7# 0.153 {NADP+}  <21>
KM	#7# 1239 {xylitol}  <21>
KM	#8# 0.03 {NADPH}  <8>
KM	#8# 0.13 {NADP+}  <8>
KM	#8# 17 {L-xylulose}  <8>
KM	#8# 25 {L-xylulose}  (#8# pH 7.0, 22°C <32>) <32>
KM	#8# 925 {xylitol}  <8>
KM	#9# 0.26 {L-xylulose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.003 {NADPH}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.2 {Diacetyl}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.12 {NADH}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 3.3 {acetoin}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 4.3 {L-threose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 2.7 {D-threose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.91 {NAD+}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 3.9 {D-Erythrose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 2.9 {L-Erythrulose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 5.1 {DL-glyceraldehyde}  (#9# pH 7.0, 25°C <14>) <14>

PH_OPTIMUM
PHO	#1# 7.5 (#1# approximately <6>) <6>
PHO	#1,2,3,4,7,16,17,18,19,20,21# 7 (#2,3,4,16,18,19,20,21# assay at
	<11,13,14,17>; #7# reductase activity <21>; #17# forward, reduction
	reaction <15>) <1,11,13,14,15,17,21>
PHO	#7,17# 9 (#7# oxidase activity <21>; #17# reverse, oxidation reaction
	<15>) <15,21>
PHO	#8# 6.5 (#8# reduction of L-xylulose <8>) <8>
PHO	#8# 10-11 (#8# oxidation of xylitol <8>) <8>

PH_RANGE
PHR	#7# 4.5-8.5 (#7# pH 4.5: about 55% of maximal activity, pH 8.5: about
	70% of maximal activity, reductase activity <21>) <21>
PHR	#7# 7-10.5 (#7# pH 7.0: about 40% of maximal activity, pH 10.5: about
	60% of maximal activity, oxidase activity <21>) <21>
PHR	#8# 5-8.5 (#8# reduction of L-xylulose <8>) <8>
PHR	#8# 8-11.5 (#8# oxidation of xylitol <8>) <8>

SPECIFIC_ACTIVITY
SA	#11# 0.23 (#11# xylitol dehydrogenase activity <4>) <4>
SA	#20# 143.0 (#20# purified native enzyme, L-xylulose reductase activity
	<14>) <14>
SA	#21# 642.0 (#21# purified native enzyme, L-xylulose reductase activity
	<14>) <14>
SA	#8# 1.4 (#8# substrate ribulose, pH 7.0, 22°C <32>) <32>
SA	#8# 1.0 (#8# substrate xylitol, pH 7.0, 22°C <32>) <32>
SA	#8# 200.0 (#8# L-xylulose reduction, NADPH <8>) <8>
SA	#8# 1.8 (#8# substrate L-xylulose, pH 7.0, 22°C <32>) <32>
SA	#8# 33.0 (#8# xylitol oxidation, NADP+ <8>) <8>

TEMPERATURE_OPTIMUM
TO	#17# 30 (#17# assay at <15>) <15>
TO	#2,3,4,16,18,19,20,21# 25 (#2,3,4,16,18,19,20,21# assay at
	<11,13,14,17>) <11,13,14,17>
TO	#7# 37 (#7# reductase activity <21>) <21>

TEMPERATURE_RANGE
TR	#7# 15-55 (#7# 15°C: about 65% of maximal activity, 55°C: about 60%
	of maximal activity, reductase activity <21>) <21>

COFACTOR
CF	#1,2,3,4,6,7,8,16,18,19,20,21# NADP+ (#1# B-specific hydrogen transfer
	from xylitol to NADP+ <2>; #1# much more effective than NAD+ <6>; #3#
	binding structure determination <17>; #16,18,19,20,21# preferred
	cofactor, reverse reaction <14>) <2,5,6,8,11,13,14,17,20,21>
CF	#1,6,8,11,13,16,17,18,19,20,21# NAD+ (#1# much less effective than
	NADP+ <6>; #1,13# preference for, coenzyme-binding domain is a
	beta-alpha-beta-fold typical for NAD+ dehydrogenases <2,9>; #8# no
	activity with <8>; #17# specific for, no activity with NADP+ <15>)
	<2,4,5,6,8,9,14,15>
CF	#1,7,8# more (#8# determination of Ki of NADP+ and NADPH in competition
	with each other <8>; #7# the enzyme does not accept NAD+ <21>; #8# no
	activitiy with NADH <32>) <1,8,21,32>
CF	#16,17,18,19,20,21# NADH (#17# specific for no activity with NADPH
	<15>) <14,15>
CF	#2,3,4,5,8,10,13,15,16,18,19,20,21# NADPH (#10# dependent on <30,31>;
	#8# preference for <8>; #3# binding structure determination <17>;
	#16,18,19,20,21# preferred cofactor, forward reaction <14>; #13# has a
	higher affinity for NADPH than for NADH <26>)
	<8,11,12,13,14,17,18,20,25,26,27,28,29,30,31,32>

INHIBITORS
IN	#1# Fluoride (#1# 50 mM <7>) <7>
IN	#1# iodoacetate (#1# not inhibitory <1>; #1# complete inhibition of
	L-xylulose reductive activity at 5 mM <6>) <1,6>
IN	#1# p-chloromercuribenzoate <1>
IN	#1# Phosphate buffer <7>
IN	#1# aminopyrine (#1# 70 mM <7>) <7>
IN	#1,3,10,16,18,19,21# more (#1# not: EDTA <1>; #21# acetic acid is a
	poor inhibitor <14>; #18# acetic acid, acetoacetic acid, 3-OH-butyric
	acid, and octanoic acid are poor inhibitors <14>; #19# acetic acid,
	oxaloacetic acid, and octanoic acid are poor inhibitors <14>; #16#
	acetic acid, threonic acid, and octanoic acid are poor inhibitors <14>;
	#3# modelling of structure-based inhibitor binding into the active site
	<12>; #10# the level of xylose reductase decreases when the initial
	xylose concentration is increased from 30 to 70 g/l <31>) <1,12,14,31>
IN	#16,18,19,21# Hexanoic acid (#16# 50% inhibition at 0.10 mM <14>; #21#
	50% inhibition at 0.40 mM <14>; #19# 50% inhibition at 0.42 mM <14>;
	#18# 50% inhibition at 1.1 mM <14>) <14>
IN	#16,18,19,21# pentanoic acid (#19# 50% inhibition at 0.5 mM <14>; #16#
	50% inhibition at 0.15 mM <14>; #21# 50% inhibition at 0.20 mM <14>;
	#18# 50% inhibition at 0.38 mM <14>) <14>
IN	#16,18,19,21# Propionic acid (#21# 50% inhibition at 0.096 mM <14>;
	#19# 50% inhibition at 0.13 mM <14>; #18# 50% inhibition at 0.17 mM
	<14>; #16# 50% inhibition at 0.38 mM <14>) <14>
IN	#16,18,19,21# Pyruvic acid (#18# 50% inhibition at 1.5 mM <14>; #16#
	50% inhibition at 0.50 mM <14>; #21# 50% inhibition at 0.88 mM <14>;
	#19# 50% inhibition at 1.0 mM <14>) <14>
IN	#16,18,19,21# heptanoic acid (#19# 50% inhibition at 2.5 mM <14>; #21#
	50% inhibition at 1.4 mM <14>; #16# 50% inhibition at 0.38 mM <14>;
	#18# 50% inhibition at 2.0 mM <14>) <14>
IN	#16,18,21# oxaloacetic acid (#18,21# 50% inhibition at 2.5 mM <14>;
	#16# 50% inhibition at 0.91 mM <14>) <14>
IN	#16,19,21# 3-hydroxybutyric acid (#21# 50% inhibition at 1.0 mM <14>;
	#16# 50% inhibition at 1.1 mM <14>; #19# 50% inhibition at 2.0 mM <14>)
	<14>
IN	#16,19,21# acetoacetic acid (#19# 50% inhibition at 2.5 mM <14>; #21#
	50% inhibition at 1.8 mM <14>; #16# 50% inhibition at 0.63 mM <14>) <14>
IN	#18,19,21# threonic acid (#18# 50% inhibition at 1.5 mM <14>; #21# 50%
	inhibition at 0.75 mM <14>; #19# 50% inhibition at 1.9 mM <14>) <14>
IN	#21# Octanoic acid (#21# 50% inhibition at 2.5 mM <14>) <14>
IN	#3# cysteine (#3# the addition of cysteine (more than 2 mM) inactivates
	human L-xylulose reductase and is accompanied by a 10fold decrease in
	catalytic efficiency, the activity of the cysteine-inactivated enzyme
	is not recovered by the addition of 10 mM dithiothreitol and
	2-mercaptoethanol <29>) <29>
IN	#3# Potassium phosphate (#3# when the purified enzyme containing 2 mM
	2-mercaptoethanol is diluted with 10 mM potassium phosphate pH 7.0, its
	diacetyl reductase activity is gradually decreased <29>) <29>
IN	#3,4# 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid benzyloxyamide
	(#4# IC50: 0.00023 mM for wild-type enzyme, 0.0019 mM for mutant enzyme
	L143F, 0.0018 mM for mutant enzyme H146L, 0.0029 mM for mutant enzyme
	W191S, 0.00079 mM for mutant enzyme W191F <20>) <20>
IN	#3,4,16,18,19,21# n-butyric acid (#18# 50% inhibition at 0.05 mM <14>;
	#21# 50% inhibition at 0.026 mM <14>; #19# 50% inhibition at 0.052 mM
	<14>; #16# 50% inhibition at 0.064 mM <14>; #3# binds to the active
	site of the enzyme, complex structure determination and analysis <12>;
	#4# specific, binds to the enzyme-NADP+ complex, the mutant enzymes
	show altered sensitivity to inhibition, overview <13>) <12,13,14>
IN	#4# 4-methylthiophene-2-carboxylic acid
	N'-(2,3,3-trichloroacryloyl)-hydrazide (#4# IC50: 0.0003 mM for
	wild-type enzyme, 0.00056 mM for mutant enzyme L143F, 0.002 mM for
	mutant enzyme H146L, 0.0002 mM for mutant enzyme W191S, 0.0022 mM for
	mutant enzyme W191F <20>) <20>

KI_VALUE
KI	#3# 0.00037 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#3# competitive with respect to xylitol <20>) <20>
KI	#3# 0.00044 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#3# uncompetitive with respect to NADPH <20>) <20>

METALS_IONS
ME	#1,17# Mg2+ <6,15>

MOLECULAR_WEIGHT
MW	#11# 136000 (#11# non-denaturing PAGE <4>) <4>
MW	#12# 102000 (#12# 4D2P, nondenaturing PAGE <3>) <3>
MW	#8# 250000 (#8# gel filtration <8>) <8>

SUBUNITS
SU	#2# More (#2# the dimeric form is inactive <11>) <11>
SU	#2,3,4,5,14# tetramer (#14# 4 * 40000, about, sequence calculation
	<10>; #2,3# amino acid residues Trp242, Glu238, Arg203, and Cys244 are
	important for tetramer formation <11>) <10,11,18,20>
SU	#3# dimer (#3# x-ray crystallography <29>) <29>
SU	#4,9# ? (#9# x * 31000, SDS-PAGE <16>; #4# x * 26500 <13>) <13,16>
SU	#8# octamer (#8# 8 * 32000, SDS-PAGE <8>) <8>

APPLICATION
AP	#3# pharmacology (#3# enzyme is a target for design and development of
	potent and specific structure-based inhibitors binding in the active
	site <12>) <12>

ENGINEERING
EN	#13# more (#13# several mutants per site-directed mutagenesis to change
	the coenzyme binding specificity, mutants showed reduced NAD+
	specificity <9>) <9>
EN	#13# S96C/S99C/Y102C/D207A/I208R/F209S (#13# mutation produces a
	further 4fold improvement in the kcat/Km for NADP+ compared to mutant
	enzyme D207/I208R/F209S <24>) <24>
EN	#13# D207/I208R/F209S (#13# kcat/Km of mutant enzyme for NAD+ dropps
	15fold compared with the native enzyme, kcat/Km for NADP+ increases up
	to 4100fold <24>) <24>
EN	#2# D238E (#2# site-directed mutagenesis, mutant exists in dimeric form
	at low temperature like the wild-type enzyme resulting in cold
	inactivation <11>) <11>
EN	#2# L242W (#2# site-directed mutagenesis, mutation leads to partial
	prevention of cold inactivation, mutant exists in dimeric and
	tetrameric form at low temperature <11>) <11>
EN	#2# T244C (#2# site-directed mutagenesis, mutant exists in dimeric form
	at low temperature like the wild-type enzyme resulting in cold
	inactivation <11>) <11>
EN	#2# D238E/L242W (#2# site-directed mutagenesis, mutation leads to
	complete prevention of cold inactivation, mutant exists in tetrameric
	form at low temperature <11>) <11>
EN	#2# L242W/T244C (#2# site-directed mutagenesis, double mutation leads
	to partial prevention of cold inactivation, mutant exists in dimeric
	and tetrameric form at low temperature <11>) <11>
EN	#2# D238E/L242W/T244C (#2# site-directed mutagenesis, double mutation
	leads to partial prevention of cold inactivation, mutant exists in
	dimeric and tetrameric form at low temperature <11>) <11>
EN	#3# N107L (#3# site-directed mutagenesis, active site residue mutant,
	inactive <17>) <17>
EN	#3# N107D (#3# site-directed mutagenesis, active site residue mutant,
	inactive <17>) <17>
EN	#4# K153M (#4# site-directed mutagenesis, active site mutant, complete
	loss of activity <13>) <13>
EN	#4# Y149F (#4# site-directed mutagenesis, active site mutant, complete
	loss of activity <13>) <13>
EN	#4# W191F (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 3.4fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 7.3fold higher than wild-type
	value <20>) <13,20>
EN	#4# S136A (#4# site-directed mutagenesis, active site mutant, complete
	loss of activity <13>) <13>
EN	#4# N190V/W191S (#4# site-directed mutagenesis, almost complete loss of
	L-xylulose reductase activity <13>) <13>
EN	#4# Q137M/L143F (#4# site-directed mutagenesis, increased Km for
	L-xylulose compared to the wild-type <13>) <13>
EN	#4# Q137M/L143F/H146L (#4# site-directed mutagenesis, almost complete
	loss of L-xylulose reductase activity, mutant shows 3-ketosteroid
	reductase activity <13>) <13>
EN	#4# N190V/W191S/Q137M/L143F/H146L (#4# site-directed mutagenesis,
	almost complete loss of L-xylulose reductase activity, mutant shows
	high 3-ketosteroid reductase activity <13>) <13>
EN	#4# Q137M (#4# site-directed mutagenesis, altered activity, stable
	against cold inactivation <13>) <13>
EN	#4# Q137M/F241L (#4# site-directed mutagenesis, altered activity,
	sensitive to cold inactivation like the wild-type enzyme <13>) <13>
EN	#4# L143F (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 8.3fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 1.9fold higher than wild-type
	value <20>) <13,20>
EN	#4# H146L (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 7.8fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 6.7fold higher than wild-type
	value <20>) <13,20>
EN	#4# N190V (#4# site-directed mutagenesis, altered activity <13>) <13>
EN	#4# W191S (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 13fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 1.5fold lower than wild-type
	value <20>) <13,20>

CLONED
CL	#2# (expression of wild-type and mutant enzymes in Escherichia coli
	strain BL21(DE3)) <11>
CL	#2# (transgenic mice over-expressing dicarbonyl/L-xylulose reductase
	gene crossed with KK-A(y) diabetic model mice serve as an animal model
	for the metabolism of renal carbonyl compounds) <19>
CL	#3# (expression of wild-type and mutant enzymes in Escherichia coli)
	<17>
CL	#3# (expressed in Escherichia coli BL21 (DE3) cells) <29>
CL	#4# (expression of wild-type and mutant enzymes in Escherichia coli)
	<13>
CL	#7# (expressed in Escherichia coli as a His6 tag fusion protein) <21>
CL	#8# (expression in Saccharomyces cerevisiae) <32>
CL	#11# (Tn5 transposon transfer) <4>
CL	#13# (expressed in Saccharomyces cerevisiae) <27>
CL	#13# (a recombinant Saccharomyces cerevisiae strain D-XR/ARSdR/XK, in
	which protein engineered NADP+-dependent XDH is expressed, shows 40%
	increased ethanol production and 23% decrease in xylitol excretion as
	compared with the reference strain D-XR/XDH/XK expressing the wild-type
	XDH) <23>
CL	#13# (expression of Pichia stipitis mutated XYL2 (D207/I208R/F209S or
	XYL2 S96C/S99C/Y102C/D207A/I208R/F209S) in Saccharomyces cerevisiae)
	<24>
CL	#13# (expressed in Saccharomyces cerevisiae strain MA-R4) <25>
CL	#13# (expressed in Saccharomyces cerevisiae strains MA-N2, MA-N3,
	MA-N4, and MA-N5) <26>
CL	#15# (expressed in Saccharomyces cerevisiae) <28>
CL	#17# (construction of a cDNA library, DNA sequence determination and
	analysis, subcloning in Escherichia coli DH5alpha, overexpression as
	His-tagged enzyme in Saccharomyces cerevisiae strain CEN.PK2) <15>
CL	#20# (DNA sequence determination and analysis, expression in
	Escherichia coli strain BL21(DE3)) <14>
CL	#274945# (DNA sequence determination and analysis, expression in
	Escherichia coli strain BL21(DE3)) <14>

CRYSTALLIZATION
CR	#2# <18>
CR	#3# <18>
CR	#3# (structure of the biological tetramer of human L-xylulose reductase
	in complex with NADP+ and the competitive inhibitor
	4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid benzyloxyamide, vapor
	diffusion method) <20>
CR	#3# (vapour diffusion method, using 15% PEG 8000, 0.05 M potassium
	phosphate and 0.1 M MES buffer, pH 6.5) <29>
CR	#16# (18 mg/ml purified enzyme complexed with NADPH, in 10 mM Tris-HCl,
	pH 7.5, 2 mM 2-mercaptoethanol, 20% glycerol, replacement buffer is 10
	mM Tris-HCl, pH 7.5, 2 mM 2-mercaptoethanol, mixed with 12.9 mM NADPH,
	in a molar ratio of enzyme and cofactor of 1:8, equal volume of 0.003
	ml of enzyme complex mixture and well solution, containing 15% PEG
	8000, 50 mM potassium phosphate, and 0.1 M MES, pH 6.5, 1 week, X-ray
	diffraction structure determination and analysis, molecular replacement
	method, 1.96 A resolution, molecular modeling) <17>
CR	#16# (crystal structure analysis and modelling) <11>

PURIFICATION
PU	#1# (partial) <1>
PU	#2# (recombinant wild-type and mutant enzymes from Escherichia coli)
	<11>
PU	#3# <29>
PU	#7# (recombinant enzyme) <21>
PU	#8# <8>
PU	#9# (recombinant enzyme from Escherichia coli, native from liver) <14>
PU	#11# (partial from strain DM101) <4>
PU	#12# (strain 4D2P, partial) <3>
PU	#14# <10>
PU	#17# (recombinant His-tagged enzyme from Saccharomyces cerevisiae by
	nickel affinity chromatography) <15>
PU	#20# (recombinant enzyme from Escherichia coli, native from liver) <14>
PU	#274945# (recombinant enzyme from Escherichia coli) <14>

GENERAL_STABILITY
GS	#1# (inactivation during dialysis) <6>

PH_STABILITY
PHS	#1# 9 (#1# room temperature, several h stable <6>) <6>
PHS	#1# 4 (#1# 2°C, 2 h stable <6>) <6>

STORAGE_STABILITY
SS	#1# (2°C, aqueous solution, many weeks) <6>
SS	#1# (frozen, ammonium sulfate precipitate, several days) <1>
SS	#1# (0°C, mitochondria, 0.15 M KCl- 0.01 M NaHCO3, minimum 2 days) <7>
SS	#8# (4°C, Tris-HCl 20 mM, pH 7.0, at leat several weeks) <8>

TEMPERATURE_STABILITY
TS	#1# 50 (#1# 20 min stable <6>) <6>
TS	#2,3,4,5# -999 (#2# dissociation into inactive dimers at low
	temperatures <11>; #3# stable at low temperatures <11>; #2,4,5# rapidly
	dissociates into the inactive dimeric form at low temperature <18>)
	<11,18>

REFERENCE
RF	<1> Hickman, J.; Ashwell, G.: A sensitive and stereospecific enzymatic
	assay for xylulose. J. Biol. Chem. (1959) 234, 758-761.
	{Pubmed:13654257} (c)
RF	<2> Alizade, M.A.; Brendel, K.; Gaede, K.: Chirality of
	xylitol-oxidizing enzymes from mammalian liver. FEBS Lett. (1976) 67,
	41-44. {Pubmed:8339} (c)
RF	<3> Doten, R.C.; Mortlock, R.P.: Inducible xylitol dehydrogenases in
	enteric bacteria. J. Bacteriol. (1985) 162, 845-848. {Pubmed:3886639}
	(c)
RF	<4> Doten, R.C.; Mortlock, R.P.: Characterization of xylitol-utilizing
	mutants of Erwinia uredovora. J. Bacteriol. (1985) 161, 529-533.
	{Pubmed:2981816}
RF	<5> Lowe, C.R.; Mosbach, K.; Dean, P.D.G.: Some applications of
	insolubilised cofactors to the purification of pyridine
	nucleotide-dependent dehydrogenases. Biochem. Biophys. Res. Commun.
	(1972) 48, 1004-1010. {Pubmed:4404621}
RF	<6> Hollmann, S.; Touster, O.: The L-xylulose-xylitol enzyme and other
	polyol dehydrogenases of guinea pig liver mitochondria. J. Biol. Chem.
	(1957) 225, 87-102. {Pubmed:13416220}
RF	<7> Touster, O.; Reynolds, V.H.; Hutcheson, R.M.: The reduction of
	L-xylulose to xylitol by guinea pig liver mitochondria. J. Biol. Chem.
	(1954) 221, 697-709. {Pubmed:}
RF	<8> Witteveen, C.F.B.; Weber, F.; Busink, R.; Visser, J.: Isolation and
	characterization of two xylitol dehydrogenases from Aspergillus niger.
	Microbiology (1994) 140, 1679-1685. {Pubmed:}
RF	<9> Metzger, M.H.; Hollenberg, C.P.: Amino acid substitutions in the
	yeast Pichia stipitis xylitol dehydrogenase coenzyme-binding domain
	affect the coenzyme specificity. Eur. J. Biochem. (1995) 228, 50-54.
	{Pubmed:7883010}
RF	<10> Ishikura, S.; Isaji, T.; Usami, N.; Kitahara, K.; Nakagawa, J.;
	Hara, A.: Molecular cloning, expression and tissue distribution of
	hamster diacetyl reductase. Identity with L-xylulose reductase. Chem.
	Biol. Interact. (2001) 130-132, 879-889. {Pubmed:11306103}
RF	<11> Ishikura, S.; Usami, N.; El-Kabbani, O.; Hara, A.: Structural
	determinant for cold inactivation of rodent L-xylulose reductase.
	Biochem. Biophys. Res. Commun. (2003) 308, 68-72. {Pubmed:12890481}
RF	<12> Carbone, V.; Darmanin, C.; Ishikura, S.; Hara, A.; El-Kabbani, O.:
	Structure-based design of inhibitors of human L-xylulose reductase
	modelled into the active site of the enzyme. Bioorg. Med. Chem. Lett.
	(2003) 13, 1469-1474. {Pubmed:12668014}
RF	<13> Ishikura, S.; Isaji, T.; Usami, N.; Nakagawa, J.; El-Kabbani, O.;
	Hara, A.: Identification of amino acid residues involved in substrate
	recognition of L-xylulose reductase by site-directed mutagenesis. Chem.
	Biol. Interact. (2003) 143-144, 543-550. {Pubmed:12604240}
RF	<14> Nakagawa, J.; Ishikura, S.; Asami, J.; Isaji, T.; Usami, N.; Hara,
	A.; Sakurai, T.; Tsuritani, K.; Oda, K.; Takahashi, M.; Yoshimoto, M.;
	Otsuka, N.; Kitamura, K.: Molecular characterization of mammalian
	dicarbonyl/L-xylulose reductase and its localization in kidney. J.
	Biol. Chem. (2002) 277, 17888-17891. {Pubmed:11882650}
RF	<15> Verho, R.; Putkonen, M.; Londesborough, J.; Penttilä, M.;
	Richard, P.: A novel NADH-linked L-xylulose reductase in the
	L-arabinose catabolic pathway of yeast. J. Biol. Chem. (2004) 279,
	14746-14751. {Pubmed:14736891}
RF	<16> Saint-Cyr, A.; Legare, C.; Frenette, G.; Gaudreault, C.; Sullivan,
	R.: P26h and dicarbonyl/L-xylulose reductase are two distinct proteins
	present in the hamster epididymis. Mol. Reprod. Dev. (2004) 69,
	137-145. {Pubmed:15293214}
RF	<17> El-Kabbani, O.; Ishikura, S.; Darmanin, C.; Carbone, V.; Chung,
	R.P.T.; Usami, N.; Hara, A.: Crystal structure of human L-xylulose
	reductase holoenzyme: probing the role of Asn107 with site-directed
	mutagenesis. Proteins (2004) 55, 724-732. {Pubmed:15103634}
RF	<18> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian
	reductases for xenobiotic carbonyl compounds. Drug Metab.
	Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389}
RF	<19> Sudo, T.; Ishii, A.; Asami, J.; Uematsu, Y.; Saitoh, M.; Nakamura,
	A.; Tada, N.; Ohnuki, T.; Komurasaki, T.; Nakagawa, J.: Transgenic mice
	over-expressing dicarbonyl/L-xylulose reductase gene crossed with
	KK-A(y) diabetic model mice: an animal model for the metabolism of
	renal carbonyl compounds. Exp. Anim. (2005) 54, 385-394.
	{Pubmed:16365515}
RF	<20> El-Kabbani, O.; Carbone, V.; Darmanin, C.; Ishikura, S.; Hara, A.:
	Structure of the tetrameric form of human L-xylulose reductase: probing
	the inhibitor-binding site with molecular modeling and site-directed
	mutagenesis. Proteins (2005) 60, 424-432. {Pubmed:15906319}
RF	<21> Nair, N.; Zhao, H.: Biochemical characterization of an L-Xylulose
	reductase from Neurospora crassa. Appl. Environ. Microbiol. (2007) 73,
	2001-2004. {Pubmed:17261518}
RF	<22> Matsunaga, T.; Kamiya, T.; Sumi, D.; Kumagai, Y.; Kalyanaraman,
	B.; Hara, A.: L-Xylulose reductase is involved in
	9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.
	Free Radic. Biol. Med. (2008) 44, 1191-1202. {Pubmed:18206670}
RF	<23> Matsushika, A.; Watanabe, S.; Kodaki, T.; Makino, K.; Sawayama,
	S.: Bioethanol production from xylose by recombinant Saccharomyces
	cerevisiae expressing xylose reductase, NADP(+)-dependent xylitol
	dehydrogenase, and xylulokinase. J. Biosci. Bioeng. (2008) 105,
	296-299. {Pubmed:18397783}
RF	<24> Hou, J.; Shen, Y.; Li, X.P.; Bao, X.M.: Effect of the reversal of
	coenzyme specificity by expression of mutated Pichia stipitis xylitol
	dehydrogenase in recombinant Saccharomyces cerevisiae. Lett. Appl.
	Microbiol. (2007) 45, 184-189. {Pubmed:17651216}
RF	<25> Matsushika, A.; Inoue, H.; Watanabe, S.; Kodaki, T.; Makino, K.;
	Sawayama, S.: Efficient bioethanol production by a recombinant
	flocculent Saccharomyces cerevisiae strain with a genome-integrated
	NADP+-dependent xylitol dehydrogenase gene. Appl. Environ. Microbiol.
	(2009) 75, 3818-3822. {Pubmed:19329659}
RF	<26> Matsushika, A.; Watanabe, S.; Kodaki, T.; Makino, K.; Inoue, H.;
	Murakami, K.; Takimura, O.; Sawayama, S.: Expression of protein
	engineered NADP+-dependent xylitol dehydrogenase increases ethanol
	production from xylose in recombinant Saccharomyces cerevisiae. Appl.
	Microbiol. Biotechnol. (2008) 81, 243-255. {Pubmed:18751695}
RF	<27> Hou, J.; Vemuri, G.N.; Bao, X.; Olsson, L.: Impact of
	overexpressing NADH kinase on glucose and xylose metabolism in
	recombinant xylose-utilizing Saccharomyces cerevisiae. Appl. Microbiol.
	Biotechnol. (2009) 82, 909-919. {Pubmed:19221731}
RF	<28> Krahulec, S.; Klimacek, M.; Nidetzky, B.: Engineering of a matched
	pair of xylose reductase and xylitol dehydrogenase for xylose
	fermentation by Saccharomyces cerevisiae. Biotechnol. J. (2009) 4,
	684-694. {Pubmed:19452479}
RF	<29> Zhao, H.T.; Endo, S.; Ishikura, S.; Chung, R.; Hogg, P.J.; Hara,
	A.; El-Kabbani, O.: Structure/function analysis of a critical disulfide
	bond in the active site of L-xylulose reductase. Cell. Mol. Life Sci.
	(2009) 66, 1570-1579. {Pubmed:19337691}
RF	<30> Branco, R.; dos Santos, J.; Sarrouh, B.; Rivaldi, J.; Pessoa Jr.,
	A.; da Silva, S.: Profiles of xylose reductase, xylitol dehydrogenase
	and xylitol production under different oxygen transfer volumetric
	coefficient values. J. Chem. Technol. Biotechnol. (2009) 84, 326-330.
	{Pubmed:}
RF	<31> Gurpilhares, D.B.; Hasmann, F.A.; Pessoa, A.; Roberto, I.C.: The
	behavior of key enzymes of xylose metabolism on the xylitol production
	by Candida guilliermondii grown in hemicellulosic hydrolysate. J. Ind.
	Microbiol. Biotechnol. (2009) 36, 87-93. {Pubmed:18830730}
RF	<32> Mojzita, D.; Vuoristo, K.; Koivistoinen, O.M.; Penttilae, M.;
	Richard, P.: The true L-xylulose reductase of filamentous fungi
	identified in Aspergillus niger. FEBS Lett. (2010) 584, 3540-3544.
	{Pubmed:20654618}

KI_VALUE
KI	#3# 0.00037 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#3# competitive with respect to xylitol <20>) <20>
KI	#3# 0.00044 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#3# uncompetitive with respect to NADPH <20>) <20>

IC50_VALUE
IC50	#4# 0.0003 {4-methylthiophene-2-carboxylic acid
	N'-(2,3,3-trichloroacryloyl)-hydrazide}  (#4# IC50: 0.0003 mM for
	wild-type enzyme, 0.00056 mM for mutant enzyme L143F, 0.002 mM for
	mutant enzyme H146L, 0.0002 mM for mutant enzyme W191S, 0.0022 mM for
	mutant enzyme W191F <20>) <20>
IC50	#4# 0.00023 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#4# IC50: 0.00023 mM for wild-type enzyme, 0.0019 mM
	for mutant enzyme L143F, 0.0018 mM for mutant enzyme H146L, 0.0029 mM
	for mutant enzyme W191S, 0.00079 mM for mutant enzyme W191F <20>) <20>

IC50_VALUE
IC50	#4# 0.0003 {4-methylthiophene-2-carboxylic acid
	N'-(2,3,3-trichloroacryloyl)-hydrazide}  (#4# IC50: 0.0003 mM for
	wild-type enzyme, 0.00056 mM for mutant enzyme L143F, 0.002 mM for
	mutant enzyme H146L, 0.0002 mM for mutant enzyme W191S, 0.0022 mM for
	mutant enzyme W191F <20>) <20>
IC50	#4# 0.00023 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#4# IC50: 0.00023 mM for wild-type enzyme, 0.0019 mM
	for mutant enzyme L143F, 0.0018 mM for mutant enzyme H146L, 0.0029 mM
	for mutant enzyme W191S, 0.00079 mM for mutant enzyme W191F <20>) <20>

///
ID	1.1.1.100
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Salmonella enterica subsp. enterica serovar Typhimurium   <19,49>
PR	#2# Staphylococcus aureus   <47,49>
PR	#3# Bacillus subtilis   <13>
PR	#4# Escherichia coli   <1,4,5,14,16,19,22,27,33,34,43,45,49>
PR	#5# Homo sapiens   <28>
PR	#6# Saccharomyces cerevisiae   <46,48>
PR	#7# Euglena gracilis   <9>
PR	#8# Spinacia oleracea   <1,8,10>
PR	#9# Pisum sativum   <8>
PR	#10# Arabidopsis thaliana   <40>
PR	#11# Enterobacter cloacae   <49>
PR	#12# Enterobacter aerogenes   <49>
PR	#13# Pseudomonas aeruginosa   <20,29,33,47,49>
PR	#14# Lactococcus lactis   <18>
PR	#15# Brassica napus   <3,6,15,16,37>
PR	#16# Acinetobacter calcoaceticus   <49>
PR	#17# Haloferax volcanii   <42>
PR	#18# Serratia marcescens   <49>
PR	#19# Streptococcus pneumoniae   <24,47>
PR	#20# Proteus vulgaris   <49>
PR	#21# Caenorhabditis elegans   <46>
PR	#22# Klebsiella pneumoniae   <49>
PR	#23# Mycobacterium tuberculosis   <21,25,32,48>
PR	#24# Staphylococcus epidermidis   <33,49>
PR	#25# Plasmodium falciparum   <17,26,30,35,44,50>
PR	#26# Persea americana   (#26# gene xyn11F63 <3>) <3,7,8,11>
PR	#27# Salmonella enterica subsp. enterica serovar Typhi   <49>
PR	#28# Brassica juncea   <8>
PR	#29# Carthamus tinctorius   <2,8>
PR	#30# Cuphea lanceolata   <12>
PR	#31# Streptococcus sp.   <47>
PR	#32# Shigella sonnei   <49>
PR	#33# Shigella dysenteriae   <49>
PR	#34# Cuphea lutea   <8>
PR	#35# Shigella flexneri   <49>
PR	#36# synthetic construct   <47>
PR	#37# Enterococcus sp.   <49>
PR	#38# Haloarcula hispanica   <42>
PR	#39# Pseudomonas sp. Q4AE87 SwissProt <22>
PR	#40# Plasmodium falciparum Q86RB1 SwissProt <23>
PR	#41# Aquifex aeolicus VF5   <31>
PR	#42# Bacillus anthracis Q81JG6 SwissProt <38,51>
PR	#43# Pseudomonas putida A5HIF6 UniProt <39>
PR	#44# Synechococcus elongatus PCC 7942 Q31QF3 UniProt <41>
PR	#45# Mycobacterium tuberculosis P0A5Y4 UniProt <48>
PR	#46# Mycobacterium tuberculosis O53665 UniProt <48>
PR	#47# Plasmodium falciparum K1   <36>

RECOMMENDED_NAME
RN	3-oxoacyl-[acyl-carrier-protein] reductase


SYSTEMATIC_NAME
SN	(3R)-3-hydroxyacyl-[acyl-carrier protein]:NADP+ oxidoreductase


SYNONYMS
SY	 reductase, 3-oxoacyl-[acyl carrier protein]
SY	 beta-ketoacyl-[acyl-carrier protein] (ACP) reductase
SY	 beta-ketoacyl acyl carrier protein (ACP) reductase
SY	 beta-ketoacyl thioester reductase
SY	 3-ketoacyl acyl carrier protein reductase
SY	 NADPH-specific 3-oxoacyl-[acylcarrier protein]reductase
SY	 3-oxoacyl-[ACP]reductase
SY	#1,2,4,11,12,13,16,17,18,19,20,22,24,25,27,31,32,33,35,36,37,38,47#
	beta-ketoacyl-ACP reductase <24,27,30,36,42,43,45,47,49,50>
SY	#1,2,4,11,12,13,16,18,19,20,22,24,25,27,31,32,33,35,36,37,39,40,43,47#
	FabG <17,19,20,22,23,26,27,30,36,39,43,44,45,47,49,50>
SY	#1,4,23# beta-ketoacyl-acyl carrier protein reductase <19,25>
SY	#10# KCR1 <40>
SY	#10# KCR2 <40>
SY	#13# RhlG <29>
SY	#13,25# beta-ketoacyl acyl carrier protein reductase <20,26,44>
SY	#14,17,38,45# FabG1 <18,42,48>
SY	#17,38# PhaB <42>
SY	#17,38# polyhydroxyalkanoate-specific acetoacetyl coenzyme A reductase
	<42>
SY	#17,38# PHA-specific acetoacetyl-CoA reductase <42>
SY	#19# KACPR <24>
SY	#23# 3-ketoacyl-ACP(CoA) reductase <21>
SY	#23# ACP reductase <25>
SY	#23# MabA <25>
SY	#4# beta-ketoacyl-[acyl carrier protein] reductase <43>
SY	#4,39,43# 3-ketoacyl-acyl carrier protein reductase <22,39>
SY	#4,5,15# BKR <14,15,16,28>
SY	#40# OAR <23>
SY	#42# 3-oxoacyl-(acyl carrier protein) reductase <51>
SY	#43# 3-ketoacyl-ACP reductase <39>
SY	#44# 3-ketoacyl-[acyl-carrier-protein] reductase <41>
SY	#45,46# 3-oxoacyl-AcpM reductase <48>
SY	#5,10,13# beta-ketoacyl reductase <28,29,40>
SY	#6# Oar1p <46>
SY	#6,21,23# 3-oxoacyl-thioester reductase <46,48>
SY	#6,23,46# fabG4 <48>
SY	#6,40# 3-oxoacyl-ACP reductase <23,46>

CAS_REGISTRY_NUMBER
CR	37250-34-3

REACTION
RE	a (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ = a
	3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#15# belongs to family
	of short-chain alcohol dehydrogenases (SDR) with catalytic triad
	Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #23# chemical and
	kinetic mechanism <25>; #25# cofactor and substrate binding kinetics,
	allosteric regulation mechanism, overview <26>; #40# ordered bi bi
	kinetic mechanism, [acyl-carrier protein] recognition mechanism <23>;
	#19# reaction mechanism, random bi bi kinetic mechanism <24>; #23#
	positive cooperativity in binding of NADPH to enzyme, no cooperativity
	in binding of acetoacyl-CoA. Pre-existing equilibrium of two forms of
	free MabA in solution followed by a bimolecular association process
	<32>)

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#10# embryo (#10# KCR1 and KCR2 <40>) <40>
ST	#10# inflorescence (#10# KCR1 and KCR2 present in inflorescence stem
	<40>) <40>
ST	#10# silique (#10# KCR1 and KCR2 <40>) <40>
ST	#10,30# root (#10# only KCR1 <40>) <12,40>
ST	#10,30# flower (#10# KCR1 and KCR2 <40>) <12,40>
ST	#26# mesocarp <3,7,11>
ST	#26,28,29,30,34# seed <2,8,12>
ST	#43# cell culture (#43# strain KCTC1639 <39>) <39>
ST	#8,9,10,30# leaf (#10# KCR1 and KCR2 <40>) <1,8,10,12,40>

LOCALIZATION
LO	#10# endoplasmic reticulum (#10# KCR1 and KCR2 <40>) <40>
LO	#6,21# mitochondrion <46>
LO	#6,23,25# soluble (#25# recombinant enzyme from Escherichia coli <17>)
	<17,48>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1,4# beta-ketoacyl-[acyl-carrier protein] + NADPH =
	beta-hydroxyacyl-[acyl-carrier protein] + NADP+ (#1,4# first reductive
	step in the elongation cycle of fatty acid biosynthesis <19>) <19>
NSP	#19# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA + NADP+ <24>
NSP	#19# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA + NADP+ {r} <24>
NSP	#23,25# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	3-hydroxyacyl-[acyl-carrier protein] + NADP+ {r} <25,26>
NSP	#4,5,13,14,43# More = ? (#4# catalyzes also the reduction of the
	beta-keto group of unsaturated acyl chains during biosynthesis of
	unsaturated fatty acids <16>; #14# FabG1 is responsible for the first
	reductive step of the fatty acid synthetic cycle. FabG2 is inactive in
	fatty acid synthesis <18>; #13# the beta-ketoacyl acyl carrier protein
	reductase activity of the fatty acid biosynthetic pathway is a
	determining factor of 3-oxo-homoserine lactone acyl chain lengths <20>;
	#13# the enzyme is essential in the rhamnolipid biosynthetic pathway of
	Pseudomonas aeruginosa <29>; #5# the enzyme is part of the fatty acid
	synthase multienzyme complex, and shares probably a single active site
	with the enoyl reductase activity of the complex <28>; #43# fabG
	overexpression tends to depress the biosynthesis of medium-chain-length
	polyhydroxyalkanoate due to the reversible conversion of
	(R)-3-hydroxyalkanoate monomer units into 3-ketoacyl-CoA <39>) {}
	<16,18,20,28,29,39>
NSP	#4,5,13,14,43# More = ? (#4# catalyzes also the reduction of the
	beta-keto group of unsaturated acyl chains during biosynthesis of
	unsaturated fatty acids <16>; #14# FabG1 is responsible for the first
	reductive step of the fatty acid synthetic cycle. FabG2 is inactive in
	fatty acid synthesis <18>; #13# the beta-ketoacyl acyl carrier protein
	reductase activity of the fatty acid biosynthetic pathway is a
	determining factor of 3-oxo-homoserine lactone acyl chain lengths <20>;
	#13# the enzyme is essential in the rhamnolipid biosynthetic pathway of
	Pseudomonas aeruginosa <29>; #5# the enzyme is part of the fatty acid
	synthase multienzyme complex, and shares probably a single active site
	with the enoyl reductase activity of the complex <28>; #43# fabG
	overexpression tends to depress the biosynthesis of medium-chain-length
	polyhydroxyalkanoate due to the reversible conversion of
	(R)-3-hydroxyalkanoate monomer units into 3-ketoacyl-CoA <39>) {}
	<16,18,20,28,29,39>
NSP	#4,8,15,26,29# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#15# enzyme is part
	of the dissociable fatty acid synthase type II multienzyme complex for
	de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#4,15,26# first reduction step of fatty acid synthase <3,4>; #8,15,29#
	enzyme in fatty acid synthesis <2,10,16>) <2,3,4,10,16>
NSP	#4,8,15,26,29# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#15# enzyme is part
	of the dissociable fatty acid synthase type II multienzyme complex for
	de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#4,15,26# first reduction step of fatty acid synthase <3,4>; #8,15,29#
	enzyme in fatty acid synthesis <2,10,16>) {r} <2,3,4,10,16>
NSP	#4,8,15,26,29# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#15# enzyme is part
	of the dissociable fatty acid synthase type II multienzyme complex for
	de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#4,15,26# first reduction step of fatty acid synthase <3,4>; #8,15,29#
	enzyme in fatty acid synthesis <2,10,16>) {} <2,3,4,10,16>
NSP	#43# (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ =
	3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#43# beta-oxidation
	pathway <39>) <39>

SUBSTRATE_PRODUCT
SP	#1,4# beta-ketoacyl-[acyl-carrier protein] + NADPH =
	beta-hydroxyacyl-[acyl-carrier protein] + NADP+ (#1,4# first reductive
	step in the elongation cycle of fatty acid biosynthesis <19>) <19>
SP	#1,4,8,15,25,26,30# acetoacetyl-CoA + NADPH = D-beta-hydroxybutyryl-CoA
	+ NADP+ <1,3,5,12,16,17,19,43>
SP	#1,4,8,15,25,26,30# acetoacetyl-CoA + NADPH = D-beta-hydroxybutyryl-CoA
	+ NADP+ {r} <1,3,5,12,16,17,19,43>
SP	#14# beta-ketobutyryl-CoA + NADPH = beta-hydroxybutyryl-CoA + NADP+
	(#14# complementation of Escherichia coli fabG mutant with
	Lactobacillus lactis fabG genes shows that fabG1 encodes a functional
	beta-ketoacyl ACP reductase and fabG2 encodes an enzyme that has
	activity with the model substrate beta-ketobutyryl-CoA, but lacks the
	ability to support fatty acid synthesis both in vivo and in vitro <18>)
	{} <18>
SP	#23,25# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#25# cooperative
	transitions in the enzyme due to cofactor and [acyl-carrier-protein]
	binding <26>) {r} <25,26>
SP	#25# acetoacetyl-CoA + NADPH = ? + NADP+ (#25# wild-type shows less
	activity with acetoacetyl-CoA than with acetoacetyl-[acyl-carrier
	protein] <44>) <44>
SP	#4# ethyl acetoacetate + NADPH = ? + NADP+ <49>
SP	#4# methyl acetoacetate + NADPH = ? + NADP+ (#4# is not a good
	substrate as ethyl acetoacetate <45>) <45>
SP	#4# propyl acetoacetate + NADPH = ? + NADP+ (#4# as substrate it is
	limited to its weak solubility <45>) <45>
SP	#4,15,26# acetoacetyl-N-cysteamine + NADPH =
	D-3-hydroxybutyryl-N-cysteamine + NADP+ <3,6,7,16>
SP	#4,36# ethyl acetoacetate + NADPH = ethyl 3-hydroxybutyrate + NADP+
	<45,47>
SP	#4,39# dec-2-enoyl-CoA + NADPH = 3-hydroxydecanoyl-CoA + NADP+ <22>
SP	#4,39# hex-2-enoyl-CoA + NADPH = 3-hydroxyhexanoyl-CoA + NADP+ <22>
SP	#4,5,19,23,25,39,40,47# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA
	+ NADP+ <22,23,24,25,26,27,28,30,36,50>
SP	#4,5,19,23,25,39,40,47# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA
	+ NADP+ {r} <22,23,24,25,26,27,28,30,36,50>
SP	#4,5,39# dodec-2-enoyl-CoA + NADPH = 3-hydroxydodecanoyl-CoA + NADP+
	<22,28>
SP	#4,5,39# oct-2-enoyl-CoA + NADPH = 3-hydroxyoctanoyl-CoA + NADP+ <22,28>
SP	#4,5,8,13,14,15,26,39,43,45# More = ? (#4# only D-(-) isomer is
	oxidized <4>; #4# beta-ketoacyl thioesters of CoA and pantetheine
	metabolized at slower rates <4>; #15,26# animals, yeast and
	Mycobacteria have fatty acid synthetase containing all the individual
	activities on one or two multifunctional polypeptide chains, plants and
	most bacterial systems, including E. coli, possess individual
	monofunctional enzymes and a separate acyl carrier protein <3>; #4#
	equally active on beta-ketoacyl-ACP derivatives of C4 to C16 <4>; #4#
	broad specificity for chain length of substrates <4,5>; #4,8# L-isomer
	completely inactive <1,4>; #4# catalyzes also the reduction of the
	beta-keto group of unsaturated acyl chains during biosynthesis of
	unsaturated fatty acids <16>; #14# FabG1 is responsible for the first
	reductive step of the fatty acid synthetic cycle. FabG2 is inactive in
	fatty acid synthesis <18>; #13# the beta-ketoacyl acyl carrier protein
	reductase activity of the fatty acid biosynthetic pathway is a
	determining factor of 3-oxo-homoserine lactone acyl chain lengths <20>;
	#13# the enzyme is essential in the rhamnolipid biosynthetic pathway of
	Pseudomonas aeruginosa <29>; #5# the enzyme is part of the fatty acid
	synthase multienzyme complex, and shares probably a single active site
	with the enoyl reductase activity of the complex <28>; #4,39# FabG
	substrate specificity overview <22>; #43# fabG overexpression tends to
	depress the biosynthesis of medium-chain-length polyhydroxyalkanoate
	due to the reversible conversion of (R)-3-hydroxyalkanoate monomer
	units into 3-ketoacyl-CoA <39>; #45# FabG1 is able to act on shorter
	(C4) acyl substrates <48>) {} <1,3,4,5,16,18,20,22,28,29,39,48>
SP	#4,5,8,13,14,15,26,39,43,45# More = ? (#4# only D-(-) isomer is
	oxidized <4>; #4# beta-ketoacyl thioesters of CoA and pantetheine
	metabolized at slower rates <4>; #15,26# animals, yeast and
	Mycobacteria have fatty acid synthetase containing all the individual
	activities on one or two multifunctional polypeptide chains, plants and
	most bacterial systems, including E. coli, possess individual
	monofunctional enzymes and a separate acyl carrier protein <3>; #4#
	equally active on beta-ketoacyl-ACP derivatives of C4 to C16 <4>; #4#
	broad specificity for chain length of substrates <4,5>; #4,8# L-isomer
	completely inactive <1,4>; #4# catalyzes also the reduction of the
	beta-keto group of unsaturated acyl chains during biosynthesis of
	unsaturated fatty acids <16>; #14# FabG1 is responsible for the first
	reductive step of the fatty acid synthetic cycle. FabG2 is inactive in
	fatty acid synthesis <18>; #13# the beta-ketoacyl acyl carrier protein
	reductase activity of the fatty acid biosynthetic pathway is a
	determining factor of 3-oxo-homoserine lactone acyl chain lengths <20>;
	#13# the enzyme is essential in the rhamnolipid biosynthetic pathway of
	Pseudomonas aeruginosa <29>; #5# the enzyme is part of the fatty acid
	synthase multienzyme complex, and shares probably a single active site
	with the enoyl reductase activity of the complex <28>; #4,39# FabG
	substrate specificity overview <22>; #43# fabG overexpression tends to
	depress the biosynthesis of medium-chain-length polyhydroxyalkanoate
	due to the reversible conversion of (R)-3-hydroxyalkanoate monomer
	units into 3-ketoacyl-CoA <39>; #45# FabG1 is able to act on shorter
	(C4) acyl substrates <48>) {} <1,3,4,5,16,18,20,22,28,29,39,48>
SP	#4,7,8,9,15,25,26,28,29,34# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#15# belongs to
	family of short-chain alcohol dehydrogenases (SDR) with catalytic
	triade Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #4# pH
	6.0-7.0, equilibrium almost completely favors formation of the
	beta-hydroxyacyl ACP derivatives <5>; #15# enzyme is part of the
	dissociable fatty acid synthase type II multienzyme complex for de novo
	synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#4,15,26# first reduction step of fatty acid synthase <3,4>; #8,15,29#
	enzyme in fatty acid synthesis <2,10,16>) |#4# product is the
	D-(-)-stereoisomer <5>| <1,2,3,4,5,6,7,8,9,10,11,14,15,16,50>
SP	#4,7,8,9,15,25,26,28,29,34# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#15# belongs to
	family of short-chain alcohol dehydrogenases (SDR) with catalytic
	triade Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #4# pH
	6.0-7.0, equilibrium almost completely favors formation of the
	beta-hydroxyacyl ACP derivatives <5>; #15# enzyme is part of the
	dissociable fatty acid synthase type II multienzyme complex for de novo
	synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#4,15,26# first reduction step of fatty acid synthase <3,4>; #8,15,29#
	enzyme in fatty acid synthesis <2,10,16>) |#4# product is the
	D-(-)-stereoisomer <5>| {r} <1,2,3,4,5,6,7,8,9,10,11,14,15,16,50>
SP	#4,7,8,9,15,25,26,28,29,34# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#15# belongs to
	family of short-chain alcohol dehydrogenases (SDR) with catalytic
	triade Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #4# pH
	6.0-7.0, equilibrium almost completely favors formation of the
	beta-hydroxyacyl ACP derivatives <5>; #15# enzyme is part of the
	dissociable fatty acid synthase type II multienzyme complex for de novo
	synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#4,15,26# first reduction step of fatty acid synthase <3,4>; #8,15,29#
	enzyme in fatty acid synthesis <2,10,16>) |#4# product is the
	D-(-)-stereoisomer <5>| {} <1,2,3,4,5,6,7,8,9,10,11,14,15,16,50>
SP	#4,8,15,25,26# acetoacetyl-[acyl-carrier protein] + NADPH =
	D-beta-hydroxybutyryl-[acyl-carrier protein] + NADP+ (#15,26# much
	greater specificity for acetoacetyl-ACP than for either of the model
	substrates acetoacetyl-CoA or acetoacetyl-N-acetylcysteamine <3>; #25#
	Arg187 and Arg230 are critical residues for the FabG-acyl-carrier
	protein interactions, significance of the positively
	charged/hydrophobic patch located adjacent to the active site cavities
	of FabG for interactions with acyl carrier protein <44>) <1,3,5,16,44>
SP	#4,8,15,25,26# acetoacetyl-[acyl-carrier protein] + NADPH =
	D-beta-hydroxybutyryl-[acyl-carrier protein] + NADP+ (#15,26# much
	greater specificity for acetoacetyl-ACP than for either of the model
	substrates acetoacetyl-CoA or acetoacetyl-N-acetylcysteamine <3>; #25#
	Arg187 and Arg230 are critical residues for the FabG-acyl-carrier
	protein interactions, significance of the positively
	charged/hydrophobic patch located adjacent to the active site cavities
	of FabG for interactions with acyl carrier protein <44>) {r}
	<1,3,5,16,44>
SP	#43# (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ =
	3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#43# beta-oxidation
	pathway <39>) <39>
SP	#44# propiophenone + NADPH = ? + NADP+ (#44# 123% relative activity
	compared to acetophenone <41>) <41>
SP	#44# 1,1,1-trifluoroacetone + NADPH = ? + NADP+ (#44# 792% relative
	activity compared to acetophenone <41>) <41>
SP	#44# 2',3',4',5',6'-pentafluoroacetophenone + NADPH = ? + NADP+ (#44#
	3023% relative activity compared to acetophenone <41>) <41>
SP	#44# 2-octanone + NADPH = ? + NADP+ (#44# 15% relative activity
	compared to acetophenone <41>) <41>
SP	#44# 3'-fluoroacetophenone + NADPH = ? + NADP+ (#44# 100% relative
	activity compared to acetophenone <41>) <41>
SP	#44# 4'-chloroacetophenone + NADPH = ? + NADP+ (#44# 115% relative
	activity compared to acetophenone <41>) <41>
SP	#44# 4'-fluoroacetophenone + NADPH = ? + NADP+ (#44# 62% relative
	activity compared to acetophenone <41>) <41>
SP	#44# acetophenone + NADPH = ? + NADP+ (#44# 100% relative activity
	<41>) <41>
SP	#44# alpha-chloroacetophenone + NADPH = ? + NADP+ (#44# 1885% relative
	activity compared to acetophenone <41>) <41>
SP	#44# ethyl 4-chloroacetoacetate + NADPH = ? + NADP+ (#44# 29454%
	relative activity compared to acetophenone <41>) <41>
SP	#44# ethylbenzoylacetate + NADPH = ? + NADP+ (#44# 892% relative
	activity compared to acetophenone <41>) <41>
SP	#5# crotonyl-CoA + NADPH = ? <28>

TURNOVER_NUMBER
TN	#19# 11 {acetoacetyl-CoA}  (#19# pH 7.6, 30°C <24>) <24>
TN	#19# 11 {NADPH}  (#19# pH 7.6, 30°C <24>) <24>
TN	#23# 7 {acetoacetyl-CoA}  (#23# pH 7.0, 25°C <25>) <25>
TN	#23# 7 {NADPH}  (#23# pH 7.6, 30°C <25>) <25>
TN	#25# 250 {NADPH}  (#25# without urea, pH 7.0, 25°C <50>) <50>
TN	#25# 0.014 {acetoacetyl-CoA}  (#25# pH 7.5 <17>) <17>
TN	#25# 259 {acetoacetyl-CoA}  (#25# pH 6.8, 22°C, recombinant enzyme
	<26>) <26>
TN	#25# 259 {NADPH}  (#25# pH 6.8, 22°C, recombinant enzyme <26>) <26>
TN	#25# 344.7 {NADPH}  (#25# in the presence of 1 M urea, pH 7.0, 25°C
	<50>) <50>
TN	#25# 187.3 {NADPH}  (#25# in the presence of 1.5 M urea, pH 7.0, 25°C
	<50>) <50>
TN	#25# 148.6 {NADPH}  (#25# in the presence of 4 M urea, pH 7.0, 25°C
	<50>) <50>
TN	#4# 0.3 {ethyl acetoacetate}  <45>
TN	#4# 0.59 {NADPH}  <45>
TN	#40# 265 {acetoacetyl-CoA}  (#40# pH 6.8, 25°C, recombinant enzyme
	<23>) <23>
TN	#40# 265 {NADPH}  (#40# pH 6.8, 25°C, recombinant enzyme <23>) <23>
TN	#5# 4 {acetoacetyl-CoA}  (#5# pH 7.4, 25°C, recombinant wild-type
	enzyme <28>) <28>
TN	#5# 4 {NADPH}  (#5# pH 7.4, 25°C, recombinant wild-type enzyme <28>)
	<28>
TN	#5# 0.43 {acetoacetyl-CoA}  (#5# pH 7.4, 25°C, recombinant mutant
	K1699Q <28>) <28>
TN	#5# 0.43 {NADPH}  (#5# pH 7.4, 25°C, recombinant mutant K1699Q <28>)
	<28>
TN	#5# 0.33 {acetoacetyl-CoA}  (#5# pH 7.4, 25°C, recombinant mutant
	K1699A <28>) <28>
TN	#5# 0.33 {NADPH}  (#5# pH 7.4, 25°C, recombinant mutant K1699A <28>)
	<28>

KM_VALUE
KM	#14# 0.29 {beta-ketobutyryl-CoA}  (#14# pH 7.0, 30°C, FabG1 <18>) <18>
KM	#14# 4.06 {beta-ketobutyryl-CoA}  (#14# pH 7.0, 30°C, FabG2 <18>) <18>
KM	#15# 0.003 {Acetoacetyl-[acyl-carrier protein]}  <6>
KM	#15# 0.023 {NADPH}  (#15# + acetoacetyl-[acyl-carrier-protein] <6>) <6>
KM	#15# 0.035 {N-acetoacetyl-N-cysteamine}  <6>
KM	#15# 0.261 {acetoacetyl-CoA}  <6>
KM	#19# 0.4 {NADPH}  (#19# pH 7.6, 30°C <24>) <24>
KM	#19# 2.2 {acetoacetyl-CoA}  (#19# pH 7.6, 30°C <24>) <24>
KM	#23# 0.026 {NADPH}  (#23# pH 7.6, 30°C <25>) <25>
KM	#23# 0.165 {acetoacetyl-CoA}  (#23# pH 7.6, 30°C <25>) <25>
KM	#25# 0.45 {acetoacetyl-CoA}  (#25# mutant R187A <44>) <44>
KM	#25# 0.49 {acetoacetyl-CoA}  (#25# mutant R230E <44>) <44>
KM	#25# 0.43 {acetoacetyl-CoA}  (#25# wild-type <44>; #25# pH 6.8, 22°C,
	recombinant enzyme <26>) <26,44>
KM	#25# 0.58 {acetoacetyl-CoA}  (#25# mutant R187E/R230E <44>) <44>
KM	#25# 0.075 {acetoacetyl-CoA}  (#25# pH 7.5 <17>) <17>
KM	#25# 0.44 {acetoacetyl-CoA}  (#25# mutant R230A <44>) <44>
KM	#25# 0.043 {NADPH}  (#25# pH 6.8, 22°C, recombinant enzyme <26>) <26>
KM	#25# 0.0461 {NADPH}  (#25# without urea, pH 7.0, 25°C <50>) <50>
KM	#25# 0.0434 {NADPH}  (#25# in the presence of 1 M urea, pH 7.0, 25°C
	<50>) <50>
KM	#25# 0.0412 {NADPH}  (#25# in the presence of 1.5 M urea, pH 7.0, 25°C
	<50>) <50>
KM	#25# 0.4553 {NADPH}  (#25# in the presence of 4 M urea, pH 7.0, 25°C
	<50>) <50>
KM	#25,26# 0.47 {acetoacetyl-CoA}  (#25# mutant R187A/R230A <44>; #25#
	mutant R187E <44>) <7,44>
KM	#26# 48 {Acetoacetyl-N-acetylcysteamine}  <7>
KM	#26# 0.0093 {NADPH}  <7>
KM	#26# 0.0079 {Acetoacetyl-[acyl-carrier protein]}  <7>
KM	#29# 0.009 {Acetoacetyl-[acyl-carrier protein]}  <2>
KM	#29# 0.016 {NADPH}  <2>
KM	#4# 0.01 {NADPH}  <45>
KM	#4# 0.127 {ethyl acetoacetate}  <45>
KM	#40# 0.51 {acetoacetyl-CoA}  (#40# pH 6.8, 25°C, recombinant enzyme
	<23>) <23>
KM	#40# 0.0475 {NADPH}  (#40# pH 6.8, 25°C, recombinant enzyme <23>) <23>
KM	#44# 1.92 {ethylbenzoylacetate}  (#44# with 4 mM NADPH, in 0.1 M sodium
	phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 6.03 {propiophenone}  (#44# with 4 mM NADPH, in 0.1 M sodium
	phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 2.71 {alpha-chloroacetophenone}  (#44# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 5.72 {2',3',4',5',6'-pentafluoroacetophenone}  (#44# with 4 mM
	NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 8.31 {ethyl 4-chloroacetoacetate}  (#44# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 7.38 {3'-fluoroacetophenone}  (#44# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 46.92 {acetophenone}  (#44# with 4 mM NADPH, in 0.1 M sodium
	phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 14.34 {4'-chloroacetophenone}  (#44# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 12.29 {4'-fluoroacetophenone}  (#44# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#44# 89.2 {1,1,1-trifluoroacetone}  (#44# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
KM	#5# 0.1 {NADPH}  (#5# pH 7.4, 25°C, recombinant wild-type enzyme, with
	octenoyl-CoA <28>) <28>
KM	#5# 0.003 {NADPH}  (#5# pH 7.4, 25°C, recombinant wild-type enzyme,
	with crotonyl-CoA <28>) <28>
KM	#5# 0.002 {acetoacetyl-CoA}  (#5# pH 7.4, 25°C, recombinant mutant
	K1699A <28>) <28>
KM	#5# 0.005 {NADPH}  (#5# pH 7.4, 25°C, recombinant wild-type enzyme,
	with acetoacetyl-CoA <28>) <28>
KM	#5# 0.0012 {acetoacetyl-CoA}  (#5# pH 7.4, 25°C, recombinant mutant
	K1699Q <28>) <28>
KM	#5# 0.01 {acetoacetyl-CoA}  (#5# pH 7.4, 25°C, recombinant wild-type
	enzyme <28>) <28>
KM	#5# 0.54 {NADPH}  (#5# pH 7.4, 25°C, recombinant wild-type enzyme,
	with dodecenoyl-CoA <28>) <28>
KM	#5# 0.007 {dodecenoyl-CoA}  (#5# pH 7.4, 25°C, recombinant wild-type
	enzyme <28>) <28>
KM	#5# 0.006 {crotonyl-CoA}  (#5# pH 7.4, 25°C, recombinant wild-type
	enzyme <28>) <28>
KM	#5# 0.052 {NADPH}  (#5# pH 7.4, 25°C, recombinant mutant K1699A, with
	acetoacetyl-CoA <28>) <28>
KM	#5# 0.123 {NADPH}  (#5# pH 7.4, 25°C, recombinant mutant K1699Q, with
	acetoacetyl-CoA <28>) <28>
KM	#8# 0.015 {NADPH}  <10>
KM	#8# 0.025 {NADPH}  <1>
KM	#8# 0.25 {acetoacetyl-CoA}  <1>
KM	#8# 0.017 {Acetoacetyl-[acyl-carrier protein]}  <10>
KM	#8# 0.0037 {Acetoacetyl-[acyl-carrier protein]}  <1>
KM	#8,19,23,25,26,40# -999 {more}  (#25# cooperativity kinetics, binding
	constants of substrates and cofactors <26>; #23# detailed kinetic and
	thermodynamic analysis, solvent and multiple kinetic isotope effects,
	kinetic mechanism <25>; #19# detailed steady-state kinetic analysis,
	solvent and multiple kinetic isotope effects, random bi bi kinetic
	mechanism <24>; #40# kinetic analysis of the recombinant enzyme,
	kinetic mechanism <23>) <10,11,23,24,25,26>

PH_OPTIMUM
PHO	#19# 7.6 <24>
PHO	#23# -999 (#23# increase in alpha-secondary deuterium kinetic isotope
	effect values measured at pH 10 as compared to those obtained at pH 7
	points to isotope- and pH-sensitive steps occurring concomitantly <32>)
	<32>
PHO	#25# 7.5 (#25# assay at <30>) <30>
PHO	#25,40# 6.8 (#25# assay at <26>) <23,26>
PHO	#26# 6.5 <11>
PHO	#4# 6-7 <5>
PHO	#4,23,36# 7 (#4,23# assay at <25,27>; #36# assay conditions <47>)
	<25,27,47>
PHO	#4,39,44# 8 (#4,39# assay at <22>) <22,41,45>
PHO	#5# 7.4 (#5# assay at <28>) <28>
PHO	#8# 5.7-6.2 <10>

PH_RANGE
PHR	#19# 5.5-9.5 (#19# pH profile, detailed mechanistic pH-dependence
	analysis, overview <24>) <24>
PHR	#23# 5.8-10 (#23# pH profile, pH-dependence analysis, overview <25>)
	<25>
PHR	#26# 5.5-8.5 (#26# about 50% of activity maximum at pH 5.5 and 8.5
	<11>) <11>
PHR	#44# 4-10 (#44# pH 4: about 60% of maximal activity, pH 10: about 75%
	of maximal activity <41>) <41>
PHR	#8# 6-8.7 (#8# both reaction directions <1>) <1>

SPECIFIC_ACTIVITY
SA	#15# 136000.0 (#15# purified enzyme, protein determination by
	calculation from absorption at 280 nm <6>) <6>
SA	#25# 6.9 (#25# mutant R187A, acyl-carrier protein-dependent
	spectroscopic assay <44>) <44>
SA	#25# 45.6 (#25# mutant R187A/R230A, acyl-carrier protein-independent
	spectroscopic assay <44>) <44>
SA	#25# 3.0 (#25# mutant R187A/R230A, acyl-carrier protein-dependent
	spectroscopic assay <44>) <44>
SA	#25# 2.0 (#25# mutant R187E/R230E, acyl-carrier protein-dependent
	spectroscopic assay <44>) <44>
SA	#25# 4.0 (#25# mutant R230E, acyl-carrier protein-dependent
	spectroscopic assay <44>) <44>
SA	#25# 6.3 (#25# mutant R187E, acyl-carrier protein-dependent
	spectroscopic assay <44>) <44>
SA	#25# 59.8 (#25# purified recombinant enzyme <26>; #25# wild-type,
	acyl-carrier protein-independent spectroscopic assay <44>) <26,44>
SA	#25# 55.3 (#25# mutant R230A, acyl-carrier protein-independent
	spectroscopic assay <44>) <44>
SA	#25# 6.1 (#25# mutant R230A, acyl-carrier protein-dependent
	spectroscopic assay <44>) <44>
SA	#25# 54.2 (#25# mutant R230E, acyl-carrier protein-independent
	spectroscopic assay <44>) <44>
SA	#25# 0.0019 (#25# recombinant soluble enzyme <30>) <30>
SA	#25# 54.5 (#25# mutant R187E, acyl-carrier protein-independent
	spectroscopic assay <44>) <44>
SA	#25# 57.9 (#25# mutant R187A, acyl-carrier protein-independent
	spectroscopic assay <44>) <44>
SA	#25# 0.0017 (#25# recombinant refolded enzyme <30>) <30>
SA	#25# 42.6 (#25# mutant R187E/R230E, acyl-carrier protein-independent
	spectroscopic assay <44>) <44>
SA	#25# 70.6 (#25# wild-type, acyl-carrier protein-dependent spectroscopic
	assay <44>) <44>
SA	#26# 280.0 (#26# acetoacetyl-N-acetylcysteamine <7>) <7>
SA	#26# 450.0 (#26# acetoacetyl-CoA <7>) <7>
SA	#26# 530.0 (#26# acetoacteyl-ACP <7>) <7>
SA	#26# 9401.0 (#26# purified enzyme, protein determination by amino acid
	analysis <7>) <7>
SA	#28# 0.0366 <8>
SA	#29# 0.0197 <2>
SA	#29# 0.0189 <8>
SA	#30# 3839.0 (#30# recombinant protein, cosubstrate NADH, pH 7.0,
	phosphate buffer <12>) <12>
SA	#30# 180400.0 (#30# recombinant protein, cosubstrate NADPH, pH 7.0,
	phosphate buffer <12>) <12>
SA	#30# 83140.0 (#30# cosubstrate NADPH, pH 8.35, carbonate buffer <12>)
	<12>
SA	#34# 0.0168 <8>
SA	#4# 0.0032 <1>
SA	#4# 4930.0 (#4# purified enzyme <5>) <5>
SA	#44# 0.08 (#44# with 4-fluoroacetophenone as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 0.15 (#44# with 4-chloroacetophenone as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 2.45 (#44# with alpha-chloroacetophenone as substrate, 4 mM NADPH,
	in 0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 0.16 (#44# with propiophenone as substrate, 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 1.03 (#44# with 1,1,1-trifluoroacetone as substrate, 4 mM NADPH,
	in 0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 0.02 (#44# with 2-octanone as substrate, 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 1.16 (#44# with ethylbenzoylacetate as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 0.13 (#44# with 3-fluoroacetophenone as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <41>; #44# with acetophenone as
	substrate, 4 mM NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <41>)
	<41>
SA	#44# 3.93 (#44# with 2,3,4,5,6-pentafluoroacetophenone as substrate, 4
	mM NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#44# 38.29 (#44# with ethyl 4-chloroacetoacetate as substrate, 4 mM
	NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <41>) <41>
SA	#5# 0.036 (#5# recombinant purified mutant K1699A <28>) <28>
SA	#5# 0.24 (#5# recombinant purified wild-type BKR <28>) <28>
SA	#5# 0.043 (#5# recombinant purified mutant K1699Q <28>) <28>
SA	#5,43# -999.0 (#43# the intrinsic NADPH dependent 3-ketoacyl-CoA
	reductase activity in the transformant Pseudomonas putida with
	overexpressed fabG gene increased about 1.6-fold from 0.87 to 1.39
	units/mg protein, indicating successful overexpression of the fabGJ
	genes in Pseudomonas putida KCTC1639. <39>) <28,39>
SA	#8# 0.005 <1>
SA	#8# 0.0192 <8>
SA	#8# 7.95 <1>
SA	#9# 0.0132 <8>

TEMPERATURE_OPTIMUM
TO	#19,43# 30 (#19,43# assay at <24,39>) <24,39>
TO	#4# 45 <45>
TO	#4# 37 (#4# assay at <27>) <27>
TO	#4,25,39# 22 (#4,25,39# assay at room temperature <22,26>) <22,26>
TO	#44# 44 <41>
TO	#5,23,40# 25 (#5,23,40# assay at <23,25,28>) <23,25,28>

TEMPERATURE_RANGE
TR	#23# 15-37 (#23# temperature profile <25>) <25>
TR	#44# 30-55 (#44# 30°C: about 55% of maximal activity, 55°C: about 65%
	of maximal activity <41>) <41>

COFACTOR
CF	#1,4,5,7,8,9,13,15,19,23,25,26,28,29,30,34,36,38,39,40,47# NADPH (#38#
	dependent on <42>; #4,15,26# absolute specificity for NADPH <3,5,16>;
	#8# much more effective than NADH <10>; #25# exhibits negative
	cooperativity for its interaction with the enzyme <17>; #40# cofactor
	binding structure and mechanism <23>; #25# cooperative transitions in
	the enzyme due to cofactor and [acyl-carrier-protein] binding,
	cooperative allosteric cofactor binding in presence of
	[acyl-carrier-protein] <26>; #23# positive cooperativity in binding to
	enzyme <32>; #25# 3fold enhancement in acyl-carrier protein binding to
	wild-type in the presence of NADPH <44>)
	<1,2,3,4,5,6,7,8,9,10,11,12,16,17,19,20,22,23,24,25,26,27,28,30,32,36
	42,43,44,45,47,49,50>
CF	#4,8,23,25,43# NADP+ (#25# cooperative transitions in the enzyme due to
	cofactor and [acyl-carrier-protein] binding, cooperative cofactor
	binding <26>) <1,14,25,26,39>
CF	#7,26# more (#7,26# NADH is used by NADH-dependent 3-oxoacyl
	[ACP]-reductase, EC 1.1.1.121 <9,11>) <9,11>
CF	#8# NADH (#8# NADPH is much more effective than NADH <1,10>) <1,10>

ACTIVATING_COMPOUND
AC	#25,44# more (#25# affinity of acyl-carrier protein for FabG is
	increased by 3fold in the presence of 1 M urea <50>; #44# variation of
	the buffer molarity between 25 mM and 200 mM or addition of NaCl up to
	500 mM has no significant effect on enzyme activity <41>) <41,50>

INHIBITORS
IN	#1,2,4,11,12,13,16,18,20,22,24,27,32,33,35,37# Tannic acid (#2,24#
	displays very strong inhibition <49>; #4# strongest inhibition on FabG,
	shows time-dependent irreversible inhibition <49>) <49>
IN	#1,2,4,8,11,12,13,16,18,19,20,22,24,27,31,32,33,35,36,37,40# more (#8#
	not: N-ethylmaleimide, arsenite <1>; #40# no inhibition by triclosan
	<23>; #4# cinnamic acid derivatives can be accommodated in the
	substrate-binding region of the active site, above the nicotinamide
	moiety of the NADPH cofactor <43>; #36# FabG is inhibited by extract of
	galangal (rhizome of Alpinia officinarum), strongest inhibition with
	40% ethanol extract of galangal. Inhibition is consisted of both
	reversible and irreversible inhibition. Inhibits FabG in a competitive
	pattern against NADPH, irreversible inhibition presents two phases
	(slow and fast one) <47>; #19# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	0.01-0.02 mM <47>; #31# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	0.025-0.05 mM <47>; #2# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	0.32-0.64 mM <47>; #13# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	above 1.28 mM <47>; #1,2,4,11,12,13,16,18,22,32,35,37# inhibition by
	leaf extracts from Acer platanoides, Acer campestre, Acer rubrum, Acer
	saccharum and Acer truncatum Bunge <49>; #24# inhibition by leaf
	extracts from Acer platanoides, Acer campestre, Acer rubrum, Acer
	saccharum and Acer truncatum Bunge, except strain 04-5 <49>; #20,27,33#
	inhibition by leaf extracts from Acer platanoides, Acer campestre, Acer
	rubrum, Acer saccharum and Acer truncatum Bunge. Is inhibited by the
	leaf extracts from all five kinds of maples more effectively than are
	other Gram-negative bacteria strains <49>; #4# inhibition by leaf
	extracts from Acer platanoides, Acer campestre, Acer rubrum, Acer
	saccharum and Acer truncatum Bunge. Leaf extracts of Acer saccharum and
	Acer truncatum Bunge display time-dependent irreversible inhibition of
	FabG, whereas leaf extracts of Acer platanoides, Acer campestre and
	Acer rubrum show reversible inhibition <49>) <1,23,43,47,49>
IN	#10# RNAi (#10# suppresses KCR activity, which results in a reduction
	of cuticular wax load and affects very-long-chain fatty acid
	composition of sphingolipids, seed triacylglycerols, and root
	glycerolipids. RNAi-suppressed Arabidopsis KCR1 plants display fused
	vegetative and reproductive organs, an abnormal root morphology and
	have abnormal trichome and epidermal cell morphology <40>) <40>
IN	#14# Acyl carrier protein (#14# beta-ketobutyryl-CoA reductase activity
	of FabG1 is inhibited, activity of FabG2 is unaffected <18>) <18>
IN	#19# DL-3-hydroxybutyryl-CoA (#19# competitive product inhibition <24>)
	<24>
IN	#23,40# 3-hydroxybutyryl-CoA (#40# competitive product inhibition <23>;
	#23# noncompetitive product inhibition pattern <25>) <23,25>
IN	#25# acyl-carrier protein (#25# inhibition of wild-type with increasing
	concentrations <44>) <44>
IN	#25# Guanidinium chloride (#25# FabG is fully unfolded at 4 M,
	approximately 90% of the enzyme activity can be recovered on dialyzing
	the denaturant. In presence of NADPH, there is no stabilization of FabG
	in case of equilibrium unfolding with guanidinium chloride <50>) <50>
IN	#25# Urea (#25# FabG is fully unfolded at 6 M, approximately 90% of the
	enzyme activity can be recovered on dialyzing the denaturant. Two
	states in the reversible unfolding process of FabG in presence of
	NADPH, one is an activity-enhanced state and the other, an inactive
	state in case of equilibrium unfolding with urea <50>) <50>
IN	#26,30# Phenylglyoxal (#26# with NADPH 45% remaining activity, without
	total loss of activity <7>) <7,12>
IN	#36# kaemperol <47>
IN	#4# chlorogenic acid (#4# IC50: 0.881-0.948 mM <27>) <27>
IN	#4# epigallocatechin gallate <45>
IN	#4# (E)-phenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (#4# 69% residual
	activity <43>) <43>
IN	#4# (E)-3-phenoxybenzyl 3-(benzo[d][1,3]dioxol-5-yl) acrylate (#4# 61%
	residual activity <43>) <43>
IN	#4# (E)-benzyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (#4# 71% residual
	activity <43>) <43>
IN	#4# (E)-4-cyanophenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate <43>
IN	#4# (E)-2-nitrophenyl cinnamate <43>
IN	#4# (E)-1-(4-methylpiperidin-1-yl)-3-phenylprop-2-en-1-one (#4# 80%
	residual activity <43>) <43>
IN	#4# N-(1,3-dioxoisoindolin-2-yl)-2-oxo-2H-chromene-3-carboxamide (#4#
	69% residual activity <43>) <43>
IN	#4,13,24# 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (#13# minimal
	inhibitory concentration 0.125 mg/ml <33>; #24# minimal inhibitory
	concentration 0.25 mg/ml <33>; #4# mixed type of inhibition. IC50 value
	0.9 microgramm per ml, Ki value 0.21 microgramm per ml <33>) <33>
IN	#4,19,23# NADP+ (#4,19# competitive product inhibition <24,27>; #23#
	noncompetitive product inhibition pattern <25>) <24,25,27>
IN	#4,36# quercetin <47,49>
IN	#40# Bithionol (#40# over 75% inhibition at 0.02 mM, IC50: 0.010 mM
	<23>) <23>
IN	#40# Hexachlorophene (#40# an anthelmintic and antimicrobial agent,
	over 75% inhibition at 0.02 mM, IC50: 0.002 mM <23>) <23>
IN	#40# di-resorcinol sulfide (#40# over 75% inhibition at 0.02 mM, IC50:
	0.0038 mM <23>) <23>
IN	#40# bromochlorophen (#40# an anthelmintic agent, over 75% inhibition
	at 0.02 mM, IC50: 0.0154 mM <23>) <23>
IN	#47# anthecotulide (#47# linear sesquiterpene lactone from Anthemis
	auriculata <36>) <36>
IN	#47# 4-hydroxyanthecotulide (#47# linear sesquiterpene lactone from
	Anthemis auriculata <36>) <36>
IN	#47# 4-acetoxyanthecotulide (#47# most active linear sesquiterpene
	lactone from Anthemis auriculata against FabG <36>) <36>
IN	#8# p-chloromercuribenzoate <1>

KI_VALUE
KI	#4,23# -999 {more}  (#4# inhibition kinetic analysis <27>; #23# product
	inhibition kinetics, overview <25>) <25,27>
KI	#40# 0.0102 {3-hydroxybutyryl-CoA}  (#40# pH 6.8, 25°C, recombinant
	enzyme <23>) <23>

METALS_IONS
ME	#40# more (#40# the enzyme activity is maximal at a ionic strength of
	325 mM <23>) <23>

MOLECULAR_WEIGHT
MW	#10# 35000 (#10# sequence analysis, KCR2 <40>) <40>
MW	#13# 116000 (#13# recombinant enzyme, analytical ultracentrifugation,
	tetrameric at higher enzyme concentrations <29>) <29>
MW	#13# 50400 (#13# recombinant enzyme, gel filtration <29>) <29>
MW	#13# 58400 (#13# recombinant enzyme, analytical ultracentrifugation
	<29>) <29>
MW	#15# 120000 (#15# gel filtration <6>) <6>
MW	#25# 110000 (#25# gel filtration, wild-type and mutants <44>) <44>
MW	#26# 130000 (#26# gel filtration <7>) <7>
MW	#26# 40000-46000 (#26# gel filtration, sucrose density gradient
	centrifugation <11>) <11>
MW	#43# 25500 (#43# derived from amino acid sequence containing 246 amino
	acids <39>) <39>
MW	#44# 102000 (#44# gel filtration <41>) <41>
MW	#7# 44000 (#7# gel filtration <9>) <9>
MW	#8# 97000 (#8# gel filtration <1>) <1>
MW	#8# 64000 (#8# gel filtration <10>) <10>

POSTTRANSLATIONAL_MODIFICATION
PM	#40# more (#40# the enzyme contains a signal peptide <23>) <23>

SUBUNITS
SU	#13# dimer (#13# 2 * 29000, recombinant enzyme, SDS-PAGE <29>) <29>
SU	#15,26# More (#15,26# animals, yeast and Mycobacteria have fatty acid
	synthetases containing all the individual activities on one or two
	multifunctional polypeptide chains, plants and most bacterial systems,
	including Escherichia coli, possess individual monofunctional enzymes
	and a separate acyl carrier protein <3>) <3>
SU	#25# homotetramer (#25# 4 * 31000, SDS-PAGE, wild-type and mutants
	<44>) <44>
SU	#3,14,25,30# ? (#25# x * 28000, SDS-PAGE <17>; #30# ? * 27000, DNA
	sequence calculation <12>; #3# ? * 24000, SDS-PAGE <13>; #14# x *
	24000, recombinant methionine-labelled FabG2, SDS-PAGE <18>; #14# x *
	25000, recombinant methionine-labelled FabG1, SDS-PAGE <18>)
	<12,13,17,18>
SU	#8,13,15,25,26,40,42,44# tetramer (#26# 4 * 28000, SDS-PAGE <7>; #8# 4
	* 24200, SDS-PAGE <1>; #15# 4 * 20000-30000, SDS-PAGE <3,6>; #44# 4 *
	25500, SDS-PAGE <41>; #42# crystallization data <38>; #42#
	crystallography <51>; #13# 4 * 29000, SDS-PAGE, tetrameric at higher
	enzyme concentrations <29>; #40# crystal structure and ultrafiltration,
	quarternary structure analysis, monomer interactions, conformations in
	absence and presence of cofactor NADP+ <23>; #25# cross-linking of
	native and up to 1 M urea-treated FabG <50>) <1,3,6,7,23,29,38,41,50,51>

PI_VALUE
PI	#43# 5.9 (#43# predicted <39>) <39>

APPLICATION
AP	#1,2,4,11,12,13,16,18,19,20,22,24,25,27,31,32,33,35,36,37# drug
	development (#25# the enzyme has no isoforms and thus is a good target
	for inhibitor design <26>;
	#1,2,4,11,12,13,16,18,20,22,24,27,32,33,35,37# FabG is the antibacteria
	target of maple leaf extracts and tannic acid, and both reversible and
	irreversible inhibitions of FabG are important for the antibacterial
	effect <49>; #2,13,19,31,36# galangal extract inhibits FabG, thereby
	displaying antibacterial ability <47>) <26,47,49>
AP	#4# synthesis (#4# coexpression with fabH mutant F87T and
	polyhydroxyalkanoate synthase genes enhances the production of short
	chain length-medium chain length polyhydroxyalkanoate copolymer from
	both related and unrelated carbon sources. Analysis of
	polyhydroxyalkanoate accumulation and physical characterization of
	copolymer <34>) <34>

ENGINEERING
EN	#1# M125I/S233T (#1# temperature-sensitive mutant enzyme does not allow
	growth of Escherichia coli at 42°C in complementation assay <19>) <19>
EN	#1,4# E233K (#1# temperature-sensitive mutant enzyme does not allow
	growth of Escherichia coli at 42°C in complementation assay <19>; #4#
	temperature-sensitive phenoptype, reductase activity is much more
	thermolabile than the activity of the wild-type strain <19>) <19>
EN	#25# R187A (#25# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 3fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <44>) <44>
EN	#25# R230A (#25# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 5fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <44>) <44>
EN	#25# R187E (#25# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 4fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <44>) <44>
EN	#25# R230E (#25# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 41fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <44>) <44>
EN	#25# R187A/R230A (#25# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. 5fold decreased affinity binding
	to acyl-carrier protein with respect to wild-type <44>) <44>
EN	#25# R187E/R230E (#25# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. 80fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <44>) <44>
EN	#25# R187K (#25# no decreased affinity binding to acyl-carrier protein
	with respect to wild-type <44>) <44>
EN	#4# A154T/E233K (#4# temperature-sensitive phenoptype, reductase
	activity is much more thermolabile than the activity of the wild-type
	strain <19>) <19>
EN	#4# A154T (#4# similar thermal stability as wild-type enzyme <19>) <19>
EN	#4# F87T (#4# coexpression with fabH mutant F87T and
	polyhydroxyalkanoate synthase genes enhances the production of short
	chain length-medium chain length polyhydroxyalkanoate copolymer from
	both related and unrelated carbon sources <34>) <34>
EN	#5# K1699A (#5# site-directed mutagenesis, the mutant BKR shows reduced
	Km for acetoacetyl-CoA, increased Km for NADPH and reduced activity
	compared to the wild-type enzyme <28>) <28>
EN	#5# K1699Q (#5# site-directed mutagenesis, the mutant BKR shows reduced
	Km for acetoacetyl-CoA, increased Km for NADPH and reduced activity
	compared to the wild-type enzyme <28>) <28>
EN	#5# S2151A (#5# site-directed mutagenesis, inactive mutant <28>) <28>
EN	#6,10,15,30# more (#30# glutathione-S-transferase fusion protein
	without transit peptide, expressed in Escherichia coli <12>; #15#
	transformation with 3-oxoacyl-[acyl-carrier-protein] reductase in
	antisense orientation, driven by either the cauliflower mosaic virus
	35S promoter or a seed-specific acyl carrier protein promoter. In
	plants with altered reductase activity, total seed yield is reduced in
	all cases. In less severely affected plant lines, seeds have a normal
	appearance and composition but the yield of seeds is reduced by
	approximately 50%. In more severely affected lines, reductions in both
	seed fatty acid content and the number of seeds produced per plant are
	evident, resulting in a 90% reduction in fatty acid synthesized per
	plant. Phenotypes are independent of the promoter used. In severely
	affected lines, a large proportion of seeds show precocious
	germination, and these have a reduced oleate content and increased
	levels of polyunsaturated 18-carbon fatty acids, compared with normal
	seeds of the same line <37>; #10# insertional mutants in KCR1 and KCR2
	<40>; #6# mutant cells lacking the homologous mitochondrial FASII
	enzyme 3-oxoacyl-ACP reductase Oar1p <46>; #6# oar1-DELTA mutants, lack
	3-oxoacyl-ACP reductase acitivity, expression of FabG4 gene of
	Mycobacterium tuberculosis <48>) <12,37,40,46,48>

CLONED
CL	#3# (expression in Escherichia coli) <13>
CL	#4# (overexpression of fabG gene in Escherichia coli strain BL21 (DE3))
	<14>
CL	#4# (gene fabG, expression of N-terminally His-tagged enzyme in
	Escherichia coli strain BL21(DE3)) <27>
CL	#4# (gene fabG, overexpression of His-tagged enzyme in strain
	BL21(DE3)) <22>
CL	#4# (coexpression in Escherichia coli LS5218 with fabH mutant F87T and
	polyhydroxyalkanoate synthase genes) <34>
CL	#4# (His-tagged FabG expressed in Escherichia coli strain BL21 (DE3))
	<49>
CL	#4# (NH2-terminally His-tagged FabG expressed in Escherichia coli
	strain BL21(DE3)) <45>
CL	#4# (pET15b-fabG vector construct transformed into the Escherichia coli
	BL21 DE3 strain) <43>
CL	#5# (expression of His-tagged wild-type and mutant fatty acid synthase
	complex enzymes in Spodoptera frugiperda Sf9 cells using the
	baculovirus infection system) <28>
CL	#10# (YFP-KCR1 and CFP-KCR2 fusion constructs transiently expressed in
	tobacco under the control of the 35S promoter or in Arabidopsis. KCR1
	and KCR2 expressed in the yeast ybr159DELTA mutant) <40>
CL	#13# (gene rhlG, expression of His-tagged enzyme in Escherichia coli
	strain BL21(DE3) or, as selenomethionine-labeled variant in Escherichia
	coli strain B834 in minimal medium) <29>
CL	#14# (complementation of Escherichia coli fabG mutant with
	Lactobacillus lactis fabG genes shows that fabG1 encodes a functional
	beta-ketoacyl ACP reductase and fabG2 encodes an enzyme that has
	activity with the model substrate beta-ketobutyryl-CoA, but lacks the
	ability to support fatty acid synthesis both in vivo and in vitro) <18>
CL	#15# (overexpression in Escherichia coli strain BL21 (DE3)) <15>
CL	#15# (transformation with 3-oxoacyl-[acyl-carrier-protein] reductase in
	antisense orientation, driven by either the cauliflower mosaic virus
	35S promoter or a seed-specific acyl carrier protein promoter) <37>
CL	#17# (heterologous coexpression of the polyhydroxyalkanoate synthase
	genes phaEC together with Haloarcula hispanica fabG1 reconstructs the
	polyhydroxyalkanoate biosynthetic pathway) <42>
CL	#21# (expression in Saccharomyces cerevisae mutant cells lacking the
	homologous mitochondrial FASII enzyme 3-oxoacyl-ACP reductase Oar1p)
	<46>
CL	#23# (expression in Escherichia coli) <32>
CL	#23# (selection of an Escherichia coli, BL21(DE3)NH host that stably
	expresses mutant forms of 3-ketoacyl-ACP(CoA) reductase) <21>
CL	#23# (expression in Streptomyces cerevisiae cells lacking 3-oxoacyl-ACP
	reductase) <48>
CL	#25# (expression in Escherichia coli) <17>
CL	#25# (gene fabG, DNA and amino acid sequence determination and
	analysis, expression of C-terminally His-tagged enzyme in Escherichia
	coli strain BL21(DE3)) <26>
CL	#25# (overexpression of His-tagged enzyme in Escherichia coli strain
	BL21(DE3) in inclusion bodies) <30>
CL	#25# (into pET-28a vector and expressed in Escherichia coli BL21 (DE3)
	codon plus) <50>
CL	#25# (wild-type and mutants cloned into the pET-28a(+) vector and
	expressed in Escherichia coli BL21 (DE3) codon plus) <44>
CL	#30# (expression of protein without transit peptide in Escherichia
	coli) <12>
CL	#36# (overexpressed in Escherichia coli BL21 (DE3)) <47>
CL	#38# (heterologous coexpression of the polyhydroxyalkanoate synthase
	genes phaEC together with fabG1 in Haloferax volcanii) <42>
CL	#39# (gene fabG, overexpression of His-tagged enzyme in strain
	BL21(DE3), recombinant expression in Escherichia coli strain JM109
	leads to enhanced production of polyhydroxyalkanoate, PHA, copolymer
	from glucose, PHA composition, overview) <22>
CL	#40# (gene fabG, DNA and amino acid sequence determination and
	analysis, expression of His10-tagged enzyme in Escherichia coli) <23>
CL	#41# (expression in Escherichia coli) <31>
CL	#42# (expression in Escherichia coli) <38>
CL	#42# (PCR product recombined with pDONR221 and insert from this vector
	transferred in the LR reaction to the expression vector pET15g which
	adds a histidine tag and a 3C protease cleavage site, expressed in
	Escherichia coli B834(DE3) cells) <51>
CL	#43# (Recombinant Escherichia coli (strain DH5alpha) co-expresses the
	fabG gene. The fabG gene is PCR-cloned using primers derived from the
	up and down-stream regions of the Pseudomonas putida KT2440 genome.)
	<39>
CL	#44# (transformation of the fabG gene encoding
	3-ketoacyl-[acyl-carrier-protein] reductase in fusion with a
	His6-MBP-tag (ligated into vector pETM-41) into Escherichia coli XL-10
	Gold. After isolation from XL-10 cells and DNA sequencing, transformed
	into Escherichia coli Tuner (DE3) cells) <41>
CL	#45# (FabG1 expressed from vector pPLM189 as mitochondrial protein in
	the Saccharomyces cerevisiae oar1DELTA mutant strain. FabG1 can restore
	respiratory growth of Saccharomyces cerevisiae oar1DELTA cells and
	renews lipoic acid production) <48>
CL	#46# (FabG4 expressed from vector pPLM192 as mitochondrial protein in
	the Saccharomyces cerevisiae oar1DELTA mutant strain. FabG4 can restore
	respiratory growth of Saccharomyces cerevisiae oar1DELTA cells and
	renews lipoic acid production) <48>

CRYSTALLIZATION
CR	#4# <14>
CR	#13# (purified native and selenomethionine-labeled recombinant enzyme,
	hanging drop vapour diffusion method, 18°C, 2.5 mg/ml protein in 50 mm
	HEPES, pH 7.0, 5 mM Tris, pH 8.0, 0.15 mM ammonium sulfate, 6% PEG
	4000, 0.1 M NaCl, 0.5 mM EDTA, and 0.5 mM DTT, mixed with reservoir
	solution containing 1 M HEPES, pH 7.0, 0.3 M ammonium sulfate, and 12%
	PEG 4000, plus 1 mM NADPH, X-ray diffraction structure determination
	and analysis at 2.3 A resolution) <29>
CR	#15# <15>
CR	#15# (structure determination and similarities within short-chain
	alcohol dehydrogenase family, catalytic mechanism) <16>
CR	#40# (purified recombinant enzyme, vapour diffusion method, 10 mg/ml
	protein in 20 mM HEPES, pH 6.8, 0.5 M NaCl, 1 mM DTT, and 0.5 mM EDTA,
	is mixed with an equal volume of reservoir solution containing 0.1 M
	MES, pH 6.0, 35% v/v 2-methyl-2,4-pentanediol, and 0.2 M LiSO4,
	equilibration against 1 ml of mother liquor, room temperature, 6 weeks,
	X-ray diffraction structure determination and analysis at 1.9 A
	resolution) <23>
CR	#41# (diffraction to 1.8 A, determinantion of initial phases by
	molecular replacement) <31>
CR	#42# (diffraction to 2.4 A. Final model contains two tetramers
	displaying 222 symmetry and 575 water molecules in the crystallographic
	asymmetric unit, but no bound cofactors or substrates) <38>
CR	#42# (at 2.4 A resolution, space group P21 with unit-cell parameters a
	= 70.6, b = 120.7, c = 136.4 and beta = 104.4. The structure contains
	two tetramers displaying 222 symmetry (all chains are completely
	traced, although for some chains the electron density for residues
	189-203 is poor) and 575 water molecules in the crystallographic
	asymmetric unit, but no bound cofactors or substrates) <51>

PURIFICATION
PU	#4# <5,14>
PU	#4# (recombinant His-tagged enzyme from strain BL21(DE3) by nickel
	affinity chromatography) <22>
PU	#4# (by nickel affinity chromatography) <45>
PU	#4# (recombinant N-terminally His-tagged enzyme from Escherichia coli
	strain BL21(DE3) by nickel affinity chromatography) <27>
PU	#4# (by nickel chelation affinity chromatography) <49>
PU	#4# (by sonication, centrifugation and on Ni-NTA column) <43>
PU	#5# (recombinant His-tagged wild-type and mutant fatty acid synthase
	complex enzymes from Sf9 insect cells by nickel affinity
	chromatography, gel filtration, and dialysis) <28>
PU	#8# <1,10>
PU	#13# (recombinant His-tagged enzyme from Escherichia coli strain
	BL21(DE3) by nickel affinity chromatography) <29>
PU	#15# <3,6,15>
PU	#23# (recombinant protein, modified purification protocol) <32>
PU	#25# <50>
PU	#25# (recombinant C-terminally His-tagged enzyme from Escherichia coli
	strain BL21(DE3) by nickel affinity chromatography) <26>
PU	#25# (recombinant His-tagged enzyme from Escherichia coli strain
	BL21(DE3) solubilized from inclusion bodies and refolded is further
	purified by nickel affinity chromatography) <30>
PU	#25# (wild-type and mutants purified to homogeneity using an
	Ni2+-nitrilotriacetic acid affinity column) <44>
PU	#26# <3,7,11>
PU	#36# (by nickel chelation affinity chromatography) <47>
PU	#39# (recombinant His-tagged enzyme from strain BL21(DE3) by nickel
	affinity chromatography) <22>
PU	#40# (recombinant His10-tagged enzyme from Escherichia coli by nickel
	affinity chromatography and gel filtration) <23>
PU	#41# (recombinant protein) <31>
PU	#42# (by nickel-affinity chromatography) <51>
PU	#44# (by gel filtration and ion exchange chromatography, to
	homogeneity) <41>

RENATURED
RN	#25# (solubilization of overexpressed recombinant His-tagged enzyme
	from Escherichia coli strain BL21(DE3) inclusion bodies by 8 M urea,
	and refolding by dialysis, cation exchange chromatography, and dilution
	in presence of 0.001 mM NADPH in 20 mM sodium acetate, pH 5.3, 10%
	glycerol, and 0.05% Tween 20, the refolded enzyme shows 90-95% of
	soluble enzyme activity) <30>
RN	#25# (study on guanidinium chloride-induced isothermal and thermal
	denaturation. Folding/unfolding is completely reversible and a
	two-state process. Conformational stability, i.e. DELTAGS, and the
	DELTACP value for the protein unfolding, are 22.68 kcal/mole and 5.83
	kcal/(mole K)) <35>

GENERAL_STABILITY
GS	#15,26# (inactivation by dilution can be partly prevented by inclusion
	of NADPH) <6,7>
GS	#40# (the purified recombinant enzyme is stable at room temperature at
	concentrations above 0.2 mg/ml, but unstable at 0.01 mg/ml) <23>

STORAGE_STABILITY
SS	#15# (4°C, 100 mM potassium phosphate, 52% loss of activity after 24
	h) <6>
SS	#15# (27°C, 100 mM potassium phosphate buffer, 13% loss of activity
	after 24 h) <6>
SS	#26# (27°C, 2 M NaCl, 24 h stable) <7>
SS	#4# (-80°C, 10% glycerol) <43>
SS	#4# (-20°C, phosphate buffer, 10% glycerol) <45>
SS	#4,36# (-80°C, 50% glycerol) <47,49>
SS	#8# (-20°C, stable for 2 months) <1>

TEMPERATURE_STABILITY
TS	#4# 37 (#4# wild-type enzyme: about 40% loss of activity after 15 min,
	mutant enzyme E233K: about 90% loss of activity after 10 min, mutant
	enzyme A164T: about 25% loss of activity after 15 min, mutant enzyme
	A154T/E233K: about 80% loss of activity after 5 min <19>) <19>
TS	#4# 30 (#4# wild-type enzyme: about 15% loss of activity after 15 min,
	mutant enzyme E233K: about 60% loss of activity after 10 min,mutant
	enzyme A164T: about 20% loss of activity after 15 min, mutant enzyme
	A154T/E233K: about 80% loss of activity after 15 min <19>) <19>
TS	#4# 45 (#4# wild-type enzyme: about 70% loss of activity after 15 min,
	mutant enzyme E233K: complete loss of activity after 10 min, mutant
	enzyme A164T: about 60% loss of activity after 15 min, mutant enzyme
	A154T/E233K: complete loss of activity after 5 min <19>) <19>

REFERENCE
RF	<1> Shimakata, T.; Stumpf, P.K.: Purification and characterizations of
	beta-ketoacyl-[acyl-carrier-protein] reductase,
	beta-hydroxyacyl-[acylcarrier-protein] dehydrase, and
	enoyl-[acyl-carrier-protein] reductase from Spinacia oleracea leaves.
	Arch. Biochem. Biophys. (1982) 218, 77-91. {Pubmed:6756317}
RF	<2> Shimakata, T.; Stumpf, P.K.: The procaryotic nature of the fatty
	acid synthetase of developing Carthamus tinctorius L. (Safflower)
	seeds. Arch. Biochem. Biophys. (1982) 217, 144-154. {Pubmed:7125663}
RF	<3> Sheldon, P.S.; Safford, R.; Slabas, A.R.; Kekwick, R.G.O.:
	3-Oxoacyl-[acyl carrier protein] reductase: a component of plant fatty
	acid synthase. Biochem. Soc. Trans. (1988) 16, 392-393. {Pubmed:}
	(review)
RF	<4> Volpe, J.J.; Vagelos, P.R.: Saturated fatty acid biosynthesis and
	its regulation. Annu. Rev. Biochem. (1973) 42, 21-60. {Pubmed:4147183}
	(review)
RF	<5> Toomey, R.E.; Wakil, S.J.: Studies on the mechanism of fatty acid
	synthesis. XV. Preparation and general properties of beta-ketoacyl acyl
	carrier protein reductase from Escherichia coli. Biochim. Biophys. Acta
	(1966) 116, 189-197. {Pubmed:4381013}
RF	<6> Sheldon, P.S.; Kekwick, R.G.O.; Smith, C.G.; Sidebottom, C.;
	Slabas, A.R.: 3-Oxoacyl-[ACP] reductase from oil seed rape (Brassica
	napus). Biochim. Biophys. Acta (1992) 1130, 151-159. {Pubmed:}
RF	<7> Sheldon, P.S.; Kekwick, R.G.O.; Sidebottom, C.; Smith, C.G.;
	Slabas, A.R.: 3-Oxoacyl-(acyl-carrier protein) reductase from avocado
	(Persea americana) fruit mesocarp. Biochem. J. (1990) 271, 713-720.
	{Pubmed:2244875}
RF	<8> Shimakata, T.; Stumpf, P.K.: The purification and function of
	acetyl coenzyme A:acyl carrier protein transacylase. J. Biol. Chem.
	(1983) 258, 3592-3598. {Pubmed:6833216}
RF	<9> Hendren, R.W.; Bloch, K.: Fatty acid synthetases from Euglena
	gracilis. Separation of component activities of the ACP-dependent fatty
	acid synthetase and partial purification of the beta-ketoacyl-ACP
	synthetase. J. Biol. Chem. (1980) 255, 1504-1508. {Pubmed:6766450}
RF	<10> Shimakata, T.; Stumpf, P.K.: Fatty acid synthetase of Spinacia
	oleracea leaves. Plant Physiol. (1982) 69, 1257-1262. {Pubmed:16662382}
RF	<11> Caughey, I.; Kekwick, R.G.O.: The characteristics of some
	components of the fatty acid synthetase system in the plastids from the
	mesocarp of avocado (Persea americana) fruit. Eur. J. Biochem. (1982)
	123, 553-561. {Pubmed:7075600}
RF	<12> Klein, B.; Pawlowski, K.; Höricke-Grandpierre, C.; Schell, J.;
	Töpfer, R.: Isolation and characterization of a cDNA from Cuphea
	lanceolata encoding a beta-ketoacyl-ACP reductase. Mol. Gen. Genet.
	(1992) 233, 122-128. {Pubmed:1376402}
RF	<13> Morbidoni, H.R.; de Mendoza, D.; Cronan, J.E.: Bacillus subtilis
	acyl carrier protein is encoded in a cluster of lipid biosynthesis
	genes. J. Bacteriol. (1996) 178, 4794-4800. {Pubmed:8759840}
RF	<14> Rafferty, J.B.; Fisher, M.; Langridge, S.J.; Martindale, W.;
	Thomas, N.C.; Simon, J.W.; Bithell, S.; Slabas, A.R.; Rice, D.W.:
	Crystallization of the NADP-dependent beta-keto acyl carrier protein
	reductase from Escherichia coli. Acta Crystallogr. Sect. D (1998) 54,
	427-429. {Pubmed:9761917}
RF	<15> Fisher, M.; Sedelnikowa, S.E.; Martindale, W.; Thomas, N.C.;
	Simon, J.W.; Slabas, A.R.; Rafferty, J.B.: Crystallization of the
	NADP-dependent beta-keto acyl-carrier protein reductase from Brassica
	napus. Acta Crystallogr. Sect. D (2000) 56, 86-88. {Pubmed:10666637}
RF	<16> Fisher, M.; Kroon, J.T.M.; Martindale, W.; Stuitje, A.R.; Slabas,
	A.R.; Rafferty, J.B.: The x-ray structure of Brassica napus beta-keto
	acyl carrier protein reductase and its implications for substrate
	binding and catalysis. Structure (2000) 8, 339-347. {Pubmed:10801480}
RF	<17> Pillai, S.; Rajagopal, C.; Kapoor, M.; Kumar, G.; Gupta, A.;
	Surolia, N.: Functional characterization of beta-ketoacyl-ACP reductase
	(FabG) from Plasmodium falciparum. Biochem. Biophys. Res. Commun.
	(2003) 303, 387-392. {Pubmed:12646215} (c)
RF	<18> Wang, H.; Cronan, J.E.: Only one of the two annotated Lactococcus
	lactis fabG genes encodes a functional beta-ketoacyl-acyl carrier
	protein reductase. Biochemistry (2004) 43, 11782-11789.
	{Pubmed:15362862} (c)
RF	<19> Lai, C.Y.; Cronan, J.E.: Isolation and characterization of
	beta-ketoacyl-acyl carrier protein reductase (fabG) mutants of
	Escherichia coli and Salmonella enterica serovar typhimurium. J.
	Bacteriol. (2004) 186, 1869-1878. {Pubmed:14996818} (c)
RF	<20> Hoang, T.T.; Sullivan, S.A.; Cusick, J.K.; Schweizer, H.P.:
	beta-Ketoacyl acyl carrier protein reductase (FabG) activity of the
	fatty acid biosynthetic pathway is a determining factor of
	3-oxo-homoserine lactone acyl chain lengths. Microbiology (2002) 148,
	3849-3856. {Pubmed:12480888} (c)
RF	<21> Poletto, S.S.; da Fonseca, I.O.; de Carvalho, L.P.; Basso, L.A.;
	Santos, D.S.: Selection of an Escherichia coli host that expresses
	mutant forms of Mycobacterium tuberculosis 2-trans enoyl-ACP(CoA)
	reductase and 3-ketoacyl-ACP(CoA) reductase enzymes. Protein Expr.
	Purif. (2004) 34, 118-125. {Pubmed:14766307} (c)
RF	<22> Nomura, C.T.; Taguchi, K.; Gan, Z.; Kuwabara, K.; Tanaka, T.;
	Takase, K.; Doi, Y.: Expression of 3-ketoacyl-acyl carrier protein
	reductase (fabG) genes enhances production of polyhydroxyalkanoate
	copolymer from glucose in recombinant Escherichia coli JM109. Appl.
	Environ. Microbiol. (2005) 71, 4297-4306. {Pubmed:16085817}
RF	<23> Wickramasinghe, S.R.; Inglis, K.A.; Urch, J.E.; Mueller, S.; van
	Aalten, D.M.; Fairlamb, A.H.: Kinetic, inhibition and structural
	studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key
	enzyme in fatty acid biosynthesis. Biochem. J. (2006) 393, 447-457.
	{Pubmed:16225460}
RF	<24> Patel, M.P.; Liu, W.S.; West, J.; Tew, D.; Meek, T.D.; Thrall,
	S.H.: Kinetic and chemical mechanisms of the fabG-encoded Streptococcus
	pneumoniae beta-ketoacyl-ACP reductase. Biochemistry (2005) 44,
	16753-16765. {Pubmed:16342966}
RF	<25> Silva, R.G.; de Carvalho, L.P.; Blanchard, J.S.; Santos, D.S.;
	Basso, L.A.: Mycobacterium tuberculosis beta-ketoacyl-acyl carrier
	protein (ACP) reductase: kinetic and chemical mechanisms. Biochemistry
	(2006) 45, 13064-13073. {Pubmed:17059223}
RF	<26> Karmodiya, K.; Surolia, N.: Analyses of co-operative transitions
	in Plasmodium falciparum beta-ketoacyl acyl carrier protein reductase
	upon co-factor and acyl carrier protein binding. FEBS J. (2006) 273,
	4093-4103. {Pubmed:16934037}
RF	<27> Li, B.H.; Ma, X.F.; Wu, X.D.; Tian, W.X.: Inhibitory activity of
	chlorogenic acid on enzymes involved in the fatty acid synthesis in
	animals and bacteria. IUBMB Life (2006) 58, 39-46. {Pubmed:16540431}
RF	<28> Carlisle-Moore, L.; Gordon, C.R.; Machutta, C.A.; Miller, W.T.;
	Tonge, P.J.: Substrate recognition by the human fatty-acid synthase. J.
	Biol. Chem. (2005) 280, 42612-42618. {Pubmed:16215233}
RF	<29> Miller, D.J.; Zhang, Y.M.; Rock, C.O.; White, S.W.: Structure of
	RhlG, an essential beta-ketoacyl reductase in the rhamnolipid
	biosynthetic pathway of Pseudomonas aeruginosa. J. Biol. Chem. (2006)
	281, 18025-18032. {Pubmed:16624803}
RF	<30> Karmodiya, K.; Srivastav, R.K.; Surolia, N.: Production and
	purification of refolded recombinant Plasmodium falciparum
	beta-ketoacyl-ACP reductase from inclusion bodies. Protein Expr. Purif.
	(2005) 42, 131-136. {Pubmed:15939298}
RF	<31> Mao, Q.; Duax, W.L.; Umland, T.C.: Crystallization and X-ray
	diffraction analysis of the beta-ketoacyl-acyl carrier protein
	reductase FabG from Aquifex aeolicus VF5. Acta Crystallogr. Sect. F
	(2007) 63, 106-109. {Pubmed:17277451}
RF	<32> Silva, R.G.; Rosado, L.A.; Santos, D.S.; Basso, L.A.:
	Mycobacterium tuberculosis beta-ketoacyl-ACP reductase: alpha-secondary
	kinetic isotope effects and kinetic and equilibrium mechanisms of
	substrate binding. Arch. Biochem. Biophys. (2008) 471, 1-10.
	{Pubmed:18155153}
RF	<33> Zhang, F.; Luo, S.Y.; Ye, Y.B.; Zhao, W.H.; Sun, X.G.; Wang, Z.Q.;
	Li, R.; Sun, Y.H.; Tian, W.X.; Zhang, Y.X.: The antibacterial efficacy
	of aceraceous plant may be related to inhibition of bacterial
	beta-ketoacyl-ACP reductase (FabG). Biotechnol. Appl. Biochem. (2008)
	51, 73-78. {Pubmed:18208374}
RF	<34> Nomura, C.T.; Tanaka, T.; Eguen, T.E.; Appah, A.S.; Matsumoto, K.;
	Taguchi, S.; Ortiz, C.L.; Doi, Y.: FabG mediates polyhydroxyalkanoate
	production from both related and nonrelated carbon sources in
	recombinant Escherichia coli LS5218. Biotechnol. Prog. (2008) 24,
	342-351. {Pubmed:18215055}
RF	<35> Karmodiya, K.; Sajad, S.; Sinha, S.; Maity, K.; Suguna, K.;
	Surolia, N.: Conformational stability and thermodynamic
	characterization of homotetrameric Plasmodium falciparum
	beta-ketoacyl-ACP reductase. IUBMB Life (2007) 59, 441-449.
	{Pubmed:17654120}
RF	<36> Karioti, A.; Skaltsa, H.; Zhang, X.; Tonge, P.J.; Perozzo, R.;
	Kaiser, M.; Franzblau, S.G.; Tasdemir, D.: Inhibiting enoyl-ACP
	reductase (FabI) across pathogenic microorganisms by linear
	sesquiterpene lactones from Anthemis auriculata. Phytomedicine (2008)
	15, 1125-1129. {Pubmed:18424102}
RF	<37> OHara, P.; Slabas, A.R.; Fawcett, T.: Antisense expression of
	3-oxoacyl-ACP reductase affects whole plant productivity and causes
	collateral changes in activity of fatty acid synthase components. Plant
	Cell Physiol. (2007) 48, 736-744. {Pubmed:17401135}
RF	<38> Zaccai, N.R.; Carter, L.G.; Berrow, N.S.; Sainsbury, S.;
	Nettleship, J.E.; Walter, T.S.; Harlos, K.; Owens, R.J.; Wilson, K.S.;
	Stuart, D.I.; Esnouf, R.M.: Crystal structure of a 3-oxoacyl-(acyl
	carrier protein) reductase (BA3989) from Bacillus anthracis at
	2.4-.ANG. resolution. Proteins Struct. Funct. Bioinform. (2007) 70,
	562-567. {Pubmed:}
RF	<39> Vo, M.T.; Lee, K.W.; Jung, Y.M.; Lee, Y.H.: Comparative effect of
	overexpressed phaJ and fabG genes supplementing (R)-3-hydroxyalkanoate
	monomer units on biosynthesis of mcl-polyhydroxyalkanoate in
	Pseudomonas putida KCTC1639. J. Biosci. Bioeng. (2008) 106, 95-98.
	{Pubmed:18691538}
RF	<40> Beaudoin, F.; Wu, X.; Li, F.; Haslam, R.P.; Markham, J.E.; Zheng,
	H.; Napier, J.A.; Kunst, L.: Functional characterization of the
	Arabidopsis beta-ketoacyl-coenzyme A reductase candidates of the fatty
	acid elongase. Plant Physiol. (2009) 150, 1174-1191. {Pubmed:19439572}
RF	<41> Hoelsch, K.; Havel, J.; Haslbeck, M.; Weuster-Botz, D.:
	Identification, cloning, and characterization of a novel ketoreductase
	from the cyanobacterium Synechococcus sp. strain PCC 7942. Appl.
	Environ. Microbiol. (2008) 74, 6697-6702. {Pubmed:18791006}
RF	<42> Han, J.; Lu, Q.; Zhou, L.; Liu, H.; Xiang, H.: Identification of
	the polyhydroxyalkanoate (PHA)-specific acetoacetyl coenzyme A
	reductase among multiple FabG paralogs in Haloarcula hispanica and
	reconstruction of the PHA biosynthetic pathway in Haloferax volcanii.
	Appl. Environ. Microbiol. (2009) 75, 6168-6175. {Pubmed:19648370}
RF	<43> Kristan, K.; Bratkovic, T.; Sova, M.; Gobec, S.; Prezelj, A.;
	Urleb, U.: Novel inhibitors of beta-ketoacyl-ACP reductase from
	Escherichia coli. Chem. Biol. Interact. (2009) 178, 310-316.
	{Pubmed:18977209}
RF	<44> Karmodiya, K.; Modak, R.; Sahoo, N.; Sajad, S.; Surolia, N.:
	Deciphering the key residues in Plasmodium falciparum beta-ketoacyl
	acyl carrier protein reductase responsible for interactions with
	Plasmodium falciparum acyl carrier protein. FEBS J. (2008) 275,
	4756-4766. {Pubmed:18721141}
RF	<45> Sun, Y.H.; Cheng, Q.; Tian, W.X.; Wu, X.D.: A substitutive
	substrate for measurements of beta-ketoacyl reductases in two fatty
	acid synthase systems. J. Biochem. Biophys. Methods (2008) 70, 850-856.
	{Pubmed:18201766}
RF	<46> Gurvitz, A.: Caenorhabditis elegans F09E10.3 encodes a putative
	3-oxoacyl-thioester reductase of mitochondrial type 2 fatty acid
	synthase FASII that is functional in yeast. J. Biomed. Biotechnol.
	(2009) FEHLT, 0000. {Pubmed:19746209}
RF	<47> Huang, H.; Wu, D.; Tian, W.X.; Ma, X.F.; Wu, X.D.: Antimicrobial
	effect by extracts of rhizome of Alpinia officinarum Hance may relate
	to its inhibition of beta-ketoacyl-ACP reductase. J. Enzyme Inhib. Med.
	Chem. (2008) 23, 362-368. {Pubmed:18569341}
RF	<48> Gurvitz, A.: The essential mycobacterial genes, fabG1 and fabG4,
	encode 3-oxoacyl-thioester reductases that are functional in yeast
	mitochondrial fatty acid synthase type 2. Mol. Genet. Genomics (2009)
	282, 407-416. {Pubmed:19685079}
RF	<49> Wu, D.; Wu, X.D.; You, X.F.; Ma, X.F.; Tian, W.X.: Inhibitory
	effects on bacterial growth and b-ketoacyl-ACP reductase by different
	species of maple leaf extracts and tannic acid. Phytother. Res. (2009)
	24, 535-541. {Pubmed:}
RF	<50> Karmodiya, K.; Surolia, N.: A unique and differential effect of
	denaturants on cofactor mediated activation of Plasmodium falciparum
	beta-ketoacyl-ACP reductase. Proteins Struct. Funct. Genet. (2008) 70,
	528-538. {Pubmed:17879351}
RF	<51> Zaccai, N.; Carter, L.; Berrow, N.; Sainsbury, S.; Nettleship, J.;
	Walter, T.; Harlos, K.; Owens, R.; Wilson, K.; Stuart, D.; Esnouf, R.:
	Crystal structure of a 3-oxoacyl-(acyl carrier protein) reductase
	(BA3989) from Bacillus anthracis at 2.4 A resolution. Proteins Struct.
	Funct. Genet. (2008) 70, 562-567. {Pubmed:17894349}

ACTIVATING_COMPOUND
AC	#25,44# more (#25# affinity of acyl-carrier protein for FabG is
	increased by 3fold in the presence of 1 M urea <50>; #44# variation of
	the buffer molarity between 25 mM and 200 mM or addition of NaCl up to
	500 mM has no significant effect on enzyme activity <41>) <41,50>

KI_VALUE
KI	#4,23# -999 {more}  (#4# inhibition kinetic analysis <27>; #23# product
	inhibition kinetics, overview <25>) <25,27>
KI	#40# 0.0102 {3-hydroxybutyryl-CoA}  (#40# pH 6.8, 25°C, recombinant
	enzyme <23>) <23>

IC50_VALUE
IC50	#36# 0.0212 {kaemperol}  (#36# pH 7.0 <47>) <47>
IC50	#36# -999 {more}  (#36# IC(50) value of 4.47 microg/ml for extract of
	galangal, pH 7.0 <47>) <47>
IC50	#36# 0.3048 {quercetin}  (#36# pH 7.0 <47>) <47>
IC50	#4# 0.18 {(E)-phenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate}  (#4# pH 7.0
	<43>) <43>
IC50	#4# 0.18 {(E)-4-cyanophenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate}  (#4#
	pH 7.0 <43>) <43>
IC50	#4# 0.45 {(E)-2-nitrophenyl cinnamate}  (#4# pH 7.0 <43>) <43>
IC50	#4# 0.12 {epigallocatechin gallate}  (#4# at pH 9.0 <45>) <45>
IC50	#4# 0.00078 {Tannic acid}  <49>
IC50	#4# 0.0084 {epigallocatechin gallate}  (#4# at pH 8.3 <45>) <45>
IC50	#4# 0.0105 {epigallocatechin gallate}  (#4# at pH 7.5 <45>) <45>
IC50	#4# 0.881-0.948 {chlorogenic acid}  (#4# IC50: 0.881-0.948 mM <27>) <27>
IC50	#4# 0.215
	{N-(1,3-dioxoisoindolin-2-yl)-2-oxo-2H-chromene-3-carboxamide}  (#4# pH
	7.0 <43>) <43>
IC50	#4# 0.0578 {epigallocatechin gallate}  (#4# at pH 7.0 <45>) <45>
IC50	#4# 0.0336 {epigallocatechin gallate}  (#4# at pH 8.5 <45>) <45>
IC50	#4# 0.00554 {epigallocatechin gallate}  (#4# at pH 8.0 <45>) <45>
IC50	#4# 0.1223 {epigallocatechin gallate}  (#4# at pH 6.5 <45>) <45>
IC50	#40# 0.002 {Hexachlorophene}  (#40# an anthelmintic and antimicrobial
	agent, over 75% inhibition at 0.02 mM, IC50: 0.002 mM <23>) <23>
IC50	#40# 0.01 {Bithionol}  (#40# over 75% inhibition at 0.02 mM, IC50:
	0.010 mM <23>) <23>
IC50	#40# 0.0038 {di-resorcinol sulfide}  (#40# over 75% inhibition at 0.02
	mM, IC50: 0.0038 mM <23>) <23>
IC50	#40# 0.0154 {bromochlorophen}  (#40# an anthelmintic agent, over 75%
	inhibition at 0.02 mM, IC50: 0.0154 mM <23>) <23>
IC50	#47# 1 {anthecotulide}  (#47# pH 7.0, 25°C <36>) <36>
IC50	#47# 0.5 {4-acetoxyanthecotulide}  (#47# pH 7.0, 25°C <36>) <36>
IC50	#47# 0.75 {4-hydroxyanthecotulide}  (#47# pH 7.0, 25°C <36>) <36>

PI_VALUE
PI	#43# 5.9 (#43# predicted <39>) <39>

IC50_VALUE
IC50	#36# 0.0212 {kaemperol}  (#36# pH 7.0 <47>) <47>
IC50	#36# -999 {more}  (#36# IC(50) value of 4.47 microg/ml for extract of
	galangal, pH 7.0 <47>) <47>
IC50	#36# 0.3048 {quercetin}  (#36# pH 7.0 <47>) <47>
IC50	#4# 0.18 {(E)-phenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate}  (#4# pH 7.0
	<43>) <43>
IC50	#4# 0.18 {(E)-4-cyanophenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate}  (#4#
	pH 7.0 <43>) <43>
IC50	#4# 0.45 {(E)-2-nitrophenyl cinnamate}  (#4# pH 7.0 <43>) <43>
IC50	#4# 0.12 {epigallocatechin gallate}  (#4# at pH 9.0 <45>) <45>
IC50	#4# 0.00078 {Tannic acid}  <49>
IC50	#4# 0.0084 {epigallocatechin gallate}  (#4# at pH 8.3 <45>) <45>
IC50	#4# 0.0105 {epigallocatechin gallate}  (#4# at pH 7.5 <45>) <45>
IC50	#4# 0.881-0.948 {chlorogenic acid}  (#4# IC50: 0.881-0.948 mM <27>) <27>
IC50	#4# 0.215
	{N-(1,3-dioxoisoindolin-2-yl)-2-oxo-2H-chromene-3-carboxamide}  (#4# pH
	7.0 <43>) <43>
IC50	#4# 0.0578 {epigallocatechin gallate}  (#4# at pH 7.0 <45>) <45>
IC50	#4# 0.0336 {epigallocatechin gallate}  (#4# at pH 8.5 <45>) <45>
IC50	#4# 0.00554 {epigallocatechin gallate}  (#4# at pH 8.0 <45>) <45>
IC50	#4# 0.1223 {epigallocatechin gallate}  (#4# at pH 6.5 <45>) <45>
IC50	#40# 0.002 {Hexachlorophene}  (#40# an anthelmintic and antimicrobial
	agent, over 75% inhibition at 0.02 mM, IC50: 0.002 mM <23>) <23>
IC50	#40# 0.01 {Bithionol}  (#40# over 75% inhibition at 0.02 mM, IC50:
	0.010 mM <23>) <23>
IC50	#40# 0.0038 {di-resorcinol sulfide}  (#40# over 75% inhibition at 0.02
	mM, IC50: 0.0038 mM <23>) <23>
IC50	#40# 0.0154 {bromochlorophen}  (#40# an anthelmintic agent, over 75%
	inhibition at 0.02 mM, IC50: 0.0154 mM <23>) <23>
IC50	#47# 1 {anthecotulide}  (#47# pH 7.0, 25°C <36>) <36>
IC50	#47# 0.5 {4-acetoxyanthecotulide}  (#47# pH 7.0, 25°C <36>) <36>
IC50	#47# 0.75 {4-hydroxyanthecotulide}  (#47# pH 7.0, 25°C <36>) <36>

///
ID	1.1.1.101
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Cavia porcellus   <1,5,7,9>
PR	#2# Mus musculus   <5,13>
PR	#3# Homo sapiens   <6>
PR	#4# Rattus norvegicus   <1,2,3,5>
PR	#5# Saccharomyces cerevisiae   <8,10,11,12>
PR	#6# Trypanosoma brucei   <4>

RECOMMENDED_NAME
RN	acylglycerone-phosphate reductase


SYSTEMATIC_NAME
SN	1-palmitoylglycerol-3-phosphate:NADP+ oxidoreductase


SYNONYMS
SY	 reductase, palmitoyl dihydroxyacetone phosphate
SY	 palmitoyl-dihydroxyacetone-phosphate reductase
SY	 acyldihydroxyacetone phosphate reductase
SY	 palmitoyl dihydroxyacetone phosphate reductase
SY	 palmitoyldihydroxyacetone-phosphate reductase
SY	 acyldihydroxyacetone-phosphate:NADPH oxidoreductase
SY	 acyldihydroxyacetone-phosphate oxidoreductase
SY	 1-acylglycerol-3-phosphate:NADP+ oxidoreductase
SY	 acyl/alkyl dihydroxyacetone-phosphate reductase

CAS_REGISTRY_NUMBER
CR	37250-35-4

REACTION
RE	1-palmitoylglycerol 3-phosphate + NADP+ = palmitoylglycerone phosphate
	+ NADPH + H+

REACTION_TYPE
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1# spleen <1>
ST	#1# lung <1>
ST	#1,2,4# liver <1,2,3,5,7,9>
ST	#1,4# testis <1>
ST	#1,4# ascites tumor cell (#1,4# grown in the abdomen of swiss white
	mice <1>) <1>
ST	#2# preadipocyte (#2# 3T3-L1, fibroblast-like cell <13>) <13>
ST	#3# skin fibroblast (#3# Zellweger syndrome cell lines GM0228 and
	GM4340 and normal control cells <6>) <6>
ST	#4# kidney <1>
ST	#4# heart <1>
ST	#4# brain <1>
ST	#4# adipose tissue <1>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1,2,3,4,5# acyldihydroxyacetone phosphate + NADPH = 1-acyl-sn-glycerol
	3-phosphate + NADP+ (#3,5# acyldihydroxyacetone phosphate pathway
	<6,8,10>; #2# reaction involved during conversion of 3T3-L1
	preadipocytes to adipocytes <13>; #1# enzyme links acyldihydroxyacetone
	phosphate pathway intermediates to cellular glycerolipid biosynthesis
	<7>; #1,2,4,5# reaction in non-ether lipids biosynthesis
	<1,2,5,8,10,11,12>) <1,2,5,6,7,8,10,11,12,13>
NSP	#1,2,3,4,5# alkyldihydroxyacetone phosphate + NADPH =
	1-alkyl-sn-glycerol 3-phosphate + NADP+ (#3,5# acyldihydroxyacetone
	phosphate pathway <6,8>; #2# reaction involved during conversion of
	3T3-L1 preadipocytes to adipocytes <13>; #1# enzyme links
	acyldihydroxyacetone phosphate pathway intermediates to cellular
	glycerolipid biosynthesis <7>; #1,2,4,5# reaction in ether lipids
	biosynthesis <1,2,5,8>) <1,2,5,6,7,8,13>

SUBSTRATE_PRODUCT
SP	#1,2,3,4,5,6# acyldihydroxyacetone phosphate + NADPH =
	1-acyl-sn-glycerol 3-phosphate + NADP+ (#3,5# acyldihydroxyacetone
	phosphate pathway <6,8,10>; #2# reaction involved during conversion of
	3T3-L1 preadipocytes to adipocytes <13>; #1# enzyme links
	acyldihydroxyacetone phosphate pathway intermediates to cellular
	glycerolipid biosynthesis <7>; #1,2,4,5# reaction in non-ether lipids
	biosynthesis <1,2,5,8,10,11,12>) |#5# i.e. lysophosphatidic acid
	<10,11>| <1,2,3,4,5,6,7,8,9,10,11,12,13>
SP	#1,2,3,4,5,6# alkyldihydroxyacetone phosphate + NADPH =
	1-alkyl-sn-glycerol 3-phosphate + NADP+ (#1,4# ether analog of acyl
	dihydroxyacetone phosphate <5>; #3,5# acyldihydroxyacetone phosphate
	pathway <6,8>; #2# reaction involved during conversion of 3T3-L1
	preadipocytes to adipocytes <13>; #1# enzyme links acyldihydroxyacetone
	phosphate pathway intermediates to cellular glycerolipid biosynthesis
	<7>; #1,2,4,5# reaction in ether lipids biosynthesis <1,2,5,8>)
	<1,2,3,4,5,6,7,8,9,13>
SP	#1,3,4,5,6# hexadecyldihydroxyacetone phosphate + NADPH =
	1-hexadecyl-sn-glycerol 3-phosphate + NADP+ <1,2,3,4,5,6,7,8,9,10>
SP	#1,4,5,6# palmitoylglycerone phosphate + NADPH = 1-palmitoylglycerol
	3-phosphate + NADP+ (#1,4,5,6# i.e. palmitoyldihydroxyacetone phosphate
	<1,2,3,4,5,7,8,9>) <1,2,3,4,5,7,8,9>

TURNOVER_NUMBER
TN	#1# 100 {NADPH}  <7>

KM_VALUE
KM	#1# 0.05 {NADPH}  (#1# hexadecyldihydroxyacetone phosphate, peroxisomal
	enzyme <5>; #1# liver mitochondria <1>) <1,5>
KM	#1# 0.06 {NADPH}  (#1# cosubstrate palmitoyldihydroxyacetone phosphate,
	peroxisomal enzyme <5>) <5>
KM	#1# 1.7 {NADH}  <7,9>
KM	#1# 0.021 {Hexadecyldihydroxyacetone phosphate}  (#1# cosubstrate NADPH
	<9>) <7,9>
KM	#1# 0.07 {NADPH}  (#1# in presence of NADP+, microsomal enzyme <5>) <5>
KM	#1# 0.8 {NADH}  (#1# cosubstrate hexadecyldihydroxyacetone phosphate,
	peroxisomal enzyme <5>) <5>
KM	#1# 0.08 {NADH}  (#1# cosubstrate hexadecyldihydroxyacetone phosphate,
	microsomal enzyme, NADPH, cosubstrate hexadecyldihydroxyacetone
	phosphate, peroxisomal enzyme <5>) <5>
KM	#1# 0.13 {NADPH}  (#1# in presence of NADP+, peroxisomal enzyme <5>) <5>
KM	#1# 0.0154 {Palmitoyldihydroxyacetone phosphate}  <7>
KM	#1,4# 0.01 {NADPH}  (#1# Km-value below: hexadecyldihydroxyacetone
	phosphate + NADPH, microsomal enzyme <5>; #1,4# ascites microsomes <1>)
	<1,5>
KM	#1,5# 0.015 {NADPH}  (#1# cosubstrate palmitoydihydroxyacetone
	phosphate <9>; #5# cosubstrate hexadecyldihydroxyacetone phosphate <8>)
	<8,9>
KM	#1,5# 0.02 {NADPH}  (#1# cosubstrate hexadecyldihydroxyacetone
	phosphate <9>; #1# cosubstrate palmitoyldihydroxyacetone phosphate,
	microsomal enzyme <5>; #1# ,cosubstrate hexadecyldihydroxyacetone
	phosphate, microsomal enzyme <5>) <5,7,8,9>
KM	#3# 0.0054 {NADPH}  (#3# skin Zellwenger syndrome fibroblasts <6>) <6>
KM	#3# 0.0051 {NADPH}  (#3# skin fibroblasts, normal cells <6>) <6>
KM	#4# 0.005 {NADPH}  (#4# cosubstrate hexadecyldihydroxyacetone
	phosphate, brain <1>) <1>
KM	#4# 0.007 {NADPH}  (#4# cosubstrate palmitoyldihydroxyacetone
	phosphate, brain <1>) <1>

PH_OPTIMUM
PHO	#1# 6.5 <5>
PHO	#1,4# 6.5-7.5 (#1,4# broad optimum <1,9>) <1,9>
PHO	#5# 6.7-7.2 (#5# broad optimum <8>) <8>

PH_RANGE
PHR	#1# 5.5-8.2 (#1# about half-maximal activity at pH 5.5 and 8.2 <5>) <5>

SPECIFIC_ACTIVITY
SA	#1# 62.5 <7,9>
SA	#2# 0.0186 (#2# light mitochondrial fraction <5>) <5>
SA	#2# 0.0296 (#2# light mitochondrial fraction, clofibrate-fed animals
	<5>) <5>
SA	#2# 0.0101 (#2# at day 0 during differentiation induced by insulin,
	dexamethasone, and methylisobutylxanthine <13>) <13>
SA	#4# 0.00158 <3>
SA	#4# 0.00546 (#4# light mitochondrial fraction <2>) <2>
SA	#5# 0.00393 (#5# glucose grown cells <10>) <10>

TEMPERATURE_OPTIMUM
TO	#5# 40 <8>

TEMPERATURE_RANGE
TR	#5# 28-43 (#5# about half-maximal activity at 28°C and 43°C <8>) <8>

COFACTOR
CF	#1,2,3,4,5,6# NADPH (#1,4,5# specific for NADPH <1,8,11,12>;
	#1,2,3,4,5,6# hydrogen from B-side of nicotinamide ring is transferred
	to reduce keto substrates <1,2,3,4,5,6,7,8,9,10,11,12,13>)
	<1,2,3,4,5,6,7,8,9,10,11,12,13>
CF	#1,4# NADH (#4# at high concentrations, rat liver <1>; #1# can
	substitute for NADPH with very low activity and affinity <9>; #1# can
	substitute for NADPH <7>) <1,5,7,9>

ACTIVATING_COMPOUND
AC	#1# Phosphatidylcholine (#1# micelles, activation, in presence of
	Triton X-100, slight stimulation at low concentrations <7>) <7>
AC	#1# Phosphatidylglycerol (#1# micelles, activation, in presence of
	Triton X-100, slight stimulation at low concentrations <7>) <7>
AC	#1,4# EDTA (#1,4# activation, acyldihydroxyacetone phosphate as
	substrate <1>) <1>
AC	#1,4# Triton X-100 (#4# activation <3>; #1# destabilizes during
	solubilization <7>) <3,7>
AC	#2# Clofibrate (#2# activation <5>) <5>
AC	#5# Dihydroxyacetone (#5# activation, used as carbon source in wild
	type cell cultures, greater activity compared to activity in
	glucose-grown cells <10>) <10>
AC	#5# ethanol (#5# activation, used as nonfermentable carbon source in
	wild type and tpa1 mutant cell cultures, greater activity compared to
	activity in glucose-grown cells <10>) <10>
AC	#5# glycerol (#5# activation, used as nonfermentable carbon source in
	wild type cell cultures, greater activity compared to activity in
	glucose-grown cells <10>) <10>
AC	#5# glycerol/ethanol (#5# activation, used as nonfermentable carbon
	source in wild type cell cultures, greater activity compared to
	activity in glucose-grown cells <10>) <10>

INHIBITORS
IN	#1# Alkyldihydroxyacetone phosphate (#1# at high concentrations <5>) <5>
IN	#1# palmitoyl-CoA (#1# competitive to NADPH, not to
	alkyldihydroxyacetone phosphate <7>) <5,7>
IN	#1# Palmitoyldihydroxyacetone phosphate (#1# competitive to
	hexadecyldihydroxyacetone phosphate <7>) <7>
IN	#1# PCMB <7>
IN	#1# Phosphatidylcholine (#1# at high concentrations <7>) <7>
IN	#1# Phosphatidylethanolamine <7>
IN	#1# Phosphatidylglycerol (#1# at high concentrations <7>) <7>
IN	#1# phosphatidylinositol <7>
IN	#1# NADP+ (#1# competitive to NADPH <5>) <5,7>
IN	#1# more (#1# stable to N-ethylmaleimide <5,7>; #1# DTNB and thiols
	<5>) <5,7>
IN	#1,4# Trypsin (#1,4# inactivation <3,5>) <3,5>
IN	#1,5# N-ethylmaleimide (#1# not inhibitory <7>; #5# strong inhibitor
	<8>) <7,8>
IN	#4# Chymotrypsin (#4# inactivation <3>) <3>
IN	#5# EDTA (#5# weak inhibition <8>) <8>
IN	#5# F- (#5# weak inhibition <8>) <8>
IN	#5# Divalent cations (#5# i.e. Cu2+, Co2+, Ca2+, Mg2+, Mn2+, Ni2+,
	Zn2+, strong inhibition <8>) <8>

MOLECULAR_WEIGHT
MW	#1# 75000 (#1# liver peroxisomes, gel filtration in the presence of
	octylglucoside <9>) <9>
MW	#1# 70000-75000 (#1# gel filtration <7>) <7>
MW	#5# 33000 (#5# lipid particles from wild type, systematic amino acid
	sequence analysis by mass spectrometry <12>) <12>

SUBUNITS
SU	#1# monomer (#1# 1 * 60000, SDS-PAGE <7,9>) <7,9>
SU	#1# More (#1# 27% hydrophobic amino acids by amino acid analysis <7>)
	<7>

CLONED
CL	#5# (expression in Escherichia coli, YIL124w is the structural gene of
	the enzyme) <12>

PURIFICATION
PU	#1# (affinity chromatography on NADPH-agarose gel matrix) <7,9>
PU	#1# (partial, solubilization) <5>

GENERAL_STABILITY
GS	#1# (freeze-thawing leads to rapid loss of activity) <7>
GS	#1# (NADPH enhances thermal stability) <5>
GS	#1# (Triton X-100, stable to solubilization in the presence of high
	salt concentrations) <5>
GS	#1# (stable toward high concentrations of N-ethylmaleimide or DTNB) <5>
GS	#1# (thiols stabilize solubilized enzyme) <5>
GS	#1# (NADPH stabilizes during storage and solubilization) <7>
GS	#1# (DTT stabilizes during storage) <7>
GS	#1# (high ionic strength facilitates solubilization with neutral or
	anionic detergents) <7>
GS	#1# (Triton X-100, enzyme becomes unstable during solubilization unless
	NADPH and 1 M KCl are present) <7>
GS	#1# (unstable in the absence of NADPH) <9>
GS	#1# (unstable on freezing and thawing) <9>
GS	#1,4# (trypsin inactivates) <3,5>
GS	#1,4# (freeze-thawing, stable after several cycles) <1>
GS	#4# (chymotrypsin inactivates) <3>

ORGANIC_SOLVENT_STABILITY
OSS	#1# Glycerol (#1# stabilizes <7>) <7>

STORAGE_STABILITY
SS	#1# (4°C, stable in the presence of DTT and NADPH, 1 month) <7>
SS	#5# (-80°C, membrane fraction stable) <8>
SS	#5# (-20°C, membrane fraction stable) <8>

TEMPERATURE_STABILITY
TS	#1# 55 (#1# 10% loss of activity after 15 min, NADPH enhances thermal
	stability <5>) <5>
TS	#1# 4 (#1# stable for 4-6 weeks in the presence of octylglucoside and
	NADPH <9>) <9>
TS	#1,4# 100 (#1,4# complete inactivation after 10 min <1>) <1>
TS	#3# 50 (#3# t1/2: 15 min, control fibroblasts, t1/2: 20 min, Zellweger
	syndrome fibroblasts <6>) <6>
TS	#5# 30 (#5# 10 min stable below <8>) <8>
TS	#5# 45 (#5# t1/2: 10 min <8>) <8>

REFERENCE
RF	<1> LaBelle, E.F.; Hajra, A.K.: Enzymatic reduction of alkyl and acyl
	derivatives of dihydroxyacetone phosphate by reduced pyridine
	nucleotides. J. Biol. Chem. (1972) 247, 5825-5834. {Pubmed:4403490}
RF	<2> Hajra, A.K.; Burke, C.L.; Jones, C.L.: Subcellular localization of
	acyl coenzyme A: dihydroxyacetone phosphate acyltransferase in rat
	liver peroxisomes (microbodies). J. Biol. Chem. (1979) 254,
	10896-10900. {Pubmed:500614}
RF	<3> Ballas, L.M.; Bell, R.M.: Topography of glycerolipid synthetic
	enzymes. Synthesis of phosphatidylserine, phosphatidylinositol and
	glycerolipid intermediates occurs on the cytoplasmic surface of rat
	liver microsomal vesicles. Biochim. Biophys. Acta (1981) 665, 586-595.
	{Pubmed:6271231}
RF	<4> Opperdoes, F.R.: Localization of the initial steps in
	alkoxyphospholipid biosynthesis in glycosomes (microbodies) of
	Trypanosoma brucei. FEBS Lett. (1984) 169, 35-39. {Pubmed:6562019}
RF	<5> Ghosh, M.K.; Hajra, A.K.: Subcellular distribution and properties
	of acyl/alkyl dihydroxyacetone phosphate reductase in rodent livers.
	Arch. Biochem. Biophys. (1986) 245, 523-530. {Pubmed:3954368}
RF	<6> Webber, K.O.; Datta, N.S.; Hajra, A.K.: Properties of the enzymes
	catalyzing the biosynthesis of lysophosphatidate and its ether analog
	in cultured fibroblasts from Zellweger syndrome patients and normal
	controls. Arch. Biochem. Biophys. (1987) 254, 611-620. {Pubmed:3646870}
RF	<7> Datta, S.C.; Ghosh, M.K.; Hajra, A.K.: Purification and properties
	of acyl/alkyl dihydroxyacetone-phosphate reductase from guinea pig
	liver peroxisomes. J. Biol. Chem. (1990) 265, 8268-8274.
	{Pubmed:2335525}
RF	<8> Racenis, P.V.; Lai, J.L.; Das, A.K.; Mullick, P.C.; Hajra, A.K.;
	Greenberg, M.L.: The acyl dihydroxyacetone phosphate pathway enzymes
	for glycerolipid biosynthesis are present in the yeast Saccharomyces
	cerevisiae. J. Bacteriol. (1992) 174, 5704-5710. {Pubmed:}
RF	<9> Hajra, A.K.; Datta, S.C.; Ghosh, M.K.: Acyl/alkyldihydroxyacetone
	phosphate reductase from guinea pig liver peroxisomes. Methods Enzymol.
	(1992) 209, 402-407. {Pubmed:1495422}
RF	<10> Minskoff, S.A.; Racenis, P.V.; Granger, J.; Larkins, L.; Hajra,
	A.K.; Greenberg, M.L.: Regulation of phosphatidic acid biosynthetic
	enzymes in Saccharomyces cerevisiae. J. Lipid Res. (1994) 35,
	2254-2262. {Pubmed:7897322}
RF	<11> Athenstaedt, K.; Weys, S.; Paltauf, F.; Daum, G.: Redundant
	systems of phosphatidic acid biosynthesis via acylation of
	glycerol-3-phosphate or dihydroxyacetone phosphate in the yeast
	Saccharomyces cerevisiae. J. Bacteriol. (1999) 181, 1458-1463.
	{Pubmed:10049376}
RF	<12> Athenstaedt, K.; Daum, G.: 1-Acyldihydroxyacetone-phosphate
	reductase (Ayr1p) of the yeast Saccharomyces cerevisiae encoded by the
	open reading frame YIL124w is a major component of lipid particles. J.
	Biol. Chem. (2000) 275, 235-240. {Pubmed:10617610}
RF	<13> Hajra, A.K.; Larkins, L.K.; Das, A.K.; Hemati, N.; Erickson, R.L.;
	MacDougald, O.A.: Induction of the peroxisomal
	glycerolipid-synthesizing enzymes during differentiation of 3T3-L1
	adipocytes. Role in triacylglycerol synthesis. J. Biol. Chem. (2000)
	275, 9441-9446. {Pubmed:10734090}

ACTIVATING_COMPOUND
AC	#1# Phosphatidylcholine (#1# micelles, activation, in presence of
	Triton X-100, slight stimulation at low concentrations <7>) <7>
AC	#1# Phosphatidylglycerol (#1# micelles, activation, in presence of
	Triton X-100, slight stimulation at low concentrations <7>) <7>
AC	#1,4# EDTA (#1,4# activation, acyldihydroxyacetone phosphate as
	substrate <1>) <1>
AC	#1,4# Triton X-100 (#4# activation <3>; #1# destabilizes during
	solubilization <7>) <3,7>
AC	#2# Clofibrate (#2# activation <5>) <5>
AC	#5# Dihydroxyacetone (#5# activation, used as carbon source in wild
	type cell cultures, greater activity compared to activity in
	glucose-grown cells <10>) <10>
AC	#5# ethanol (#5# activation, used as nonfermentable carbon source in
	wild type and tpa1 mutant cell cultures, greater activity compared to
	activity in glucose-grown cells <10>) <10>
AC	#5# glycerol (#5# activation, used as nonfermentable carbon source in
	wild type cell cultures, greater activity compared to activity in
	glucose-grown cells <10>) <10>
AC	#5# glycerol/ethanol (#5# activation, used as nonfermentable carbon
	source in wild type cell cultures, greater activity compared to
	activity in glucose-grown cells <10>) <10>

///
ID	1.1.1.102
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Mus musculus   <2>
PR	#2# Homo sapiens   <8>
PR	#3# Rattus norvegicus   <3,4>
PR	#4# Saccharomyces cerevisiae   <1,6,8>
PR	#5# Bos taurus   <3>
PR	#6# Candida albicans   <6>
PR	#7# Pichia ciferrii   <4>
PR	#8# Aspergillus fumigatus   <6>
PR	#9# Homo sapiens Q06136 SwissProt <5>
PR	#10# Mus musculus Q6GV12 SwissProt <5>
PR	#11# Bos taurus Q2KIJ5 SwissProt <7>

RECOMMENDED_NAME
RN	3-dehydrosphinganine reductase


SYSTEMATIC_NAME
SN	D-erythro-dihydrosphingosine:NADP+ 3-oxidoreductase


SYNONYMS
SY	 D-3-dehydrosphinganine reductase
SY	 D-3-oxosphinganine reductase
SY	 DSR
SY	 3-oxosphinganine reductase
SY	 3-oxosphinganine:NADPH oxidoreductase
SY	 D-3-oxosphinganine:B-NADPH oxidoreductase
SY	#10# m-FTV-1 <5>
SY	#2,11# Fvt1 <7,8>
SY	#4# TSC10 <6>
SY	#4# Tsc10p <8>
SY	#4,6,8# More (#4,6,8# the enzyme belongs to the short-chain
	dehydrogenase/reductase family of enzymes <6>) <6>
SY	#4,6,8# 3-ketosphinganine reductase <1,6>
SY	#6# Ksr1p <6>
SY	#8# KsrA <6>
SY	#9# h-FTV-1 <5>
SY	#9,10# 3-ketodihydrosphingosine reductase <5>
SY	#9,10# KDS reductase <5>
SY	#9,10# FVT-1 <5>

CAS_REGISTRY_NUMBER
CR	37250-36-5

REACTION
RE	sphinganine + NADP+ = 3-dehydrosphinganine + NADPH + H+

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1,3,5# liver <2,3,4>
ST	#10# placenta (#10# highest expression <5>) <5>
ST	#10# stomach (#10# high expression <5>) <5>
ST	#10# small intestine (#10# high expression <5>) <5>
ST	#2# HEK-293 cell <8>
ST	#3# brain <3>
ST	#3# muscle <3>
ST	#3# cardiac muscle <3>
ST	#3,10# kidney (#10# high expression <5>) <3,5>
ST	#3,10# spleen (#10# low level of expression <5>) <3,5>
ST	#3,10# lung (#10# high expression <5>) <3,5>
ST	#9# colon (#9# low expression <5>) <5>
ST	#9# thymus (#9# low expression <5>) <5>
ST	#9# leukocyte (#9# pheripheral blood, low expression <5>) <5>
ST	#9,10# skeletal muscle (#9# high expression <5>; #10# low level of
	expression <5>) <5>
ST	#9,10# heart (#9# high expression <5>; #10# low level of expression
	<5>) <5>

LOCALIZATION
LO	#2,4# cytoplasm (#2# C-terminus of FVT1 <8>; #4# N- and C-terminus of
	Tsc10p <8>) <8>
LO	#2,4,9,10# endoplasmic reticulum (#2# N-terminal membrane-spanning
	domain in FVT1 orients to place it in the endoplasmic reticulum lumen
	<8>; #4# Tsc10p localizes to the yeast endoplasmic reticulum membrane
	<8>) <5,8>
LO	#9,10# membrane (#10# of endoplasmic reticulum <5>; #9# of endoplasmic
	reticulum, the large hydrophilic domain, which contains putative active
	site residues, faces the cytosol <5>) <5>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1# (S)-2-amino-1-hydroxyoctadecane-3-one + NADPH =
	(S)-2-amino-1-(R)-3-dihydroxyoctadecane + NADP+ (#1# enzyme acts at the
	cytoplasmic side of endoplasmic reticulum <2>) <2>
NSP	#1# (S)-2-amino-1-hydroxyoctadecane-3-one + NADPH =
	(S)-2-amino-1-(R)-3-dihydroxyoctadecane + NADP+ (#1# enzyme acts at the
	cytoplasmic side of endoplasmic reticulum <2>) {} <2>
NSP	#4# 2-amino-1-hydroxyoctadecane-3-one + NADPH =
	2-amino-1,3-dihydroxyoctadecane + NAD+ <1>
NSP	#4,6,8# 3-dehydrosphinganine + NADPH = sphinganine + NADP+ (#4# the
	enzyme catalyzes an early step in the sphingolipid biosynthesis,
	overview <6>; #6# the enzyme is not essential for cell viability, but
	enzyme-deficient mutants produce lower levels of
	inositolphosphorylceramides <6>) <6>

SUBSTRATE_PRODUCT
SP	#1,5# (S)-2-amino-1-hydroxyoctadecane-3-one + NADPH =
	(S)-2-amino-1-(R)-3-dihydroxyoctadecane + NADP+ (#1# enzyme acts at the
	cytoplasmic side of endoplasmic reticulum <2>) <2,3>
SP	#1,5# (S)-2-amino-1-hydroxyoctadecane-3-one + NADPH =
	(S)-2-amino-1-(R)-3-dihydroxyoctadecane + NADP+ (#1# enzyme acts at the
	cytoplasmic side of endoplasmic reticulum <2>) {} <2,3>
SP	#2,4# More = ? (#2# FVT1 can replace Tsc10p in yeast <8>; #4# FVT1 is
	able to support growth of tsc10DELTA mutant cells at 26°C, but not at
	37°C <8>) {} <8>
SP	#2,4# 3-dehydrosphinganine + NADPH + H+ = sphinganine + NADP+ {?} <8>
SP	#4# 2-amino-1-hydroxyoctadecane-3-one + NADPH =
	2-amino-1,3-dihydroxyoctadecane + NAD+ <1>
SP	#4,6,8# 3-dehydrosphinganine + NADPH = sphinganine + NADP+ (#4# the
	enzyme catalyzes an early step in the sphingolipid biosynthesis,
	overview <6>; #6# the enzyme is not essential for cell viability, but
	enzyme-deficient mutants produce lower levels of
	inositolphosphorylceramides <6>; #6# C18 substrate, molecular modeling
	of substrate binding, overview <6>) <6>
SP	#4,7# 2-amino-1-hydroxyoctadecane-3-one + NADPH =
	2-amino-1-(R)-3-dihydroxyoctadecane + NADP+ <1,4>
SP	#5# (S)-2-amino-1-hydroxyeicosane-3-one + NADPH =
	(S)-2-amino-1-(R)-3-dihydroxyeicosane + NADP+ (#5# slower reduced than
	(S)-2-amino-1-hydroxyoctadecane-3-one <3>) <3>
SP	#9,10# 3-ketodihydrosphingosine + NADPH = dihydrosphingosine + NADP+ <5>

TURNOVER_NUMBER
TN	#6# 1.07 {3-dehydrosphinganine}  (#6# pH 7.5, recombinant enzyme <6>)
	<6>

KM_VALUE
KM	#5# 0.03 {(S)-2-amino-1-hydroxyeicosane-3-one}  <3>
KM	#5# 0.015 {(S)-2-amino-1-hydroxyoctadecane-3-one}  <3>
KM	#6# -999 {more}  (#6# binding kinetics of substrate analogues with
	shorter chain lengths <6>) <6>
KM	#6# 0.009 {3-dehydrosphinganine}  (#6# pH 7.5, recombinant enzyme <6>)
	<6>
KM	#9# 0.003 {3-ketodihydrosphingosine}  (#9# pH 7.5, 37°C <5>) <5>
KM	#9# 0.028 {NADPH}  (#9# pH 7.5, 37°C <5>) <5>

PH_OPTIMUM
PHO	#4,6,8# 7.5 (#4,6,8# assay at <6>) <6>
PHO	#5# 6.5-7 <3>
PHO	#7# 6-7 <4>

SPECIFIC_ACTIVITY
SA	#1# 0.000121 (#1# vesicles from smooth and rough endoplasmic reticulum
	<2>) <2>
SA	#5# 25.0 <3>

COFACTOR
CF	#1,3,4,5,6,7,8,9,10# NADPH <1,2,3,4,5,6>

ACTIVATING_COMPOUND
AC	#4# tergitol (#4# 0.2%, 10fold activation of
	2-amino-1-hydroxyoctadecane-3-one reduction <1>) <1>

INHIBITORS
IN	#2# siRNA (#2# reduces expression of transfected FVT1 mRNA and protein
	by at least 70% <8>) <8>

MOLECULAR_WEIGHT
MW	#2,4# 150000 (#4# gel filtration <8>; #2# gel filtration1 <8>) <8>

SUBUNITS
SU	#2,4# tetramer (#2,4# gel filtration <8>) <8>
SU	#6# More (#6# molecular modeling of the enzyme with bound substrates, a
	significant portion of the aliphatic chain of 3-dehydrosphinganine
	protrudes from the enzyme, overview <6>) <6>

APPLICATION
AP	#11# food industry (#11# naturally occuring missense mutation A175T is
	linked to animals with bovine spinal muscular atrophy. Protein exhibits
	no detectable in vitro catalytic activity, but the mutated gene
	complements the growth defect of a homologous yeast knock-out strain as
	well as the healthy variant <7>) <7>

ENGINEERING
EN	#2,11# A175T (#11# site-directed mutagenesis, naturally occuring
	missense mutation linked to animals with bovine spinal muscular
	atrophy. Protein exhibits no detectable in vitro catalytic activity,
	but the mutated gene complements the growth defect of a homologous
	yeast knock-out strain as well as the healthy variant <7>; #2# mutation
	is deleterious to the human enzyme <8>) <7,8>
EN	#2,4,6# more (#6# construction of an enzyme-deficient mutant by gene
	replacement, the mutant produces lower levels of
	inositolphosphorylceramides <6>; #4# construction of the deletion
	mutant TscDELTA38p <6>; #2# mutation of any of the three residues that
	constitute the catalytic triad of FVT1 do not completely inactivate the
	enzyme, as it is able to support growth of tsc10DELTA mutant cells at
	26°C, but not at 37°C. Deletion of residues 4-26 from the FVT1-GFP
	protein abolishes ER localization <8>) <6,8>

CLONED
CL	#2# (FVT1 expressed in CHO cells or yeast) <8>
CL	#4# (expressed in Escherichia coli, Myc-His-tagged enzyme) <1>
CL	#4# (gene tsc10, expression of mutant tscDELTA38 in Escherichia coli
	strain BL21(DE3)) <6>
CL	#4# (TSC10p expressed in CHO cells or yeast) <8>
CL	#6# (gene ksr1, DNA and amino acid sequence determination and analysis,
	functional expression in Escherichia coli strain JM109(DE3)) <6>
CL	#8# (gene ksrA, DNA and amino acid sequence determination and analysis,
	functional expression in Escherichia coli strain JM109(DE3)) <6>
CL	#9# (expression in yeast cells) <5>
CL	#10# (expression in yeast cells) <5>

PURIFICATION
PU	#4# (recombinant Myc-His-tagged enzyme, Ni-NTA agarose) <1>
PU	#5# (Triton X-100, ammonium sulfate, calcium apatite, density gradient)
	<3>

REFERENCE
RF	<1> Beeler, T.; Bacikova, D.; Gable, K.; Hopkins, L.; Johnson, C.;
	Slife, H.; Dunn, T.: The Saccharomyces cerevisiae TSC10/BR265w gene
	encoding 3-ketosphinganine reductase is identified in a screen for
	temperature-sensitive suppressors of the Ca2+-sensitive csg2delta
	mutant. J. Biol. Chem. (1998) 273, 30688-30694. {Pubmed:9804843}
RF	<2> Mandon, E.C.; Ehses, I.; Rother, J.; van Echten, G.; Sandhoff, K.:
	Subcellular localization and membrane topology of serine
	palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine
	N-acyltransferase in mouse liver. J. Biol. Chem. (1992) 267,
	11144-11148. {Pubmed:1317856}
RF	<3> Stoffel, W.; LeKim, D.; Sticht, G.: Stereospecificity of the
	NADPH-dependent reduction reaction of 3-oxodihydrosphingosine
	(2-amino-1-hydroxyoctadecane-3-one). Hoppe-Seyler's Z. Physiol. Chem.
	(1968) 349, 1637-1644. {Pubmed:4387676}
RF	<4> Stoffel, W.; LeKim, D.; Sticht, G.: Biosynthesis of
	dihydrosphingosine in vitro. Hoppe-Seyler's Z. Physiol. Chem. (1968)
	349, 664-670. {Pubmed:4386961}
RF	<5> Kihara, A.; Igarashi, Y.: FVT-1 is a mammalian
	3-ketodihydrosphingosine reductase with an active site that faces the
	cytosolic side of the endoplasmic reticulum membrane. J. Biol. Chem.
	(2004) 279, 49243-49250. {Pubmed:15328338} (c)
RF	<6> Fornarotto, M.; Xiao, L.; Hou, Y.; Koch, K.A.; Chang, E.; OMalley,
	R.M.; Black, T.A.; Cable, M.B.; Walker, S.S.: Sphingolipid biosynthesis
	in pathogenic fungi: identification and characterization of the
	3-ketosphinganine reductase activity of Candida albicans and
	Aspergillus fumigatus. Biochim. Biophys. Acta (2006) 1761, 52-63.
	{Pubmed:16431155}
RF	<7> Krebs, S.; Medugorac, I.; Roether, S.; Straesser, K.; Foerster, M.:
	A missense mutation in the 3-ketodihydrosphingosine reductase FVT1 as
	candidate causal mutation for bovine spinal muscular atrophy. Proc.
	Natl. Acad. Sci. USA (2007) 104, 6746-6751. {Pubmed:17420465}
RF	<8> Gupta, S.D.; Gable, K.; Han, G.; Borovitskaya, A.; Selby, L.; Dunn,
	T.M.; Harmon, J.M.: Tsc10p and FVT1: Topologically distinct short-chain
	reductases required for long-chain base synthesis in yeast and mammals.
	J. Lipid Res. (2009) 50, 1630-1640. {Pubmed:19141869}

ACTIVATING_COMPOUND
AC	#4# tergitol (#4# 0.2%, 10fold activation of
	2-amino-1-hydroxyoctadecane-3-one reduction <1>) <1>

///
ID	1.1.1.103
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Gallus gallus   <1,17,20>
PR	#2# Staphylococcus aureus   <20>
PR	#3# Mus musculus   <38>
PR	#4# Escherichia coli   <37>
PR	#5# Homo sapiens   <24>
PR	#6# Rattus norvegicus   <7,8,20,22>
PR	#7# Sus scrofa   <5,13,20,27>
PR	#8# Bos taurus   <8>
PR	#9# Oryctolagus cuniculus   <20>
PR	#10# Pyrococcus furiosus   <29>
PR	#11# Rana catesbeiana   <21>
PR	#12# Arthrobacter sp.   <19>
PR	#13# Capra hircus   (#13# aldo-keto reductase family 1 member C1,
	AKR1C1 <15>) <15>
PR	#14# Coturnix japonica   <22>
PR	#15# Pyrococcus horikoshii   <26,28,30>
PR	#16# Escherichia coli K-12   <2,3,4,6,9,10,11,12,14,16,18>
PR	#17# Mus musculus Q8K3F7 Swissprot <23>
PR	#18# Sus scrofa Q8MIR0 Swissprot <23>
PR	#19# Cytophaga sp. Q8KZM4 Swissprot <25>
PR	#20# Pyrococcus horikoshii O58389 UniProt <31,32>
PR	#21# Thermococcus kodakarensis KOD1   <35>
PR	#22# Thermococcus kodakarensis Q5JI69 UniProt <33,36>
PR	#23# Streptomyces sp. 139   <34>

RECOMMENDED_NAME
RN	L-threonine 3-dehydrogenase


SYSTEMATIC_NAME
SN	L-threonine:NAD+ oxidoreductase


SYNONYMS
SY	 threonine 3-dehydrogenase
SY	#10,15,20,21,22# L-threonine dehydrogenase <26,28,29,30,31,32,33,35,36>
SY	#10,15,20,21,22,23# TDH <26,29,30,31,32,33,34,35,36>
SY	#15# L-ThrDH <28>
SY	#20# More (#20# the enzyme belongs to the medium-chain NAD(H)-dependent
	alcohol dehydrogenases <32>) <32>
SY	#7,23# threonine dehydrogenase <27,34>

CAS_REGISTRY_NUMBER
CR	9067-99-6

REACTION
RE	L-threonine + NAD+ = L-2-amino-3-oxobutanoate + NADH + H+ (#7# it is
	suggested that the unstable L-2-amino-3-oxobutanoate spontanousely
	decarboxylates to the stable aminoacetone, there is also some evidence
	that L-threonine is oxidatively decarboxylated by threonine
	dehydrogenase to produce aminoacetone <13>; #19# ordered bi-bi
	mechanism, NAD+ binds prior to L-threonine <25>; #10# His94 is an
	active site residue, substrate binding involved residues Gly66, Gly71,
	Gly77, and Val80 <29>; #15# reaction mechanism, random bi bi kinetic
	mechanism <28>; #20# catalytic mechanism, the carboxyl group of Glu152
	is important for expressing the catalytic activity, the proton relay
	system works as a catalytic mechanism of TDH <31>)

REACTION_TYPE
RT	redox reaction

SOURCE_TISSUE
ST	#1,6,7,8,9,11,13,14,17# liver (#17# most abundant <23>)
	<1,5,7,8,13,15,17,20,21,22,23,27>
ST	#17# skeletal muscle <23>
ST	#17# spleen <23>
ST	#17# lung <23>
ST	#17# testis <23>
ST	#3# embryonic stem cell (#3# embryonic stem cells are critically
	dependent on the amino acid threonine, and threonine catabolism via the
	TDH enzyme is important to the growth and metabolic state of mouse
	embryonic stem cells <38>) <38>
ST	#6,17# kidney <20,23>
ST	#6,17# heart <20,23>
ST	#6,17# brain <20,23>
ST	#7# pancreas <27>
ST	#7# more (#7# no activity in intestine <27>) <27>
ST	#7# viscus (#7# portal drained viscera, PDV <27>) <27>
ST	#7# splanchnic tissue (#7# extensive threonine utilization <27>) <27>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1,2,6,7,8,9,11,12,13,16,20# L-threonine + NAD+ =
	L-2-amino-3-oxobutanoate + NADH + H+ {}
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,31,32>
NSP	#1,2,6,7,8,9,11,12,13,16,20# L-threonine + NAD+ =
	L-2-amino-3-oxobutanoate + NADH + H+
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,31,32>
NSP	#1,2,6,7,8,9,11,12,13,16,20# L-threonine + NAD+ =
	L-2-amino-3-oxobutanoate + NADH + H+ {r}
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,31,32>
NSP	#7,10,15# L-threonine + NAD+ = L-2-amino-3-oxobutyrate + NADH + H+ (#7#
	catabolism through the threonine dehydrogenase pathway does not account
	for the high first-pass extraction rate of dietary threonine by the
	portal drained viscera in pigs, overview <27>) <27,28,29,30>
NSP	#7,10,15# L-threonine + NAD+ = L-2-amino-3-oxobutyrate + NADH + H+ (#7#
	catabolism through the threonine dehydrogenase pathway does not account
	for the high first-pass extraction rate of dietary threonine by the
	portal drained viscera in pigs, overview <27>) {?} <27,28,29,30>

SUBSTRATE_PRODUCT
SP	#1,2,6,7,8,9,11,12,13,16,19,20# L-threonine + NAD+ =
	L-2-amino-3-oxobutanoate + NADH + H+ (#20# active site structure,
	overview <31>) {}
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,25,31,32>
SP	#1,2,6,7,8,9,11,12,13,16,19,20# L-threonine + NAD+ =
	L-2-amino-3-oxobutanoate + NADH + H+ (#20# active site structure,
	overview <31>)
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,25,31,32>
SP	#1,2,6,7,8,9,11,12,13,16,19,20# L-threonine + NAD+ =
	L-2-amino-3-oxobutanoate + NADH + H+ (#20# active site structure,
	overview <31>) {r}
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,25,31,32>
SP	#10# butane-2,3-diol + NAD+ = ? + NADH <29>
SP	#10# D-threonine + NAD+ = D-2-amino-3-oxobutyrate + NADH <29>
SP	#10,15# L-serine + NAD+ = ? + NADH (#15# 21% of the activity with
	L-threonine <28>) <28,29>
SP	#10,15,19,23# More = ? (#15# substrate specificity, overview <28>; #19#
	specific for L-form of threonine, no substrate: NADP, nicotinic acid
	adenine dinucleotide, alpha-NAD, nicotinamide hypoxanthine dinucleotide
	<25>; #10# broad substrate specificity, determinants, overview <29>;
	#15# the enzyme is an NAD+-dependent zinc-containing medium-chain
	enzyme <26>; #23# ste11 gene encoding a TDH may function as a modifier
	gene of ebosin during its biosynthesis <34>) {} <25,26,28,29,34>
SP	#10,15,19,23# More = ? (#15# substrate specificity, overview <28>; #19#
	specific for L-form of threonine, no substrate: NADP, nicotinic acid
	adenine dinucleotide, alpha-NAD, nicotinamide hypoxanthine dinucleotide
	<25>; #10# broad substrate specificity, determinants, overview <29>;
	#15# the enzyme is an NAD+-dependent zinc-containing medium-chain
	enzyme <26>; #23# ste11 gene encoding a TDH may function as a modifier
	gene of ebosin during its biosynthesis <34>) {} <25,26,28,29,34>
SP	#15# DL-threo-3-phenylserine + NAD+ = ? + NADH (#15# 53% of the
	activity with L-threonine <28>) <28>
SP	#16# DL-2-amino-3-hydroxypentanoate + NAD+ = L-2-amino-3-oxopentanoate
	+ NADH {} <2,16>
SP	#16# DL-2-amino-3-hydroxypentanoate + NAD+ = L-2-amino-3-oxopentanoate
	+ NADH <2,16>
SP	#16# L-threonine amide + NAD+ = L-2-amino-3-oxobutyramide + NADH {}
	<2,16,18>
SP	#16# L-threonine amide + NAD+ = L-2-amino-3-oxobutyramide + NADH
	<2,16,18>
SP	#16# L-threonine methyl ester + NAD+ = L-2-amino-3-oxobutanoate methyl
	ester + NADH {} <2,16,18>
SP	#16# L-threonine methyl ester + NAD+ = L-2-amino-3-oxobutanoate methyl
	ester + NADH <2,16,18>
SP	#16# DL-threo-beta-phenylserine + NAD+ =
	DL-2-amino-3-phenyl-3-oxopropionate + NADH {} <2,16,18>
SP	#16# DL-threo-beta-phenylserine + NAD+ =
	DL-2-amino-3-phenyl-3-oxopropionate + NADH <2,16,18>
SP	#16# DL-allothreonine + NAD+ = D-2-amino-3-oxobutanoate + NADH <16>
SP	#16# D-allothreonine + NAD+ = D-2-amino-3-oxobutanoate + NADH <16>
SP	#16# DL-2-amino-3-hydroxyvalerate + NAD+ = DL-2-amino-3-oxovalerate +
	NADH {} <16,18>
SP	#16# DL-2-amino-3-hydroxyvalerate + NAD+ = DL-2-amino-3-oxovalerate +
	NADH <16,18>
SP	#16# DL-threonine hydroxamate + NAD+ = DL-2-amino-3-oxobutoxamate +
	NADH <18>
SP	#16,21# L-serine + NAD+ = L-2-amino-3-oxopropionate + NADH + H+ {}
	<2,16,18,35>
SP	#16,21# L-serine + NAD+ = L-2-amino-3-oxopropionate + NADH + H+
	<2,16,18,35>
SP	#16,21# L-serine + NAD+ = L-2-amino-3-oxopropionate + NADH + H+ {?}
	<2,16,18,35>
SP	#19# DL-threo-3-hydroxynorvaline + NAD+ = ? + NADH (#19# 31% the rate
	of L-threonine <25>) <25>
SP	#19# L-threonine + 3-acetyl-pyridine adenine dinucleotide =
	L-2-amino-3-oxobutanoate + ? (#19# 60.6% the rate of NAD+ <25>) <25>
SP	#19# L-threonine + 3-pyridinealdehyde adenine dinucleotide =
	L-2-amino-3-oxobutanoate + ? (#19# 7.2% the rate of NAD+ <25>) <25>
SP	#19# L-threonine + nicotinamide guanine dinucleotide =
	L-2-amino-3-oxobutanoate + ? (#19# 5.1% the rate of NAD+ <25>) <25>
SP	#19# L-threonine + thionicotinamide-NAD+ = L-2-amino-3-oxobutanoate + ?
	(#19# 5.1% the rate of NAD+ <25>) <25>
SP	#7# L-allothreonine + NAD+ = L-2-amino-3-oxobutanoate + NADH <13>
SP	#7,10,15,21,22,23# L-threonine + NAD+ = L-2-amino-3-oxobutyrate + NADH
	+ H+ (#7# catabolism through the threonine dehydrogenase pathway does
	not account for the high first-pass extraction rate of dietary
	threonine by the portal drained viscera in pigs, overview <27>; #15#
	stereospecificity, overview <28>; #10# substrate binding involved
	residues G66, G71, G77, and V80, H94 is an active site residue <29>)
	<27,28,29,30,33,34,35,36>
SP	#7,10,15,21,22,23# L-threonine + NAD+ = L-2-amino-3-oxobutyrate + NADH
	+ H+ (#7# catabolism through the threonine dehydrogenase pathway does
	not account for the high first-pass extraction rate of dietary
	threonine by the portal drained viscera in pigs, overview <27>; #15#
	stereospecificity, overview <28>; #10# substrate binding involved
	residues G66, G71, G77, and V80, H94 is an active site residue <29>)
	{?} <27,28,29,30,33,34,35,36>

TURNOVER_NUMBER
TN	#15# 7.2 {L-threonine}  (#15# pH 7.5, 65°C <30>) <30>
TN	#15# 7.2 {NAD+}  (#15# pH 7.5, 65°C <30>) <30>
TN	#15# 551.7 {L-threonine}  (#15# pH 7.5, 65°C <30>) <30>
TN	#15# 551.7 {NAD+}  (#15# pH 7.5, 65°C <30>) <30>
TN	#16# 135 {L-threonine}  <16>
TN	#20# 0.55 {L-threonine}  (#20# pH 7.5, 65°C, recombinant mutant E199A
	<32>) <32>
TN	#20# 0.55 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E199A <32>)
	<32>
TN	#20# 3.5 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152D <31>)
	<31>
TN	#20# 0.24 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152C <31>)
	<31>
TN	#20# 0.01 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152Q <31>)
	<31>
TN	#20# 0.08 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152T <31>)
	<31>
TN	#20# 0.009 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152A <31>)
	<31>
TN	#20# 11 {L-threonine}  (#20# pH 7.5, 65°C, recombinant wild-type
	enzyme <32>) <32>
TN	#20# 11 {NAD+}  (#20# pH 7.5, 65°C, recombinant wild-type enzyme <32>)
	<32>
TN	#20# 0.667 {L-threonine}  (#20# pH 7.5, 65°C, recombinant mutant R204A
	<32>) <32>
TN	#20# 0.667 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant R204A <32>)
	<32>
TN	#20# 1.11 {NAD+}  (#20# pH 7.5, 65°C, recombinant wild-type enzyme
	<31>) <31>
TN	#20# 0.085 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152S <31>)
	<31>
TN	#7# 23.3 {L-threonine}  <13>

KM_VALUE
KM	#1# 0.98 {NAD+}  <17>
KM	#1# 8.4 {L-threonine}  <17>
KM	#1# 5.38 {L-threonine}  <1>
KM	#1,16# 0.19 {NAD+}  <1,16,18>
KM	#10# 1.5 {L-threonine}  (#10# pH 7.0, 70°C, recombinant enzyme <29>)
	<29>
KM	#10# 0.055 {NAD+}  (#10# pH 7.0, 70°C, recombinant enzyme <29>) <29>
KM	#11# 0.24 {NAD+}  <21>
KM	#11# 6.1 {L-threonine}  <21>
KM	#12# 0.14 {NAD+}  (#12# at pH 7.5 <19>) <19>
KM	#12# 10.5 {L-threonine}  (#12# at pH 7.5 <19>) <19>
KM	#13# 5.5 {L-threonine}  <15>
KM	#15# 0.013 {L-threonine}  (#15# pH 7.5, 65°C <30>) <30>
KM	#15# 0.01 {NAD+}  (#15# pH 7.5, 65°C <30>) <30>
KM	#15,20# -999 {more}  (#15# kinetics <30>; #20# kinetic analysis of
	Glu152 mutants, overview <31>) <30,31>
KM	#16# 0.18 {NAD+}  (#16# enzyme activated with 0.07 mM Cd2+ <12>) <12>
KM	#16# 0.6 {NAD+}  (#16# enzyme activated with 0.25 mM Mn2+ <12>; #16#
	enzyme saturated with 0.25 mM Mn2+ <14>) <12,14>
KM	#16# 0.11 {NAD+}  (#16# metal-ion free enzyme <12>; #16# demetallized
	enzyme <14>) <12,14>
KM	#16# 1.43 {L-threonine}  <16,18>
KM	#16# 0.7 {L-threonine}  <3>
KM	#16# 0.0164 {NAD+}  <3>
KM	#16# 1.1 {L-threonine}  (#16# metal-ion free enzyme <12>; #16#
	demetallized enzyme <14>) <12,14>
KM	#16# 0.75 {NAD+}  (#16# C38D mutant <2>) <2>
KM	#16# 8.2 {L-threonine}  (#16# enzyme activated with 0.07 mM Cd2+ <12>)
	<12>
KM	#16# 211 {L-threonine}  (#16# enzyme activated with 0.25 mM Mn2+ <12>)
	<12>
KM	#16# 221 {L-threonine}  (#16# enzyme saturated with 0.25 mM Mn2+ <14>)
	<14>
KM	#19# 3.81 {L-threonine}  (#19# pH 9.0, 10°C <25>) <25>
KM	#19# 11.2 {L-threonine}  (#19# pH 9.0, 40°C <25>) <25>
KM	#19# 19.5 {L-threonine}  (#19# pH 9.0, 50°C <25>) <25>
KM	#19# 3.56 {L-threonine}  (#19# pH 9.0, 20°C <25>) <25>
KM	#19# 5.96 {L-threonine}  (#19# pH 9.0, 30°C <25>) <25>
KM	#2# 0.047 {NAD+}  <20>
KM	#2# 8.7 {L-threonine}  <20>
KM	#20# 2.5 {L-threonine}  (#20# pH 7.5, 65°C, recombinant mutant R204A
	<32>) <32>
KM	#20# 0.163 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152C <31>)
	<31>
KM	#20# 0.0099 {NAD+}  (#20# pH 7.5, 65°C, recombinant wild-type enzyme
	<31,32>) <31,32>
KM	#20# 0.0118 {L-threonine}  (#20# pH 7.5, 65°C, recombinant wild-type
	enzyme <32>) <32>
KM	#20# 0.152 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152T <31>)
	<31>
KM	#20# 0.304 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E199A <32>)
	<32>
KM	#20# 0.216 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152Q <31>)
	<31>
KM	#20# 0.291 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant R204A <32>)
	<32>
KM	#20# 1.51 {L-threonine}  (#20# pH 7.5, 65°C, recombinant mutant E199A
	<32>) <32>
KM	#20# 0.607 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152S <31>)
	<31>
KM	#20# 0.399 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152D <31>)
	<31>
KM	#20# 0.0615 {NAD+}  (#20# pH 7.5, 65°C, recombinant mutant E152A <31>)
	<31>
KM	#21# 0.028 {NAD+}  (#21# at 50°C <35>) <35>
KM	#21# 1.6 {L-threonine}  (#21# at 50°C <35>) <35>
KM	#7# 16 {L-allothreonine}  <13>
KM	#7# 13 {L-threonine}  <13>
KM	#7,13# 1 {NAD+}  <13,15>

PH_OPTIMUM
PHO	#1# 8.6-8.7 (#1# 30% activity at pH 7.5, 80% activity at pH 9.8 <17>)
	<17>
PHO	#10,16# 7 (#10# assay at <29>; #16# C38D mutant enzyme <2>) <2,29>
PHO	#12# 8.5-8.9 <19>
PHO	#13# 8.2-8.8 <15>
PHO	#15# 10 <28>
PHO	#15,20,23# 7.5 (#15,20# assay at <30,31,32>) <30,31,32,34>
PHO	#16# 8.4 (#16# C38D mutant enzyme, stimulated with 5 mM Zn2+ <2>) <2>
PHO	#16# 10.3 (#16# 35% activity at pH 9.0, 6% activity at pH 11.0 <16>)
	<4,16,18>
PHO	#16# 10.1 (#16# wild-type enzyme <2>) <2>
PHO	#19# 9.5 <25>
PHO	#2# 8.4-8.5 <20>
PHO	#21# 12 <35>
PHO	#6# 9 (#6# crude enzyme extracts from mitochondria frozen for 14 days
	and dialyzed <8>) <8>
PHO	#6,11# 7.8 (#6# crude enzyme extracts from mitochondria <8>) <8,21>

PH_RANGE
PHR	#13# 7.4-9 <15>
PHR	#15# 9.2-12 (#15# 22% of maximal activity at pH 9.2, 50% at pH 9.5, and
	52% at pH 12.0 <28>) <28>
PHR	#19# 10.5 (#19# 31% of maximum activity <25>) <25>
PHR	#19# 8.5 (#19# 74% of maximum activity <25>) <25>
PHR	#20# -999 (#20# pH dependencies of wild-type enzyme and E152D mutant,
	overview <31>) <31>

SPECIFIC_ACTIVITY
SA	#1# 19.0 <17>
SA	#1# 18920.0 <1>
SA	#11# 339.0 <21>
SA	#12# 6.05 <19>
SA	#13# 8.45 <15>
SA	#15# 3.43 (#15# purified recombinant enzyme <28>) <28>
SA	#16# 1.2 (#16# C38D mutant, incubated with 5 mM Co2+ 15 min before
	assay <2>) <2>
SA	#16# 0.2 (#16# C38D mutant <2>) <2>
SA	#16# 0.1 (#16# C38D mutant, incubated with 1 mM Mn2+ 15 min before
	assay <2>) <2>
SA	#16# 34.0 <16,18>
SA	#16# 0.6 (#16# C38D mutant, incubated with 0.07 or 5 mM Cd2+ 15 min
	before assay <2>) <2>
SA	#16# 2.0 (#16# C38D mutant, incubated with 5 mM Zn2+ and 1 mM Mn2+ 15
	min before assay <2>) <2>
SA	#16# 11.4 (#16# C38D mutant, incubated with 5 mM Zn2+ 15 min before
	assay <2>) <2>
SA	#16# 28.3 (#16# metal-ion free enzyme <12>) <12>
SA	#16# 8.0 (#16# fully demetalized enzyme <14>) <14>
SA	#16# 10.2 (#16# C38D mutant, incubated with 5 mM Zn2+ and 0.07 mM Cd2+
	15 min before assay <2>) <2>
SA	#16# 243.0 (#16# enzyme activated with 0.07 mM Cd2+ <12>) <12>
SA	#16# 685.0 (#16# enzyme activated with 0.25 mM Mn2+ <12>) <12>
SA	#19# 284.0 (#19# pH 9.0, 30°C <25>) <25>
SA	#19# 156.0 (#19# pH 9.0, 20°C <25>) <25>
SA	#19# 91.4 (#19# pH 9.0, 10°C <25>) <25>
SA	#19# 611.0 (#19# pH 9.0, 50°C <25>) <25>
SA	#19# 722.0 (#19# pH 9.0, 40°C <25>) <25>
SA	#2# 3.28 <20>
SA	#6# 0.029 (#6# partially purified enzyme <7>) <7>
SA	#6# 0.032 (#6# enzyme activity in mitochondrial extracts prepared from
	fresh mitochondria <8>) <8>
SA	#6# 0.062 (#6# enzyme activity in mitochondrial extracts after freezing
	the mitochondria for 2 weeks at -20°C <8>) <8>
SA	#6,7,14# -999.0 (#14# specific activity in animals fed a standard diet
	is 11times higher than in the liver of rats fed a standard diet. Enzyme
	activities in the livers of fasting and threonine-rich diet groups are
	three and two times higher than in the group fed with standard diet
	<22>; #6# specific activity in Japanese quail fed a standard diet is
	11times higher than in the liver of rats fed a standard diet. Enzyme
	activities in the livers of fasting groups are the same level as in the
	group fed with standard diet <22>; #7# threonine sequestration in the
	portal drained viscera and liver, threonine flux, overview <27>) <22,27>
SA	#7# 380.0 <5>
SA	#8# 0.055 (#8# enzyme activity in mitochondrial extracts <8>) <8>

TEMPERATURE_OPTIMUM
TO	#10,15# 70 (#10# assay at <29>) <28,29>
TO	#15# -999 (#15# hyperthermophilic enzyme <26>) <26>
TO	#15,20# 65 (#15,20# assay at <30,31,32>) <30,31,32>
TO	#19,23# 45 <25,34>
TO	#21# 90 <35>

TEMPERATURE_RANGE
TR	#15# 50-106 <30>
TR	#19# 10-30 (#19# 60 min, more than 90% residual activity <25>) <25>

COFACTOR
CF	#1,2,6,7,8,9,10,11,12,13,15,16,17,18,20,22# NAD+ (#15# dependent on
	<26,30>; #17# amino terminal NAD+ binding domain <23>; #18#
	aminoterminal NAD+ binding domain <23>; #22# binding site of the
	essential co-factor NAD+ is present in all subunits, it occupies the
	active site pocket and is bound predominantly by Van der Waal
	interactions and hydrogen bonds with the surrounding amino acid
	residues <36>)
	<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29
	30,31,32,33,36>
CF	#19# 3-acetyl-pyridine adenine dinucleotide <25>
CF	#19# Nicotinamide guanine dinucleotide <25>
CF	#19# Thionicotinamide-NAD+ <25>
CF	#20# NADH <32>

INHIBITORS
IN	#1# Cd2+ (#1# 0.05 and 1.0 mM, 90% inhibition <17>) <17>
IN	#1# Zn2+ (#1# 0.05 and 1.0 mM, 90% inhibition <17>) <17>
IN	#1# adenosine-5'-diphosphoribose (#1# competive inhibition vs. NAD+,
	noncompetitive inhibition vs. L-threonine <17>) <17>
IN	#1,16# Cu2+ (#16# 3.2 mM, 20-50% inhibition <14>; #16# 3.2 mM, 67%
	inhibition <16>; #1# 0.05 and 1.0 mM, 90% inhibition <17>) <14,16,17>
IN	#1,16# Mn2+ (#16# preincubation with 1 mM, 47% inhibition of
	L-threonine amide oxidation, 73% inhibition of L-threonine methyl ester
	oxidation, 59% inhibition of L-serine oxidation, 48% inhibition of
	D,L-threo-beta-phenylserine oxidation <2>; #1# 1.0 mM, 40-50%
	inhibition <17>) <2,17>
IN	#1,16# Ni2+ (#16# 3.2 mM, 20-50% inhibition <14>; #16# 3.2 mM, 69%
	inhibition <16>; #1# 1 mM, 40-50% inhibition <17>) <14,16,17>
IN	#1,7,19# NADH (#1,7# competitive inhibition vs. NAD+, noncompetitive
	vs. L-threonine <13,17>; #19# competitive to NAD+, noncompetitive to
	L-threonine <25>) <13,17,25>
IN	#10,12,15,16,21# EDTA (#16# 50 mM, 99% inhibition after 1 h, complete
	loss of enzyme-bound Zn2+ <9>; #15# complete inhibition at 50 mM <30>;
	#10# complete inhibition, fully reversible by Zn2+ or Co2+ <29>; #21#
	retains 65% of its original activity after dialysis at 48°C against a
	buffer containing 1 mM EDTA. Activity is lost when TDH is heated at
	60°C for 40 min and in boiling water for 5 min in the presence of 1 mM
	EDTA <35>) <9,19,29,30,35>
IN	#11# p-chloromercuribenzoate (#11# complete inhibition <21>) <21>
IN	#11# Iodosobenzoic acid (#11# 0.3 mM, 17% inhibition <21>) <21>
IN	#11,12,16# Hg2+ (#16# 0.5 mM, 100% inhibition of wild-type and C38D
	mutant enzyme <2>; #16# 0.064 mM, activity is completely blocked <14>;
	#11# 0.25 mM, complete inhibition, 0.05 mM, 95% inhibition <21>)
	<2,14,19,21>
IN	#11,16# iodoacetamide (#16# 3.2 mM, 10% inhibition <10>; #11# 30 mM,
	15% inhibition <21>) <10,21>
IN	#12,16# Ag+ (#16# 0.064 mM, activity is completely blocked <14>) <14,19>
IN	#12,16# p-Mercuribenzoate (#16# 10fold excess leads to immidiate
	inactivation <10>; #16# 0.0013 mM, 75% inhibition, completely reversed
	within 20 min by addition of 0.02-0.2 mM 2-mercaptoethanol or
	dithiothreitol <16>) <10,16,19>
IN	#13# Methylglyoxal (#13# 1.0 mM, 42% inhibition, 2 mM, 63% inhibition,
	methylglyoxal binds at an allosteric site of the enzyme <15>) <15>
IN	#15# L-2-amino-3-oxobutyrate (#15# competitive product inhibition by
	the unstable L-2-amino-3-oxobutyrate only in presence of NADH, which
	stabilizes <28>) <28>
IN	#16# 1,10-phenanthroline (#16# 1.26 mM, 41% inhibition after 1 h, 82%
	inhibition after 2 h, no change in remaining activity after removal of
	1,10-phenanthroline <9>) <9>
IN	#16# Be2+ (#16# 3.2 mM, 20-50% inhibition <14>) <14>
IN	#16# dipicolinic acid (#16# 40 mM, 99% inhibition after 1 h, complete
	loss of enzyme-bound Zn2+ <9>) <9>
IN	#16# iodoacetate (#16# iodoacetate reacts with 1 sulfhydryl group per
	subunit of the enzyme, enzyme retains 15% of its initial activity <9>;
	#16# enzyme contains 6 half-cystine residues per subunit, 2 disulfide
	bonds and 4 sulfhydryl groups <10>; #16# 15% protection against
	inhibition with 5 mM NAD+, 30% with 5 mM L-threonine, 60-70% protection
	in the presence of both NAD+ and L-threonine, inactivation occurs more
	rapidly in the presence of Cd2+ <10>) <9,10>
IN	#16# Methylmethanethiosulfonate (#16# 0.4 mM, 350fold molar excess over
	enzyme sulfhydryl groups leads to complete inactivation <10>) <10>
IN	#16# NAD+ (#16# competitive inhibition of L-2-amino-3-oxobutanoate
	reduction <6>) <6>
IN	#16# methyl p-nitrobenzenesulfonate (#16# 2 mM, 40% inhibition within
	80 min, 65% protection with 250 mM L-threonine, 64% with 250 mM
	L-threonine methyl ester, 58% with 250 mM L-threonine amide <3>) <3>
IN	#16# thionitrobenzoate (#16# 40fold molar excess, gradual 99% loss of
	enzyme activity <10>) <10>
IN	#16# 5,5'-dithiobis-(2-nitrobenzoic acid) (#16# 0.25 mM, 90%
	inhibition, 67% activity is recovered after incubation with 1 mM,
	2-mercaptoethanol or dithieothreitol for 15 min <16>) <16>
IN	#16,19# N-ethylmaleimide (#19# 10 mM, 48% inhibition <25>; #16# 0.32
	mM, 10 min, 37°C, 23% inhibition <16>) <16,25>
IN	#19# CuCl2 (#19# 1 mM, 100% inhibition <25>) <25>
IN	#19# HgCl2 (#19# 10 mM, 100% inhibition <25>) <25>
IN	#19# monoiodoacetate (#19# 10 mM, 100% inhibition <25>) <25>
IN	#19# p-chloromercuribenzoic acid (#19# 10 mM, 44% inhibition <25>) <25>
IN	#19# pyruvate (#19# competitive to L-threonine <25>) <25>
IN	#19# ZnCl2 (#19# 1 mM, 72% inhibition <25>) <25>
IN	#7# Aminoacetone (#7# uncompetitive inhibition vs. NAD+ or L-threonine
	<13>) <13>
IN	#7# HCO3- (#7# noncompetitive inhibition vs. NAD+ or L-threonine <13>)
	<13>

KI_VALUE
KI	#19# 0.37 {adenosine-5'-diphosphoribose}  (#19# substrate NAD+, pH 9.0,
	30°C <25>) <25>
KI	#19# 23.2 {pyruvate}  (#19# substrate L-threonine, pH 9.0, 30°C <25>)
	<25>
KI	#19# 1.42 {adenosine-5'-diphosphoribose}  (#19# substrate L-threonine,
	pH 9.0, 30°C <25>) <25>
KI	#19# 50.7 {pyruvate}  (#19# substrate NAD+, pH 9.0, 30°C <25>) <25>

METALS_IONS
ME	#10,12,15,16,20,21# Zn2+ (#15# required <26,28>; #12# restores enzyme
	activity after EDTA treatment <19>; #16# 5 mM, 60fold increase of C38D
	mutant enzyme activity, Zn2+ stimulated activity decreases to 10% when
	1 mM Mn2+ is added, no increase in activity for wild-type enzyme <2>;
	#16# enzyme contains 1 Zn2+ atom per subunit <4,9>; #16# exchange of
	Zn2+ with Co2+ or Cd2+ does not change the specific activity of the
	enzyme <9>; #10# 2 Zn2+ per enzyme subunit, binding involves residues
	G168, G175, G180, and G212, overview <29>; #15# required, 1.22 mol Zn2+
	per mol of enzyme subunit <30>; #20# 1.22 mol of Zn2+ per mol of enzyme
	subunit, the catalytic zinc atom at the active center of TDH is
	coordinated by the highly conserved four residues Cys42, His67, Glu68
	and Glu152 with low affinity <31>; #20# one molecule of TDH contains
	one zinc ion playing a structural role, the metal ion is ligated by
	foru Cys residues, coenzyme-binding domain shows a larger interdomain
	cleft compared to other ADHs, binding structure, overview <32>; #21#
	four zinc-binding cysteine residues, 0.1 mM reactivates EDTA-100%
	inhibited enzyme by 75%, 0.05 mM reactivates by 100% <35>)
	<2,4,9,19,26,28,29,30,31,32,35>
ME	#10,12,15,16,21# Co2+ (#10# activates <29>; #16# 5 mM, 6fold increase
	of C38D mutant enzyme activity <2>; #12# restores enzyme activity after
	EDTA treatment <19>; #15# can replace Zn2+ with 35% of the activity
	with Zn2+ <28>; #21# 0.1 mM reactivates EDTA-100% inhibited enzyme by
	54% <35>) <2,19,28,29,35>
ME	#12,15,16,21# Mn2+ (#12# restores enzyme activity after EDTA treatment
	<19>; #16# preincubation with 1 mM, 3.5fold increase of L-threonine
	oxidation <2>; #16# 0.064 or 3.2 mM, 4fold increase of L-threonine
	dehydrogenase activity, activation is dependent on the presence of a
	reduced thiol in all enzyme stock solutions and assay buffers, binding
	of 0.86 mol of Mn2+ per mol of enzyme subunit <14>; #16# 0.064 mM,
	1.6fold activation, 3.2 mM, 2.4fold activation <16>; #15# can replace
	Zn2+ with 77% of the activity with Zn2+ <28>; #21# 0.1 mM reactivates
	EDTA-100% inhibited enzyme by 38% <35>) <2,14,16,19,28,35>
ME	#15,21# Ca2+ (#15# 0.54 mol Ca2+ per mol of enzyme subunit <30>; #21#
	0.1 mM reactivates EDTA-100% inhibited enzyme by 40% <35>) <30,35>
ME	#15,21# Cu2+ (#15# 0.29 mol Ca2+ per mol of enzyme subunit <30>; #21#
	0.1 mM reactivates EDTA-100% inhibited enzyme by 63% <35>) <30,35>
ME	#15,21# Mg2+ (#15# 0.2 mol Ca2+ per mol of enzyme subunit <30>; #21#
	0.1 mM reactivates EDTA-100% inhibited enzyme by 27% <35>) <30,35>
ME	#16# Cd2+ (#16# preincubation with 0.07 or 5 mM leads to 3fold increase
	of C38D mutant enzyme activity, 0.5 mM, 6.5fold increase of wild-type
	enzyme activity, substrate L-threonine <2>; #16# 0.064 or 3.2 mM, 6fold
	increase of L-threonine dehydrogenase activity <14>; #16# activation is
	not thiol-dependent <10>; #16# activity of metal-ion free enzyme
	increases 10fold <12>) <2,10,12,14>
ME	#21# Ni2+ (#21# 0.1 mM reactivates EDTA-100% inhibited enzyme by 30%
	<35>) <35>
ME	#22# more (#22# the active site catalytic zinc ion is absent from the
	TDH structure <36>) <36>

MOLECULAR_WEIGHT
MW	#1# 78000 (#1# gel filtration <17>) <17>
MW	#1# 88000 (#1# density gradient <17>) <17>
MW	#1# 74000 (#1# gel filtration <1>) <1>
MW	#10# 155000 (#10# about, recombinant enzyme, gel filtration <29>) <29>
MW	#13# 86000 (#13# gel filtration <15>) <15>
MW	#15# 76000 (#15# recombinant enzyme, gel filtration <30>) <30>
MW	#15# 192000 (#15# recombinant enzyme, gel filtration <28>) <28>
MW	#16# 140000 (#16# sucrose density and sedimentation equilibrium <16>)
	<16,18>
MW	#16# 149000 (#16# non-denaturing PAGE, wild-type and C38D mutant <2>)
	<2>
MW	#19# 139000 (#19# gel filtration <25>) <25>
MW	#21# 154000 (#21# by gel filtration <35>) <35>
MW	#21# 38100 (#21# sequence analysis <35>) <35>
MW	#7# 73000 (#7# gel filtration <5>) <5>

POSTTRANSLATIONAL_MODIFICATION
PM	#18# proteolytic modification (#18# pro-protein is cleaved to produce a
	36000 Da mature enzyme <23>) <23>

SUBUNITS
SU	#1,13# monomer (#1# 1 * 88000, SDS-PAGE <17>; #13# 1 * 89000, SDS-PAGE
	<15>) <15,17>
SU	#1,7,15# dimer (#1# 2 * 36000, SDS-PAGE <1>; #7# 2 * 37000, SDS-PAGE
	<5>; #15# 2 * 36000-38000, recombinant enzyme, SDS-PAGE, 2 * 37742,
	sequence calculation <30>) <1,5,30>
SU	#10,13,15,20# tetramer (#13# 4 * 35000, SDS-PAGE <15>; #10# 4 * 40000,
	recombinant enzyme, SDS-PAGE, 4 * 37823, sequence calculation <29>;
	#15# 4 * 41200, recombinant enzyme, SDS-PAGE, 4 * 41815, sequence
	calculation <28>; #20# 4 * 35000, recombinant enzyme, SDS-PAGE <32>)
	<15,28,29,32>
SU	#15,17,18,20# ? (#17# x * 41500, deduced from gene sequence,
	aminoterminal mitochondrial targeting sequence <23>; #18# x * 41500,
	pro-protein, x * 36000, mature enzyme, deduced from gene sequence,
	aminoterminal mitochondrial targeting sequence <23>; #15# x * 37700,
	recombinant enzyme, SDS-PAGE <26>; #20# x * 38000, recombinant
	wild-type and mutant enzymes, SDS-PAGE <31>) <23,26,31>
SU	#19,22# homotetramer (#19# 4 * 35000, SDS-PAGE <25>; #22# 4 * 38016,
	electrospray mass spectrometry and gel filtration <33,36>) <25,33,36>
SU	#20# More (#20# crystal structure analysis, each subunit is composed of
	two domains: an NAD(H)-binding domain and a catalytic domain. The
	NAD(H)-binding domain contains the alpha/beta Rossmann fold motif,
	characteristic of the NAD(H)-binding protein <32>) <32>

PI_VALUE
PI	#17,18# 6.9 (#17,18# predicted from gene sequence <23>) <23>

APPLICATION
AP	#4# synthesis (#4# over-expression of a feedback-resistant threonine
	operon thrA*BC, with deletion of the genes that encode threonine
	dehydrogenase tdh and threonine transporters tdcC and sstT, and
	introduction of a mutant threonine exporter rhtA23 in Escherichia
	coliMDS42. The resulting strain shows about 83% increase in L-threonine
	production when cells are grown by flask fermentation, compared to a
	wild-type Escherichia coli strain MG1655 engineered with the same
	threonine-specific modifications described above <37>) <37>

ENGINEERING
EN	#16# C38S (#16# site-directed mutagenesis, catalytically inactive
	mutant, C38 is located in an activating divalent metal-ion binding site
	<2>; #16# 1 cysteine residue per subunit is essential for catalytic
	activity and Mn2+ binding <4>) <2,4>
EN	#16# C38D (#16# site-directed mutagenesis <2>) <2>
EN	#20# E152Q (#20# site-directed mutagenesis, the mutant shows reduced
	activity compared to the wild-type enzyme <31>) <31>
EN	#20# E199A (#20# site-directed mutagenesis, the mutant shows altered
	kinetics compared to the wild-type enzyme <32>) <32>
EN	#20# E152K (#20# site-directed mutagenesis, inactive mutant <31>) <31>
EN	#20# E152A (#20# site-directed mutagenesis, the mutant shows reduced
	activity compared to the wild-type enzyme <31>) <31>
EN	#20# E152D (#20# site-directed mutagenesis, the E152D mutant shows
	3-fold higher turnover rate and reduced affinities toward L-threonine
	and NAD+ compared to wild-type TDH, Glu152 to Asp substitution causes
	the enhancement of deprotonation of His47 or ionization of zinc-bound
	water and threonine in the enzyme-NAD+ complex <31>) <31>
EN	#20# E152C (#20# site-directed mutagenesis, the mutant shows reduced
	activity compared to the wild-type enzyme <31>) <31>
EN	#20# E152S (#20# site-directed mutagenesis, the mutant shows reduced
	activity compared to the wild-type enzyme <31>) <31>
EN	#20# E152T (#20# site-directed mutagenesis, the mutant shows reduced
	activity compared to the wild-type enzyme <31>) <31>
EN	#20# R204A (#20# site-directed mutagenesis, the mutant shows altered
	kinetics compared to the wild-type enzyme <32>) <32>
EN	#5,23# more (#5# all individuals examined contain at least two
	mutations that on translation would generate truncated proteins that
	would be non-functional since they have lost the splicing acceptor site
	preceding exon 6 and codon Arg214 is mutated to a stop codon. Therefore
	the gene is an expressed pseudogene <24>; #23# ste11 gene knocked out
	with a double crossover via homologous recombination. Monosaccharide
	composition of exopolysaccharide produced by the mutant strain is
	altered from that of ebosin. Bioactivity of the mutant is lower than
	ebosin <34>) <24,34>

CLONED
CL	#10# (gene tdh, functional expression in Escherichia coli) <29>
CL	#15# (orf PH0655, amino acid sequence determination and analysis,
	expression of His-tagged enzyme in Escherichia coli strain TOP10) <28>
CL	#15# (orf PH0655, expression in Escherichia coli) <26>
CL	#15# (orf PH0655, gene TDH, overexpression in Escherichia coli strain
	BL21(DE3)) <30>
CL	#16# (cloned as a 3562-base pair EcoRI fragment) <11>
CL	#19# <25>
CL	#20# (orf PH0655, NA and amino acid sequence determination, analysis,
	and comparison, expression of selenomethionine-labeled wild-type and
	mutant enzymes in Escherichia coli strain BL21(DE3)) <32>
CL	#20# (orf PH0655, overexpression of wild-type and mutant enzymes in
	Escherichia coli strain BL21(DE3)) <31>
CL	#21# (plasmid pTZ-tdh transformed in Escherichia coli DH5alpha
	competent cells. NcoI-EcoRI restriction fragment inserted into the
	pET-8c expression vector at the corresponding sites. The resulting
	plasmid pET-tdh expressed in Escherichia coli strain
	BL21(DE3)CodonPlus-RIL) <35>
CL	#22# (ligated into the pTZ57R/T cloning vector. The recombinant pTZ-tdh
	plasmid digested with NcoI and EcoRI and the TDH gene ligated with
	pET-8c, giving the recombinant pET-tdh plasmid, used to transform
	Escherichia coli DH5alpha competent cells. Recombinant and purified
	pET-tdh plasmid expressed in Escherichia coli BL21 (DE3)) <33>
CL	#22# (recombinant pET-tdh plasmid expressed in Escherichia coli BL21
	(DE3)) <36>
CL	#23# (into pET-30a digested with KpnI–EcoRI to construct pET-ste11
	and expressed in Escherichia coli BL21) <34>

CRYSTALLIZATION
CR	#15# (purified recombinant enzyme, hanging drop vapour diffusion
	method, 4°C, 10 mg/ml protein in 50 mM Tris-HCl, pH 7.5, 0.0015 ml of
	protein and reservoir solution are mixed, the reservoir solution
	contains 0.2 M NaCl, 0.1 M HEPES, pH 7.5, and 40% v/v PEG 400, 5 days,
	X-ray diffraction structure determination and preliminary analysis at
	2.2 A resolution) <26>
CR	#20# (selenomethionine-substituted enzyme, 10 mg/ml protein in 50 mM
	Tris-HCl buffer, pH 7.5, hanging-drop vapor-diffusion method at 4°C,
	mixing of 0.0015 ml of each, protein and reservoir solution, the latter
	containing 0.2 M sodium chloride, 0.1 M HEPES buffer, pH 7.5, and 40%
	v/v PEG 400, five days, X-ray diffraction structure determination and
	analysis, single wavelength anomalous diffraction method) <32>
CR	#22# (at room temperature using hanging-drop vapour diffusion method,
	at 2.4 A resolution. The enzyme is a homotetramer, each monomer
	consisting of 350 amino acids that form two domains, a catalytic domain
	and a NAD+-binding domain, which contains an alpha/beta Rossmann fold
	motif. An extended twelve-stranded beta-sheet is formed by the
	association of pairs of monomers in the tetramer) <36>
CR	#22# (by hanging-drop vapour-diffusion method, to 2.6 A resolution.
	Crystals grow in the tetragonal space group P43212, with unit-cell
	parameters a=b=124.5, c=271.1 A. There are four molecules in the
	asymmetric unit of the crystal) <33>

PURIFICATION
PU	#1# (DEAE-cellulose, hydrophobic interaction chromatography, Affi-Gel
	Blue, Matrex Red A) <1>
PU	#1# (DEAE-cellulose, ammonium sulfate, DEAE-cellulose, Blue
	dextran-Sepharose, Sephadex G-200, amylamine sepharose, Sephadex G-200)
	<17>
PU	#2# (MnCl2, ammonium sulfate, calcium phosphate gel, protamine sulfate,
	DEAE-cellulose, 7fold purification) <20>
PU	#6# (hydroxyapatite) <7>
PU	#7# (DEAE Sepharose FF, Affi-Gel blue, Sephacryl S-200, Matrix Gel red
	A, Matrix gel Green A) <5>
PU	#10# (recombinant enzyme 48fold from Escherichia coli to homogeneity by
	heat treatment and anion exchange chromatography) <29>
PU	#11# (ammonium sulfate, DEAE-cellulose, 7fold purification) <21>
PU	#12# (protamine sulfate, Sephadex G-200, DEAE-cellulose) <19>
PU	#13# (acid precipitation, ammonium sulfate, Sephadex G-100, Sephadex
	G-200) <15>
PU	#15# (recombinant enzyme from Escherichia coli) <26>
PU	#15# (recombinant enzyme from Escherichia coli strain BL21(DE3) by heat
	treatment at 85°C for 30 min, centrifugation, ion exchange
	chromatography, and gel filtration) <30>
PU	#15# (recombinant His-tagged enzyme from Escherichia coli strain TOP10
	by nickel affinity chromatography) <28>
PU	#16# <14,16,18>
PU	#16# (treatment of cell extract at 60°C, DEAE-Sephadex, Mn2+
	activation, Blue 2-Sepharose CL-6B, C38D mutant was purified without
	Mn2+ activation) <2>
PU	#19# <25>
PU	#20# (recombinant wild-type and mutant enzymes from Escherichia coli
	strain BL21(DE3) by heat treatment at 85°C for 30 min, anion exchange
	and hydrophobic interaction chromatography) <31>
PU	#21# (by heat treatment (about 80% pure recombinant TDH protein) and
	gel filtration) <35>
PU	#22# (by sonication, centrifugation, heating of the soluble fraction,
	anion-exchange and hydrophobic interaction chromatography) <33>
PU	#22# (by sonication, heating of the cell lysate, anion exchange and
	hydrophobic interaction chromatography) <36>
PU	#23# (by sonication, centrifugation and on a Ni-NTA resin column) <34>

GENERAL_STABILITY
GS	#12# (most stable in Tris-HCl, pH 8, purified preparations in phosphate
	buffers lose their activity overnight) <19>

PH_STABILITY
PHS	#23# 5.5-7.5 (#23# activity at pH 5.5 is 50% of that at pH 7.5 <34>)
	<34>

STORAGE_STABILITY
SS	#1# (-20°C, 14 mM 2-mercaptoethanol, 20% glycerol, at least 1 month,
	little loss of activity) <17>
SS	#16# (4°C, 50 mM Tris-HCl, pH 8.4, 1 mM 2-mercaptoethanol, 2 months,
	no loss of activity) <18>
SS	#19# (-20°C, 10 mM potassium phosphate, pH 7.0, 30% sucrose, 0.1 mM
	NAD+, 5 mM L-threonine, several months, no loss of activity) <25>
SS	#22# (50 mM Tris–HCl buffer, pH 8.0) <33>
SS	#23# (-20°C) <34>

TEMPERATURE_STABILITY
TS	#15# 100 (#15# 30 min, pH 7.0, over 90% remaining activity, purified
	recombinant enzyme <28>) <28>
TS	#15# 80 (#15# 60 min, pH 7.0, over 90% remaining activity, purified
	recombinant enzyme <28>) <28>
TS	#15# 120 (#15# 20 min, inactivation, purified recombinant enzyme <28>)
	<28>
TS	#15# 105 (#15# higher loss of activity above, purified recombinant
	enzyme <28>) <28>
TS	#15# 108 (#15# 2-step thermal inactivation <30>) <30>
TS	#19# 50 (#19# rapid inactivation <25>) <25>
TS	#19# 40 (#19# half-life 160 min <25>) <25>
TS	#19# 45 (#19# half-life 14 min <25>) <25>
TS	#2# 25-35 (#2# 85% inactivation after 2 min at 35°C, 10% inactivation
	at 35°C in the presence of 80 mM KCl <20>) <20>
TS	#21# 85 (#21# the enzyme shows a half life of 2 h at 85°C and 24 min
	in boiling water <35>) <35>
TS	#23# 25-45 (#23# enzyme shows 50% activity at 25°C compared with that
	at 35°C <34>) <34>

REFERENCE
RF	<1> Yuan, J.H.; austic, R.E.: Characterization of hepatic L-threonine
	dehydrogenase of chicken. Comp. Biochem. Physiol. (2001) 130, 65-73.
	{Pubmed:11470445}
RF	<2> Johnson, A.R.; Chen, Y.W.; Dekker, E.E.: Investigation of a
	catalytic zinc binding site in Escherichia coli L-threonine
	dehydrogenase by site-directed mutagenesis of cysteine-38. Arch.
	Biochem. Biophys. (1998) 358, 211-221. {Pubmed:9784233}
RF	<3> Marcus, J.P.; Dekker, E.E.: Identification of a second active site
	residue in Escherichia coli L-threonine dehydrogenase: methylation of
	histidin-90 with methyl p-nitrobenzenesulfonate. Arch. Biochem.
	Biophys. (1995) 316, 413-420. {Pubmed:7840645}
RF	<4> Chen, Y.W.; Dekker, E.E.; Somerville, R.L.: Functional analysis of
	E. coli threonine dehydrogenase by means of mutant isolation and
	characterization. Biochim. Biophys. Acta (1995) 1253, 208-214.
	{Pubmed:8519804}
RF	<5> Kao, Y.C.; Davis, L.: Purification and structural characterization
	of porcine L-threonine dehydrogenase. Protein Expr. Purif. (1994) 5,
	423-431. {Pubmed:7827500}
RF	<6> Marcus, J.P.; Dekker, E.E.: Threonine formation via the coupled
	activity of 2-amino-3-ketobutyrate coenzyme A lyase and threonine
	dehydrogenase. J. Bacteriol. (1993) 175, 6505-6511. {Pubmed:8407827}
RF	<7> Pagani, R.; Leoncini, R.; Righi, S.; Guerranti, R.; Lazzerretti,
	L.; Marinello, E.: Mitochondrial L-threonine dehydrogenase. Biochem.
	Soc. Trans. (1992) 20, 379. {Pubmed:}
RF	<8> Pagani, R.; Guerranti, R.; Right, S.; Leoncini, R.; Vannoni, D.;
	Marinello, E.: Rat liver L-threonine dehydrogenase. Biochem. Soc.
	Trans. (1991) 20, 24. {Pubmed:}
RF	<9> Epperly, B.R.; Dekker, E.E.: L-Threonine dehydrogenase from
	Escherichia coli. J. Biol. Chem. (1991) 266, 6086-6092. {Pubmed:2007567}
RF	<10> Craig, P.A.; Dekker, E.E.: The sulfhydryl content of L-threonine
	dehydrogenase from Escherichia coli K-12: relation to catalytic
	activity and Mn2+ activation. Biochim. Biophys. Acta (1990) 1037,
	30-38. {Pubmed:2104757}
RF	<11> Aronson, B.D.; Somerville, R.L.; Epperly, B.R.; Dekker, E.E.: The
	primary structure of Escherichia coli L-threonine dehydrogenase. J.
	Biol. Chem. (1989) 264, 5226-5232. {Pubmed:2647748}
RF	<12> Craig, P.A.; Dekker, E.E.: Cd2+ activation of L-threonine
	dehydrogenase from Escherichia coli K-12. Biochim. Biophys. Acta (1988)
	957, 222-229. {Pubmed:3056527}
RF	<13> Tressel, T.; Thompson, R.; Zieske, L.R.; Menendez, M.I.T.S.;
	Davis, L.: Interaction between L-threonine dehydrogenase and
	aminoacetone synthetase and mechanism of aminoacetone production. J.
	Biol. Chem. (1986) 261, 16428-16437. {Pubmed:3536927}
RF	<14> Craig, P.A.; Dekker, E.E.: L-Threonine dehydrogenase from
	Escherichia coli K-12: thiol-dependent activation by Mn2+. Biochemistry
	(1986) 25, 1870-1876. {Pubmed:3518793}
RF	<15> Ray, M.; Ray, S.: L-Threonine dehydrogenase from goat liver. J.
	Biol. Chem. (1985) 260, 5913-5918. {Pubmed:3888978}
RF	<16> Boylan, S.A.; Dekker, E.E.: L-threonine dehydrogenase. J. Biol.
	Chem. (1981) 256, 1809-1815. {Pubmed:6780553}
RF	<17> Aoyama, Y.; Motokawa, Y.: L-Threonine dehydrogenase of chicken
	liver. J. Biol. Chem. (1981) 256, 12367-12373. {Pubmed:7028754}
RF	<18> Boylan, S.A.; Dekker, E.E.: L-Threonine dehydrogenase of
	Escherichia coli K-12. Biochem. Biophys. Res. Commun. (1978) 85,
	190-197. {Pubmed:33672}
RF	<19> McGilvray, D.; Morris, J.G.: L-Threonine dehydrogenase
	(Arthrobacter). Methods Enzymol. (1971) 17B, 580-584. {Pubmed:}
RF	<20> Green, M.L.; Elliott, W.H.: The enzymatic formation of
	aminoacetone from threonine and its further metabolism. biochem. J.
	(1964) 92, 537-548. {Pubmed:4284408}
RF	<21> Hartshorne, D.; Greenberg, D.M.: Studies on liver threonine
	dehydrogenase. Arch. Biochem. Biophys. (1964) 105, 173-178.
	{Pubmed:14165492}
RF	<22> Akagi, S.; Sato, K.; Ohmori, S.: Threonine metabolism in Japanese
	quail liver. Amino Acids (2004) 26, 235-242. {Pubmed:15221503}
RF	<23> Edgar, A.J.: Molecular cloning and tissue distribution of
	mammalian L-threonine 3-dehydrogenases. BMC Biochem. (2002) 3, 19.
	{Pubmed:12097150}
RF	<24> Edgar, A.J.: The human L-threonine 3-dehydrogenase gene is an
	expressed pseudogene. BMC Genet. (2002) 3, 18. {Pubmed:12361482}
RF	<25> Kazuoka, T.; Takigawa, S.; Arakawa, N.; Hizukuri, Y.; Muraoka, I.;
	Oikawa, T.; Soda, K.: Novel psychrophilic and thermolabile L-threonine
	dehydrogenase from psychrophilic Cytophaga sp. strain KUC-1. J.
	Bacteriol. (2003) 185, 4483-4489. {Pubmed:12867457}
RF	<26> Higashi, N.; Matsuura, T.; Nakagawa, A.; Ishikawa, K.:
	Crystallization and preliminary X-ray analysis of hyperthermophilic
	L-threonine dehydrogenase from the archaeon Pyrococcus horikoshii. Acta
	crystallogr. Sect. F (2005) 61, 432-434. {Pubmed:16511061}
RF	<27> Le Floch, N.; Seve, B.: Catabolism through the threonine
	dehydrogenase pathway does not account for the high first-pass
	extraction rate of dietary threonine by the portal drained viscera in
	pigs. Br. J. Nutr. (2005) 93, 447-456. {Pubmed:15946406}
RF	<28> Shimizu, Y.; Sakuraba, H.; Kawakami, R.; Goda, S.; Kawarabayasi,
	Y.; Ohshima, T.: L-Threonine dehydrogenase from the hyperthermophilic
	archaeon Pyrococcus horikoshii OT3: gene cloning and enzymatic
	characterization. Extremophiles (2005) 9, 317-324. {Pubmed:15902509}
RF	<29> Machielsen, R.; van der Oost, J.: Production and characterization
	of a thermostable L-threonine dehydrogenase from the hyperthermophilic
	archaeon Pyrococcus furiosus. FEBS J. (2006) 273, 2722-2729.
	{Pubmed:16817900}
RF	<30> Higashi, N.; Fukada, H.; Ishikawa, K.: Kinetic study of
	thermostable L-threonine dehydrogenase from an archaeon Pyrococcus
	horikoshii. J. Biosci. Bioeng. (2005) 99, 175-180. {Pubmed:16233775}
RF	<31> Higashi, N.; Tanimoto, K.; Nishioka, M.; Ishikawa, K.; Taya, M.:
	Investigating a catalytic mechanism of hyperthermophilic L-threonine
	dehydrogenase from Pyrococcus horikoshii. J. Biochem. (2008) 144,
	77-85. {Pubmed:18390572}
RF	<32> Ishikawa, K.; Higashi, N.; Nakamura, T.; Matsuura, T.; Nakagawa,
	A.: The first crystal structure of L-threonine dehydrogenase. J. Mol.
	Biol. (2007) 366, 857-867. {Pubmed:17188300}
RF	<33> Bowyer, A.; Mikolajek, H.; Wright, J.N.; Coker, A.; Erskine, P.T.;
	Cooper, J.B.; Bashir, Q.; Rashid, N.; Jamil, F.; Akhtar, M.:
	Crystallization and preliminary X-ray diffraction analysis of
	L-threonine dehydrogenase (TDH) from the hyperthermophilic archaeon
	Thermococcus kodakaraensis. Acta Crystallogr. Sect. F (2008) 64,
	828-830. {Pubmed:18765916}
RF	<34> Bao, Y.; Xie, H.; Shan, J.; Jiang, R.; Zhang, Y.; Guo, L.; Zhang,
	R.; Li, Y.: Biochemical characteristics and function of a threonine
	dehydrogenase encoded by ste11 in Ebosin biosynthesis of Streptomyces
	sp. 139. J. Appl. Microbiol. (2009) 106, 1140-1146. {Pubmed:19191964}
RF	<35> Bashir, Q.; Rashid, N.; Jamil, F.; Imanaka, T.; Akhtar, M.: Highly
	thermostable L-threonine dehydrogenase from the hyperthermophilic
	archaeon Thermococcus kodakaraensis. J. Biochem. (2009) 146, 95-102.
	{Pubmed:19307254}
RF	<36> Bowyer, A.; Mikolajek, H.; Stuart, J.W.; Wood, S.P.; Jamil, F.;
	Rashid, N.; Akhtar, M.; Cooper, J.B.: Structure and function of the
	l-threonine dehydrogenase (TkTDH) from the hyperthermophilic archaeon
	Thermococcus kodakaraensis. J. Struct. Biol. (2009) 168, 294-304.
	{Pubmed:19616102}
RF	<37> Lee, J.H.; Sung, B.H.; Kim, M.S.; Blattner, F.R.; Yoon, B.H.; Kim,
	J.H.; Kim, S.C.: Metabolic engineering of a reduced-genome strain of
	Escherichia coli for L-threonine production. Microb. Cell Fact. (2009)
	8, 02. {Pubmed:19128451}
RF	<38> Wang, J.; Alexander, P.; Wu, L.; Hammer, R.; Cleaver, O.;
	McKnight, S.L.: Dependence of mouse embryonic stem cells on threonine
	catabolism. Science (2009) 325, 435-439. {Pubmed:19589965}

KI_VALUE
KI	#19# 0.37 {adenosine-5'-diphosphoribose}  (#19# substrate NAD+, pH 9.0,
	30°C <25>) <25>
KI	#19# 23.2 {pyruvate}  (#19# substrate L-threonine, pH 9.0, 30°C <25>)
	<25>
KI	#19# 1.42 {adenosine-5'-diphosphoribose}  (#19# substrate L-threonine,
	pH 9.0, 30°C <25>) <25>
KI	#19# 50.7 {pyruvate}  (#19# substrate NAD+, pH 9.0, 30°C <25>) <25>

PI_VALUE
PI	#17,18# 6.9 (#17,18# predicted from gene sequence <23>) <23>

///
ID	1.1.1.104
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Oryctolagus cuniculus   <1>

RECOMMENDED_NAME
RN	4-oxoproline reductase


SYSTEMATIC_NAME
SN	4-hydroxy-L-proline:NAD+ oxidoreductase


SYNONYMS
SY	 hydroxy-L-proline oxidase

CAS_REGISTRY_NUMBER
CR	37250-37-6

REACTION
RE	4-hydroxy-L-proline + NAD+ = 4-oxoproline + NADH + H+

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1# kidney <1>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1# 4-oxo-proline + NADH = 4-hydroxy-L-proline + NAD+ {ir} <1>

SUBSTRATE_PRODUCT
SP	#1# 4-oxoproline + NADH = 4-hydroxy-L-proline + NAD+ {ir} <1>
SP	#1# 4-oxo-proline + NADH = 4-hydroxy-L-proline + NAD+ {ir} <1>

KM_VALUE
KM	#1# 0.6 {4-Oxoproline}  <1>
KM	#1# 0.84 {NADH}  <1>

PH_OPTIMUM
PHO	#1# 6-6.5 (#1# decrease of activity below pH 6.0 <1>) <1>

SPECIFIC_ACTIVITY
SA	#1# 5.21 <1>

COFACTOR
CF	#1# NADH <1>

PURIFICATION
PU	#1# (ammonium sulfate, negative alumina gel, positive alumina gel) <1>

STORAGE_STABILITY
SS	#1# (-10°C, 160 mM phosphate buffer, pH 6.0, 3 months, no loss of
	activity) <1>

REFERENCE
RF	<1> Smith, T.E.; Mitoma, C.: Partial purification and some properties
	of 4-ketoproline reductase. J. Biol. Chem. (1962) 237, 1177-1180.
	{Pubmed:13914427}

///
ID	1.1.1.105
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Gallus gallus   <7>
PR	#2# Mus musculus   <4,10,12,17>
PR	#3# Homo sapiens   <6,8,9,12,15,17>
PR	#4# Rattus norvegicus   <1,2,3,17>
PR	#5# Bos taurus   <12>
PR	#6# Branchiostoma floridae   <13>
PR	#7# Peromyscus maniculatus   <3>
PR	#8# Homo sapiens Q96NR8 Swissprot <24>
PR	#9# Mus musculus O88451 SwissProt <21>
PR	#10# Mus musculus O55240 SwissProt <14>
PR	#11# Homo sapiens Q8IZV5 SwissProt <16>
PR	#12# Homo sapiens Q8N3Y7 UniProt <19>
PR	#13# Mus musculus O54909 UniProt <20>
PR	#14# Mus musculus Q8VIJ7 UniProt <22>
PR	#15# Homo sapiens O75452 UniProt <5,11>
PR	#16# Homo sapiens O75462 UniProt <18>
PR	#17# Xenopus laevis C3TWL9 UniProt <23>

RECOMMENDED_NAME
RN	retinol dehydrogenase


SYSTEMATIC_NAME
SN	retinol:NAD+ oxidoreductase


SYNONYMS
SY	 retinol dehydrogenase (vitamin A1)
SY	 MDR
SY	 microsomal retinol dehydrogenase
SY	 dehydrogenase, retinol
SY	 all-trans retinol dehydrogenase
SY	 retinal reductase
SY	 retinene reductase
SY	 11-cis RDH
SY	 P32
SY	#11,17# RDH10 <16,23>
SY	#11,17# retinol dehydrogenase 10 <16,23>
SY	#12# retinol dehydrogenase 2 <19>
SY	#12# epidermal retinol dehydrogenase 2 <19>
SY	#12# RDH-E2 <19>
SY	#13# CRAD <20>
SY	#14# mRDH1 (#14# multifunctional enzyme. In addition to retinol
	dehydrogenase activity, RDH1 has strong 3alpha-hydroxy and weak
	17beta-hydroxy steroid dehydrogenase activities <22>) <22>
SY	#2# Rdh1 <10>
SY	#3# RoDH4 <17>
SY	#3# RDHL <17>
SY	#3# 11-cis-retinol dehydrogenase <15>
SY	#3# RoDH-like 3alpha-hydroxysteroid dehydrogenase <17>
SY	#3# RL-HSD <17>
SY	#3# RDH-like SDR <17>
SY	#3# DHRS9 <17>
SY	#3# NAD+-dependent retinoid-active short-chain dehydrogenase/reductase
	<17>
SY	#3,10# RDH5 <14,15>
SY	#3,15# retinol dehydrogenase 4 <5,17>
SY	#3,15,16# RoDH-4 (#16# RoDH-4 belongs to the group of short-chain
	dehydrogenase/reductases that are active toward two types of
	substrates, retinoids and 3alpha-hydroxysteroids <18>) <5,9,11,18>
SY	#8# RDH12 <24>
SY	#8# retinol dehydrogenase 12 <24>
SY	#9# CRAD2 <21>
SY	#9,13# cis-retinol/3alpha-hydroxysterol short-chain dehydrogenase
	(#9,13# multifunctional enzyme <20,21>) <20,21>

CAS_REGISTRY_NUMBER
CR	9033-53-8

REACTION
RE	retinol + NAD+ = retinal + NADH + H+

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#14# smooth muscle (#14# mRNA expression <22>) <22>
ST	#14# more (#14# RDH1 has widespread and intense mRNA expression in
	tissues of embryonic and adult mice <22>) <22>
ST	#14# submandibular gland (#14# strong mRNA expression <22>) <22>
ST	#14# eye (#14# mRNA expression <22>) <22>
ST	#14# epididymis (#14# mRNA expression <22>) <22>
ST	#14# prostate (#14# mRNA expression <22>) <22>
ST	#14,17# embryo (#14# the mouse embryo expresses RDH1 as early as 7.0
	days post-coitus, and expression is especially intense within the
	neural tube, gut, and neural crest at embryo day 10.5 <22>; #17# dorsal
	blastopore lip <23>) <22,23>
ST	#2,3,12# epidermis (#3# epidermal keratinocytes, gene is expressed
	predominantly in the differentiating spinous layers <6>; #12# retinal
	dehydrogenase 2 is significantly elevated in psoriatic skin <19>)
	<4,6,19>
ST	#3# mammary gland (#3# 97% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# placenta (#3# 9% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# spleen (#3# 28% mRNA expression of Rdh5 compared to liver <15>) <15>
ST	#3# cerebral cortex (#3# 5% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# stomach (#3# 21% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# cerebellum (#3# 6% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# adrenal gland (#3# 17% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# bone marrow (#3# 11% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# spinal cord (#3# 24% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# colon (#3# 45% mRNA expression of Rdh5 compared to liver <15>) <15>
ST	#3# leukocyte (#3# 9% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# salivary gland (#3# 10% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# lymph node (#3# 21% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# fetus (#3# fetal brain (5% mRNA expression of Rdh5 compared to
	adult liver), fetal heart (6% mRNA expression of Rdh5 compared to
	adultliver), fetal kidney (17% mRNA expression of Rdh5 compared to
	adult liver), fetal liver (20% mRNA expression of Rdh5 compared to
	adult liver), fetal spleen (5% mRNA expression of Rdh5 compared to
	adult liver), fetal thymus (7% mRNA expression of Rdh5 compared to
	adult liver), fetal lung (14% mRNA expression of Rdh5 compared to
	liver) <15>) <15>
ST	#3# hippocampus (#3# 7% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# bladder (#3# 29% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# aorta (#3# 26% mRNA expression of Rdh5 compared to liver <15>) <15>
ST	#3# trachea (#3# 17% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# caudate putamen (#3# 9% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# caudate nucleus (#3# 9% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# frontal lobe (#3# 3% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# vermiform appendix (#3# 24% mRNA expression of Rdh5 compared to
	liver <15>) <15>
ST	#3# thalamus (#3# 7% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# pituitary gland (#3# 20% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# substantia nigra (#3# 11% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# medulla oblongata (#3# 7% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# amygdala (#3# 5% mRNA expression of Rdh5 compared to liver <15>)
	<15>
ST	#3# temporal lobe (#3# 6% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# occipital lobe (#3# 8% mRNA expression of Rdh5 compared to liver
	<15>) <15>
ST	#3# subthalamic nucleus (#3# 9% mRNA expression of Rdh5 compared to
	liver <15>) <15>
ST	#3,13# small intestine (#13# low mRNA expression <20>; #3# 39% mRNA
	expression of Rdh5 compared to liver <15>) <15,20>
ST	#3,13,14# heart (#13# low mRNA expression <20>; #3# 26% mRNA expression
	of Rdh5 compared to liver <15>; #14# strong mRNA expression <22>)
	<15,20,22>
ST	#3,14# ovary (#14# mRNA expression <22>; #3# 25% mRNA expression of
	Rdh5 compared to liver <15>) <15,22>
ST	#3,14# thyroid gland (#14# mRNA expression <22>; #3# 9% mRNA expression
	of Rdh5 compared to liver <15>) <15,22>
ST	#3,14# uterus (#14# mRNA expression <22>; #3# 25% mRNA expression of
	Rdh5 compared to liver <15>) <15,22>
ST	#3,14# skeletal muscle (#3# 5% mRNA expression of Rdh5 compared to
	liver <15>; #14# strong mRNA expression <22>) <15,22>
ST	#3,14# thymus (#14# mRNA expression <22>; #3# 43% mRNA expression of
	Rdh5 compared to liver <15>) <15,22>
ST	#3,4,7,8,9,13,14,15# liver (#3# high mRNA expression of Rdh5 <15>; #9#
	intense expression of CRAD2 mRNA <21>; #15# mRNA for RoDH-4 is abundant
	in adult liver, where it is translated into RoDH-4 protein. Significant
	amounts of RoDH-4 message is detected in fetal liver <5>; #13# mRNA is
	expressed intensely <20>; #14# strong mRNA expression <22>)
	<1,2,3,5,15,20,21,22,24>
ST	#3,8# prostate gland (#3# 21% mRNA expression of Rdh5 compared to liver
	<15>) <15,24>
ST	#3,8,13,14# kidney (#3# 37% mRNA expression of Rdh5 compared to liver
	<15>; #13# mRNA is expressed intensely <20>; #14# strong mRNA
	expression <22>) <15,20,22,24>
ST	#3,8,14# pancreas (#3# 28% mRNA expression of Rdh5 compared to liver
	<15>; #14# strong mRNA expression <22>) <15,22,24>
ST	#3,8,14# brain (#3# 8% mRNA expression of Rdh5 compared to liver <15>;
	#14# strong mRNA expression <22>) <15,22,24>
ST	#3,8,14# testis (#3# 22% mRNA expression of Rdh5 compared to liver
	<15>; #14# strong mRNA expression <22>) <15,22,24>
ST	#3,9,14,15# lung (#14# mRNA expression <22>; #3# 10% mRNA expression of
	Rdh5 compared to liver <15>; #9# expression of CRAD2 mRNA is 3% of that
	in liver <21>; #15# significant amounts of RoDH-4 message is detected
	in fetal lung <5>) <5,15,21,22>
ST	#4,8,10,13# retina (#13# pigment epithelium and sclera, low mRNA
	expression <20>; #8# the highest level of RDH12 expression is in the
	retina where it is localised to the inner segments and cell bodies of
	rod and cone photoreceptors <24>) <1,14,20,24>

LOCALIZATION
LO	#1,3# microsome (#3# integral membrane protein facing cytosolic side of
	the membrane <9>) <7,8,9>
LO	#11,12,15,16# membrane (#12# of endoplasmic reticulum <19>; #15#
	associated with microsomal membrane <5>; #16# behaves as an integral
	membrane protein, RoDH-4 contains four potential membrane-spanning
	domains <18>) <5,16,18,19>
LO	#2# mitochondrion <10>
LO	#2,6,12# endoplasmic reticulum (#2# facing the cytoplasm, mutants
	lacking amino-terminal 18 or 30 amino acids do not localize to
	endoplasmic reticulum but to mitochondria instead. Deletion mutant
	lacking 28 C-terminal amino acids localizes both to microsomal and
	mitochondrial fractions. Deletion of both 18 N-terminal and 28
	C-terminal amino acids leeds to overwhelming detection in mitochondria.
	Fusion of N-terminal 22 amino acids of enzyme with green fluorescent
	protein localizes in endoplasmic reticulum. Fusion of N-terminal 18
	amino acids of enzyme with green fluorescent protein shows diffuse
	localization. Fusion of green fluorescent protein with C-terminal 29
	amino acids of enzyme shows diffuse cytoplasmic and nuclear
	localization <10>; #6# both isoforms 1 and 2, associated with
	endoplasmic reticulum with no nuclear or plasma membrane localization
	<13>; #12# RDH-E2 protein exhibits a punctuate localization pattern,
	surrounding the nucleus suggesting that RDH-E2 is associated with
	endoplasmic reticulum <19>) <10,13,19>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1# retinal + NAD(P)H = retinol + NAD(P)+ {ir} <7>
NSP	#10# all-trans-retinal + NAD(P)H + H+ = all-trans-retinol + NAD(P)+
	(#10# RDH5 has only a minor in vivo all-trans RDH activity <14>) <14>
NSP	#12,14,15# all-trans-retinol + NAD+ = all-trans-retinal + NADH + H+
	(#12# exhibits a strong preference for NAD+/NADH as cofactors. Activity
	toward all-trans-retinal in the presence of NADH is 2fold lower than
	activity with all-trans-retinol and NAD+. The preference for NAD+
	suggests that RDH-E2 is likely to function in the oxidative direction
	in vivo, further supporting its potential role in the oxidation of
	retinol to retinaldehyde for retinoic acid biosynthesis in human
	keratinocytes <19>; #14# RDH1 functions in a path of all-trans-retinoic
	acid biosynthesis starting early during embryogenesis <22>; #15# RoDH-4
	can potentially contribute to the biosynthesis of two powerful
	modulators of gene expression: retinoic acid from retinol and
	dihydrotestosterone from 3alpha-androstane-diol <5>) <5,19,22>
NSP	#12,14,15# all-trans-retinol + NAD+ = all-trans-retinal + NADH + H+
	(#12# exhibits a strong preference for NAD+/NADH as cofactors. Activity
	toward all-trans-retinal in the presence of NADH is 2fold lower than
	activity with all-trans-retinol and NAD+. The preference for NAD+
	suggests that RDH-E2 is likely to function in the oxidative direction
	in vivo, further supporting its potential role in the oxidation of
	retinol to retinaldehyde for retinoic acid biosynthesis in human
	keratinocytes <19>; #14# RDH1 functions in a path of all-trans-retinoic
	acid biosynthesis starting early during embryogenesis <22>; #15# RoDH-4
	can potentially contribute to the biosynthesis of two powerful
	modulators of gene expression: retinoic acid from retinol and
	dihydrotestosterone from 3alpha-androstane-diol <5>) {r} <5,19,22>
NSP	#13# 9-cis-retinol + NAD+ = 9-cis-retinal + NADH + H+ (#13# the
	multifunctional cis-retinol/3alpha-hydroxysterol short-chain
	dehydrogenase may catalyze the first step in an enzymatic pathway from
	9-cis-retinol to generate the retinoid X receptor ligand 9-cis-retinoic
	acid and/or may regenerate dihydrotestosterone from its catabolite
	5alpha-androstan-3alpha,17beta-diol <20>) <20>
NSP	#15# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#15# RoDH-4
	is capable of contributing to the oxidation of retinol to retinaldehyde
	for retinoic acid biosynthesis in the cellular context <11>) <11>
NSP	#15# 13-cis-retinol + NAD+ = 13-cis-retinal + NADH + H+ (#15# RoDH-4
	can potentially contribute to the biosynthesis of two powerful
	modulators of gene expression: retinoic acid from retinol and
	dihydrotestosterone from 3alpha-androstane-diol <5>) <5>
NSP	#2# retinal + NADH = retinol + NAD+ <4>
NSP	#2# retinal + NADH = retinol + NAD+ {r} <4>
NSP	#3# 9-cis-retinol + NAD+ = 9-cis-retinal + NADH (#3# Rdh5 catalyses
	9-cis-retinol metabolism equally efficiently as 11-cis-retinol
	metabolism <15>) <15>
NSP	#3# 11-cis-retinol + NAD+ = 11-cis-retinal + NADH (#3# Rdh5 catalyses
	9-cis-retinol metabolism equally efficiently as 11-cis-retinol
	metabolism. Substrate specificity and expression locus of Rdh5 suggest
	that it could serve as both an 11-cis-retinol dehydrogenase in the RPE
	and a 9-cis-retinol dehydrogenase and/or an androgen dehydrogenase
	outside of the retinal pigment epithelium <15>) <15>
NSP	#3,4,7,12,17# More = ? (#3# the enzyme is expressed predominantly in
	the differentiating spinous layers and is under positive, feed-forward
	regulation by retinoic acid <6>; #4,7# chronic ethanol consumption
	results in an increased activity of the microsomal retinol
	dehydrogenase which may contribute to hepatic retinol depletion,
	especially in the view of the insensitivity of the enzyme to ethanol
	inhibition <3>; #3# NAD+-dependent retinoid-active SDRs have higher
	catalytic efficiencies for the oxidation of 3alpha-hydroxysterols than
	of retinols <17>; #12# RDH-E2 may be involved in the pathogenesis of
	psoriasis through its potential role in retinoic acid biosynthesis and
	stimulation of keratinocyte proliferation <19>; #17# RDH10 is required
	for proper retinoic acid signalling in the early embryo, RDH10
	cooperates with retinal dehydrogenase 2 during axis development and
	central nervous system patterning <23>) {} <3,6,17,19,23>
NSP	#3,4,7,12,17# More = ? (#3# the enzyme is expressed predominantly in
	the differentiating spinous layers and is under positive, feed-forward
	regulation by retinoic acid <6>; #4,7# chronic ethanol consumption
	results in an increased activity of the microsomal retinol
	dehydrogenase which may contribute to hepatic retinol depletion,
	especially in the view of the insensitivity of the enzyme to ethanol
	inhibition <3>; #3# NAD+-dependent retinoid-active SDRs have higher
	catalytic efficiencies for the oxidation of 3alpha-hydroxysterols than
	of retinols <17>; #12# RDH-E2 may be involved in the pathogenesis of
	psoriasis through its potential role in retinoic acid biosynthesis and
	stimulation of keratinocyte proliferation <19>; #17# RDH10 is required
	for proper retinoic acid signalling in the early embryo, RDH10
	cooperates with retinal dehydrogenase 2 during axis development and
	central nervous system patterning <23>) {} <3,6,17,19,23>
NSP	#3,4,7,12,17# More = ? (#3# the enzyme is expressed predominantly in
	the differentiating spinous layers and is under positive, feed-forward
	regulation by retinoic acid <6>; #4,7# chronic ethanol consumption
	results in an increased activity of the microsomal retinol
	dehydrogenase which may contribute to hepatic retinol depletion,
	especially in the view of the insensitivity of the enzyme to ethanol
	inhibition <3>; #3# NAD+-dependent retinoid-active SDRs have higher
	catalytic efficiencies for the oxidation of 3alpha-hydroxysterols than
	of retinols <17>; #12# RDH-E2 may be involved in the pathogenesis of
	psoriasis through its potential role in retinoic acid biosynthesis and
	stimulation of keratinocyte proliferation <19>; #17# RDH10 is required
	for proper retinoic acid signalling in the early embryo, RDH10
	cooperates with retinal dehydrogenase 2 during axis development and
	central nervous system patterning <23>) {} <3,6,17,19,23>

SUBSTRATE_PRODUCT
SP	#1# retinal + NAD(P)H = retinol + NAD(P)+ {ir} <7>
SP	#10# all-trans-retinal + NAD(P)H + H+ = all-trans-retinol + NAD(P)+
	(#10# RDH5 has only a minor in vivo all-trans RDH activity <14>) <14>
SP	#12# all-trans-retinol + NADP+ = all-trans-retinal + NADPH + H+ (#12#
	exhibits a strong preference for NAD+/NADH as cofactors. Activity with
	NAD+ is about 10fold higher than activity in presence of NADP+ <19>)
	{r} <19>
SP	#12# all-trans-retinaldehyde + NADH + H+ = ? {?} <19>
SP	#17# retinal + NADH + H+ = retinol + NAD+ {r} <23>
SP	#2,4,7# retinal + NADH = retinol + NAD+ <2,3,4>
SP	#2,4,7# retinal + NADH = retinol + NAD+ {r} <2,3,4>
SP	#3# 9-cis-retinol + NAD+ = 9-cis-retinal + NADH (#3# Rdh5 catalyses
	9-cis-retinol metabolism equally efficiently as 11-cis-retinol
	metabolism <15>) <15>
SP	#3# 11-cis-retinol + NAD+ = 11-cis-retinal + NADH (#3# Rdh5 catalyses
	9-cis-retinol metabolism equally efficiently as 11-cis-retinol
	metabolism. Substrate specificity and expression locus of Rdh5 suggest
	that it could serve as both an 11-cis-retinol dehydrogenase in the RPE
	and a 9-cis-retinol dehydrogenase and/or an androgen dehydrogenase
	outside of the retinal pigment epithelium <15>) <15>
SP	#3# 13-cis-retinol + NAD+ = 13-cis-retinal + NADH <15>
SP	#3# 3,4-didehydroretinol + NAD+ = 3,4-didehydroretinal + NADH (#3# 60%
	of the efficiency against all-trans-retinol <8>) <8>
SP	#3# 5alpha-androstan-3alpha-ol-17-one + NAD+ = ? + NADH {} <8>
SP	#3# androsterone + NAD+ = ? + NADH <8,9>
SP	#3# retinol bound to cellular retinol binding protein + NAD+ = retinal
	bound to cellular retinol binding protein + NADH {} <9>
SP	#3,15# all-trans-retinol + NAD+ = all-trans-retinal + NADH (#15# RoDH-4
	is capable of contributing to the oxidation of retinol to retinaldehyde
	for retinoic acid biosynthesis in the cellular context <11>) <6,8,11>
SP	#3,4# retinol + NAD+ = retinal + NADH <1,2,6,9>
SP	#3,4# retinol + NAD+ = retinal + NADH {r} <1,2,6,9>
SP	#3,4,6,7,12,15,16,17# More = ? (#3# the enzyme is expressed
	predominantly in the differentiating spinous layers and is under
	positive, feed-forward regulation by retinoic acid <6>; #4,7# chronic
	ethanol consumption results in an increased activity of the microsomal
	retinol dehydrogenase which may contribute to hepatic retinol
	depletion, especially in the view of the insensitivity of the enzyme to
	ethanol inhibition <3>; #3# substrate bound to cellular retinol binding
	protein is preferred <9>; #6# negligible activity with 9-cis-retinol
	<13>; #12# no activity was detected with 11-cis-retinol or
	11-cis-retinaldehyde as substrates with either NAD+/NADH or NADP+/NADPH
	<19>; #3# no significant activity with all-trans-retinol. Rdh5
	recognizes 5alpha-androstan-3alpha,17beta-diol (3alpha-adiol) and
	androsterone as substrates <15>; #16# RoDH-4 belongs to the group of
	short-chain dehydrogenase/reductases that are active toward two types
	of substrates, retinoids and 3alpha-hydroxysteroids <18>; #15# the
	enzymes utilizes retinol bound to cellular retinol binding protein type
	I at a much lower rate than free retinol <11>; #15# the multifunctional
	enzyme oxidizes the 3alpha-hydroxysteroids androstane-diol and
	androsterone to dihydrotestosterone and androstanedione, respectively
	<5>; #3# NAD+-dependent retinoid-active SDRs have higher catalytic
	efficiencies for the oxidation of 3alpha-hydroxysterols than of
	retinols <17>; #12# RDH-E2 may be involved in the pathogenesis of
	psoriasis through its potential role in retinoic acid biosynthesis and
	stimulation of keratinocyte proliferation <19>; #17# RDH10 is required
	for proper retinoic acid signalling in the early embryo, RDH10
	cooperates with retinal dehydrogenase 2 during axis development and
	central nervous system patterning <23>; #12# no activity is detected
	with 11-cis-retinol or 11-cis-retinaldehyde as substrates with either
	NAD+/NADH or NADP+/NADPH <19>) {} <3,5,6,9,11,13,15,17,18,19,23>
SP	#3,4,6,7,12,15,16,17# More = ? (#3# the enzyme is expressed
	predominantly in the differentiating spinous layers and is under
	positive, feed-forward regulation by retinoic acid <6>; #4,7# chronic
	ethanol consumption results in an increased activity of the microsomal
	retinol dehydrogenase which may contribute to hepatic retinol
	depletion, especially in the view of the insensitivity of the enzyme to
	ethanol inhibition <3>; #3# substrate bound to cellular retinol binding
	protein is preferred <9>; #6# negligible activity with 9-cis-retinol
	<13>; #12# no activity was detected with 11-cis-retinol or
	11-cis-retinaldehyde as substrates with either NAD+/NADH or NADP+/NADPH
	<19>; #3# no significant activity with all-trans-retinol. Rdh5
	recognizes 5alpha-androstan-3alpha,17beta-diol (3alpha-adiol) and
	androsterone as substrates <15>; #16# RoDH-4 belongs to the group of
	short-chain dehydrogenase/reductases that are active toward two types
	of substrates, retinoids and 3alpha-hydroxysteroids <18>; #15# the
	enzymes utilizes retinol bound to cellular retinol binding protein type
	I at a much lower rate than free retinol <11>; #15# the multifunctional
	enzyme oxidizes the 3alpha-hydroxysteroids androstane-diol and
	androsterone to dihydrotestosterone and androstanedione, respectively
	<5>; #3# NAD+-dependent retinoid-active SDRs have higher catalytic
	efficiencies for the oxidation of 3alpha-hydroxysterols than of
	retinols <17>; #12# RDH-E2 may be involved in the pathogenesis of
	psoriasis through its potential role in retinoic acid biosynthesis and
	stimulation of keratinocyte proliferation <19>; #17# RDH10 is required
	for proper retinoic acid signalling in the early embryo, RDH10
	cooperates with retinal dehydrogenase 2 during axis development and
	central nervous system patterning <23>; #12# no activity is detected
	with 11-cis-retinol or 11-cis-retinaldehyde as substrates with either
	NAD+/NADH or NADP+/NADPH <19>) {} <3,5,6,9,11,13,15,17,18,19,23>
SP	#3,4,6,7,12,15,16,17# More = ? (#3# the enzyme is expressed
	predominantly in the differentiating spinous layers and is under
	positive, feed-forward regulation by retinoic acid <6>; #4,7# chronic
	ethanol consumption results in an increased activity of the microsomal
	retinol dehydrogenase which may contribute to hepatic retinol
	depletion, especially in the view of the insensitivity of the enzyme to
	ethanol inhibition <3>; #3# substrate bound to cellular retinol binding
	protein is preferred <9>; #6# negligible activity with 9-cis-retinol
	<13>; #12# no activity was detected with 11-cis-retinol or
	11-cis-retinaldehyde as substrates with either NAD+/NADH or NADP+/NADPH
	<19>; #3# no significant activity with all-trans-retinol. Rdh5
	recognizes 5alpha-androstan-3alpha,17beta-diol (3alpha-adiol) and
	androsterone as substrates <15>; #16# RoDH-4 belongs to the group of
	short-chain dehydrogenase/reductases that are active toward two types
	of substrates, retinoids and 3alpha-hydroxysteroids <18>; #15# the
	enzymes utilizes retinol bound to cellular retinol binding protein type
	I at a much lower rate than free retinol <11>; #15# the multifunctional
	enzyme oxidizes the 3alpha-hydroxysteroids androstane-diol and
	androsterone to dihydrotestosterone and androstanedione, respectively
	<5>; #3# NAD+-dependent retinoid-active SDRs have higher catalytic
	efficiencies for the oxidation of 3alpha-hydroxysterols than of
	retinols <17>; #12# RDH-E2 may be involved in the pathogenesis of
	psoriasis through its potential role in retinoic acid biosynthesis and
	stimulation of keratinocyte proliferation <19>; #17# RDH10 is required
	for proper retinoic acid signalling in the early embryo, RDH10
	cooperates with retinal dehydrogenase 2 during axis development and
	central nervous system patterning <23>; #12# no activity is detected
	with 11-cis-retinol or 11-cis-retinaldehyde as substrates with either
	NAD+/NADH or NADP+/NADPH <19>) {} <3,5,6,9,11,13,15,17,18,19,23>
SP	#3,8,11,12# all-trans-retinal + NADH + H+ = all-trans-retinol + NAD+
	(#11# wild type RDH10 catalyzes both oxidation of all-trans retinol and
	reduction of all-trans retinal in vitro. On cultured cells, however,
	oxidation is the favored reaction catalyzed by RDH10. <16>) {?}
	<16,17,19,24>
SP	#3,8,11,12# all-trans-retinal + NADH + H+ = all-trans-retinol + NAD+
	(#11# wild type RDH10 catalyzes both oxidation of all-trans retinol and
	reduction of all-trans retinal in vitro. On cultured cells, however,
	oxidation is the favored reaction catalyzed by RDH10. <16>) {r}
	<16,17,19,24>
SP	#4# retinal + NADPH = retinol + NAD+ (#4# activity is lower than with
	NASDH <2>) <2,3>
SP	#6# all-trans retinal + NADH + H+ = all-trans-retinol + NAD+ (#6#
	oxidative activity is below the detection limit <13>) {i} <13>
SP	#7# retinol + NADP+ = retinal + NADPH <3>
SP	#9# 9-cis-retinol + NADP+ = 9-cis-retinal + NADPH + H+ (#9# activity
	with NAD+ is about 8fold higher than with NADP+ <21>) <21>
SP	#9# 11-cis-retinol + NADP+ = 11-cis-retinal + NADPH + H+ (#9# activity
	with NAD+ is about 10fold higher than with NADP+ <21>) <21>
SP	#9,12,14,15# all-trans-retinol + NAD+ = all-trans-retinal + NADH + H+
	(#12# exhibits a strong preference for NAD+/NADH as cofactors. Activity
	toward all-trans-retinal in the presence of NADH is 2fold lower than
	activity with all-trans-retinol and NAD+. The preference for NAD+
	suggests that RDH-E2 is likely to function in the oxidative direction
	in vivo, further supporting its potential role in the oxidation of
	retinol to retinaldehyde for retinoic acid biosynthesis in human
	keratinocytes <19>; #14# RDH1 functions in a path of all-trans-retinoic
	acid biosynthesis starting early during embryogenesis <22>; #15# RoDH-4
	can potentially contribute to the biosynthesis of two powerful
	modulators of gene expression: retinoic acid from retinol and
	dihydrotestosterone from 3alpha-androstane-diol <5>; #12# exhibits a
	strong preference for NAD+/NADH as cofactors. Activity with NAD+ is
	about 10fold higher than activity in presence of NADP+. Activity toward
	all-trans-retinal in the presence of NADH is 2fold lower than activity
	with all-trans-retinol and NAD+ <19>; #14# RDH1 has 8–11fold higher
	activity with NAD+ versus NADP+. Higher activity with all-trans-retinol
	versus 9-cis-retinol. Multifunctional enzyme. In addition to retinol
	dehydrogenase activity, RDH1 has strong 3alpha-hydroxy and weak
	17beta-hydroxy steroid dehydrogenase activities <22>) <5,11,19,21,22>
SP	#9,12,14,15# all-trans-retinol + NAD+ = all-trans-retinal + NADH + H+
	(#12# exhibits a strong preference for NAD+/NADH as cofactors. Activity
	toward all-trans-retinal in the presence of NADH is 2fold lower than
	activity with all-trans-retinol and NAD+. The preference for NAD+
	suggests that RDH-E2 is likely to function in the oxidative direction
	in vivo, further supporting its potential role in the oxidation of
	retinol to retinaldehyde for retinoic acid biosynthesis in human
	keratinocytes <19>; #14# RDH1 functions in a path of all-trans-retinoic
	acid biosynthesis starting early during embryogenesis <22>; #15# RoDH-4
	can potentially contribute to the biosynthesis of two powerful
	modulators of gene expression: retinoic acid from retinol and
	dihydrotestosterone from 3alpha-androstane-diol <5>; #12# exhibits a
	strong preference for NAD+/NADH as cofactors. Activity with NAD+ is
	about 10fold higher than activity in presence of NADP+. Activity toward
	all-trans-retinal in the presence of NADH is 2fold lower than activity
	with all-trans-retinol and NAD+ <19>; #14# RDH1 has 8–11fold higher
	activity with NAD+ versus NADP+. Higher activity with all-trans-retinol
	versus 9-cis-retinol. Multifunctional enzyme. In addition to retinol
	dehydrogenase activity, RDH1 has strong 3alpha-hydroxy and weak
	17beta-hydroxy steroid dehydrogenase activities <22>) {r}
	<5,11,19,21,22>
SP	#9,13# 11-cis-retinol + NAD+ = 11-cis-retinal + NADH + H+ (#9# activity
	with NAD+ is about 10fold higher than with NADP+ <21>; #13# little
	preference between 9-cis-retinol and 11-cis-retinol. Uses NAD+ as its
	preferred cofactor <20>) <20,21>
SP	#9,13,14# 9-cis-retinol + NAD+ = 9-cis-retinal + NADH + H+ (#13# the
	multifunctional cis-retinol/3alpha-hydroxysterol short-chain
	dehydrogenase may catalyze the first step in an enzymatic pathway from
	9-cis-retinol to generate the retinoid X receptor ligand 9-cis-retinoic
	acid and/or may regenerate dihydrotestosterone from its catabolite
	5alpha-androstan-3alpha,17beta-diol <20>; #9# activity with NAD+ is
	about 8fold higher than with NADP+ <21>; #14# higher activity with
	all-trans-retinol versus 9-cis-retinol <22>; #13# little preference
	between 9-cis-retinol and 11-cis-retinol. Uses NAD+ as its preferred
	cofactor, activity with NADP+ is 4% of the activity with NAD+ <20>)
	<20,21,22>
SP	#9,15# 13-cis-retinol + NAD+ = 13-cis-retinal + NADH + H+ (#15# RoDH-4
	can potentially contribute to the biosynthesis of two powerful
	modulators of gene expression: retinoic acid from retinol and
	dihydrotestosterone from 3alpha-androstane-diol <5>) <5,21>

TURNOVER_NUMBER
TN	#15# 0.02 {All-trans-Retinol}  (#15# 37°C <11>) <11>

KM_VALUE
KM	#11# 0.0015 {NADPH}  (#11# wild type enzyme, in 100 mM sodium
	phosphate, pH 7.4 <16>) <16>
KM	#11# 0.027 {NADP+}  (#11# wild type enzyme, in 100 mM sodium phosphate,
	pH 7.4 <16>) <16>
KM	#11# 0.11 {NADH}  (#11# wild type enzyme, in 100 mM sodium phosphate,
	pH 7.4 <16>) <16>
KM	#11# 0.036 {NAD+}  (#11# wild type enzyme, in 100 mM sodium phosphate,
	pH 7.4 <16>) <16>
KM	#11# 0.57 {all-trans-Retinal}  (#11# wild type enzyme, in 100 mM sodium
	phosphate, pH 7.4 <16>) <16>
KM	#11# 0.0041 {All-trans-Retinol}  (#11# wild type enzyme, in 100 mM
	sodium phosphate, pH 7.4 <16>) <16>
KM	#14# 0.0026 {All-trans-Retinol}  (#14# pH 8, 37°C <22>) <22>
KM	#14# 0.0022 {9-cis-retinol}  (#14# pH 8, 37°C <22>) <22>
KM	#15# 0.0011 {All-trans-Retinol}  (#15# 37°C <11>) <11>
KM	#3# 0.00024 {NAD+}  (#3# pH 7.3, 37°C <9>) <9>
KM	#3# 0.0002 {androsterone}  (#3# pH 7.3, 37°C <9>) <9>
KM	#3# 0.0063 {11-cis-retinol}  (#3# pH 8, 37°C <15>) <15>
KM	#3# 0.0027 {retinol bound to cellular retinol binding protein}  (#3# pH
	7.3, 37°C <9>) <9>
KM	#3# 0.0066 {9-cis-retinol}  (#3# pH 8, 37°C <15>) <15>
KM	#4# 0.12 {Retinol}  <2>
KM	#6# 0.0089 {all-trans-Retinal}  (#6# isoform 2, pH 6.0, 37°C <13>) <13>
KM	#6# 0.098 {NADH}  (#6# isoform 2, pH 6.0, 37°C <13>) <13>
KM	#6# 0.0087 {all-trans-Retinal}  (#6# isoform 1, pH 6.0, 37°C <13>) <13>
KM	#6# 0.224 {NADH}  (#6# isoform 1, pH 6.0, 37°C <13>) <13>
KM	#9,13# -999 {more}  (#9# cooperative kinetics <21>; #13# the enzyme
	exhibits cooperative kinetics for 9-cis-retinol with a K0.5 value of
	0.0054 mM and a Hill coefficient of 1.7. The enzyme recognized
	11-cis-retinol as substrate with a K0.5 value of 0.0076 and a Hill
	coefficient of 2.8 <20>) <20,21>

PH_OPTIMUM
PHO	#14# 8 <22>
PHO	#2# 6 (#2# reduction of retinal <4>) <4>
PHO	#4# -999 (#4# maximal activity at physiological pH <2>) <2>

PH_RANGE
PHR	#14# 7.5-8 (#14# pH 7.5: 54% of maximal activity, pH 8: maximal
	activity <22>) <22>

SPECIFIC_ACTIVITY
SA	#6# 0.0014 (#6# per mg of microsome, isoform 2 <13>) <13>
SA	#6# 0.00025 (#6# per mg of microsome, isoform 1 <13>) <13>

COFACTOR
CF	#1# NAD(P)H <7>
CF	#2,3,4,5,6,7,8,11,12,15,17# NADH (#2,4,7# cofactor <2,3,4>; #15# NAD+
	and NADH are the preferred cofactors <5>; #12# exhibits a strong
	preference for NAD+/NADH as cofactors <19>; #3# prefers NADH as
	cofactor <17>; #11# the enzyme has higher affinity for NADH than for
	NADPH <16>) <2,3,4,5,12,13,16,17,19,23,24>
CF	#2,3,4,5,6,7,9,12,13,14,15,16# NAD+ (#2,3,4,7# cofactor <1,2,3,4,6>;
	#3,15# preferred cofactor <6,11>; #9# activity with NAD+ is about
	10fold higher than with NADP+ <21>; #12# exhibits a strong preference
	for NAD+/NADH as cofactors. Activity with NAD+ is about 10fold higher
	than activity in presence of NADP+ <19>; #15# NAD+ and NADH are the
	preferred cofactors <5>; #13# NAD+ is the preferred cofactor <20>; #14#
	RDH1 has 8–11fold higher activity with NAD+ versus NADP+ <22>)
	<1,2,3,4,5,6,8,9,11,12,13,15,17,18,19,20,21,22>
CF	#4,7,11# NADPH (#4,7# cofactor <3>; #11# the enzyme has lower affinity
	for NADPH than for NADH <16>) <3,16>
CF	#6# more (#6# no significant activity with NADPH <13>) <13>
CF	#7,9,12,14# NADP+ (#7# cofactor <3>; #9# activity with NAD+ is about
	10fold higher than with NADP+ <21>; #12# exhibits a strong preference
	for NAD+/NADH as cofactors. Activity with NAD+ is about 10fold higher
	than activity in presence of NADP+ <19>; #14# RDH1 has 8–11fold
	higher activity with NAD+ versus NADP+ <22>) <3,19,21,22>

ACTIVATING_COMPOUND
AC	#4# BigCHAP (#4# 10-20% stimulation <2>) <2>

INHIBITORS
IN	#12# imidazole (#12# increasing the amount of imidazole in the reaction
	mixture with purified RDH-E2 from 25 to 225mM significantly decreases
	RDH-E2 activity <19>) <19>
IN	#13# 4-Methylpyrazole <20>
IN	#3# 13-cis-Retinoic acid <8>
IN	#3# 3,4-didehydroretinoic acid <8>
IN	#3# 3,4-didehydroretinol <8>
IN	#3# cellular retinol binding protein (#3# free form without retinol
	<9>) <9>
IN	#4# Chloral hydrate <2,3>
IN	#4# Lubrol Px <2>
IN	#4# Sodium deoxycholate <2>
IN	#4# Triton X-100 <2>
IN	#4,7,15,17# more (#4,7# chronic ethanol consumption results in an
	increased activity of the microsomal retinol dehydrogenase which may
	contribute to hepatic retinol depletion, especially in the view of the
	insensitivity of the enzyme to ethanol inhibition <3>; #15#
	all-trans-retinol and 13-cis-retinol inhibit RoDH-4 catalyzed oxidation
	of androsterone <5>; #17# treatment with 0.005 mM retinoic acid induces
	a severe reduction of RDH10 expression, a combination of retinal
	dehydrogenase 2 mRNA and treatment with 0.005 mM retinal causes a
	robust downregulation of RDH10 transcription <23>) <3,5,23>
IN	#7# SKF525A (#7# moderately <3>) <3>

KI_VALUE
KI	#3# 0.0025 {3,4-didehydroretinol}  (#3# pH 7.3, 37°C, substrate
	androsterone <8>) <8>
KI	#3# 0.0011 {13-cis-Retinoic acid}  (#3# pH 7.3, 37°C, substrate
	androsterone <8>) <8>
KI	#3# 3e-05 {cellular retinol binding protein}  (#3# pH 7.3, 37°C <9>)
	<9>
KI	#3# 0.0022 {3,4-didehydroretinol}  (#3# pH 7.3, 37°C, substrate
	3alpha-adiol <8>) <8>
KI	#3# 0.0035 {3,4-didehydroretinoic acid}  (#3# pH 7.3, 37°C, substrate
	androsterone <8>) <8>
KI	#3# 0.0069 {3,4-didehydroretinoic acid}  (#3# pH 7.3, 37°C, substrate
	3alpha-adiol <8>) <8>
KI	#3# 0.00021 {13-cis-Retinoic acid}  (#3# pH 7.3, 37°C, substrate
	3alpha-adiol <8>) <8>

MOLECULAR_WEIGHT
MW	#11# 40000 (#11# SDS-PAGE <16>) <16>
MW	#8# 35000 (#8# calculated from amino acid sequence <24>) <24>

POSTTRANSLATIONAL_MODIFICATION
PM	#2,3# no glycoprotein <9,10>

SUBUNITS
SU	#3# ? (#3# x * 36000, SDS-PAGE <9>) <9>

APPLICATION
AP	#8# medicine (#8# mutations in RDH12 are associated with Leber
	congenital amaurosis <24>) <24>

ENGINEERING
EN	#11# K214A (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# S197A (#11# mutant retains significant enzymatic activities,
	although lower than that of wild type enzyme <16>) <16>
EN	#11# S197T (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# K214R (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# N169D (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# N169A (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# S197G (#11# mutant retains significant enzymatic activities,
	although lower than that of wild type enzyme <16>) <16>
EN	#11# S197C (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# S197V (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# Y210A (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# Y210F (#11# the mutation completely abolishes the enzymatic
	activity of RDH10 without affecting its protein level <16>) <16>
EN	#11# G43A/G47A/G49A (#11# the triple mutation completely abolishes the
	enzymatic activity of RDH10 without affecting its protein level <16>)
	<16>
EN	#16# DELTAM1-Y13 (#16# truncated RoDH-4 that lacks the first thirteen
	amino acids of the N-terminal segment is partially active and exhibits
	the apparent Km value for androsterone similar to that of the wild-type
	enzyme, truncated mutant behaves as an integral membrane protein <18>)
	<18>
EN	#16# DELTAS295-L317 (#16# removal of 23 N-terminal hydrophobic amino
	acids results in significant loss of activity and a 14fold increase in
	the apparent Km value, truncated mutant behaves as an integral membrane
	protein <18>) <18>
EN	#16# DELTAY291-L317 (#16# removal of the C-terminal 27 amino acid
	segment results in about 600fold increase in the apparent Km value,
	truncated mutant behaves as an integral membrane protein <18>) <18>
EN	#2,16# more (#2# mutants lacking amino-terminal 18 or 30 amino acids do
	not localize to endoplasmic reticulum but to mitochondria instead.
	Deletion mutant lacking 28 C-terminal amino acids localizes both to
	microsomal and mitochondrial fractions. Deletion of both 18 N-terminal
	and 28 C-terminal amino acids leeds to overwhelming detection in
	mitochondria. Fusion of N-terminal 22 amino acids of enzyme with green
	fluorescent protein localizes in endoplasmic reticulum. Fusion of
	N-terminal 18 amino acids of enzyme with green fluorescent protein
	shows diffuse localization. Fusion of green fluorescent protein with
	C-terminal 29 amino acids of enzyme shows diffuse cytoplasmic and
	nuclear localization. <10>; #16# protein that lacked all four
	hydrophobic segments remains associated with the membrane. Thus, the
	N-terminal and the C-terminal ends are both important for RoDH-4
	activity and the removal of the putative transmembrane segments does
	not convert RoDH-4 into a soluble protein, suggesting additional sites
	of membrane interaction <18>) <10,18>
EN	#8# C201R (#8# the loss of function mutant is associated with severe
	loss of retinal functionand early onset severe retinal dystrophy <24>)
	<24>

CLONED
CL	#3# (expression in CHO cells) <15>
CL	#3# (retinol dehydrogenase 4) <6>
CL	#6# (both isoforms 1 and 2, expression in COS-7 cell with N-terminal
	His-tag) <13>
CL	#9# (expressed in CHO cells) <21>
CL	#11# (expressed in COS-1 cells) <16>
CL	#12# (RDH-E2 is expressed in Sf9 insect cells as a fusion to the
	C-terminal His6-tag) <19>
CL	#12# (expressed in Sf9 insect cells and in HEK-293 cells) <19>
CL	#13# (expressed in CHO cells) <20>
CL	#14# (expression in CHO-K1 cells) <22>
CL	#15# <11>
CL	#15# (recombinant RoDH-4, expressed in microsomes of Sf9 insect cells)
	<5>
CL	#16# <18>
CL	#17# (expressed in HEK-293T cells) <23>

PURIFICATION
PU	#3# (solubilized enzyme is extremely unstabel and loses almost 80% of
	initial activity even at partially purified stage, purification uses
	resistance of enzyme to proteolysis at 4°C in the presence of 1%
	Triton) <9>
PU	#12# (recombinant enzyme) <19>
PU	#12# (Ni2+-NTA resin column chromatography) <19>
PU	#15# (preparation of RoDH-4 contains a minor contaminating protein
	band. Therefore, the exact concentration of RoDH-4 is determined based
	on the calibration curve constructed from several concentrations of BSA
	loaded on to the same SDS/PAGE gel) <11>

GENERAL_STABILITY
GS	#12# (the enzyme is sensitive to desalting) <19>
GS	#12# (gel-filtration of RDH-E2 preparation to remove imidazole results
	in significant loss of activity (about 90%) despite nearly complete
	recovery of the protein suggesting that RDH-E2 is sensitive to
	desalting) <19>
GS	#4# (repeated freezing and thawing strikingly affects activity) <2>

STORAGE_STABILITY
SS	#3# (4°C, reconstitution of enzyme into proteoliposomes, stable for at
	least 4 months) <9>

REFERENCE
RF	<1> Koen, A.L.; Shaw, C.R.: Retinol and alcohol dehydrogenases in
	retina and liver. Biochim. Biophys. Acta (1966) 128, 48-54.
	{Pubmed:5972368}
RF	<2> Leo, M.A.; Lieber, C.S.: NAD+-dependent retinol dehydrogenase in
	liver microsomes. Methods Enzymol. (1990) 189, 520-524.
	{Pubmed:2292967} (review)
RF	<3> Leo, M.A.; Kim., C.I.; Lieber, C.S.: NAD+-dependent retinol
	dehydrogenase in liver microsomes. Arch. Biochem. Biophys. (1987) 259,
	241-249. {Pubmed:3322195}
RF	<4> Kishore, G.S.; Boutwell, R.K.: Enzymatic oxidation and reduction of
	retinal by mouse epidermis. Biochem. Biophys. Res. Commun. (1980) 94,
	1381-1386. {Pubmed:6994741}
RF	<5> Gough, W.H.; VanOoteghem, S.; Sint, T.; Kedishvili, N.Y.: cDNA
	cloning and characterization of a new human microsomal NAD+-dependent
	dehydrogenase that oxidizes all-trans-retinol and
	3alpha-hydroxysteroids. J. Biol. Chem. (1998) 273, 19778-19785.
	{Pubmed:9677409} (c)
RF	<6> Jurukovski, V.; Markova, N.G.; Karaman-Jurukovska, N.; Randolph,
	R.K.; Su, J.; Napoli, J.L.; Simon, M.: Cloning and characterization of
	retinol dehydrogenase transcripts expressed in human epidermal
	keratinocytes. Mol. Genet. Metab. (1999) 67, 62-73. {Pubmed:10329026}
	(c)
RF	<7> Tajima, S.; Goda, T.; Takase, S.: Co-ordinated induction of
	beta-caroten cleavage enzyme and retinal reductase in the duodenum of
	the developing chicks. Comp. Biochem. Physiol. B (2001) 128, 425-434.
	{Pubmed:11250537}
RF	<8> Karlsson, T.; Vahlquist, A.; Kedishvili, N.; Torma, H.:
	13-cis-retinoic acid competitively inhibits 3alpha-hydroxysteroid
	oxidation by retinol dehydrogenase RoDH-4: a mechanism for its
	anti-androgenic effects in sebaceous glands?. Biochem. Biophys. Res.
	Commun. (2003) 303, 273-278. {Pubmed:12646198}
RF	<9> Lapshina, E.A.; Belyaeva, O.V.; Chumakova, O.V.; Kedishvili, N.Y.:
	Differential recognition of the free versus bound retinol by human
	microsomal retinol/sterol dehydrogenases: characterization of the
	holo-CRBP dehydrogenase activity of RoDH-4. Biochemistry (2003) 42,
	776-784. {Pubmed:12534290}
RF	<10> Zhang, M.; Hu, P.; Napoli, J.L.: Elements in the N-terminal
	signaling sequence that determine cytosolic topology of short-chain
	dehydrogenases/reductases. Studies with retinol dehydrogenase type 1
	and cis-retinol/androgen dehydrogenase type 1. J. Biol. Chem. (2004)
	279, 51482-51489. {Pubmed:15355969}
RF	<11> Gallego, O.; Belyaeva, O.V.; Porte, S.; Ruiz, F.X.; Stetsenko,
	A.V.; Shabrova, E.V.; Kostereva, N.V.; Farres, J.; Pares, X.;
	Kedishvili, N.Y.: Comparative functional analysis of human medium-chain
	dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto
	reductases with retinoids. Biochem. J. (2006) 399, 101-109.
	{Pubmed:16787387}
RF	<12> Liden, M.; Eriksson, U.: Understanding retinol metabolism:
	Structure and function of retinol dehydrogenases. J. Biol. Chem. (2006)
	281, 13001-13004. {Pubmed:16428379}
RF	<13> Dalfo, D.; Marques, N.; Albalat, R.: Analysis of the
	NADH-dependent retinaldehyde reductase activity of amphioxus retinol
	dehydrogenase enzymes enhances our understanding of the evolution of
	the retinol dehydrogenase family. FEBS J. (2007) 274, 3739-3752.
	{Pubmed:17608724}
RF	<14> Maeda, A.; Maeda, T.; Sun, W.; Zhang, H.; Baehr, W.; Palczewski,
	K.: Redundant and unique roles of retinol dehydrogenases in the mouse
	retina. Proc. Natl. Acad. Sci. USA (2007) 104, 19565-19570.
	{Pubmed:18048336}
RF	<15> Wang, J.; Chai, X.; Eriksson, U.; Napoli, J.L.: Activity of human
	11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and
	expression of its mRNA in extra-ocular human tissue.. Biochem. J.
	(1999) 338, 23-27. {Pubmed:9931293}
RF	<16> Takahashi, Y.; Moiseyev, G.; Farjo, K.; Ma, J.X.: Characterization
	of key residues and membrane association domains in retinol
	dehydrogenase 10. Biochem. J. (2009) 419, 113-122. {Pubmed:19102727}
RF	<17> Pares, X.; Farres, J.; Kedishvili, N.; Duester, G.: Medium- and
	short-chain dehydrogenase/reductase gene and protein families:
	Medium-chain and short-chain dehydrogenases/reductases in retinoid
	metabolism. Cell. Mol. Life Sci. (2008) 65, 3936-3949. {Pubmed:19011747}
RF	<18> Belyaeva, O.V.; Chetyrkin, S.V.; Kedishvili, N.Y.:
	Characterization of truncated mutants of human microsomal short-chain
	dehydrogenase/reductase RoDH-4. Chem. Biol. Interact. (2003) 143-144,
	279-287. {Pubmed:12604214}
RF	<19> Lee, S.A.; Belyaeva, O.V.; Kedishvili, N.Y.: Biochemical
	characterization of human epidermal retinol dehydrogenase 2. Chem.
	Biol. Interact. (2009) 178, 182-187. {Pubmed:18926804}
RF	<20> Chai, X.; Zhai, Y.; Napoli, J.L.: cDNA cloning and
	characterization of a cis-retinol/3alpha-hydroxysterol short-chain
	dehydrogenase. J. Biol. Chem. (1997) 272, 33125-33131. {Pubmed:9407098}
RF	<21> Su, J.; Chai, X.; Kahn, B.; Napoli, J.L.: cDNA cloning, tissue
	distribution, and substrate characteristics of a
	cis-Retinol/3alpha-hydroxysterol short-chain dehydrogenase isozyme.. J.
	Biol. Chem. (1998) 273, 17910-17916. {Pubmed:9651397}
RF	<22> Zhang, M.: Chen, W.; Smith, S.M.; Napoli, J.L.: Molecular
	characterization of a mouse short chain dehydrogenase/reductase active
	with all-trans-retinol in intact cells, mRDH1. J. Biol. Chem. (2001)
	276, 44083-44090. {Pubmed:11562362}
RF	<23> Strate, I.; Min, T.H.; Iliev, D.; Pera, E.M.: Retinol
	dehydrogenase 10 is a feedback regulator of retinoic acid signalling
	during axis formation and patterning of the central nervous system.
	Development (2009) 136, 461-472. {Pubmed:19141675}
RF	<24> Moradi, P.; Mackay, D.; Hunt, D.; Moore, A.: Focus on molecules:
	Retinol dehydrogenase 12 (RDH12). Exp. Eye Res. (2008) 87, 160-161.
	{Pubmed:18599039}

ACTIVATING_COMPOUND
AC	#4# BigCHAP (#4# 10-20% stimulation <2>) <2>

KI_VALUE
KI	#3# 0.0025 {3,4-didehydroretinol}  (#3# pH 7.3, 37°C, substrate
	androsterone <8>) <8>
KI	#3# 0.0011 {13-cis-Retinoic acid}  (#3# pH 7.3, 37°C, substrate
	androsterone <8>) <8>
KI	#3# 3e-05 {cellular retinol binding protein}  (#3# pH 7.3, 37°C <9>)
	<9>
KI	#3# 0.0022 {3,4-didehydroretinol}  (#3# pH 7.3, 37°C, substrate
	3alpha-adiol <8>) <8>
KI	#3# 0.0035 {3,4-didehydroretinoic acid}  (#3# pH 7.3, 37°C, substrate
	androsterone <8>) <8>
KI	#3# 0.0069 {3,4-didehydroretinoic acid}  (#3# pH 7.3, 37°C, substrate
	3alpha-adiol <8>) <8>
KI	#3# 0.00021 {13-cis-Retinoic acid}  (#3# pH 7.3, 37°C, substrate
	3alpha-adiol <8>) <8>

///
